A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E> A FLUOCINONIDE TOPICAL d01294A D L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E> A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A0 E> A CLONIDINE d00044A C- G47.0 Insomnia A0 E> A GUANFACINE d00717A B[ F90 Attention-deficit hyperactivity disorders A0 E> A LOSARTAN d03821A B I10 Essential (primary) hypertension A E>0 A . . . E>@ A . . . E>P A . . . E>` A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E>` A ATENOLOL d00004A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified Ap E>` A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia Ap E>` A GABAPENTIN d03182A C G40.P Prevent seizures Ap E>` A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified Ap E>` A IBUPROFEN d00015A C T14.9 Unspecified injury Ap E>` A PAROXETINE d03157A Dc F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E>p A . . . E> A 99999 . . A E> A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E> A ALBUTEROL d00749A C J45 Asthma A E> A BECLOMETHASONE d00760A C J45 Asthma A E> A . . . E> A AMLODIPINE d00689A CDp 99999 A E> A CLOPIDOGREL d04258A C[@ 99999 A E> A FINASTERIDE d00563A CDp 99999 A E> A GLIPIZIDE d00246A Cr 99999 A E> A HYDROXYUREA d01373A C- 99999 A E> A IBUPROFEN d00015A C[@ 99999 A E> A LISINOPRIL d00732A C[@ 99999 A E> A TAMSULOSIN d04121A C- 99999 A E> A TRAMADOL d03826A C- 99999 A E> A AMOXICILLIN d00088A A@ H66.9 Otitis media, unspecified A E> A ANTIPYRINE; BENZOCAINE OTIC d03627A A@ H60 Otitis externa A E> A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E> A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E> A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E> A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction A E> A FUROSEMIDE d00070A D I10 Essential (primary) hypertension A E> A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A C"0 I10 Essential (primary) hypertension A E> A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A D I10 Essential (primary) hypertension A E> A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E> A METFORMIN; SAXAGLIPTIN d07709A C"0 E11 Type 2 diabetes mellitus A E> A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A E> A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E> A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A E> A . . . E> A . . . E? A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E? A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E? A . . . E? A . . . E?0 A . . . E?@ A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E?P A . . . E?` A DULOXETINE d05355A Cr F32.9 Major depressive disorder, single episode, unspecified A E?p A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E? A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E? A ENALAPRIL d00013A D9 I10 Essential (primary) hypertension A0 E? A SOTALOL d00371A Cr I49.9 Cardiac arrhythmia, unspecified A0 E? A . . . E? A . . . E? A . . . E? A FINASTERIDE d00563A A L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E? A ARIPIPRAZOLE d04825A A F91.9 Conduct disorder, unspecified A0 E? A ARIPIPRAZOLE d04825A C- F91.9 Conduct disorder, unspecified A0 E? A LISDEXAMFETAMINE d06663A C9 F90 Attention-deficit hyperactivity disorders A0 E? A GUANFACINE d00717A CDp F91.9 Conduct disorder, unspecified A E? A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E@ A . . . E@ A . . . E@ A . . . E@0 A . . . E@@ A CLONIDINE d00044A C I10 Essential (primary) hypertension A E@P A . . . E@` A BACLOFEN d00967A Cr G99.8 Other specified disorders of nervous system in diseases classified elsewhere AP E@` A ONDANSETRON d00867A C R11 Nausea and vomiting AP E@` A SERTRALINE d00880A Cr F32.9 K58 Major depressive disorder, single episode, unspecified Irritable bowel syndrome AP E@` A SPIRONOLACTONE d00373A B L70 Acne AP E@` A TRIHEXYPHENIDYL d00970A C[@ 55555 AP E@p A . . . E@ A FINASTERIDE d00563A C- N42.9 Disorder of prostate, unspecified A E@ A ALBUTEROL d00749A D9 J45 Asthma A@ E@ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C R60.9 Edema, unspecified A@ E@ A IPRATROPIUM d00265A Dc J44.9 Chronic obstructive pulmonary disease, unspecified A@ E@ A THEOPHYLLINE d00142A D J45 Asthma A@ E@ A INSULIN ISOPHANE; INSULIN REGULAR d04374A C[@ E11 Type 2 diabetes mellitus A E@ A . . . E@ A . . . E@ A PHENTERMINE d00806A B E66 Overweight and obesity A E@ A . . . E@ A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A CP L29.9 R21 Pruritus, unspecified Rash and other nonspecific skin eruption Ap E@ A BUPROPION d00181A CP 99999 Ap E@ A DONEPEZIL d04099A CP G31.9 R41 Degenerative disease of nervous system, unspecified Other symptoms and signs involving cognitive functions and awareness Ap E@ A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion Ap E@ A OLMESARTAN d04801A CP I21.P Prevent heart attack/myocardial infarction Ap E@ A QUETIAPINE d04220A C G47.0 Insomnia Ap E@ A TAMSULOSIN d04121A CP R39.1 Other difficulties with micturition Ap EA A AZITHROMYCIN d00091A0 AP J01.9 Acute sinusitis, unspecified A EA A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B E34 N92 Other endocrine disorders Excessive, frequent and irregular menstruation A EA A . . . EA A . . . EA0 A . . . EA@ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A EA@ A MONTELUKAST d04289A C- J45 Asthma A EAP A APIXABAN d07804A C[@ I21.P Prevent heart attack/myocardial infarction A EAP A DOCUSATE d01021A C[@ K59.0 Constipation A EAP A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A EAP A EZETIMIBE d04824A C[@ I21.P Prevent heart attack/myocardial infarction A EAP A FENOFIBRATE d04286A C- I21.P Prevent heart attack/myocardial infarction A EAP A FINASTERIDE d00563A C[@ N39.4 Other specified urinary incontinence A EAP A FUROSEMIDE d00070A C[@ R60.9 Edema, unspecified A EAP A NEBIVOLOL d05265A Cr I10 Essential (primary) hypertension A EAP A SIMVASTATIN d00746A C[@ I21.P Prevent heart attack/myocardial infarction A EAP A SPIRONOLACTONE d00373A C[@ I10 Essential (primary) hypertension A EAP A TAMSULOSIN d04121A CDp R35 Polyuria A EAP A TERAZOSIN d00386A C[@ I10 Essential (primary) hypertension A EA` A ALBUTEROL d00749A C[@ J45 Asthma A EAp A . . . EA A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EA A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EA A . . . EA A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A EA A AMLODIPINE d00689A D ^ I20.9 Angina pectoris, unspecified A0 EA A CLOPIDOGREL d04258A D ^ D75.9P Prevent blood clots A0 EA A LOSARTAN d03821A D ^ I10 Essential (primary) hypertension A0 EA A . . . EA A . . . EA A . . . EA A . . . EB A IBUPROFEN d00015A Ap M54 Dorsalgia A EB A . . . EB A . . . EB0 A . . . EB@ A . . . EBP A . . . EB` A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A EB` A FENOFIBRIC ACID d07371A C E78.0 Pure hypercholesterolemia A EB` A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A EB` A INSULIN ASPART d04697A C"0 R73 Elevated blood glucose level A EB` A INSULIN DETEMIR d05436A C- R73 Elevated blood glucose level A EB` A LEVETIRACETAM d04499A C9 G40 Epilepsy and recurrent seizures A EB` A METFORMIN d03807A C R73 Elevated blood glucose level A EB` A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A EBp A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` EBp A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C[@ E11 Type 2 diabetes mellitus A` EBp A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` EBp A MEMANTINE d04899A C G30.9 Alzheimer's disease, unspecified A` EBp A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EBp A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` EB A . . . EB A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A@ EB A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ EB A OMEPRAZOLE d00325A B= K25 Gastric ulcer A@ EB A RAMIPRIL d00728A B= I10 Essential (primary) hypertension A@ EB A . . . EB A ALBUTEROL d00749A Ap J45 Asthma A EB A MONTELUKAST d04289A Ap T78.40 Allergy, unspecified A EB A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A EB A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A EB A . . . EB A 99999 . . A EB A . . . EC A . . . EC A . . . EC A . . . EC0 A . . . EC@ A . . . ECP A . . . EC` A . . . ECp A . . . EC A . . . EC A . . . EC A . . . EC A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A` EC A ATENOLOL d00004A C I10 Essential (primary) hypertension A` EC A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A` EC A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EC A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` EC A URSODIOL d01005A C[@ K76.9 Liver disease, unspecified A` EC A . . . EC A . . . EC A . . . EC A . . . ED A ADRENAL CORTICAL STEROIDS - UNSPECIFIED c00098A AP R06.2 Wheezing A0 ED A ALBUTEROL d00749A Ap R06.2 Wheezing A0 ED A FLUTICASONE NASAL d04283A Ap R06.2 Wheezing A0 ED A . . . ED A . . . ED0 A . . . ED@ A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A0 ED@ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 ED@ A OMEPRAZOLE d00325A C R12 Heartburn A0 EDP A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus AP EDP A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension AP EDP A INSULIN GLARGINE d04538A B= E11 Type 2 diabetes mellitus AP EDP A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP EDP A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia AP ED` A . . . EDp A AMLODIPINE d00689A B I10 Essential (primary) hypertension A` EDp A ATENOLOL d00004A CDp I21.P Prevent heart attack/myocardial infarction A` EDp A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` EDp A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A` EDp A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A` EDp A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A` ED A . . . ED A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP ED A HYDROCHLOROTHIAZIDE d00253A B R60.9 Edema, unspecified AP ED A METOPROLOL d00134A B[ I49.9 Cardiac arrhythmia, unspecified AP ED A OMEPRAZOLE d00325A C- K27 Peptic ulcer, site unspecified AP ED A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP ED A LOSARTAN d03821A C I10 Essential (primary) hypertension A ED A METFORMIN d03807A C E11 Type 2 diabetes mellitus A ED A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ ED A NAPROXEN d00019A C M79.1 Myalgia A@ ED A PREDNISONE d00350A B= M25.5 Pain in joint A@ ED A TEMAZEPAM d00384A C G47.9 Sleep disorder, unspecified A@ ED A . . . ED A . . . ED A . . . ED A . . . EE A . . . EE A . . . EE A ATORVASTATIN d04105A Cr E78.0P Prevent high cholesterol A EE A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A EE A DIAZEPAM d00148A Cr F41.9 Anxiety disorder, unspecified A EE A DILTIAZEM d00045A C[@ I10 Essential (primary) hypertension A EE A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A EE A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A EE A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A EE A TRAZODONE d00395A C G47.0 Insomnia A EE0 A 77777 . . A@ EE0 A BACLOFEN d00967A Cr M62.83 Muscle spasm A@ EE0 A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A@ EE0 A METHOTREXATE d00060A D M06.9 Rheumatoid arthritis, unspecified A@ EE@ A . . . EEP A ALBUTEROL d00749A B R06.9P Prevent breathing difficulty AP EEP A AZITHROMYCIN d00091A B= N42.9 Disorder of prostate, unspecified AP EEP A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP EEP A OMEPRAZOLE d00325A B R12 Heartburn AP EEP A TAMSULOSIN d04121A Bz N40 Enlarged prostate AP EE` A AMPHETAMINE d00803A C- F90 Attention-deficit hyperactivity disorders A EEp A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A D G43 M54 R51 Migraine Dorsalgia Headache A EEp A ALBUTEROL d00749A Dc J45 Asthma A EEp A ALPRAZOLAM d00168A C"0 F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A EEp A CETIRIZINE d03827A C J45 Asthma A EEp A CYCLOBENZAPRINE d00963A C M62.83 M79.1 T14.9 Muscle spasm Myalgia Unspecified injury A EEp A DONEPEZIL d04099A Ap R41 Other symptoms and signs involving cognitive functions and awareness A EEp A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A EEp A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A EEp A LIDOCAINE TOPICAL d00683A A R52 Pain, unspecified A EEp A MONTELUKAST d04289A D J45 Asthma A EEp A NAPROXEN d00019A B M19.9 M25.5 T14.9 Osteoarthritis, unspecified site Pain in joint Unspecified injury A EEp A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation A EEp A PROPRANOLOL d00032A C- G43 Migraine A EEp A TRAMADOL d03826A D M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A EEp A TRAZODONE d00395A C R52 Pain, unspecified A EE A LEVOTHYROXINE d00278A C} E03.9 Hypothyroidism, unspecified A EE A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A0 EE A HYDROCORTISONE TOPICAL d03205A C- L20.9 Atopic dermatitis, unspecified A0 EE A TRETINOIN TOPICAL d01244A C L70 Acne A0 EE A . . . EE A PERMETHRIN TOPICAL d01279A B R21 Rash and other nonspecific skin eruption A EE A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia A0 EE A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 EE A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 EE A . . . EE A . . . EE A AMLODIPINE d00689A C"0 I10 Essential (primary) hypertension Ap EE A CANAGLIFLOZIN d08080A C"0 E11 Type 2 diabetes mellitus Ap EE A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap EE A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus Ap EE A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension Ap EE A LOVASTATIN d00280A C"0 E78.0P Prevent high cholesterol Ap EE A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap EF A . . . EF A . . . EF A LOSARTAN d03821A C I10 Essential (primary) hypertension A EF0 A . . . EF@ A . . . EFP A . . . EF` A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A C I10 Essential (primary) hypertension A EFp A FLUOCINOLONE TOPICAL d01293A B[ R05 Cough AP EFp A FLUOXETINE d00236A B[ F32.9 Major depressive disorder, single episode, unspecified AP EFp A METOPROLOL d00134A B I10 Essential (primary) hypertension AP EFp A NORETHINDRONE d00555A B Z79.3 Long term (current) use of hormonal contraceptives AP EFp A THYROID DESICCATED d00655A C- E03.9 Hypothyroidism, unspecified AP EF A . . . EF A CLONAZEPAM d00197A Dc R42 Dizziness and giddiness A EF A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc R42 Dizziness and giddiness A EF A . . . EF A . . . EF A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A D# Z79.3 Long term (current) use of hormonal contraceptives A EF A VENLAFAXINE d03181A D F32.9 Major depressive disorder, single episode, unspecified A EF A . . . EF A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension A EF A . . . EG A . . . EG A . . . EG A . . . EG0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EG0 A CANAGLIFLOZIN d08080A C R73 Elevated blood glucose level A EG0 A INSULIN GLARGINE d04538A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A EG0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A EG0 A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus A EG0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EG0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EG0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A EG0 A OMEPRAZOLE d00325A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A EG@ A 99999 . . A EGP A FLUTICASONE d01296A Ap J20.9 Acute bronchitis, unspecified A EG` A ANASTROZOLE d03873A C C50.P Prevent barest cancer A EGp A . . . EG A TRIAMCINOLONE NASAL d04233A C- J30.9 Allergic rhinitis, unspecified A EG A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A EG A WARFARIN d00022A C"0 I49.9 Cardiac arrhythmia, unspecified A EG A ALBUTEROL d00749A B[ J45 T78.40 Asthma Allergy, unspecified A0 EG A MECLIZINE d00859A B[ R42 Dizziness and giddiness A0 EG A PSEUDOEPHEDRINE d00769A B[ J01.9 Acute sinusitis, unspecified A0 EG A RANITIDINE d00021A C- K30 Functional dyspepsia A EG A . . . EG A . . . EG A DAPSONE TOPICAL d05543A C- L70 Acne A0 EG A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp L70 Acne A0 EG A MINOCYCLINE d00110A CDp L70 Acne A0 EG A ACYCLOVIR d00001A C B00.1 Herpesviral vesicular dermatitis A@ EG A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ EG A DICLOFENAC d00848A B= M54 Dorsalgia A@ EG A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ EH A . . . EH A . . . EH A . . . EH0 A . . . EH@ A . . . EHP A GENTAMICIN OPHTHALMIC d03974A Ap H10 Conjunctivitis A EH` A BUSPIRONE d00182A A F41.9 Anxiety disorder, unspecified A EH` A LITHIUM d00061A A F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder A EHp A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ EHp A OMEPRAZOLE d00325A C- K92.9 Disease of digestive system, unspecified A@ EHp A PRAVASTATIN d00348A C I63.P Prevent stroke A@ EHp A PRIMIDONE d00352A C R25.1 Tremor, unspecified A@ EH A . . . EH A . . . EH A METHYLPREDNISOLONE d00293A B[ M25.5 Pain in joint A EH A DICLOFENAC d00848A B[ M54 Dorsalgia A EH A METHYLPREDNISOLONE d00293A A 55555 A EH A . . . EH A . . . EH A . . . EH A . . . EI A . . . EI A . . . EI A . . . EI0 A . . . EI@ A . . . EIP A . . . EI` A GABAPENTIN d03182A B[ M79.6 Pain in limb, hand, foot, fingers and toes A@ EI` A HYDROXYZINE d00907A B= F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A@ EI` A SERTRALINE d00880A B[ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ EI` A SUMATRIPTAN d03160A C G43 Migraine A@ EIp A PROPRANOLOL d00032A Ap R25.1 Tremor, unspecified A EI A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ N92 Excessive, frequent and irregular menstruation A EI A KETOROLAC d00273A B M54 R10 Dorsalgia Abdominal and pelvic pain A EI A AMLODIPINE d00689A . I10 Essential (primary) hypertension AP EI A ATENOLOL d00004A . I10 Essential (primary) hypertension AP EI A HYDROCHLOROTHIAZIDE d00253A . I10 Essential (primary) hypertension AP EI A LOSARTAN d03821A . I10 Essential (primary) hypertension AP EI A POTASSIUM CHLORIDE d00345A . E87.6 Hypokalemia AP EI A . . . EI A LAMOTRIGINE d03809A CDp G40 Epilepsy and recurrent seizures A EI A . . . EI A . . . EI A CEFUROXIME d00056A B[ N42.9 Disorder of prostate, unspecified A@ EI A DICLOFENAC d00848A B M25.5 Pain in joint A@ EI A ERYTHROMYCIN OPHTHALMIC d03973A B H10 Conjunctivitis A@ EI A OLOPATADINE OPHTHALMIC d04117A B H10 Conjunctivitis A@ EI A . . . EJ A FLUCONAZOLE d00071A0 A B37 Candidiasis A0 EJ A LEVONORGESTREL d00557A Cr Z79.3 Long term (current) use of hormonal contraceptives A0 EJ A NITROFURANTOIN d00112A0 AP N39.0 Urinary tract infection, site not specified A0 EJ A . . . EJ A AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN d07440A CDp I10 Essential (primary) hypertension A EJ0 A . . . EJ@ A . . . EJP A . . . EJ` A . . . EJp A CONTRACEPTIVES - UNSPECIFIED c00102A B Z79.3 Long term (current) use of hormonal contraceptives A EJ A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A EJ A IBUPROFEN d00015A C K08.8 M79.1 Other specified disorders of teeth and supporting structures Myalgia A` EJ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` EJ A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A` EJ A NIFEDIPINE d00051A D9 R00 Abnormalities of heart beat A` EJ A PAROXETINE d03157A C- F32.9 Major depressive disorder, single episode, unspecified A` EJ A PHENYTOIN d00143A DGJ G40 Epilepsy and recurrent seizures A` EJ A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A` EJ A DEXLANSOPRAZOLE d07395A Ei 99999 A` EJ A MECLIZINE d00859A Ei 99999 A` EJ A METOPROLOL d00134A C- I21.P Prevent heart attack/myocardial infarction A` EJ A MONTELUKAST d04289A Ei 99999 A` EJ A SIMVASTATIN d00746A Ei 99999 A` EJ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A EJ A . . . EJ A . . . EJ A . . . EJ A GABAPENTIN d03182A C- M79.6 Pain in limb, hand, foot, fingers and toes A@ EJ A METOPROLOL d00134A D I49.9 Cardiac arrhythmia, unspecified A@ EJ A PRAVASTATIN d00348A D# E78.0 Pure hypercholesterolemia A@ EJ A WARFARIN d00022A D D75.9P Prevent blood clots A@ EK A . . . EK A FAMOTIDINE d00141A C- K30 Functional dyspepsia A EK A . . . EK0 A MELOXICAM d04532A A K31.9 Disease of stomach and duodenum, unspecified A EK@ A . . . EKP A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A` EKP A HYDRALAZINE d00132A CDp I10 Essential (primary) hypertension A` EKP A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CDp I10 Essential (primary) hypertension A` EKP A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A B= E11 Type 2 diabetes mellitus A` EKP A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` EKP A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension A` EK` A . . . EKp A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A EKp A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EK A . . . EK A . . . EK A . . . EK A . . . EK A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension AP EK A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia AP EK A FLUTICASONE; SALMETEROL d04611A B J20.9 Acute bronchitis, unspecified AP EK A METOPROLOL d00134A Dc I10 Essential (primary) hypertension AP EK A PIOGLITAZONE d04442A C- E11 Type 2 diabetes mellitus AP EK A SPIRONOLACTONE d00373A B L70 Acne A EK A . . . EK A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A0 EK A LISINOPRIL d00732A C E11.2 Type 2 diabetes mellitus with kidney complications A0 EK A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 EL A . . . EL A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A EL A CLONIDINE d00044A Ei I10 Essential (primary) hypertension A EL A . . . EL0 A . . . EL@ A AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE d05399A A B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A@ EL@ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ EL@ A CLARITHROMYCIN d00097A A B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A@ EL@ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ ELP A . . . EL` A CLONAZEPAM d00197A B= F41.9 Anxiety disorder, unspecified A EL` A OLANZAPINE d04050A C- F32.9 Major depressive disorder, single episode, unspecified A ELp A . . . EL A . . . EL A . . . EL A . . . EL A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures A EL A . . . EL A . . . EL A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C[@ E87.7 Fluid overload A0 EL A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 EL A SITAGLIPTIN d05896A C[@ E11 Type 2 diabetes mellitus A0 EL A AMOXICILLIN; CLAVULANATE d00089A A@ J02 Acute pharyngitis A0 EL A FLUTICASONE d01296A B J45 Asthma A0 EL A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A0 EM A BUPROPION d00181A C[@ F43.1 Post-traumatic stress disorder (PTSD) AP EM A DIPHENHYDRAMINE d00212A C[@ G47.0 Insomnia AP EM A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension AP EM A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease AP EM A VENLAFAXINE d03181A C[@ F43.1 Post-traumatic stress disorder (PTSD) AP EM A . . . EM A CLOBETASOL TOPICAL d01288A CDp L20.9 Atopic dermatitis, unspecified A0 EM A CLONAZEPAM d00197A B[ G47.9 Sleep disorder, unspecified A0 EM A FLUOXETINE d00236A Cr F32.9 Major depressive disorder, single episode, unspecified A0 EM0 A . . . EM@ A CLONIDINE d00044A CDp F41.9 Anxiety disorder, unspecified A0 EM@ A RISPERIDONE d03180A Cr F90 Attention-deficit hyperactivity disorders A0 EM@ A SERTRALINE d00880A Bz F32.9 Major depressive disorder, single episode, unspecified A0 EMP A . . . EM` A . . . EMp A . . . EM A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A EM A PREDNISONE d00350A B 55555 A EM A ATENOLOL d00004A CP I10 Essential (primary) hypertension AP EM A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus AP EM A LOSARTAN d03821A CDp I10 Essential (primary) hypertension AP EM A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP EM A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia AP EM A ETHINYL ESTRADIOL; NORGESTIMATE d03781A D Z79.3 Long term (current) use of hormonal contraceptives A EM A . . . EM A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A EM A FINASTERIDE d00563A C- N40 Enlarged prostate A EM A INSULIN GLARGINE d04538A C R73 Elevated blood glucose level A EM A LEVOTHYROXINE d00278A B[ E03.9 Hypothyroidism, unspecified A EM A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A EM A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A EM A PANTOPRAZOLE d04514A C[@ K25.P Prevent gastric ulcer A EM A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified A EM A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia A EM A SULFAMETHOXAZOLE d00119A C[@ 99999 A EM A TACROLIMUS d03752A C[@ T86.9P Prevent transplanted organ and tissue rejection A EM A ALENDRONATE d03849A C[@ M81 Osteoporosis without current pathological fracture A EM A CETIRIZINE d03827A C 99999 A EM A FENTANYL d00233A C R52 Pain, unspecified A EM A FLUTICASONE NASAL d04283A B[ R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems A EM A HYDROMORPHONE d00255A C[@ R52 Pain, unspecified A EM A MEGESTROL d01348A C C50 Malignant neoplasm of breast A EM A OMEPRAZOLE d00325A C K30 Functional dyspepsia A EM A PREDNISONE d00350A C- I99.9 Unspecified disorder of circulatory system A EM A PROCHLORPERAZINE d00355A C R11 Nausea and vomiting A EM A VALSARTAN d04113A C 99999 A EM A ZOLPIDEM d00910A C G47.0 Insomnia A EM A . . . EM A . . . EN A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia AP EN A DIAZEPAM d00148A C- F41.9 Anxiety disorder, unspecified AP EN A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified AP EN A GABAPENTIN d03182A C- F41.9 Anxiety disorder, unspecified AP EN A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified AP EN A . . . EN A . . . EN0 A . . . EN@ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A EN@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A ENP A . . . EN` A CLONAZEPAM d00197A C G47.9 Sleep disorder, unspecified A ENp A . . . EN A . . . EN A ALBUTEROL d00749A A J20.9 Acute bronchitis, unspecified A0 EN A AMOXICILLIN d00088A A J40 Bronchitis, not specified as acute or chronic A0 EN A LANSOPRAZOLE d03828A B K21 Gastro-esophageal reflux disease A0 EN A . . . EN A ALBUTEROL d00749A C- R06.2 Wheezing A@ EN A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ EN A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A@ EN A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A@ EN A . . . EN A CYCLOBENZAPRINE d00963A C- M54 Dorsalgia A EN A ALPRAZOLAM d00168A C[@ F41.9 Anxiety disorder, unspecified Ap EN A DAPAGLIFLOZIN d07928A Bz E11 Type 2 diabetes mellitus Ap EN A DIGOXIN d00210A D I49.9 Cardiac arrhythmia, unspecified Ap EN A LISINOPRIL d00732A Dc 55555 Ap EN A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap EN A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus Ap EN A SOTALOL d00371A D I49.9 Cardiac arrhythmia, unspecified Ap EN A . . . EO A . . . EO A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A EO A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A EO A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A EO A CONJUGATED ESTROGENS TOPICAL d04396A C- N95 Menopausal and other perimenopausal disorders A EO A CYCLOBENZAPRINE d00963A CDp M62.83 Muscle spasm A EO A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A EO A METOPROLOL d00134A C I10 Essential (primary) hypertension A EO A POLYETHYLENE GLYCOL 3350 WITH ELECTROLYTES d01023A CDp K59.0 Constipation A EO A ROPINIROLE d04215A CDp G25.81 Restless legs syndrome A EO A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified A EO A TIOTROPIUM d04829A B[ J44.9 Chronic obstructive pulmonary disease, unspecified A EO A TRAZODONE d00395A CDp G47.0 Insomnia A EO A . . . EO0 A . . . EO@ A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A@ EO@ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ EO@ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ EO@ A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A@ EOP A . . . EO` A . . . EOp A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 Pain in joint Ap EOp A ALLOPURINOL d00023A C M1A Chronic gout Ap EOp A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap EOp A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 R60.9 Essential (primary) hypertension Edema, unspecified Ap EOp A METOPROLOL d00134A B I10 Essential (primary) hypertension Ap EOp A QUETIAPINE d04220A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap EOp A RISPERIDONE d03180A B= F32.9 F39 F99 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Mental disorder, not otherwise specified Ap EO A . . . EO A ACETAMINOPHEN; OXYCODONE d03431A B= M54 Dorsalgia A0 EO A HYDROCHLOROTHIAZIDE d00253A A I10 Essential (primary) hypertension A0 EO A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 EO A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A EO A GEMFIBROZIL d00245A C- 99999 A EO A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A EO A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A EO A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A EO A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EO A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A EO A METFORMIN d03807A D E11 Type 2 diabetes mellitus A EO A RANITIDINE d00021A C- K30 Functional dyspepsia A EO A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A EO A VERAPAMIL d00048A CDp I10 Essential (primary) hypertension A EO A WARFARIN d00022A D D75.9P Prevent blood clots A EO A . . . EO A . . . EO A . . . EO A ACETAMINOPHEN; HYDROCODONE d03428A B G89 Pain, not elsewhere classified A0 EO A CIPROFLOXACIN d00011A Ap N39.0 Urinary tract infection, site not specified A0 EO A IBUPROFEN d00015A B 55555 A0 EO A . . . EP A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A0 EP A DIPHENHYDRAMINE d00212A CDp T78.40 Allergy, unspecified A0 EP A FLUTICASONE NASAL d04283A CDp T78.40 Allergy, unspecified A0 EP A TOPIRAMATE d04115A B E66 Overweight and obesity A EP A . . . EP0 A . . . EP@ A . . . EPP A . . . EP` A . . . EPp A CEPHALEXIN d00096A AP N30 Cystitis A EP A . . . EP A . . . EP A BENAZEPRIL d00730A B= R00 Abnormalities of heart beat A EP A METOPROLOL d00134A A I49.9 Cardiac arrhythmia, unspecified A EP A . . . EP A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A EP A PAROXETINE d03157A Cr F41.9 Anxiety disorder, unspecified A EP A . . . EP A . . . EP A . . . EQ A . . . EQ A . . . EQ A ALLOPURINOL d00023A C- M10.9 Gout, unspecified A EQ A ATENOLOL d00004A0 C- I10 Essential (primary) hypertension A EQ A CETIRIZINE d03827A B L23 Allergic contact dermatitis A EQ A COLCHICINE d00150A C- E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A EQ A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A EQ A GABAPENTIN d03182A B= M79.6 Pain in limb, hand, foot, fingers and toes A EQ A MEMANTINE d04899A B= G31.8 Other specified degenerative diseases of nervous system A EQ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A EQ A PANTOPRAZOLE d04514A C- K30 Functional dyspepsia A EQ0 A . . . EQ@ A ALENDRONATE d03849A B[ M81 Osteoporosis without current pathological fracture AP EQ@ A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia AP EQ@ A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus AP EQ@ A INSULIN ISOPHANE (NPH) d04370A C[@ E11 Type 2 diabetes mellitus AP EQ@ A LISINOPRIL d00732A Cr E11.2 Type 2 diabetes mellitus with kidney complications AP EQP A 77777 . . A EQ` A . . . EQp A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EQ A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified A EQ A BENZONATATE d00796A A` R05 R06.2 Cough Wheezing A EQ A CLARITHROMYCIN d00097A A` J42 Unspecified chronic bronchitis A EQ A CONJUGATED ESTROGENS d00541A D1 Z79.890 Hormone replacement therapy A EQ A DILTIAZEM d00045A C I10 Essential (primary) hypertension A EQ A HYDROCHLOROTHIAZIDE d00253A D# N28.9 Disorder of kidney and ureter, unspecified A EQ A LOSARTAN d03821A C E11.2 Type 2 diabetes mellitus with kidney complications A EQ A METFORMIN d03807A D# E11 Type 2 diabetes mellitus A EQ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EQ A PIOGLITAZONE d04442A Cr E11 Type 2 diabetes mellitus A EQ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EQ A . . . EQ A . . . EQ A . . . EQ A . . . EQ A ALBUTEROL d00749A C J45 Asthma AP EQ A BECLOMETHASONE d00760A Bz J45 Asthma AP EQ A ESTRADIOL d00537A A E28 Ovarian dysfunction AP EQ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B E28 Ovarian dysfunction AP EQ A HYDROXYZINE d00907A B[ L50 Urticaria AP EQ A . . . ER A . . . ER A IBUPROFEN d00015A A M79.6 Pain in limb, hand, foot, fingers and toes A ER A . . . ER0 A . . . ER@ A MINOCYCLINE d00110A B J02 R50.9 Acute pharyngitis Fever, unspecified A ERP A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A CDp I10 Essential (primary) hypertension A ER` A . . . ERp A CELECOXIB d04380A D& M06.9 Rheumatoid arthritis, unspecified A ERp A DIAZEPAM d00148A DK F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A ERp A FLUOCINONIDE TOPICAL d01294A C L29.9 Pruritus, unspecified A ERp A FLUTICASONE NASAL d04283A B J30.1 J30.2 R09.81 Allergic rhinitis due to pollen Other seasonal allergic rhinitis Nasal congestion A ERp A METOCLOPRAMIDE d00298A CDp K58 Irritable bowel syndrome A ERp A MONTELUKAST d04289A B J45 Asthma A ERp A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A ERp A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A ER A . . . ER A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP ER A CETIRIZINE d03827A C[@ J30.9 Allergic rhinitis, unspecified AP ER A INSULIN d00262A Cr E11 Type 2 diabetes mellitus AP ER A LISINOPRIL d00732A DK I10 Essential (primary) hypertension AP ER A METOPROLOL d00134A D I21.P Prevent heart attack/myocardial infarction AP ER A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia Ap ER A CLONAZEPAM d00197A B F32.9 Major depressive disorder, single episode, unspecified Ap ER A DEXAMETHASONE d00206A CDp Z51.1 Encounter for antineoplastic chemotherapy and immunotherapy Ap ER A MECLIZINE d00859A CDp R11.P Prevent nausea or vomiting Ap ER A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap ER A OMEPRAZOLE d00325A CDp K27 Peptic ulcer, site unspecified Ap ER A TRAMADOL d03826A CDp M79.6 Pain in limb, hand, foot, fingers and toes Ap ER A . . . ER A . . . ER A 99999 . . A ER A CITALOPRAM d04332A C[@ F32.9 Major depressive disorder, single episode, unspecified A@ ER A DONEPEZIL d04099A CP G30.9 Alzheimer's disease, unspecified A@ ER A MEMANTINE d04899A CP G30.9 Alzheimer's disease, unspecified A@ ER A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ ER A ALBUTEROL d00749A0 D J42 J45 Unspecified chronic bronchitis Asthma B ER A ALBUTEROL d00749A0 D- J42 J45 Unspecified chronic bronchitis Asthma B ER A ALLOPURINOL d00023A0 C- M1A Chronic gout B ER A AMLODIPINE d00689A0 D1 I10 Essential (primary) hypertension B ER A ATENOLOL d00004A0 CDp I10 Essential (primary) hypertension B ER A BACITRACIN TOPICAL d03756A C 55555 B ER A CLONIDINE d00044A0 D# I10 Essential (primary) hypertension B ER A COLCHICINE d00150A0 C- M1A Chronic gout B ER A CYANOCOBALAMIN d00413A0 D ^ E53.9 Vitamin B deficiency, unspecified B ER A ESOMEPRAZOLE d04749A0 D- K21 Gastro-esophageal reflux disease B ER A FLUTICASONE NASAL d04283A0 B J30.9 Allergic rhinitis, unspecified B ER A LEVOTHYROXINE d00278A0 D# E03.9 Hypothyroidism, unspecified B ER A LIDOCAINE TOPICAL d00683A0 Dc M54 Dorsalgia B ER A LISINOPRIL d00732A0 D# I10 Essential (primary) hypertension B ER A MIRABEGRON d07876A0 B N32.81 Overactive bladder B ER A SENNA d01013A0 C- K59.0 Constipation B ER A TAMSULOSIN d04121A0 B R32 Unspecified urinary incontinence B ES A DESOXIMETASONE TOPICAL d01291A Cr L20.9 Atopic dermatitis, unspecified A ES A MONTELUKAST d04289A B= J30.2 Other seasonal allergic rhinitis A ES A ACETAMINOPHEN; OXYCODONE d03431A CDp M54 Dorsalgia Ap ES A CYCLOBENZAPRINE d00963A B M54 Dorsalgia Ap ES A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia Ap ES A FUROSEMIDE d00070A C[@ R60.9 Edema, unspecified Ap ES A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension Ap ES A MELOXICAM d04532A0 C[@ M54 Dorsalgia Ap ES A TRAMADOL d03826A CDp M54 Dorsalgia Ap ES A . . . ES0 A ACETAMINOPHEN; OXYCODONE d03431A A M79.6 Pain in limb, hand, foot, fingers and toes A0 ES0 A IBUPROFEN d00015A A M25.5 Pain in joint A0 ES0 A LEVOTHYROXINE d00278A C- E03.9 E04 Hypothyroidism, unspecified Other nontoxic goiter A0 ES@ A . . . ESP A . . . ES` A . . . ESp A BUPROPION d00181A A F99 Mental disorder, not otherwise specified A0 ESp A FLUOXETINE d00236A C F99 Mental disorder, not otherwise specified A0 ESp A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A0 ES A . . . ES A . . . ES A AMLODIPINE d00689A C I10 Essential (primary) hypertension A ES A . . . ES A . . . ES A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A ES A ALBUTEROL d00749A B J45 Asthma A@ ES A ALBUTEROL d00749A Cr J45 Asthma A@ ES A FLUTICASONE d01296A B J45 Asthma A@ ES A FLUTICASONE NASAL d04283A Ei J30.9 Allergic rhinitis, unspecified A@ ES A . . . ET A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified A ET A . . . ET A . . . ET0 A . . . ET@ A . . . ETP A . . . ET` A . . . ETp A . . . ET A . . . ET A . . . ET A . . . ET A . . . ET A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C E66 Overweight and obesity A@ ET A PROGESTERONE d00550A C N95 Menopausal and other perimenopausal disorders A@ ET A TESTOSTERONE d00558A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A@ ET A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A@ ET A . . . ET A . . . ET A ACETAMINOPHEN; HYDROCODONE d03428A0 B M54 Dorsalgia Ap ET A BUSPIRONE d00182A0 B F41.9 Anxiety disorder, unspecified Ap ET A CITALOPRAM d04332A0 B F32.9 Major depressive disorder, single episode, unspecified Ap ET A GABAPENTIN d03182A0 B M79.2 Neuralgia and neuritis, unspecified Ap ET A MORPHINE d00308A0 Ap M54 Dorsalgia Ap ET A PREDNISONE d00350A0 B T78.40 Allergy, unspecified Ap ET A TIZANIDINE d04102A0 B M62.83 Muscle spasm Ap EU A . . . EU A . . . EU A . . . EU0 A . . . EU@ A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A EUP A CONJUGATED ESTROGENS d00541A Dc Z79.890 Hormone replacement therapy A EUP A CYCLOBENZAPRINE d00963A Bz M62.83 Muscle spasm A EUP A FESOTERODINE d07162A Dc N32.81 Overactive bladder A EUP A HYDROMORPHONE d00255A C- K92.9 Disease of digestive system, unspecified A EUP A LANSOPRAZOLE d03828A D K21 Gastro-esophageal reflux disease A EUP A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A EUP A PENTOSAN POLYSULFATE SODIUM d04052A Dc N30 Cystitis A EUP A RANITIDINE d00021A D* K30 Functional dyspepsia A EU` A . . . EUp A COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR d07899A CDp B20 Human immunodeficiency virus [HIV] disease A EU A HYDROCHLOROTHIAZIDE d00253A Ei I10 R60.9 Essential (primary) hypertension Edema, unspecified A@ EU A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified A@ EU A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A@ EU A WARFARIN d00022A Ei D75.9P Prevent blood clots A@ EU A . . . EU A . . . EU A ARIPIPRAZOLE d04825A B[ F32.9 Major depressive disorder, single episode, unspecified A EU A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A EU A ENTECAVIR d05525A D B19 Unspecified viral hepatitis A EU A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A EU A LIRAGLUTIDE d07466A Cr R73 Elevated blood glucose level A EU A LIRAGLUTIDE d07466A D E11 Type 2 diabetes mellitus A EU A LOSARTAN d03821A D I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A EU A METOCLOPRAMIDE d00298A C- K30 Functional dyspepsia A EU A METOPROLOL d00134A D I20.9 I50.9 R07.9 Angina pectoris, unspecified Heart failure, unspecified Chest pain, unspecified A EU A RANOLAZINE d05719A D I20.9 R07.9 Angina pectoris, unspecified Chest pain, unspecified A EU A SERTRALINE d00880A B[ F41.9 Anxiety disorder, unspecified A EU A HYDROCHLOROTHIAZIDE; SPIRONOLACTONE d03247A D# I10 Essential (primary) hypertension A EU A VERAPAMIL d00048A D# I10 Essential (primary) hypertension A EU A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A EU A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A EU A . . . EU A BENZOYL PEROXIDE; CLINDAMYCIN TOPICAL d04742A C- L70 Acne A@ EU A DESONIDE TOPICAL d01290A C- R21 Rash and other nonspecific skin eruption A@ EU A ENALAPRIL d00013A Cr I51.9P Prevent heart disease A@ EU A NYSTATIN TOPICAL d04399A B[ R21 Rash and other nonspecific skin eruption A@ EV A . . . EV A . . . EV A . . . EV0 A . . . EV@ A . . . EVP A . . . EV` A . . . EVp A . . . EV A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 EV A METOPROLOL d00134A D I10 Essential (primary) hypertension A0 EV A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A0 EV A . . . EV A . . . EV A . . . EV A . . . EV A . . . EV A . . . EV A . . . EW A . . . EW A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension A EW A . . . EW0 A . . . EW@ A . . . EWP A AMLODIPINE d00689A B= I10 I21.P N28.9 Essential (primary) hypertension Prevent heart attack/myocardial infarction Disorder of kidney and ureter, unspecified A0 EWP A CARVEDILOL d03847A B= I10 Essential (primary) hypertension A0 EWP A LOSARTAN d03821A B= I10 I50.9 N28.9 Essential (primary) hypertension Heart failure, unspecified Disorder of kidney and ureter, unspecified A0 EW` A . . . EWp A DICLOFENAC d00848A C- M06.9 M19.9 Rheumatoid arthritis, unspecified Osteoarthritis, unspecified site A@ EWp A DOXAZOSIN d00726A B= N40 Enlarged prostate A@ EWp A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A@ EWp A TRAMADOL d03826A CDp M06.9 M25.5 M54 Rheumatoid arthritis, unspecified Pain in joint Dorsalgia A@ EW A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A EW A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A Dc E78.0 Pure hypercholesterolemia A EW A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A0 EW A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 EW A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 EW A . . . EW A . . . EW A . . . EW A . . . EW A . . . EW A . . . EX A . . . EX A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture AP EX A LETROZOLE d04156A C9 C50 Malignant neoplasm of breast AP EX A LEVOTHYROXINE d00278A DU E03.9 Hypothyroidism, unspecified AP EX A LIOTHYRONINE d00658A C E03.9 Hypothyroidism, unspecified AP EX A SUCRALFATE d00377A B K27 Peptic ulcer, site unspecified AP EX A . . . EX0 A . . . EX@ A . . . EXP A ACETAMINOPHEN; OXYCODONE d03431A B M54 T14.9 Dorsalgia Unspecified injury A EXP A ALBUTEROL d00749A B R06.2 Wheezing A EXP A ALPRAZOLAM d00168A C F43.9 Reaction to severe stress, unspecified A EXP A CLOPIDOGREL d04258A C E78.0 Pure hypercholesterolemia A EXP A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc R60.9 Edema, unspecified A EXP A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A EXP A PAROXETINE d03157A C[@ F39 Unspecified mood [affective] disorder A EXP A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A EX` A FLUTICASONE d01296A CDp R06.2 Wheezing A0 EX` A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A0 EX` A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A0 EXp A . . . EX A . . . EX A . . . EX A . . . EX A AMLODIPINE d00689A D ^ I10 Essential (primary) hypertension Ap EX A GLIPIZIDE d00246A D ^ R73 Elevated blood glucose level Ap EX A METFORMIN d03807A D ^ E11 Type 2 diabetes mellitus Ap EX A METOPROLOL d00134A D ^ I10 Essential (primary) hypertension Ap EX A PIOGLITAZONE d04442A D ^ R73 Elevated blood glucose level Ap EX A SIMVASTATIN d00746A D ^ E78.0 Pure hypercholesterolemia Ap EX A TRAMADOL d03826A CDp M06.9 Rheumatoid arthritis, unspecified Ap EX A AMITRIPTYLINE d00146A B= R10 Abdominal and pelvic pain A EX A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EX A . . . EX A . . . EX A . . . EY A . . . EY A . . . EY A . . . EY0 A . . . EY@ A BUDESONIDE d04276A C J45 Asthma A EYP A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` EYP A CARVEDILOL d03847A C- I10 I48.9 I49.9 Essential (primary) hypertension Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified A` EYP A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A` EYP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 R60.9 Essential (primary) hypertension Edema, unspecified A` EYP A LINAGLIPTIN d07767A B[ E11 Type 2 diabetes mellitus A` EYP A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` EY` A . . . EYp A . . . EY A . . . EY A . . . EY A ALBUTEROL d00749A B J45 Asthma A EY A CELECOXIB d04380A C- M13 Other arthritis Ap EY A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified Ap EY A LEVOTHYROXINE d00278A Cr E05 Thyrotoxicosis [hyperthyroidism] Ap EY A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap EY A RANITIDINE d00021A D K30 Functional dyspepsia Ap EY A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap EY A TRAMADOL d03826A C T14.9 Unspecified injury Ap EY A . . . EY A . . . EY A . . . EY A . . . EZ A ALBUTEROL d00749A Cr J45 Asthma A0 EZ A CETIRIZINE d03827A C J45 Asthma A0 EZ A MONTELUKAST d04289A C J45 Asthma A0 EZ A FLUTICASONE NASAL d04283A CDp J30.2 Other seasonal allergic rhinitis A EZ A . . . EZ0 A . . . EZ@ A . . . EZP A METOPROLOL d00134A D I50.9 Heart failure, unspecified A0 EZP A OMEPRAZOLE d00325A D K30 Functional dyspepsia A0 EZP A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A0 EZ` A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A0 EZ` A CEFDINIR d04256A A H66.9 N30 Otitis media, unspecified Cystitis A0 EZ` A LOSARTAN d03821A B= I10 Essential (primary) hypertension A0 EZp A . . . EZ A METOPROLOL d00134A CDp 99999 A EZ A PRAVASTATIN d00348A C- 99999 A EZ A . . . EZ A CITALOPRAM d04332A B= F41.9 Anxiety disorder, unspecified A@ EZ A CLONAZEPAM d00197A B= K30 Functional dyspepsia A@ EZ A DONEPEZIL d04099A B= R41 Other symptoms and signs involving cognitive functions and awareness A@ EZ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ EZ A . . . EZ A ERYTHROMYCIN OPHTHALMIC d03973A C- H57.9 Unspecified disorder of eye and adnexa A EZ A . . . EZ A . . . EZ A ISOTRETINOIN d01245A B L70 Acne A E[ A . . . E[ A . . . E[ A . . . E[0 A . . . E[@ A DILTIAZEM d00045A C I49.9 R00 Cardiac arrhythmia, unspecified Abnormalities of heart beat A E[P A AMOXICILLIN; CLAVULANATE d00089A CDp J00.P Prevent common cold AP E[P A ASPIRIN d00170A D I21.P Prevent heart attack/myocardial infarction AP E[P A CARVEDILOL d03847A D I10 I99.9 Essential (primary) hypertension Unspecified disorder of circulatory system AP E[P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E[P A TIZANIDINE d04102A B M79.1 Myalgia AP E[` A . . . E[p A . . . E[ A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified A E[ A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A E[ A . . . E[ A . . . E[ A . . . E[ A INSULIN ISOPHANE; INSULIN REGULAR d04374A D E11 Type 2 diabetes mellitus AP E[ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E[ A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP E[ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E[ A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia AP E[ A . . . E[ A . . . E[ A CARBOXYMETHYLCELLULOSE; SODIUM HYALURONATE d07686A C- H04 Disorders of lacrimal system Ap E[ A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E[ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E[ A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E[ A NAPROXEN d00019A C M79.1 Myalgia Ap E[ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E[ A TRAZODONE d00395A C- F41.9 F99 G47.0 Anxiety disorder, unspecified Mental disorder, not otherwise specified Insomnia Ap E\ A . . . E\ A DRONEDARONE d07458A CDp I48.9 Unspecified atrial fibrillation and atrial flutter A@ E\ A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A@ E\ A SILODOSIN d07354A B N40 Enlarged prostate A@ E\ A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A@ E\ A RANITIDINE d00021A B L50 Urticaria A E\ A RANITIDINE d00021A B L50 Urticaria A E\0 A . . . E\@ A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A` E\@ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E\@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E\@ A METOPROLOL d00134A C G43.P Prevent migraine A` E\@ A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E\@ A TOPIRAMATE d04115A B G43 Migraine A` E\P A . . . E\` A ATENOLOL; CHLORTHALIDONE d03258A Dc I49.9 Cardiac arrhythmia, unspecified A@ E\` A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ E\` A RANITIDINE d00021A B= K31.9 Disease of stomach and duodenum, unspecified A@ E\` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E\p A . . . E\ A ALBUTEROL d00749A D* J45 Asthma AP E\ A ALPRAZOLAM d00168A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E\ A AMITRIPTYLINE d00146A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E\ A IBUPROFEN d00015A C- M54 Dorsalgia AP E\ A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP E\ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E\ A RALOXIFENE d04261A B[ M81 Osteoporosis without current pathological fracture A E\ A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ E\ A DABIGATRAN d07137A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A@ E\ A HYDROCHLOROTHIAZIDE; SPIRONOLACTONE d03247A Cr R60.9 Edema, unspecified A@ E\ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E\ A AMPHETAMINE d00803A Bz F90 Attention-deficit hyperactivity disorders A E\ A . . . E\ A . . . E\ A ALBUTEROL d00749A C J45 Asthma A E\ A AMITRIPTYLINE d00146A BF R10 Abdominal and pelvic pain A E] A . . . E] A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E] A . . . E]0 A IBUPROFEN d00015A A M19.9 Osteoarthritis, unspecified site A@ E]0 A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A@ E]0 A TRAMADOL d03826A C- M13 Other arthritis A@ E]0 A WARFARIN d00022A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E]@ A . . . E]P A . . . E]` A IBUPROFEN d00015A A G89 Pain, not elsewhere classified A E]` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E]p A ALLOPURINOL d00023A C- M1A Chronic gout A` E]p A ESCITALOPRAM d04812A Cr M79.7 Fibromyalgia A` E]p A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A` E]p A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A` E]p A PROGESTERONE d00550A C G47.0 Insomnia A` E]p A ZOLPIDEM d00910A D G47.0 Insomnia A` E] A . . . E] A . . . E] A CEFUROXIME d00056A Ap J01.9 Acute sinusitis, unspecified A E] A IBUPROFEN d00015A B R51 Headache A E] A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified Ap E] A AMLODIPINE d00689A CDp 99999 Ap E] A AMOXICILLIN d00088A CDp K04.7P Prevent tooth infection Ap E] A ATORVASTATIN d04105A CDp 99999 Ap E] A METOPROLOL d00134A CDp I10 Essential (primary) hypertension Ap E] A PANTOPRAZOLE d04514A CDp 99999 Ap E] A TRAMADOL d03826A CDp M54 Dorsalgia Ap E] A BENZTROPINE d00175A C- G25.0 G25.81 T88.7P Essential tremor Restless legs syndrome Prevent drug side effect A E] A HALOPERIDOL d00027A D F20 Schizophrenia A E] A ALBUTEROL d00749A C J45 Asthma A E] A HYDROXYZINE d00907A CP L23 Allergic contact dermatitis A E] A . . . E] A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A E] A METFORMIN d03807A Cr R73 Elevated blood glucose level A E^ A MELOXICAM d04532A B M19.9 M54 Osteoarthritis, unspecified site Dorsalgia A E^ A . . . E^ A . . . E^0 A . . . E^@ A LAMOTRIGINE d03809A C G40 Epilepsy and recurrent seizures A E^@ A PHENYTOIN d00143A Dc G40 Epilepsy and recurrent seizures A E^P A . . . E^` A . . . E^p A HYDROXYZINE d00907A B* F41.9 Anxiety disorder, unspecified A E^p A SERTRALINE d00880A B* F41.9 Anxiety disorder, unspecified A E^ A . . . E^ A . . . E^ A . . . E^ A CLOPIDOGREL d04258A D I10 I51.9 Essential (primary) hypertension Heart disease, unspecified A` E^ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E^ A METOPROLOL d00134A D I10 Essential (primary) hypertension A` E^ A PANTOPRAZOLE d04514A Dc K21 Gastro-esophageal reflux disease A` E^ A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E^ A TAMSULOSIN d04121A C R35 Polyuria A` E^ A BUPROPION d00181A B= F90 Attention-deficit hyperactivity disorders A E^ A APIXABAN d07804A C D75.9P Prevent blood clots A E^ A CINACALCET d05218A B 55555 A E^ A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A E^ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E^ A NORTRIPTYLINE d00144A C 99999 A E^ A PANTOPRAZOLE d04514A B R63 Symptoms and signs concerning food and fluid intake A E^ A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A E^ A PREGABALIN d05508A B[ E11.4 Type 2 diabetes mellitus with neurological complications A E^ A TAMSULOSIN d04121A B R35 Polyuria A E^ A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E^ A ASPIRIN d00170A CDp D75.9P Prevent blood clots Ap E^ A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E^ A NAPROXEN d00019A Cr M79.1 Myalgia Ap E^ A PREDNISOLONE OPHTHALMIC d03221A C Z48.8 Encounter for other specified postprocedural aftercare Ap E^ A TAMSULOSIN d04121A CDp N40 Enlarged prostate Ap E^ A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma Ap E^ A . . . E_ A . . . E_ A . . . E_ A ALBUTEROL d00749A C J45 Asthma A E_ A DOXAZOSIN d00726A C R39.1 Other difficulties with micturition A E_ A FINASTERIDE d00563A B N40 Enlarged prostate A E_ A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E_ A LOSARTAN d03821A C I10 Essential (primary) hypertension A E_ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E_ A MONTELUKAST d04289A A J45 Asthma A E_ A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A E_0 A FLUOXETINE d00236A Ap F41.9 Anxiety disorder, unspecified A0 E_0 A HYDROXYZINE d00907A B T78.40 Allergy, unspecified A0 E_0 A MELOXICAM d04532A CDp G89 Pain, not elsewhere classified A0 E_@ A . . . E_P A . . . E_` A ALBUTEROL d00749A CDp J45 Asthma A E_p A . . . E_ A ALBUTEROL d00749A C R06.2 Wheezing AP E_ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives AP E_ A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified AP E_ A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension AP E_ A METFORMIN d03807A C[@ R73 Elevated blood glucose level AP E_ A ALBUTEROL d00749A0 D* J44.9 Chronic obstructive pulmonary disease, unspecified A E_ A ARFORMOTEROL d05893A0 C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E_ A AZITHROMYCIN d00091A0 CDp J42 Unspecified chronic bronchitis A E_ A BUDESONIDE d04276A0 C- J44.9 Chronic obstructive pulmonary disease, unspecified A E_ A BUDESONIDE d04276A0 C- J44.9 Chronic obstructive pulmonary disease, unspecified A E_ A CEFDINIR d04256A0 CDp Z79 Long term (current) drug therapy A E_ A DIGOXIN d00210A0 B I50.9 Heart failure, unspecified A E_ A DOXYCYCLINE d00037A0 CDp J20.9 Acute bronchitis, unspecified A E_ A FUROSEMIDE d00070A0 Cr I51.9 Heart disease, unspecified A E_ A IPRATROPIUM d00265A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A E_ A ISOSORBIDE MONONITRATE d00269A0 C- I21.P Prevent heart attack/myocardial infarction A E_ A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified A E_ A NITROGLYCERIN d00321A0 C R07.9 Chest pain, unspecified A E_ A ONDANSETRON d00867A0 C R11 Nausea and vomiting A E_ A THEOPHYLLINE d00142A0 D9 J44.9 Chronic obstructive pulmonary disease, unspecified A E_ A . . . E_ A . . . E_ A . . . E_ A . . . E_ A . . . E_ A . . . E` A . . . E` A . . . E` A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A0 E` A GABAPENTIN d03182A B M79.7 Fibromyalgia A0 E` A LISINOPRIL d00732A B[ I21.P Prevent heart attack/myocardial infarction A0 E`0 A . . . E`@ A LOSARTAN d03821A B I51.9P Prevent heart disease A E`@ A SIMVASTATIN d00746A B 99999 A E`P A . . . E`` A . . . E`p A . . . E` A LINACLOTIDE d07902A B K59.0 Constipation A E` A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A E` A . . . E` A . . . E` A . . . E` A . . . E` A ETHINYL ESTRADIOL; ETONOGESTREL d04773A Cr N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E` A . . . E` A . . . Ea A ALLOPURINOL d00023A B M1A Chronic gout A` Ea A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A` Ea A CARVEDILOL d03847A B I50.9 Heart failure, unspecified A` Ea A CLOPIDOGREL d04258A B Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` Ea A COLCHICINE d00150A Cr M1A Chronic gout A` Ea A TRAZODONE d00395A C G47.0 Insomnia A` Ea A ACETAMINOPHEN; HYDROCODONE d03428A A T14.9 Unspecified injury A Ea A . . . Ea0 A . . . Ea@ A . . . EaP A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A EaP A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A Ea` A . . . Eap A . . . Ea A . . . Ea A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 Ea A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A0 Ea A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 Ea A . . . Ea A NAPROXEN d00019A B[ M79.1 Myalgia A Ea A RANITIDINE d00021A B[ R12 Heartburn A Ea A ISOTRETINOIN d01245A B L70 Acne A Ea A DONEPEZIL d04099A Cr G31.9 Degenerative disease of nervous system, unspecified A` Ea A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` Ea A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` Ea A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A` Ea A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Ea A TAMSULOSIN d04121A C N40 Enlarged prostate A` Ea A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A Ea A . . . Eb A . . . Eb A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP Eb A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP Eb A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP Eb A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease AP Eb A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP Eb A . . . Eb0 A . . . Eb@ A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A EbP A MOMETASONE TOPICAL d01300A A L20.9 Atopic dermatitis, unspecified A Eb` A 99999 . . A Ebp A . . . Eb A . . . Eb A ECONAZOLE TOPICAL d01271A C B35 Dermatophytosis AP Eb A FINASTERIDE d00563A Dc N40 Enlarged prostate AP Eb A MOMETASONE TOPICAL d01300A A C80.1 Malignant (primary) neoplasm, unspecified AP Eb A PRAZOSIN d00138A B[ F43.1 Post-traumatic stress disorder (PTSD) AP Eb A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia AP Eb A ALBUTEROL; IPRATROPIUM d04066A Bz 55555 Ap Eb A ATENOLOL d00004A Bz I10 Essential (primary) hypertension Ap Eb A CALCIUM ACETATE d03689A Bz 99999 Ap Eb A CLONIDINE d00044A Bz I10 Essential (primary) hypertension Ap Eb A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension Ap Eb A METOPROLOL d00134A Bz 99999 Ap Eb A MINOXIDIL d00135A Bz 99999 Ap Eb A . . . Eb A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Eb A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A Eb A . . . Eb A . . . Eb A . . . Ec A . . . Ec A ENALAPRIL d00013A Dc I10 Essential (primary) hypertension A Ec A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A Ec A . . . Ec0 A . . . Ec@ A METHYLPHENIDATE d00900A D F84 F90 Pervasive developmental disorders Attention-deficit hyperactivity disorders A EcP A 99999 . . A Ec` A ASPIRIN d00170A C[@ D75.9P Prevent blood clots A@ Ec` A INSULIN ISOPHANE (NPH) d04370A Cr E11 Type 2 diabetes mellitus A@ Ec` A METFORMIN d03807A D# E11 Type 2 diabetes mellitus A@ Ec` A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus A@ Ecp A ALFUZOSIN d04797A B[ N40 Enlarged prostate A0 Ecp A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A0 Ecp A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 Ec A . . . Ec A . . . Ec A . . . Ec A . . . Ec A . . . Ec A . . . Ec A . . . Ec A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A Ec A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A Ed A . . . Ed A MONTELUKAST d04289A Cr J45 Asthma A Ed A . . . Ed0 A CETIRIZINE d03827A A@ J00 Acute nasopharyngitis [common cold] A Ed@ A AMOXICILLIN d00088A A0 H66.9 Otitis media, unspecified A Ed@ A CEFDINIR d04256A A H66.9 Otitis media, unspecified A EdP A AMOXICILLIN d00088A Ap N30 Cystitis A EdP A BROMPHENIRAMINE; DIPHENHYDRAMINE; PHENYLEPHRINE d07064A A0 J00 R05 R09.81 Acute nasopharyngitis [common cold] Cough Nasal congestion A Ed` A . . . Edp A . . . Ed A . . . Ed A . . . Ed A AMOXICILLIN d00088A A@ K05.6 Periodontal disease, unspecified A Ed A CARVEDILOL d03847A C[@ I49.9 Cardiac arrhythmia, unspecified A Ed A CLOPIDOGREL d04258A C[@ 99999 A Ed A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A Ed A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A Ed A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A Ed A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Ed A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A Ed A WARFARIN d00022A C[@ I49.9 I80.3 Cardiac arrhythmia, unspecified Phlebitis and thrombophlebitis of lower extremities, unspecified A Ed A AMIODARONE d00002A C I49.9 Cardiac arrhythmia, unspecified A Ed A AMLODIPINE d00689A C I21.P Prevent heart attack/myocardial infarction A Ed A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A Ed A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A Ed A NIACIN d00314A C E78.0 Pure hypercholesterolemia A Ed A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A Ed A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A Ed A RIVAROXABAN d07356A C I48.9 Unspecified atrial fibrillation and atrial flutter A Ed A TRAMADOL d03826A Cr R52 Pain, unspecified A Ed A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ Ed A METOPROLOL d00134A C- I10 Essential (primary) hypertension A@ Ed A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A@ Ed A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ Ed A . . . Ed A BENZTROPINE d00175A C- T88.7P Prevent drug side effect A Ed A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified A Ed A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified A Ed A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A Ed A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A Ed A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Ed A METOPROLOL d00134A C- I10 Essential (primary) hypertension A Ed A MIRTAZAPINE d04025A C- F32.9 Major depressive disorder, single episode, unspecified A Ed A NALTREXONE d01406A C- E66 Overweight and obesity A Ed A OLANZAPINE d04050A C- F29 Unspecified psychosis not due to a substance or known physiological condition A Ed A POTASSIUM CHLORIDE d00345A C- T88.7P Prevent drug side effect A Ed A RANITIDINE d00021A C- K21 R12 Gastro-esophageal reflux disease Heartburn A Ed A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A Ed A . . . Ee A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A Ee A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A Ee A . . . Ee A . . . Ee0 A . . . Ee@ A 99999 . . AP Ee@ A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified AP Ee@ A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm AP Ee@ A TIZANIDINE d04102A B M62.83 Muscle spasm AP Ee@ A TOPIRAMATE d04115A B= G43 Migraine AP EeP A TRIMETHOBENZAMIDE d00862A C ` G43 Migraine A Ee` A ALLOPURINOL d00023A C N20.0 Calculus of kidney A` Ee` A CYCLOSPORINE d00079A C R39.9 Unspecified symptoms and signs involving the genitourinary system A` Ee` A METOPROLOL d00134A C I10 Essential (primary) hypertension A` Ee` A MYCOPHENOLATE MOFETIL d03839A C 55555 A` Ee` A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A` Ee` A PREDNISONE d00350A C N28.9 Disorder of kidney and ureter, unspecified A` Eep A 99999 . . A0 Eep A LOSARTAN d03821A C- 99999 A0 Eep A METFORMIN d03807A C- R73 Elevated blood glucose level A0 Ee A WARFARIN d00022A C L93 Lupus erythematosus A Ee A . . . Ee A . . . Ee A . . . Ee A . . . Ee A LEVOTHYROXINE d00278A B= E03.9 Hypothyroidism, unspecified A Ee A METFORMIN d03807A B E11 Type 2 diabetes mellitus A Ee A ACETAMINOPHEN; HYDROCODONE d03428A D M19.9 Osteoarthritis, unspecified site A Ee A PANTOPRAZOLE d04514A D K30 Functional dyspepsia A Ee A BECLOMETHASONE NASAL d04275A A J30.9 Allergic rhinitis, unspecified A Ef A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 Ef A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A0 Ef A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A0 Ef A . . . Ef A ALBUTEROL d00749A B= J98.9 Respiratory disorder, unspecified A Ef0 A . . . Ef@ A CLONIDINE d00044A C- I10 Essential (primary) hypertension AP Ef@ A LABETALOL d00016A CP I10 Essential (primary) hypertension AP Ef@ A OLMESARTAN d04801A B I10 Essential (primary) hypertension AP Ef@ A OMEPRAZOLE d00325A C K30 Functional dyspepsia AP Ef@ A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia AP EfP A . . . Ef` A . . . Efp A AZELASTINE OPHTHALMIC d04541A C H10.1 Acute atopic conjunctivitis A@ Efp A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A@ Efp A DILTIAZEM d00045A C I10 Essential (primary) hypertension A@ Efp A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Eg A . . . Eg A IBUPROFEN d00015A A N94 Pain and other conditions associated with female genital organs and menstrual cycle A@ Eg A ONDANSETRON d00867A A R11 Nausea and vomiting A@ Eg A RANITIDINE d00021A B K30 Functional dyspepsia A@ Eg A TRAMADOL d03826A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A@ Eg A . . . Eg0 A . . . Eg@ A . . . EgP A METFORMIN d03807A CDp R73 Elevated blood glucose level A Eg` A . . . Egp A ACETAMINOPHEN; HYDROCODONE d03428A0 C M79.6 Pain in limb, hand, foot, fingers and toes A@ Egp A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ Egp A KETOCONAZOLE TOPICAL d03202A0 C[@ B35 Dermatophytosis A@ Egp A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ Eg A . . . Eg A AMLODIPINE d00689A CDp 99999 B Eg A AMOXICILLIN d00088A A K05.6 Periodontal disease, unspecified B Eg A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A CDp H40 Glaucoma B Eg A BUTALBITAL d03061A C- R51 Headache B Eg A CLOPIDOGREL d04258A C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets B Eg A DEXLANSOPRAZOLE d07395A C[@ K21 Gastro-esophageal reflux disease B Eg A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma B Eg A LOSARTAN d03821A CDp 99999 B Eg A MELOXICAM d04532A C 99999 B Eg A METFORMIN d03807A C- E11 Type 2 diabetes mellitus B Eg A NEBIVOLOL d05265A CDp R51 Headache B Eg A PHENYTOIN d00143A CDp G40 Epilepsy and recurrent seizures B Eg A PILOCARPINE OPHTHALMIC d01191A CDp H26.9 H40 Unspecified cataract Glaucoma B Eg A TAMSULOSIN d04121A C- N42.9 Disorder of prostate, unspecified B Eg A TOPIRAMATE d04115A C- R51 Headache B Eg A TRAMADOL d03826A C- R51 Headache B Eg A . . . Eg A . . . Eg A . . . Eg A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A Eg A . . . Eg A ALBUTEROL d00749A C J45 Asthma A@ Eg A CETIRIZINE d03827A C J45 Asthma A@ Eg A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A@ Eg A MONTELUKAST d04289A C J45 Asthma A@ Eh A . . . Eh A . . . Eh A . . . Eh0 A . . . Eh@ A . . . EhP A . . . Eh` A . . . Ehp A . . . Eh A AMLODIPINE d00689A C"0 I10 Essential (primary) hypertension AP Eh A GLIMEPIRIDE d03864A C[@ E11 Type 2 diabetes mellitus AP Eh A HYDRALAZINE d00132A C I10 Essential (primary) hypertension AP Eh A QUINAPRIL d00365A Cr I10 Essential (primary) hypertension AP Eh A TRIAMTERENE d00396A C[@ I10 Essential (primary) hypertension AP Eh A . . . Eh A LOSARTAN d03821A B I10 Essential (primary) hypertension A Eh A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia AP Eh A DILTIAZEM d00045A0 C I49.9 Cardiac arrhythmia, unspecified AP Eh A FLUTICASONE NASAL d04283A0 CDp R09.81 Nasal congestion AP Eh A METOPROLOL d00134A0 Dc I10 Essential (primary) hypertension AP Eh A RIVAROXABAN d07356A0 CDp I48.9 Unspecified atrial fibrillation and atrial flutter AP Eh A GLIPIZIDE d00246A C E11.P Prevent diabetes A0 Eh A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 Eh A WARFARIN d00022A C I26 I80.3 Pulmonary embolism Phlebitis and thrombophlebitis of lower extremities, unspecified A0 Eh A . . . Eh A . . . Eh A . . . Ei A HYDRALAZINE d00132A C L93 Lupus erythematosus AP Ei A HYDROXYCHLOROQUINE d00817A C I10 Essential (primary) hypertension AP Ei A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP Ei A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP Ei A WARFARIN d00022A C D75.9P Prevent blood clots AP Ei A CARBAMAZEPINE d00058A BL F31.9 Bipolar disorder, unspecified A@ Ei A LORAZEPAM d00149A B[ F41.9 Anxiety disorder, unspecified A@ Ei A MIRTAZAPINE d04025A BL F32.9 Major depressive disorder, single episode, unspecified A@ Ei A QUETIAPINE d04220A B= F31.9 Bipolar disorder, unspecified A@ Ei A FLUTICASONE NASAL d04283A C- J30.2 R09.81 Other seasonal allergic rhinitis Nasal congestion A Ei0 A . . . Ei@ A . . . EiP A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A@ EiP A CETIRIZINE d03827A C T78.40 Allergy, unspecified A@ EiP A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A@ EiP A PREDNISOLONE d00084A A J42 Unspecified chronic bronchitis A@ Ei` A 99999 . . A0 Ei` A BECLOMETHASONE d00760A C"0 J45 Asthma A0 Ei` A CETIRIZINE d03827A C"0 T78.40 Allergy, unspecified A0 Eip A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction AP Eip A ATENOLOL d00004A C I49.9 Cardiac arrhythmia, unspecified AP Eip A COLCHICINE d00150A C- M1A Chronic gout AP Eip A METFORMIN d03807A Ei R73 Elevated blood glucose level AP Eip A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP Ei A . . . Ei A . . . Ei A ALENDRONATE d03849A B[ 55555 A Ei A AMIODARONE d00002A CDp I51.9 Heart disease, unspecified A Ei A AMLODIPINE d00689A B 55555 A Ei A ATORVASTATIN d04105A C[@ I21.P Prevent heart attack/myocardial infarction A Ei A CLOPIDOGREL d04258A C[@ Z48.8 Encounter for other specified postprocedural aftercare A Ei A FUROSEMIDE d00070A C[@ I51.9 Heart disease, unspecified A Ei A LEVOTHYROXINE d00278A C 99999 A Ei A SAXAGLIPTIN d07467A C E11 Type 2 diabetes mellitus A Ei A IBUPROFEN d00015A B= F43.1 Post-traumatic stress disorder (PTSD) A Ei A . . . Ei A . . . Ei A EZETIMIBE; SIMVASTATIN d05348A Dc E78.1 Pure hyperglyceridemia A Ei A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A Ei A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A Ei A OLMESARTAN d04801A C- I10 Essential (primary) hypertension A Ej A . . . Ej A BROMPHENIRAMINE; PHENYLEPHRINE d03311A Ap R09.81 Nasal congestion A@ Ej A CETIRIZINE d03827A C T78.40 Allergy, unspecified A@ Ej A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A@ Ej A SERTRALINE d00880A B= F41.9 Anxiety disorder, unspecified A@ Ej A . . . Ej0 A . . . Ej@ A 77777 . . A EjP A FENOFIBRATE d04286A B= E78.0 Pure hypercholesterolemia A@ EjP A FLUTICASONE d01296A0 B= R06.2 Wheezing A@ EjP A HYDROCHLOROTHIAZIDE d00253A0 B= I10 Essential (primary) hypertension A@ EjP A OMEPRAZOLE d00325A0 B= K21 Gastro-esophageal reflux disease A@ Ej` A . . . Ejp A . . . Ej A . . . Ej A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A0 Ej A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 Ej A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A0 Ej A . . . Ej A . . . Ej A . . . Ej A . . . Ej A . . . Ej A ANASTROZOLE d03873A B= C50 Malignant neoplasm of breast Ap Ej A DAPAGLIFLOZIN; METFORMIN d08245A C E11 Type 2 diabetes mellitus Ap Ej A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension Ap Ej A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus Ap Ej A METOPROLOL d00134A B[ E11 Type 2 diabetes mellitus Ap Ej A POLYETHYLENE GLYCOL 3350 d05350A B[ K59.0 Constipation Ap Ej A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus Ap Ek A ALBUTEROL d00749A C J45 Asthma A0 Ek A BECLOMETHASONE d00760A CDp J45 Asthma A0 Ek A CETIRIZINE d03827A Ap T78.40 Allergy, unspecified A0 Ek A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A Ek A . . . Ek0 A . . . Ek@ A . . . EkP A FLUTICASONE NASAL d04283A C"0 J34.9 Unspecified disorder of nose and nasal sinuses A Ek` A ACETAMINOPHEN; OXYCODONE d03431A C M19.9 M54 M79.7 Osteoarthritis, unspecified site Dorsalgia Fibromyalgia A Ek` A AMOXICILLIN d00088A A K04.7P Prevent tooth infection A Ek` A FUROSEMIDE d00070A CDp J98.9 R60.9 Respiratory disorder, unspecified Edema, unspecified A Ek` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A Ek` A HYDROXYCHLOROQUINE d00817A C- M79.7 Fibromyalgia A Ek` A MONTELUKAST d04289A C J45 Asthma A Ek` A OXYBUTYNIN d00328A C R32 Unspecified urinary incontinence A Ek` A TIZANIDINE d04102A CDp M62.83 M79.1 Muscle spasm Myalgia A Ekp A . . . Ek A AMLODIPINE d00689A B I10 Essential (primary) hypertension A@ Ek A CARVEDILOL d03847A0 Cr I10 Essential (primary) hypertension A@ Ek A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A@ Ek A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia A@ Ek A CETIRIZINE d03827A A L23 Allergic contact dermatitis A Ek A . . . Ek A . . . Ek A . . . Ek A . . . Ek A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Ek A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A El A 99999 . . A El A . . . El A ATORVASTATIN d04105A C 99999 A El A METFORMIN d03807A Ei E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A El0 A . . . El@ A . . . ElP A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A0 ElP A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 ElP A PITAVASTATIN d07637A Bz E78.0 Pure hypercholesterolemia A0 El` A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension AP El` A HYDROXYZINE d00907A B L20.9 Atopic dermatitis, unspecified AP El` A SERTRALINE d00880A Dc F32.9 Major depressive disorder, single episode, unspecified AP El` A TOPIRAMATE d04115A C G47.0 Insomnia AP El` A TRAZODONE d00395A Dc G47.0 Insomnia AP Elp A . . . El A . . . El A IBUPROFEN d00015A A@ R50.9 Fever, unspecified A El A . . . El A . . . El A . . . El A FLUTICASONE NASAL d04283A Cr J30.1 J30.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified A0 El A MONTELUKAST d04289A C J45 R06.9 Asthma Unspecified abnormalities of breathing A0 El A RANITIDINE d00021A C- K30 Functional dyspepsia A0 El A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 El A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A0 El A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 El A CEFPROZIL d00073A A H66.9 Otitis media, unspecified A Em A . . . Em A ATENOLOL d00004A D I10 Essential (primary) hypertension A0 Em A LOSARTAN d03821A D I10 Essential (primary) hypertension A0 Em A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 Em A LISINOPRIL d00732A B I10 Essential (primary) hypertension A Em0 A . . . Em@ A ALBUTEROL d00749A C- J20.9 R05 R06.02 Acute bronchitis, unspecified Cough Shortness of breath A Em@ A BUDESONIDE d04276A C J20.9 R05 R06.02 Acute bronchitis, unspecified Cough Shortness of breath A EmP A . . . Em` A . . . Emp A . . . Em A . . . Em A . . . Em A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ Em A ATORVASTATIN d04105A D9 E78.0 Pure hypercholesterolemia A@ Em A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A@ Em A METFORMIN d03807A C R73 Elevated blood glucose level A@ Em A . . . Em A . . . Em A . . . Em A . . . Em A . . . En A . . . En A ALENDRONATE d03849A C[@ M81 Osteoporosis without current pathological fracture A@ En A ATENOLOL d00004A C[@ I49.9 Cardiac arrhythmia, unspecified A@ En A DILTIAZEM d00045A C R00 Abnormalities of heart beat A@ En A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ En A ALENDRONATE d03849A D"8 M81 Osteoporosis without current pathological fracture A En A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A En A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A En A DULOXETINE d05355A CDp R10 Abdominal and pelvic pain A En A ESTRADIOL d00537A D"8 N95 Menopausal and other perimenopausal disorders A En A FLUTICASONE; SALMETEROL d04611A CP J44.9 Chronic obstructive pulmonary disease, unspecified A En A OMEPRAZOLE d00325A CDp R10 Abdominal and pelvic pain A En A ROPINIROLE d04215A C G25.81 Restless legs syndrome A En A ZOLPIDEM d00910A C G47.0 Insomnia A En0 A . . . En@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A En@ A SPIRONOLACTONE d00373A B( E28 Ovarian dysfunction A EnP A APIXABAN d07804A C I48.9 Unspecified atrial fibrillation and atrial flutter A EnP A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A EnP A DRONEDARONE d07458A C- I48.9 Unspecified atrial fibrillation and atrial flutter A EnP A FLUTICASONE d01296A D* J45 Asthma A EnP A FLUTICASONE NASAL d04283A Cr J45 Asthma A EnP A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A EnP A METOPROLOL d00134A CDp I51.9 Heart disease, unspecified A EnP A OMEPRAZOLE d00325A Dc K30 Functional dyspepsia A EnP A TAMSULOSIN d04121A C[@ N32.9 Bladder disorder, unspecified A EnP A TIOTROPIUM d04829A CDp J45 Asthma A En` A . . . Enp A CHOLESTYRAMINE d00193A D 55555 A Enp A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A En A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP En A ENALAPRIL d00013A D I10 Essential (primary) hypertension AP En A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension AP En A OMEPRAZOLE d00325A D K92.9 R12 Disease of digestive system, unspecified Heartburn AP En A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP En A . . . En A MINOCYCLINE d00110A B R50.9 Fever, unspecified A En A . . . En A . . . En A . . . En A . . . En A . . . Eo A DESONIDE TOPICAL d01290A C L20.9 Atopic dermatitis, unspecified A Eo A TRIAMCINOLONE TOPICAL d03206A Bz L20.9 Atopic dermatitis, unspecified A Eo A . . . Eo A . . . Eo0 A AMLODIPINE d00689A B I10 Essential (primary) hypertension A Eo0 A ATENOLOL d00004A C I10 Essential (primary) hypertension A Eo0 A ENALAPRIL d00013A D I10 Essential (primary) hypertension A Eo0 A FUROSEMIDE d00070A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A Eo0 A GABAPENTIN d03182A Dc G25.81 M79.2 Restless legs syndrome Neuralgia and neuritis, unspecified A Eo0 A OMEPRAZOLE d00325A D K30 Functional dyspepsia A Eo0 A RIVAROXABAN d07356A Cr I48.9 I80.3 Unspecified atrial fibrillation and atrial flutter Phlebitis and thrombophlebitis of lower extremities, unspecified A Eo0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A Eo0 A SITAGLIPTIN d05896A Dc E11 Type 2 diabetes mellitus A Eo@ A . . . EoP A . . . Eo` A DEXTROMETHORPHAN; PROMETHAZINE d03360A A@ R05 Cough A0 Eo` A METHOCARBAMOL d00965A A` M79.1 Myalgia A0 Eo` A NAPROXEN d00019A A0 M79.1 Myalgia A0 Eop A BUPROPION d00181A D F41.9 Anxiety disorder, unspecified AP Eop A CLONAZEPAM d00197A B F32.9 Major depressive disorder, single episode, unspecified AP Eop A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified AP Eop A QUETIAPINE d04220A C F43.1 Post-traumatic stress disorder (PTSD) AP Eop A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified AP Eo A . . . Eo A . . . Eo A . . . Eo A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A` Eo A ATENOLOL d00004A C I10 Essential (primary) hypertension A` Eo A CLONIDINE d00044A C I10 Essential (primary) hypertension A` Eo A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` Eo A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` Eo A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Eo A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Eo A . . . Eo A . . . Eo A . . . Ep A . . . Ep A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia AP Ep A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified AP Ep A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP Ep A OMEPRAZOLE d00325A Cr K21 K30 Gastro-esophageal reflux disease Functional dyspepsia AP Ep A TAMSULOSIN d04121A CDp R39.1 Other difficulties with micturition AP Ep A . . . Ep0 A 77777 . . A Ep@ A . . . EpP A . . . Ep` A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B= Z79.3 Long term (current) use of hormonal contraceptives A Epp A . . . Ep A . . . Ep A ALBUTEROL d00749A C J45 Asthma A Ep A PREDNISOLONE d00084A B R09.3 Abnormal sputum A Ep A ASPIRIN d00170A C[@ I21.P Prevent heart attack/myocardial infarction AP Ep A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia AP Ep A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Ep A LOSARTAN d03821A B I10 Essential (primary) hypertension AP Ep A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP Ep A . . . Ep A . . . Ep A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B= 55555 A0 Ep A METOPROLOL d00134A C- I49.9 Cardiac arrhythmia, unspecified A0 Ep A PHENTERMINE d00806A B- E66 Overweight and obesity A0 Ep A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A Ep A . . . Eq A ACETAMINOPHEN; HYDROCODONE d03428A B[ M54 Dorsalgia A Eq A ALBUTEROL d00749A Cr J45 Asthma A Eq A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A Eq A BACLOFEN d00967A C[@ M62.83 Muscle spasm A Eq A CETIRIZINE d03827A Bz T78.40 Allergy, unspecified A Eq A GABAPENTIN d03182A CDp M79.7 Fibromyalgia A Eq A HYDROXYCHLOROQUINE d00817A CDp M06.9 Rheumatoid arthritis, unspecified A Eq A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A Eq A LISINOPRIL d00732A D I10 Essential (primary) hypertension A Eq A METFORMIN d03807A D E11 Type 2 diabetes mellitus A Eq A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Eq A TRAMADOL d03826A B[ M54 Dorsalgia A Eq A VENLAFAXINE d03181A C M54 Dorsalgia A Eq A . . . Eq A . . . Eq0 A . . . Eq@ A . . . EqP A . . . Eq` A . . . Eqp A . . . Eq A NAPROXEN d00019A C- M13 R06.9 Other arthritis Unspecified abnormalities of breathing AP Eq A NIFEDIPINE d00051A Dc R07.9 Chest pain, unspecified AP Eq A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP Eq A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia AP Eq A QUINAPRIL d00365A Cr I10 Essential (primary) hypertension AP Eq A ARIPIPRAZOLE d04825A Cr F32.9 Major depressive disorder, single episode, unspecified A Eq A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified A Eq A CHLORHEXIDINE TOPICAL d01231A C K05.6 Periodontal disease, unspecified A Eq A CICLOPIROX TOPICAL d01272A C- B35 Dermatophytosis A Eq A FLUTICASONE d01296A C- R06.2 Wheezing A Eq A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Eq A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A Eq A PREDNISOLONE OPHTHALMIC d03221A C 55555 A Eq A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A Eq A . . . Eq A . . . Eq A . . . Eq A . . . Eq A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A Eq A . . . Er A BICALUTAMIDE d03850A C C61 Malignant neoplasm of prostate A@ Er A HYDROCHLOROTHIAZIDE d00253A DGJ I10 Essential (primary) hypertension A@ Er A LEUPROLIDE d01353A C C61 Malignant neoplasm of prostate A@ Er A LISINOPRIL d00732A DGJ I10 Essential (primary) hypertension A@ Er A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A Er A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A Er A HYDROCHLOROTHIAZIDE d00253A Ei I10 Essential (primary) hypertension A Er0 A BACLOFEN d00967A A M79.1 Myalgia A` Er0 A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A` Er0 A LEVOTHYROXINE d00278A CDp E04 Other nontoxic goiter A` Er0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` Er0 A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A` Er0 A TERBINAFINE d04012A B[ B35 Dermatophytosis A` Er@ A ACETAMINOPHEN; HYDROCODONE d03428A C"0 M54 Dorsalgia A ErP A . . . Er` A . . . Erp A . . . Er A MECLIZINE d00859A B R42 Dizziness and giddiness A Er A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A Er A . . . Er A . . . Er A ASPIRIN d00170A B 99999 A Er A CLONIDINE d00044A C 99999 A Er A CLOPIDOGREL d04258A B 99999 A Er A FAMOTIDINE d00141A B 99999 A Er A LABETALOL d00016A C 99999 A Er A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Er A METFORMIN d03807A C 99999 A Er A ROSUVASTATIN d04851A B 99999 A Er A VERAPAMIL d00048A B I63.P Prevent stroke A Er A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A0 Er A RANITIDINE d00021A C R12 Heartburn A0 Er A VALACYCLOVIR d03838A D ^ A60.9 Anogenital herpesviral infection, unspecified A0 Er A . . . Er A . . . Er A . . . Es A . . . Es A . . . Es A CETIRIZINE d03827A C T78.40 Allergy, unspecified A Es A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A Es0 A . . . Es@ A . . . EsP A . . . Es` A . . . Esp A . . . Es A . . . Es A . . . Es A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Es A . . . Es A CEPHALEXIN d00096A Ap N39.0 Urinary tract infection, site not specified A Es A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A Es A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ Es A INSULIN ISOPHANE; INSULIN REGULAR d04374A Cr E11 Type 2 diabetes mellitus A@ Es A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ Es A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ Es A 99999 . . A@ Es A BUSPIRONE d00182A C F32.9 Major depressive disorder, single episode, unspecified A@ Es A IBUPROFEN d00015A C M54 Dorsalgia A@ Es A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ Et A AMLODIPINE d00689A B= I10 Essential (primary) hypertension AP Et A DICYCLOMINE d00999A C K50 Crohn's disease [regional enteritis] AP Et A ESOMEPRAZOLE d04749A C K50 Crohn's disease [regional enteritis] AP Et A FLUTICASONE d01296A C[@ J45 Asthma AP Et A FLUTICASONE; SALMETEROL d04611A C J45 Asthma AP Et A AZATHIOPRINE d00024A Cr K51 Ulcerative colitis AP Et A COLCHICINE d00150A C[@ M1A Chronic gout AP Et A MESALAMINE d01031A CDp K51 Ulcerative colitis AP Et A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP Et A WARFARIN d00022A D I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified AP Et A ANTIFUNGALS - UNSPECIFIED c00004. . B37 Candidiasis A Et A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A Et0 A . . . Et@ A . . . EtP A . . . Et` A . . . Etp A . . . Et A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 Et A CONJUGATED ESTROGENS d00541A DGJ N95 Menopausal and other perimenopausal disorders A0 Et A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A0 Et A . . . Et A . . . Et A . . . Et A . . . Et A ESCITALOPRAM d04812A C- F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder A Et A . . . Et A APIXABAN d07804A A D75.9P I21.P I63.P Prevent blood clots Prevent heart attack/myocardial infarction Prevent stroke A Et A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Et A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A Ei H40 Glaucoma A Et A BRINZOLAMIDE OPHTHALMIC d04301A Ei H40 Glaucoma A Et A CITALOPRAM d04332A Ei M79.2 Neuralgia and neuritis, unspecified A Et A INSULIN DETEMIR d05436A Ei E11 Type 2 diabetes mellitus A Et A LATANOPROST OPHTHALMIC d04017A Ei H40 Glaucoma A Et A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A Eu A . . . Eu A . . . Eu A . . . Eu0 A . . . Eu@ A . . . EuP A AMOXICILLIN d00088A Cr H66.9 J02 Otitis media, unspecified Acute pharyngitis A Eu` A . . . Eup A ACETAMINOPHEN; OXYCODONE d03431A Cr M54 Dorsalgia A Eup A ALBUTEROL; IPRATROPIUM d04066A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A Eup A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A Eup A ATORVASTATIN d04105A B I20.9 Angina pectoris, unspecified A Eup A BACLOFEN d00967A C- M62.83 Muscle spasm A Eup A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A Eup A CLOPIDOGREL d04258A B E78.0 Pure hypercholesterolemia A Eup A GABAPENTIN d03182A Cr M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia A Eup A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A Eup A IBUPROFEN d00015A Cr M54 Dorsalgia A Eup A NITROGLYCERIN d00321A B I20.9 Angina pectoris, unspecified A Eup A OMEPRAZOLE d00325A Ap K30 Functional dyspepsia A Eu A . . . Eu A ADALIMUMAB d04835A Dc L40 M06.9 Psoriasis Rheumatoid arthritis, unspecified A Eu A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Eu A . . . Eu A . . . Eu A . . . Eu A CLONIDINE d00044A B F41.9 Anxiety disorder, unspecified A@ Eu A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified A@ Eu A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A@ Eu A TRAZODONE d00395A B G47.0 Insomnia A@ Eu A . . . Eu A ALBUTEROL d00749A C J45 Asthma A Eu A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Eu A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Eu A FLUTICASONE; SALMETEROL d04611A C J43 Emphysema A Eu A FUROSEMIDE d00070A D= J98.9 Respiratory disorder, unspecified A Eu A GABAPENTIN d03182A B E11.4 Type 2 diabetes mellitus with neurological complications A Eu A GLIMEPIRIDE d03864A Bz E11.P Prevent diabetes A Eu A HYDROXYZINE d00907A C J45 Asthma A Eu A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Eu A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Eu A METOLAZONE d00299A C R60.9 Edema, unspecified A Eu A MOMETASONE NASAL d04223A C J30.9 Allergic rhinitis, unspecified A Eu A NITROGLYCERIN d00321A C I99.9 Unspecified disorder of circulatory system A Eu A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A Ev A . . . Ev A . . . Ev A . . . Ev0 A . . . Ev@ A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A EvP A . . . Ev` A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified AP Ev` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP Ev` A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP Ev` A METFORMIN d03807A B R73 Elevated blood glucose level AP Ev` A VENLAFAXINE d03181A Dc F32.9 Major depressive disorder, single episode, unspecified AP Evp A . . . Ev A . . . Ev A . . . Ev A . . . Ev A . . . Ev A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B[ 55555 A@ Ev A OMEPRAZOLE d00325A C K30 Functional dyspepsia A@ Ev A QUETIAPINE d04220A C F29 F32.9 Unspecified psychosis not due to a substance or known physiological condition Major depressive disorder, single episode, unspecified A@ Ev A RISPERIDONE d03180A C F29 Unspecified psychosis not due to a substance or known physiological condition A@ Ev A . . . Ev A . . . Ev A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ev A METFORMIN d03807A D E11 Type 2 diabetes mellitus A Ew A LOSARTAN d03821A C I10 Essential (primary) hypertension A Ew A ATENOLOL d00004A D G43.P Prevent migraine AP Ew A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease AP Ew A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension AP Ew A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension AP Ew A MELOXICAM d04532A C M13 Other arthritis AP Ew A CLINDAMYCIN d00043A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A@ Ew A MELOXICAM d04532A B M79.1 Myalgia A@ Ew A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A@ Ew A TAMSULOSIN d04121A B N40 Enlarged prostate A@ Ew0 A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures A Ew@ A . . . EwP A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A Ew` A . . . Ewp A . . . Ew A . . . Ew A AMOXICILLIN d00088A A N30 Cystitis A Ew A . . . Ew A . . . Ew A . . . Ew A ALBUTEROL d00749A A R06.2 Wheezing A Ew A BUDESONIDE d04276A B R07.9 Chest pain, unspecified A Ew A INSULIN ASPART d04697A B= E11 Type 2 diabetes mellitus A Ew A INSULIN DETEMIR d05436A B= E11 Type 2 diabetes mellitus A Ew A . . . Ex A . . . Ex A . . . Ex A . . . Ex0 A . . . Ex@ A BISACODYL d01015A Dc K59.0 Constipation Ap Ex@ A BUMETANIDE d00179A Dc R60.9 Edema, unspecified Ap Ex@ A DIPHENHYDRAMINE d00212A Dc L23 Allergic contact dermatitis Ap Ex@ A FINASTERIDE d00563A Dc N39.4 N40 Other specified urinary incontinence Enlarged prostate Ap Ex@ A METOPROLOL d00134A Dc I50.9 Heart failure, unspecified Ap Ex@ A MONTELUKAST d04289A Dc J45 Asthma Ap Ex@ A TAMSULOSIN d04121A Dc N40 R39.1 Enlarged prostate Other difficulties with micturition Ap ExP A . . . Ex` A . . . Exp A TOBRAMYCIN OPHTHALMIC d03222A A@ H57.9 Unspecified disorder of eye and adnexa A Ex A . . . Ex A . . . Ex A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A Ex A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A Ex A . . . Ex A . . . Ex A . . . Ex A ARIPIPRAZOLE d04825A C F91.9 Conduct disorder, unspecified A@ Ex A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ Ex A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ Ex A TRAZODONE d00395A Cr G47.9 Sleep disorder, unspecified A@ Ex A HYDROCHLOROTHIAZIDE d00253A C E87.7 Fluid overload A@ Ex A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ Ex A SOTALOL d00371A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ Ex A WARFARIN d00022A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ Ey A . . . Ey A ACLIDINIUM d07885A0 C- J44.9 Chronic obstructive pulmonary disease, unspecified A Ey A ALBUTEROL d00749A0 C- J44.9 Chronic obstructive pulmonary disease, unspecified A Ey A ALENDRONATE d03849A0 Dc M81 Osteoporosis without current pathological fracture A Ey A AMLODIPINE d00689A0 D I10 Essential (primary) hypertension A Ey A FLUTICASONE; SALMETEROL d04611A B* J44.9 Chronic obstructive pulmonary disease, unspecified A Ey A FUROSEMIDE d00070A0 B R60.9 Edema, unspecified A Ey A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A0 D I10 Essential (primary) hypertension A Ey A LEVOTHYROXINE d00278A0 DGJ E07.9 Disorder of thyroid, unspecified A Ey A METHOTREXATE d00060A0 D M06.9 Rheumatoid arthritis, unspecified A Ey A PREDNISONE d00350A0 D M06.9 Rheumatoid arthritis, unspecified A Ey A . . . Ey0 A . . . Ey@ A ALLOPURINOL d00023A B M1A Chronic gout A Ey@ A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A EyP A . . . Ey` A . . . Eyp A . . . Ey A . . . Ey A . . . Ey A ALLOPURINOL d00023A D M1A Chronic gout A` Ey A ALPRAZOLAM d00168A Bz F41.9 Anxiety disorder, unspecified A` Ey A ATORVASTATIN d04105A C I21.P Prevent heart attack/myocardial infarction A` Ey A MELOXICAM d04532A C M79.1 Myalgia A` Ey A METOPROLOL d00134A C I10 Essential (primary) hypertension A` Ey A OMEPRAZOLE d00325A D K30 Functional dyspepsia A` Ey A . . . Ey A . . . Ey A NORETHINDRONE d00555A B Z79.3 Long term (current) use of hormonal contraceptives A Ey A . . . Ey A . . . Ez A . . . Ez A . . . Ez A . . . Ez0 A . . . Ez@ A . . . EzP A AMOXICILLIN d00088A Ap J01.9 Acute sinusitis, unspecified A Ez` A ESOMEPRAZOLE d04749A Ap K30 Functional dyspepsia A Ezp A ATORVASTATIN d04105A Cr 99999 A Ezp A CARVEDILOL d03847A Cr 99999 A Ez A . . . Ez A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP Ez A CETIRIZINE d03827A Cr 99999 AP Ez A GUAIFENESIN d00797A C[@ H04 R09.3 Disorders of lacrimal system Abnormal sputum AP Ez A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP Ez A PIOGLITAZONE d04442A Cr E11 Type 2 diabetes mellitus AP Ez A . . . Ez A . . . Ez A . . . Ez A . . . Ez A . . . Ez A . . . E{ A ALENDRONATE d03849A Bz M81 Osteoporosis without current pathological fracture A0 E{ A FEXOFENADINE d04040A C T78.40 Allergy, unspecified A0 E{ A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A0 E{ A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E{ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E{ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E{ A FLUOXETINE d00236A Cr F41.9 Anxiety disorder, unspecified AP E{ A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E{ A TAMSULOSIN d04121A CDp R35 Polyuria AP E{0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E{0 A CARVEDILOL d03847A C I21.P Z79.0 Prevent heart attack/myocardial infarction Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E{0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E{0 A TICAGRELOR d07721A C D75.9P Prevent blood clots A@ E{@ A . . . E{P A . . . E{` A ACETAMINOPHEN; HYDROCODONE d03428A D# M54 Dorsalgia B E{` A CEPHALEXIN d00096A A N39.0 Urinary tract infection, site not specified B E{` A DEXLANSOPRAZOLE d07395A C K22 Other diseases of esophagus B E{` A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified B E{` A FUROSEMIDE d00070A C- I50.9 Heart failure, unspecified B E{` A METFORMIN d03807A DU R73 Elevated blood glucose level B E{` A METOCLOPRAMIDE d00298A C R11 Nausea and vomiting B E{` A METOPROLOL d00134A CDp I50.9 Heart failure, unspecified B E{` A MONTELUKAST d04289A C J45 Asthma B E{` A NITROGLYCERIN d00321A D* R07.9 Chest pain, unspecified B E{` A PHENYTOIN d00143A D# G40 Epilepsy and recurrent seizures B E{` A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia B E{` A PREGABALIN d05508A C- M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia B E{` A QUETIAPINE d04220A Cr F31.9 Bipolar disorder, unspecified B E{` A RALOXIFENE d04261A C C50 Malignant neoplasm of breast B E{` A TIZANIDINE d04102A C- M62.83 Muscle spasm B E{p A ALBUTEROL d00749A A@ J42 Unspecified chronic bronchitis A E{p A AMOXICILLIN d00088A A@ J42 Unspecified chronic bronchitis A E{ A . . . E{ A . . . E{ A ALBUTEROL d00749A D1 J45 Asthma A E{ A ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE d08284A B B20 Human immunodeficiency virus [HIV] disease A E{ A ALBUTEROL d00749A B J45 Asthma A E{ A ALENDRONATE d03849A B= M81 Osteoporosis without current pathological fracture A E{ A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A E{ A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A E{ A FLUTICASONE d01296A C J45 Asthma A E{ A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A E{ A LAMIVUDINE; ZIDOVUDINE d04219A Cr R19.7 Diarrhea, unspecified A E{ A MOMETASONE NASAL d04223A CDp J30.9 Allergic rhinitis, unspecified A E{ A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A E{ A QUETIAPINE d04220A B F39 Unspecified mood [affective] disorder A E{ A . . . E{ A . . . E{ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E{ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E{ A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma A E{ A CLOBETASOL TOPICAL d01288A D* L30.9 Dermatitis, unspecified A E{ A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma A E{ A GABAPENTIN d03182A C M19.9 Osteoarthritis, unspecified site A E{ A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A E{ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E{ A METHOCARBAMOL d00965A B M79.6 Pain in limb, hand, foot, fingers and toes A E{ A NADOLOL d00018A CDp I10 Essential (primary) hypertension A E{ A . . . E| A CYCLOBENZAPRINE d00963A B[ F41.9 G47.0 Anxiety disorder, unspecified Insomnia A@ E| A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A@ E| A IBUPROFEN d00015A B M54 Dorsalgia A@ E| A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ E| A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A E| A LATANOPROST OPHTHALMIC d04017A Dc H40 Glaucoma A E|0 A BETHANECHOL d01427A C N42.9 Disorder of prostate, unspecified A E|0 A SILODOSIN d07354A C N40 Enlarged prostate A E|@ A AMOXICILLIN d00088A A J02 Acute pharyngitis A E|P A . . . E|` A . . . E|p A . . . E| A . . . E| A . . . E| A ALBUTEROL d00749A C[@ J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma Ap E| A FORMOTEROL d04572A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified Ap E| A FUROSEMIDE d00070A Ei 99999 Ap E| A LOSARTAN d03821A C- I10 Essential (primary) hypertension Ap E| A METOPROLOL d00134A Cr 99999 Ap E| A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia Ap E| A TIOTROPIUM d04829A C[@ J45 Asthma Ap E| A EXENATIDE d05529A C- E11 Type 2 diabetes mellitus A E| A FENOFIBRIC ACID d07371A C[@ E78.1 Pure hyperglyceridemia A E| A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E| A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ N28.9 Disorder of kidney and ureter, unspecified A E| A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E| A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E| A OMEPRAZOLE d00325A A K30 Functional dyspepsia A E| A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E| A TERBINAFINE d04012A A B35 Dermatophytosis A E| A . . . E| A . . . E| A . . . E| A . . . E} A . . . E} A . . . E} A ATENOLOL d00004A C"0 F41.9 Anxiety disorder, unspecified A0 E} A CLONAZEPAM d00197A B F41.9 Anxiety disorder, unspecified A0 E} A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified A0 E}0 A INSULIN ASPART d04697A C"0 E11 Type 2 diabetes mellitus A@ E}0 A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A@ E}0 A LISINOPRIL d00732A C[@ E11.2 Type 2 diabetes mellitus with kidney complications A@ E}0 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E}@ A HYDROCHLOROTHIAZIDE d00253A D I10 N20.0 Essential (primary) hypertension Calculus of kidney AP E}@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E}@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E}@ A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia AP E}@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E}P A . . . E}` A . . . E}p A ALBUTEROL d00749A C R05 Cough A E}p A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E} A . . . E} A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified Ap E} A FENTANYL d00233A Bz M54 Dorsalgia Ap E} A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications Ap E} A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A B E78.0 Pure hypercholesterolemia Ap E} A OXYCODONE d00329A CDp M54 Dorsalgia Ap E} A PROMETHAZINE d00787A C[@ R11 Nausea and vomiting Ap E} A ZOLPIDEM d00910A C- G47.9 Sleep disorder, unspecified Ap E} A BECLOMETHASONE d00760A B J45 Asthma A E} A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified A E} A . . . E} A . . . E} A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E} A CLOPIDOGREL d04258A D D75.9P Prevent blood clots AP E} A FENOFIBRATE d04286A D 99999 AP E} A NEBIVOLOL d05265A D E78.1 Pure hyperglyceridemia AP E} A RAMIPRIL d00728A D I10 Essential (primary) hypertension AP E} A . . . E} A . . . E~ A . . . E~ A . . . E~ A TRAMADOL d03826A B K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A E~0 A . . . E~@ A . . . E~P A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified A E~` A . . . E~p A . . . E~ A BUTALBITAL d03061A D G43 Migraine A E~ A . . . E~ A AZILSARTAN; CHLORTHALIDONE d07818A B[ I10 Essential (primary) hypertension A0 E~ A NEBIVOLOL d05265A Cr I49.9 Cardiac arrhythmia, unspecified A0 E~ A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A0 E~ A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E~ A ACETAMINOPHEN; HYDROCODONE d03428A A R10 Abdominal and pelvic pain A E~ A KETOROLAC d00273A A N94 Pain and other conditions associated with female genital organs and menstrual cycle A E~ A . . . E~ A . . . E~ A . . . E A CEPHALEXIN d00096A B N39.0 Urinary tract infection, site not specified A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ep A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma A E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A BUDESONIDE d04276A C J45 Asthma A E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E A LISINOPRIL d00732A A I10 Essential (primary) hypertension A E A IBUPROFEN d00015A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A RANITIDINE d00021A C K25.P Prevent gastric ulcer A E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ALBUTEROL d00749A0 C[@ J45 Asthma AP Ep A BENZOYL PEROXIDE TOPICAL d01246A0 B L70 Acne AP Ep A CLINDAMYCIN d00043A0 B L70 Acne AP Ep A HYDROCORTISONE TOPICAL d03205A0 D L40 Psoriasis AP Ep A PREDNISONE d00350A Ap J45 Asthma AP E A . . . E A . . . E A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A B= R51 Headache A E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B= F90 Attention-deficit hyperactivity disorders A E A FLUOXETINE d00236A B F41.9 Anxiety disorder, unspecified A E A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A0 E A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A B= K25 Gastric ulcer A0 E A MONTELUKAST d04289A A T78.40 Allergy, unspecified A E0 A MELOXICAM d04532A B[ M19.9 M79.6 Osteoarthritis, unspecified site Pain in limb, hand, foot, fingers and toes A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A BENAZEPRIL d00730A CDp I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A E A MELOXICAM d04532A CDp M79.1 Myalgia A E A METHIMAZOLE d00290A CDp E05 Thyrotoxicosis [hyperthyroidism] A E A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A E A SOLIFENACIN d05413A CDp N32.81 Overactive bladder A E A . . . E A MIRTAZAPINE d04025A C- F32.9 Major depressive disorder, single episode, unspecified A` E A MONTELUKAST d04289A C"0 J30.9 J45 Allergic rhinitis, unspecified Asthma A` E A PANTOPRAZOLE d04514A C"0 K21 K25 Gastro-esophageal reflux disease Gastric ulcer A` E A SIMVASTATIN d00746A Ei 99999 A` E A TAMSULOSIN d04121A Bz R35 Polyuria A` E A TRAMADOL d03826A Ei 99999 A` E A . . . E A DIPHENHYDRAMINE d00212A Ei 99999 A@ E A DONEPEZIL d04099A Ei 99999 A@ E A DULOXETINE d05355A Ei 99999 A@ E A MECLIZINE d00859A C- R42 Dizziness and giddiness A@ E0 A ATENOLOL d00004A C I10 Essential (primary) hypertension A E0 A OLMESARTAN d04801A C I10 Essential (primary) hypertension A E@ A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified A0 E@ A MIRABEGRON d07876A B= N32.81 Overactive bladder A0 E@ A TAMSULOSIN d04121A B N40 Enlarged prostate A0 EP A . . . E` A LOSARTAN d03821A B I10 Essential (primary) hypertension AP E` A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP E` A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus AP E` A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease AP E` A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia AP Ep A . . . E A . . . E A . . . E A . . . E A . . . E A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture A E A LOSARTAN d03821A B N28.9 Disorder of kidney and ureter, unspecified A E A BECLOMETHASONE d00760A C- J45 Asthma A E A MONTELUKAST d04289A C- J45 Asthma A E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E A ZOLPIDEM d00910A C[@ G47.0 Insomnia A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A@ E A IBUPROFEN d00015A B M54 Dorsalgia A@ E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ E A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified Ap E A ANASTROZOLE d03873A C E29.1 Testicular hypofunction Ap E A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension Ap E A DABIGATRAN d07137A C[@ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Cr R60.9 Edema, unspecified Ap E A RANITIDINE d00021A C[@ K21 Gastro-esophageal reflux disease Ap E A SOTALOL d00371A Cr I48.9 Unspecified atrial fibrillation and atrial flutter Ap E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 Ep A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A0 Ep A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A0 E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia Ap E A GABAPENTIN d03182A0 C M25.5 M54 Pain in joint Dorsalgia Ap E A GLIMEPIRIDE d03864A0 C 99999 Ap E A HYDROCHLOROTHIAZIDE d00253A0 D# I10 Essential (primary) hypertension Ap E A LISINOPRIL d00732A0 C[@ I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A0 C 99999 Ap E A PANTOPRAZOLE d04514A0 C K30 Functional dyspepsia Ap E A . . . E A . . . E A . . . E A . . . E A DIVALPROEX SODIUM d03833A C"0 G43 Migraine A0 E A PROPRANOLOL d00032A C- G43 I10 Migraine Essential (primary) hypertension A0 E A VERAPAMIL d00048A C"0 I10 Essential (primary) hypertension A0 E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A E A ALBUTEROL d00749A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E A AMILORIDE d00169A C I10 Essential (primary) hypertension A E A CARISOPRODOL d00960A C M62.83 Muscle spasm A E A CHOLESTYRAMINE d00193A B K92.9 Disease of digestive system, unspecified A E A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified A E A CLONAZEPAM d00197A B[ F41.9 R45 Anxiety disorder, unspecified Symptoms and signs involving emotional state A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A TIOTROPIUM d04829A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E A . . . E A . . . E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E0 A OMEPRAZOLE d00325A CDp R12 Heartburn A0 E0 A TEMAZEPAM d00384A C- G47.0 Insomnia A0 E@ A . . . EP A . . . E` A ATENOLOL d00004A C I10 Essential (primary) hypertension A E` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A Ep A FLUTICASONE d01296A B R06.9 Unspecified abnormalities of breathing A E A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm A` E A DOCUSATE d01021A C: K59.0 Constipation A` E A ENOXAPARIN d03041A B I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A` E A GABAPENTIN d03182A B M62.83 Muscle spasm A` E A OXYCODONE d00329A B T14.9 Unspecified injury A` E A SENNA d01013A B K59.0 Constipation A` E A AMLODIPINE d00689A D0z I10 Essential (primary) hypertension A E A BACLOFEN d00967A C M62.83 Muscle spasm A E A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified A E A HYDROCHLOROTHIAZIDE d00253A D> I10 Essential (primary) hypertension A E A LIDOCAINE TOPICAL d00683A Bz M25.5 Pain in joint A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A TRAMADOL d03826A Cr M25.5 M54 Pain in joint Dorsalgia A E A CABERGOLINE d04112A C D49.9 Neoplasm of unspecified behavior of unspecified site A E A . . . E A . . . E A . . . E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A E A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E A CARVEDILOL d03847A C I10 Essential (primary) hypertension Ap E A CLOPIDOGREL d04258A C[@ D75.9P Prevent blood clots Ap E A FUROSEMIDE d00070A C[@ R60.9 Edema, unspecified Ap E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia Ap E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A IBUPROFEN d00015A C M06.9 Rheumatoid arthritis, unspecified A E A . . . E0 A . . . E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E@ A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A@ E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ EP A AZELASTINE NASAL d04068A C[@ J30.9 Allergic rhinitis, unspecified A` EP A CYCLOSPORINE OPHTHALMIC d04836A C- H04 Disorders of lacrimal system A` EP A FLUOXETINE d00236A D F42 Obsessive-compulsive disorder A` EP A FLUTICASONE NASAL d04283A D J30.9 Allergic rhinitis, unspecified A` EP A HYDROXYCHLOROQUINE d00817A C- 55555 A` EP A ZALEPLON d04452A B G47.0 Insomnia A` E` A LISDEXAMFETAMINE d06663A C[@ F90 Attention-deficit hyperactivity disorders A E` A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A Ep A ALLOPURINOL d00023A Cr M1A Chronic gout AP Ep A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP Ep A COLCHICINE d00150A Cr E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease AP Ep A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP Ep A METFORMIN d03807A A E11 Type 2 diabetes mellitus AP E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A DOXAZOSIN d00726A C I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A@ E A PANTOPRAZOLE d04514A C"0 K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E A . . . E A . . . E A CARBAMAZEPINE d00058A D* G40 Epilepsy and recurrent seizures A0 E A CITALOPRAM d04332A D' F39 Unspecified mood [affective] disorder A0 E A RISPERIDONE d03180A D* F39 Unspecified mood [affective] disorder A0 E A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A . . . E0 A CETIRIZINE d03827A Bz B99.9 Unspecified infectious disease A E0 A DIPHENHYDRAMINE d00212A Ap L50 Urticaria A E@ A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E@ A HYDROCHLOROTHIAZIDE d00253A B R60.9 Edema, unspecified A0 E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 EP A . . . E` A . . . Ep A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A@ Ep A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C[@ F90 Attention-deficit hyperactivity disorders A@ Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ Ep A OXYCODONE d00329A CO M54 Dorsalgia A@ E A ARIPIPRAZOLE d04825A C[@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A DESVENLAFAXINE d07113A C F32.9 Major depressive disorder, single episode, unspecified A E A SERTRALINE d00880A C F41.0 F41.9 R51 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified Headache A E A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A@ E A METOPROLOL d00134A B E05 Thyrotoxicosis [hyperthyroidism] A@ E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ E A . . . E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A Dc H40 Glaucoma AP E A LEVOTHYROXINE d00278A0 C[@ E03.9 Hypothyroidism, unspecified AP E A LISINOPRIL d00732A0 C[@ I10 Essential (primary) hypertension AP E A METOPROLOL d00134A0 C[@ I10 Essential (primary) hypertension AP E A SIMVASTATIN d00746A0 C[@ E78.0 Pure hypercholesterolemia AP E A ALBUTEROL d00749A Cr R06.02 Shortness of breath AP E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP E A CLOPIDOGREL d04258A C[@ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets AP E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP E A MIRTAZAPINE d04025A Bz G47.0 Insomnia AP E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A CDp I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A E A ISOSORBIDE MONONITRATE d00269A C R07.9 Chest pain, unspecified A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A C[@ I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A E A TAMSULOSIN d04121A B R35 R39.1 Polyuria Other difficulties with micturition A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A AZITHROMYCIN d00091A A@ J01.9 Acute sinusitis, unspecified A Ep A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C- Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified A` E A FLUVOXAMINE d03804A C- F32.9 Major depressive disorder, single episode, unspecified A` E A LAMOTRIGINE d03809A B F32.9 Major depressive disorder, single episode, unspecified A` E A LANSOPRAZOLE d03828A C- K21 Gastro-esophageal reflux disease A` E A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A` E A LURASIDONE d07705A C- F32.9 Major depressive disorder, single episode, unspecified A` E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A D I50.9 Heart failure, unspecified A E A DIGOXIN d00210A D I50.9 Heart failure, unspecified A E A ENALAPRIL d00013A D I50.9 Heart failure, unspecified A E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E A INSULIN d00262A CDp E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A METOPROLOL d00134A CDp I50.9 Heart failure, unspecified A E A POTASSIUM CHLORIDE d00345A Cr E87.6P Prevent hypokalemia A E A SIMVASTATIN d00746A D E78.0P Prevent high cholesterol A E A SPIRONOLACTONE d00373A Cr I10 Essential (primary) hypertension A E A TAMSULOSIN d04121A CDp R35 Polyuria A E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A E0 A . . . E@ A OMEPRAZOLE d00325A B R12 Heartburn A EP A ALPRAZOLAM d00168A C[@ I10 Essential (primary) hypertension A@ EP A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A@ EP A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A@ EP A TAMOXIFEN d00381A C- C50 Malignant neoplasm of breast A@ E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension AP E A HYDROXYCHLOROQUINE d00817A C[@ M06.9 Rheumatoid arthritis, unspecified AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A . . . E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A . . . E A CARBAMAZEPINE d00058A D G40 Epilepsy and recurrent seizures A E0 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C R51 Headache A E0 A BACLOFEN d00967A C R25.2 Cramp and spasm A E0 A DEXLANSOPRAZOLE d07395A C K21 Gastro-esophageal reflux disease A E0 A HYDROXYZINE d00907A C 55555 A E0 A LEVETIRACETAM d04499A C I63 Cerebral infarction A E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E0 A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E0 A MECLIZINE d00859A C R42 Dizziness and giddiness A E0 A MELOXICAM d04532A C M19.9 T14.9 Osteoarthritis, unspecified site Unspecified injury A E0 A MONTELUKAST d04289A C J45 Asthma A E0 A PROMETHAZINE d00787A C- 55555 A E0 A PROPRANOLOL d00032A C I49.9 Cardiac arrhythmia, unspecified A E0 A SERTRALINE d00880A C R45 Symptoms and signs involving emotional state A E@ A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A Ap R05 R09.81 Cough Nasal congestion AP E@ A CEPHALEXIN d00096A A J02 Acute pharyngitis AP E@ A FLUCONAZOLE d00071A A0 B37 Candidiasis AP E@ A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures AP E@ A MONTELUKAST d04289A A0 J30.9 R05 Allergic rhinitis, unspecified Cough AP EP A CEFPROZIL d00073A Ap H66.9 J02 Otitis media, unspecified Acute pharyngitis A E` A . . . Ep A . . . E A . . . E A . . . E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E A TERAZOSIN d00386A B[ R39.1 Other difficulties with micturition A@ E A . . . E A AMOXICILLIN d00088A A J02 J02.0 Acute pharyngitis Streptococcal pharyngitis A E A . . . E A AMOXICILLIN d00088A0 B K04.7 Periapical abscess without sinus A E A OMEPRAZOLE d00325A B[ K30 Functional dyspepsia A E A BUPROPION d00181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A OMEPRAZOLE d00325A D K30 Functional dyspepsia A E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A E A . . . E0 A AMOXICILLIN d00088A A` K04.7 Periapical abscess without sinus A E0 A IBUPROFEN d00015A A` K08.8 Other specified disorders of teeth and supporting structures A E@ A . . . EP A AMLODIPINE d00689A C"0 I63.P Prevent stroke Ap EP A CARBIDOPA; LEVODOPA d03473A C"0 G20 Parkinson's disease Ap EP A CITALOPRAM d04332A C"0 F32.9 Major depressive disorder, single episode, unspecified Ap EP A CLOPIDOGREL d04258A C"0 I63.P Prevent stroke Ap EP A LEVOTHYROXINE d00278A C"0 E03.9 Hypothyroidism, unspecified Ap EP A METOPROLOL d00134A C"0 E05 Thyrotoxicosis [hyperthyroidism] Ap EP A PANTOPRAZOLE d04514A C"0 K21 Gastro-esophageal reflux disease Ap E` A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A0 E` A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E` A SERTRALINE d00880A D F41.9 Anxiety disorder, unspecified A0 Ep A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A Ep A CLOPIDOGREL d04258A C[@ D75.9P Prevent blood clots A Ep A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A Ep A PANTOPRAZOLE d04514A B R12 Heartburn A Ep A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A Ep A PREDNISONE d00350A CP L93 Lupus erythematosus A Ep A QUINAPRIL d00365A Dc I10 Essential (primary) hypertension A Ep A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A Ep A TRAMADOL d03826A CDp M54 M79.1 T14.9 Dorsalgia Myalgia Unspecified injury A E A ATENOLOL; CHLORTHALIDONE d03258A Cr I10 Essential (primary) hypertension A0 E A GLYBURIDE; METFORMIN d04703A C E11 Type 2 diabetes mellitus A0 E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A0 E A . . . E A ANTI-INFECTIVES - UNSPECIFIED c00001A A N76.0 Acute vaginitis A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I21.P Prevent heart attack/myocardial infarction A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C 99999 A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A DULOXETINE d05355A C- F32.9 Major depressive disorder, single episode, unspecified AP E A ICOSAPENT d07891A B E78.1 Pure hyperglyceridemia AP E A NEBIVOLOL d05265A CDp I10 Essential (primary) hypertension AP E A NORTRIPTYLINE d00144A C- F41.9 Anxiety disorder, unspecified AP E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E A . . . E0 A CAPECITABINE d04311A C C50 Malignant neoplasm of breast A0 E0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A 99999 . . A@ E A LAMOTRIGINE d03809A D# 55555 A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A RISPERIDONE d03180A D# R45 Symptoms and signs involving emotional state A@ E A DESOGESTREL; ETHINYL ESTRADIOL d03782A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A LEVOTHYROXINE d00278A A@ E03.9 Hypothyroidism, unspecified A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E0 A METHYLPHENIDATE d00900A B= F90 Attention-deficit hyperactivity disorders A E@ A . . . EP A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A E` A . . . Ep A . . . E A FOSINOPRIL d00242A C 55555 AP E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus AP E A INSULIN DETEMIR d05436A CDp R73 Elevated blood glucose level AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN; CLAVULANATE d00089A AP A49.9P Prevent bacterial infection A E A CEFDINIR d04256A A B99.9 Unspecified infectious disease A E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C- J45 Asthma A E A AMOXICILLIN d00088A B J01.9 Acute sinusitis, unspecified A E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D* I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A D* E07.9 Disorder of thyroid, unspecified A0 E A METOPROLOL d00134A D* I10 Essential (primary) hypertension A0 E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A . . . E A LEVOTHYROXINE d00278A0 D9 E04 Other nontoxic goiter A E A MELOXICAM d04532A0 C- M79.1 Myalgia A E A . . . E0 A DOXYCYCLINE d00037A A@ J01.9 Acute sinusitis, unspecified AP E0 A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus AP E0 A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension AP E0 A OXYBUTYNIN d00328A C R35 Polyuria AP E0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E@ A ALBUTEROL d00749A Dc J45 Asthma A E@ A AMLODIPINE d00689A Cr I49.9 Cardiac arrhythmia, unspecified A E@ A ATENOLOL d00004A D ^ I10 Essential (primary) hypertension A E@ A CYCLOBENZAPRINE d00963A D M54 M62.83 Dorsalgia Muscle spasm A E@ A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E@ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A E@ A LEVOTHYROXINE d00278A D ^ E03.9 Hypothyroidism, unspecified A E@ A MELOXICAM d04532A C M54 Dorsalgia A E@ A MORPHINE d00308A C M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A E@ A PREGABALIN d05508A C M79.2 Neuralgia and neuritis, unspecified A EP A . . . E` A . . . Ep A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A Ep A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus A E A . . . E A . . . E A AMLODIPINE d00689A C[@ 99999 A E A CELECOXIB d04380A B M54 Dorsalgia A E A FUROSEMIDE d00070A CDp 99999 A E A GABAPENTIN d03182A CDp G40 Epilepsy and recurrent seizures A E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A E A LAMOTRIGINE d03809A C[@ G40 Epilepsy and recurrent seizures A E A LEVOTHYROXINE d00278A CDp 99999 A E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E A MONTELUKAST d04289A C- 99999 A E A OMEPRAZOLE d00325A C- 99999 A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A PREGABALIN d05508A Ap M54 Dorsalgia A E A SIMVASTATIN d00746A C 99999 A E A . . . E A . . . E A . . . E A CETIRIZINE d03827A B L23 Allergic contact dermatitis AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP E A METRONIDAZOLE d00108A A` N30 Cystitis AP E A RANITIDINE d00021A B R21 Rash and other nonspecific skin eruption AP E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A ATENOLOL d00004A C G43.P I10 Prevent migraine Essential (primary) hypertension A@ E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E A VENLAFAXINE d03181A C- F32.9 Major depressive disorder, single episode, unspecified A@ E A . . . E A . . . E0 A ALBUTEROL d00749A D* J45 Asthma B E0 A BACLOFEN d00967A0 C M62.83 Muscle spasm B E0 A ESTRIOL d05027A B[ Z79.890 Hormone replacement therapy B E0 A HYDROXYCHLOROQUINE d00817A0 C M06.9 Rheumatoid arthritis, unspecified B E0 A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified B E0 A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension B E0 A LOVASTATIN d00280A0 C E78.0 Pure hypercholesterolemia B E0 A MIRABEGRON d07876A0 B[ N39.4 Other specified urinary incontinence B E0 A MONTELUKAST d04289A0 C J45 Asthma B E0 A PANTOPRAZOLE d04514A0 C K21 Gastro-esophageal reflux disease B E0 A PILOCARPINE d04031A0 C 55555 B E0 A SPIRONOLACTONE d00373A0 C I10 Essential (primary) hypertension B E0 A SUMATRIPTAN d03160A C G43 Migraine B E0 A TRAMADOL d03826A0 C M13 Other arthritis B E0 A TRAZODONE d00395A0 C G47.0 M79.2 Insomnia Neuralgia and neuritis, unspecified B E0 A VENLAFAXINE d03181A0 C M79.7 Fibromyalgia B E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A BUPROPION d00181A C 99999 AP E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP E A METFORMIN d03807A C[@ R73 Elevated blood glucose level AP E A NIFEDIPINE d00051A D I10 Essential (primary) hypertension AP E A . . . E A . . . E A . . . E A . . . E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A CDp R73 Elevated blood glucose level AP E A OMEPRAZOLE d00325A C K30 Functional dyspepsia AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension AP E A CELECOXIB d04380A C[@ M19.9 M54 Osteoarthritis, unspecified site Dorsalgia A` E A CETIRIZINE d03827A D T78.40 Allergy, unspecified A` E A FLUTICASONE d01296A D R06.2 Wheezing A` E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A` E A ROSUVASTATIN d04851A Dc E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A` E A SILDENAFIL d04299A C[@ I99.9 N52.9 Unspecified disorder of circulatory system Male erectile dysfunction, unspecified A` E A CYANOCOBALAMIN d00413A C K92.9 Disease of digestive system, unspecified A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A . . . E A ETHINYL ESTRADIOL; ETONOGESTREL d04773A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A ANTIHYPERLIPIDEMIC AGENTS - UNSPECIFIED c00019A A E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ASPIRIN d00170A C D75.9P Prevent blood clots A E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C R60.9 Edema, unspecified A E A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A E A FENOFIBRATE d04286A C 99999 A E A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E A PRAMIPEXOLE d04145A C"0 G25.81 Restless legs syndrome A E0 A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A E@ A . . . EP A . . . E` A . . . Ep A . . . E A DILTIAZEM d00045A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A RIVAROXABAN d07356A C I63 Cerebral infarction A E A ALBUTEROL d00749A B[ R06.2 Wheezing A0 E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A0 E A BUDESONIDE d04276A B R06.2 Wheezing A0 E A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E A MESALAMINE d01031A Dc K51 Ulcerative colitis AP E A TAMSULOSIN d04121A CDp N40 Enlarged prostate AP E A . . . E A . . . E A NITROFURANTOIN d00112A Ap N39.0 Urinary tract infection, site not specified A E A VALACYCLOVIR d03838A Ap N39.0 Urinary tract infection, site not specified A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A Cr E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A@ E A CLONIDINE d00044A C F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A@ E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A@ E A . . . E A . . . E A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C[@ N92 Excessive, frequent and irregular menstruation A E0 A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E0 A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E@ A . . . EP A DEXMETHYLPHENIDATE d04777A C- F90 Attention-deficit hyperactivity disorders A E` A . . . Ep A . . . E A . . . E A FLUTICASONE NASAL d04283A Ap T78.40 Allergy, unspecified A0 E A METHOTREXATE d00060A C[@ L40 Psoriasis A0 E A USTEKINUMAB d07396A C L40 Psoriasis A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A CP E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A NAPROXEN d00019A Cr G43 Migraine AP E A PREDNISONE d00350A B G43 Migraine AP E A SUMATRIPTAN d03160A B G43 Migraine AP E A SUMATRIPTAN d03160A D G43 Migraine AP E A VERAPAMIL d00048A B G43.P Prevent migraine AP E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ALPRAZOLAM d00168A B F41.0 F41.9 G47.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified Sleep disorder, unspecified A EP A . . . E` A . . . Ep A . . . E A . . . E A AMANTADINE d00086A C- G20 Parkinson's disease A@ E A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A@ E A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified A@ E A TOPIRAMATE d04115A CDp G43 Migraine A@ E A . . . E A BACLOFEN d00967A C M54 Dorsalgia A E A CLONAZEPAM d00197A C G47.0 Insomnia A E A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A E A FAMOTIDINE d00141A CDp K21 Gastro-esophageal reflux disease A E A HYDROMORPHONE d00255A B= M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A E A LOSARTAN d03821A CP I10 Essential (primary) hypertension A E A METFORMIN d03807A CDp R73 Elevated blood glucose level A E A OXYCODONE d00329A C- M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A ZOLPIDEM d00910A Ei G47.9 Sleep disorder, unspecified A E A LEVETIRACETAM d04499A CDp G40 Epilepsy and recurrent seizures A E A PHENYTOIN d00143A D9 G40 Epilepsy and recurrent seizures A E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A A T14.9 Unspecified injury A E A CLONAZEPAM d00197A C G47.9 Sleep disorder, unspecified A@ E A DULOXETINE d05355A C M79.1 Myalgia A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A TOPIRAMATE d04115A D M79.7 R51 Fibromyalgia Headache A@ E A BENZTROPINE d00175A C G25.0 Essential tremor A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E A CLOPIDOGREL d04258A C I49.9 Cardiac arrhythmia, unspecified A E A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A E A RIVASTIGMINE d04537A C G30.9 Alzheimer's disease, unspecified A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A SOLIFENACIN d05413A C N39.4 Other specified urinary incontinence A E A VALSARTAN d04113A C I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C- I10 Essential (primary) hypertension A0 E A INSULIN DETEMIR d05436A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A0 E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 E0 A . . . E@ A ACETAMINOPHEN; HYDROCODONE d03428A C[@ M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A E@ A ALLOPURINOL d00023A C E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A E@ A AMLODIPINE d00689A CP I10 Essential (primary) hypertension A E@ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E@ A CARBIDOPA; LEVODOPA d03473A Cr G25.81 Restless legs syndrome A E@ A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E@ A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E@ A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A E@ A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A E@ A TRAZODONE d00395A CDp G47.0 G47.9 Insomnia Sleep disorder, unspecified A EP A . . . E` A AMLODIPINE d00689A D* I10 Essential (primary) hypertension A0 E` A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A0 E` A PRAVASTATIN d00348A D* E78.0 Pure hypercholesterolemia A0 Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A A0 R51 Headache AP E A DIVALPROEX SODIUM d03833A C"0 F31.9 M79.2 Bipolar disorder, unspecified Neuralgia and neuritis, unspecified AP E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp Z79.3 Long term (current) use of hormonal contraceptives AP E A HYDROCODONE; IBUPROFEN d04225A C R51 Headache AP E A PROPRANOLOL d00032A B[ G50 Disorders of trigeminal nerve AP E A . . . E A GUANFACINE d00717A C- F91.9 Conduct disorder, unspecified A E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A E A BACLOFEN d00967A B M62.83 Muscle spasm A E A DIAZEPAM d00148A B F41.9 M62.83 Anxiety disorder, unspecified Muscle spasm A E A DULOXETINE d05355A CDp M79.2 Neuralgia and neuritis, unspecified A E A GABAPENTIN d03182A D E11.4 Type 2 diabetes mellitus with neurological complications A E A HYDROCODONE d03075A C[@ M54 Dorsalgia A E A HYDROXYZINE d00907A B 55555 A E A LISINOPRIL d00732A CP I10 Essential (primary) hypertension A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A NORTRIPTYLINE d00144A CDp G47.0 Insomnia A E A OMEPRAZOLE d00325A D* K21 Gastro-esophageal reflux disease A E A PRIMIDONE d00352A C R25.1 Tremor, unspecified A E0 A . . . E@ A . . . EP A ALENDRONATE d03849A B M81 Osteoporosis without current pathological fracture A EP A BACLOFEN d00967A B M62.83 Muscle spasm A EP A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A EP A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A EP A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A EP A METOPROLOL d00134A C I10 Essential (primary) hypertension A EP A PREDNISONE d00350A C"0 55555 A EP A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Ep A . . . E A . . . E A RANITIDINE d00021A C- K30 Functional dyspepsia A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A Ap E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A CYCLOBENZAPRINE d00963A B M79.1 Myalgia A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A0 E A MELOXICAM d04532A B= M79.1 Myalgia A0 E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ N92 Excessive, frequent and irregular menstruation A E A AMLODIPINE; BENAZEPRIL d03829A D0z I10 Essential (primary) hypertension A E0 A . . . E@ A ALBUTEROL d00749A B= J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A ATENOLOL d00004A C I10 Essential (primary) hypertension A E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E@ A BUDESONIDE d04276A B= J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A FORMOTEROL d04572A B= J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A LEVOTHYROXINE d00278A CDp E04 Other nontoxic goiter A E@ A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E@ A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A E@ A TORSEMIDE d03189A B I50.9 Heart failure, unspecified A EP A . . . E` A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A0 E` A METOPROLOL d00134A D G43.P I10 Prevent migraine Essential (primary) hypertension A0 E` A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A0 Ep A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A0 Ep A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A0 Ep A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A@ E A METFORMIN d03807A C- R73 Elevated blood glucose level A@ E A ATORVASTATIN d04105A Cr I21.P Prevent heart attack/myocardial infarction A` E A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified A` E A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A` E A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A` E A PREGABALIN d05508A Cr M79.7 Fibromyalgia A` E A RAMIPRIL d00728A Cr I50.9 Heart failure, unspecified A` E A . . . E A . . . E A . . . E A ACYCLOVIR d00001A Cr B00.9 Herpesviral infection, unspecified A E A . . . E A . . . E A ATENOLOL; CHLORTHALIDONE d03258A D I10 Essential (primary) hypertension A@ E A DILTIAZEM d00045A D I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ E A WARFARIN d00022A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A@ E A . . . E A . . . E0 A CYCLOBENZAPRINE d00963A A0 M54 Dorsalgia A0 E0 A NAPROXEN d00019A A` 99999 A0 E0 A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A` N39.0 Urinary tract infection, site not specified A0 E@ A . . . EP A . . . E` A . . . Ep A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A0 Ep A METFORMIN d03807A D E11 Type 2 diabetes mellitus A0 Ep A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A B= J45 Asthma A E A LOSARTAN d03821A B= I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E0 A . . . E@ A ACYCLOVIR d00001A B= K30 Functional dyspepsia A E@ A ATENOLOL d00004A C I10 Essential (primary) hypertension A E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E@ A BUSPIRONE d00182A B 99999 A E@ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E@ A OMEPRAZOLE d00325A B 55555 A E@ A SULFAMETHOXAZOLE d00119A B D64.9 Anemia, unspecified A EP A . . . E` A . . . Ep A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Dc Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A` E A DOXEPIN d00217A Cr F32.9 Major depressive disorder, single episode, unspecified A` E A FLUTICASONE; SALMETEROL d04611A Dc J45 Asthma A` E A GABAPENTIN d03182A C[@ F32.9 Major depressive disorder, single episode, unspecified A` E A OLMESARTAN d04801A C I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A C K30 Functional dyspepsia A` E A . . . E A GABAPENTIN d03182A C M19.9 Osteoarthritis, unspecified site A@ E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A@ E A METHOTREXATE d00060A B M06.9 Rheumatoid arthritis, unspecified A@ E A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A@ E A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified Ap E A AMLODIPINE d00689A C R60.9 Edema, unspecified Ap E A DONEPEZIL d04099A C- G30.9 R41 Alzheimer's disease, unspecified Other symptoms and signs involving cognitive functions and awareness Ap E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension Ap E A MEMANTINE d04899A B= G31.8 Other specified degenerative diseases of nervous system Ap E A MEMANTINE d04899A C G30.9 Alzheimer's disease, unspecified Ap E A TRAMADOL d03826A B= M06.9 Rheumatoid arthritis, unspecified Ap E0 A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A@ E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E0 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E@ A . . . EP A . . . E` A . . . Ep A ANTI-INFECTIVES - UNSPECIFIED c00001A A 55555 A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A OFLOXACIN OTIC d04265A A H60 Otitis externa A E A SERTRALINE d00880A Ap F31.9 F32.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A E A . . . E A TOBRAMYCIN OPHTHALMIC d03222A A H10 Conjunctivitis A E A . . . E A . . . E A OMEPRAZOLE d00325A C K30 Functional dyspepsia A E A . . . E A . . . E A . . . E A PREDNISOLONE OPHTHALMIC d03221A Cr H57.9 Unspecified disorder of eye and adnexa A E A GLYBURIDE d00248A0 Cr E11 Type 2 diabetes mellitus Ap E A INSULIN ASPART d04697A0 Cr E11 Type 2 diabetes mellitus Ap E A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A0 Cr I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A0 Cr I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A SIMVASTATIN d00746A0 Cr E78.0 Pure hypercholesterolemia Ap E A WARFARIN d00022A0 C I48.9 Unspecified atrial fibrillation and atrial flutter Ap E0 A LISINOPRIL d00732A D= I10 Essential (primary) hypertension A E0 A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E@ A LISINOPRIL d00732A C 55555 A@ E@ A MESALAMINE d01031A C K51 Ulcerative colitis A@ E@ A METFORMIN d03807A C R73 Elevated blood glucose level A@ E@ A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ EP A MUPIROCIN TOPICAL d01267A B* L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A EXEMESTANE d04461A Cr C50 Malignant neoplasm of breast A0 E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A0 E A OLMESARTAN d04801A D I10 Essential (primary) hypertension A0 E A CLOPIDOGREL d04258A Cr I63 Cerebral infarction A E A METOPROLOL d00134A Cr I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A GABAPENTIN d03182A B E11.4 Type 2 diabetes mellitus with neurological complications AP E A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension AP E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus AP E A ZOLPIDEM d00910A B G47.0 Insomnia AP E A . . . E A OLMESARTAN d04801A C I10 Essential (primary) hypertension A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A CITALOPRAM d04332A C 99999 Ap E A DIGOXIN d00210A C 99999 Ap E A GLIMEPIRIDE d03864A C 99999 Ap E A INSULIN LISPRO d04373A A E11 Type 2 diabetes mellitus Ap E A LEVOTHYROXINE d00278A C 99999 Ap E A LOVASTATIN d00280A C 99999 Ap E A POTASSIUM CHLORIDE d00345A C 99999 Ap E A . . . E A AMOXICILLIN d00088A A@ J02.0 Streptococcal pharyngitis A E0 A . . . E@ A . . . EP A ADALIMUMAB d04835A C- L40 Psoriasis A E` A . . . Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders A0 E A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A0 E A RISPERIDONE d03180A C[@ F90 Attention-deficit hyperactivity disorders A0 E A ALBUTEROL d00749A A R06.02 Shortness of breath A E A PENTOSAN POLYSULFATE SODIUM d04052A B= N32.9 Bladder disorder, unspecified A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M54 Pain in joint Dorsalgia A E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A BUDESONIDE; FORMOTEROL d04795A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A DICLOFENAC TOPICAL d04722A C- M25.5 Pain in joint A E A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A E A FLUTICASONE NASAL d04283A Cr R09.81 Nasal congestion A E A MORPHINE d00308A C M25.5 M54 Pain in joint Dorsalgia A E A TRAZODONE d00395A C- G47.9 Sleep disorder, unspecified A E A . . . E0 A MONTELUKAST d04289A C J45 Asthma A E0 A POLYETHYLENE GLYCOL 3350 d05350A C[@ K59.0 Constipation A E@ A . . . EP A CITALOPRAM d04332A CDp F39 Unspecified mood [affective] disorder A EP A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E` A RALOXIFENE d04261A C- M81 Osteoporosis without current pathological fracture A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A C- I10 Essential (primary) hypertension A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A E A ALBUTEROL d00749A C- J45 Asthma A E A FLUTICASONE d01296A C J45 Asthma A E A 55555 A C K21 Gastro-esophageal reflux disease A E0 A . . . E@ A . . . EP A DIVALPROEX SODIUM d03833A C P G40 Epilepsy and recurrent seizures A EP A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures A E` A . . . Ep A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A CDp M79.7 Fibromyalgia A` E A DOXYCYCLINE d00037A B< L23 Allergic contact dermatitis A` E A GABAPENTIN d03182A CDp M79.7 Fibromyalgia A` E A ONDANSETRON d00867A C R11 Nausea and vomiting A` E A PANTOPRAZOLE d04514A CDp K27 Peptic ulcer, site unspecified A` E A TOPIRAMATE d04115A CDp G99.8 H93.9 Other specified disorders of nervous system in diseases classified elsewhere Unspecified disorder of ear A` E A . . . E A . . . E A CLONIDINE d00044A Cr F41.9 F43.1 G47.0 Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) Insomnia Ap E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A TRAMADOL d03826A C M54 Dorsalgia Ap E A ZOLPIDEM d00910A Cr F41.9 Anxiety disorder, unspecified Ap E A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified AP E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A HYOSCYAMINE d00985A CDp K58 Irritable bowel syndrome AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C- I49.9 Cardiac arrhythmia, unspecified AP E A . . . E0 A . . . E@ A . . . EP A . . . E` A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A Ep A ATORVASTATIN d04105A C- I21.P Prevent heart attack/myocardial infarction AP Ep A CLOPIDOGREL d04258A C- I63.P Prevent stroke AP Ep A DOCUSATE d01021A CDp K59.0 Constipation AP Ep A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified AP Ep A METOPROLOL d00134A C- I21.P Prevent heart attack/myocardial infarction AP E A . . . E A . . . E A . . . E A BECLOMETHASONE d00760A C R06.2 Wheezing A E A . . . E A . . . E A ALBUTEROL; IPRATROPIUM d04066A C- J45 R06.9P Asthma Prevent breathing difficulty A E A BUDESONIDE; FORMOTEROL d04795A C[@ J45 Asthma A E A FAMOTIDINE d00141A C K21 R12 Gastro-esophageal reflux disease Heartburn A E A FLUTICASONE NASAL d04283A B J30.2 R09.81 Other seasonal allergic rhinitis Nasal congestion A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A BECLOMETHASONE d00760A B J45 Asthma A E A MONTELUKAST d04289A B[ J30.2 J45 Other seasonal allergic rhinitis Asthma A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A E0 A . . . E@ A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E@ A TRAVOPROST OPHTHALMIC d04753A C- H40 Glaucoma A EP A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified A E` A ETHINYL ESTRADIOL; ETONOGESTREL d04773A C- Z79.3 Long term (current) use of hormonal contraceptives A Ep A ATORVASTATIN d04105A D ^ E78.0 I70 Pure hypercholesterolemia Atherosclerosis A` Ep A CYANOCOBALAMIN d00413A Dc 55555 A` Ep A DILTIAZEM d00045A D I10 Essential (primary) hypertension A` Ep A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A` Ep A SPIRONOLACTONE d00373A C E87.6 R60.9 Hypokalemia Edema, unspecified A` Ep A TELMISARTAN d04364A D I10 Essential (primary) hypertension A` E A ALBUTEROL d00749A C J45 Asthma A E A OLOPATADINE OPHTHALMIC d04117A B T78.40 Allergy, unspecified A E A . . . E A . . . E A 99999 . . A E A . . . E A . . . E A ALBUTEROL d00749A Cr J45 Asthma A0 E A CODEINE; GUAIFENESIN d03393A A R05 Cough A0 E A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A0 E A . . . E A . . . E A . . . E A CANDESARTAN d04322A D I10 Essential (primary) hypertension A E0 A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E0 A METHADONE d00050A C- 55555 A E@ A . . . EP A FAMOTIDINE d00141A B= K21 Gastro-esophageal reflux disease A EP A SIMVASTATIN d00746A C"0 E78.0 Pure hypercholesterolemia A E` A . . . Ep A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A C- Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A` E A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A` E A FLUTICASONE NASAL d04283A C- J30.2 Other seasonal allergic rhinitis A` E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A` E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia A` E A . . . E A ALBUTEROL d00749A D J45 Asthma A E A ALBUTEROL d00749A D J45 Asthma A E A ACETAMINOPHEN; HYDROCODONE d03428A B 55555 AP E A CITALOPRAM d04332A D F32.9 Major depressive disorder, single episode, unspecified AP E A MORPHINE d00308A B 55555 AP E A MYCOPHENOLATE MOFETIL d03839A D 55555 AP E A PREDNISONE d00350A Dc 55555 AP E A EZETIMIBE d04824A B= E78.1 Pure hyperglyceridemia A0 E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C[@ E87.6 Hypokalemia A0 E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ E A DIVALPROEX SODIUM d03833A C- K31.9 Disease of stomach and duodenum, unspecified A@ E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ E A RISPERIDONE d03180A CDp G47.0 Insomnia A@ E0 A . . . E@ A ALBUTEROL d00749A CDp J45 Asthma Ap E@ A AZITHROMYCIN d00091A A J01.9 Acute sinusitis, unspecified Ap E@ A ETODOLAC d00851A B= T14.9 Unspecified injury Ap E@ A FLUTICASONE; SALMETEROL d04611A C J45 Asthma Ap E@ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified Ap E@ A MONTELUKAST d04289A C[@ T78.40 Allergy, unspecified Ap E@ A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified Ap EP A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus AP EP A IBUPROFEN d00015A A K08.8 Other specified disorders of teeth and supporting structures AP EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP EP A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP EP A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia AP E` A . . . Ep A 99999 . . A0 Ep A ATORVASTATIN d04105A A0 E78.0 Pure hypercholesterolemia A0 Ep A CIPROFLOXACIN d00011A A N39.0 Urinary tract infection, site not specified A0 E A . . . E A . . . E A AMITRIPTYLINE d00146A Ei G47.0 Insomnia A` E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E A IBUPROFEN d00015A C M54 Dorsalgia A` E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E A NIFEDIPINE d00051A CDp R07.9 Chest pain, unspecified A` E A VALSARTAN d04113A D I10 Essential (primary) hypertension A` E A . . . E A . . . E A . . . E A . . . E A 77777 . . A E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension AP E A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia AP E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A RISPERIDONE d03180A C F20 Schizophrenia AP E A DESVENLAFAXINE d07113A C[@ F32.9 Major depressive disorder, single episode, unspecified A@ E A MIRTAZAPINE d04025A C G47.9 Sleep disorder, unspecified A@ E A RABEPRAZOLE d04448A C[@ K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A@ E A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E0 A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E0 A ESOMEPRAZOLE d04749A D K21 Gastro-esophageal reflux disease A E@ A CANAGLIFLOZIN d08080A B[ R73 Elevated blood glucose level AP E@ A LIRAGLUTIDE d07466A CDp E11 Type 2 diabetes mellitus AP E@ A METFORMIN d03807A Ap E11 Type 2 diabetes mellitus AP E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E@ A RAMIPRIL d00728A C E11.2 I50.9 Type 2 diabetes mellitus with kidney complications Heart failure, unspecified AP EP A . . . E` A . . . Ep A . . . E A GABAPENTIN d03182A C[@ E11.4 Type 2 diabetes mellitus with neurological complications A0 E A INSULIN ISOPHANE (NPH) d04370A Cr E11 Type 2 diabetes mellitus A0 E A LISINOPRIL d00732A B[ E11.2 Type 2 diabetes mellitus with kidney complications A0 E A AZELAIC ACID TOPICAL d03848A C- C80.1 Malignant (primary) neoplasm, unspecified A E A CLOBETASOL TOPICAL d01288A D L23 Allergic contact dermatitis A E A ESOMEPRAZOLE d04749A D K25 Gastric ulcer A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A E A LEVOTHYROXINE d00278A D E04 Other nontoxic goiter A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A E A . . . E A ANALGESICS - UNSPECIFIED c00058A A0 R52 Pain, unspecified A E A ASPIRIN d00170A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A0 E A BEZAFIBRATE h00036A B I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E@ A ENALAPRIL d00013A C 99999 Ap E@ A FUROSEMIDE d00070A C N28.9 Disorder of kidney and ureter, unspecified Ap E@ A INSULIN GLARGINE d04538A B= E11 Type 2 diabetes mellitus Ap E@ A ISOSORBIDE DINITRATE d00268A D I51.9 Heart disease, unspecified Ap E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E@ A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap EP A . . . E` A CLONIDINE d00044A C- I10 Essential (primary) hypertension A` E` A HYDROCHLOROTHIAZIDE d00253A B= R60.9 Edema, unspecified A` E` A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` E` A PRAVASTATIN d00348A C"0 E78.0 Pure hypercholesterolemia A` E` A RANITIDINE d00021A B= R21 Rash and other nonspecific skin eruption A` E` A TRAMADOL d03826A C M54 Dorsalgia A` Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A AMITRIPTYLINE d00146A C[@ F41.9 Anxiety disorder, unspecified AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus AP E A METFORMIN d03807A D= E11 Type 2 diabetes mellitus AP E A SITAGLIPTIN d05896A C[@ E11 Type 2 diabetes mellitus AP E A . . . E0 A . . . E@ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E@ A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension AP E@ A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified AP E@ A INSULIN DETEMIR d05436A C[@ E11 Type 2 diabetes mellitus AP E@ A METFORMIN; SITAGLIPTIN d06720A Cr E11 Type 2 diabetes mellitus AP EP A ALBUTEROL d00749A C J45 Asthma A E` A METFORMIN d03807A B E28 Ovarian dysfunction A Ep A . . . E A IRBESARTAN d04222A D I10 Essential (primary) hypertension A E A BACLOFEN d00967A D M54 Dorsalgia A` E A GABAPENTIN d03182A C M25.5 M54 Pain in joint Dorsalgia A` E A HYDROCODONE d03075A Bz M25.5 M54 Pain in joint Dorsalgia A` E A IBUPROFEN d00015A C M54 Dorsalgia A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A METHIMAZOLE d00290A D E05 Thyrotoxicosis [hyperthyroidism] A` E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A A M79.1 Myalgia A E A HYDROXYZINE d00907A B= Z48.8 Encounter for other specified postprocedural aftercare A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A SERTRALINE d00880A D F41.9 Anxiety disorder, unspecified A0 E A TRAZODONE d00395A D# G47.9 Sleep disorder, unspecified A0 E0 A ANTI-INFECTIVES - UNSPECIFIED c00001A Ap 77777 A E0 A CONTRACEPTIVES - UNSPECIFIED c00102A B* Z79.3 Long term (current) use of hormonal contraceptives A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A ESOMEPRAZOLE d04749A A K21 Gastro-esophageal reflux disease A0 E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A B= I10 Essential (primary) hypertension A0 E A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia A@ E A METFORMIN d03807A CDp E78.0 Pure hypercholesterolemia A@ E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A@ E A TAMSULOSIN d04121A CDp N40 Enlarged prostate A@ E A . . . E A . . . E A . . . E A . . . E A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ E A HYDROCODONE d03075A Ap K08.8 Other specified disorders of teeth and supporting structures A0 E A IBUPROFEN d00015A A0 K08.8 Other specified disorders of teeth and supporting structures A0 E A PENICILLIN V POTASSIUM d07730A A K04.7 Periapical abscess without sinus A0 E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C R73 Elevated blood glucose level A0 E A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma Ap E A IRBESARTAN d04222A D I10 Essential (primary) hypertension Ap E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma Ap E A METOPROLOL d00134A D I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction Ap E A OXYBUTYNIN d00328A C N32.81 Overactive bladder Ap E A PREDNISONE d00350A D M35 Other systemic involvement of connective tissue Ap E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E0 A ACETAMINOPHEN; CODEINE d03423A C M25.5 M54 Pain in joint Dorsalgia A@ E0 A BACLOFEN d00967A C- M79.1 Myalgia A@ E0 A HYDROXYCHLOROQUINE d00817A Ap M06.9 Rheumatoid arthritis, unspecified A@ E0 A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A@ E@ A ATORVASTATIN d04105A C 99999 A E@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I50.9 Heart failure, unspecified A E@ A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E@ A ISOSORBIDE MONONITRATE d00269A C 99999 A E@ A METOPROLOL d00134A C 99999 A E@ A NITROGLYCERIN d00321A B= Z95 Presence of cardiac and vascular implants and grafts A E@ A PREGABALIN d05508A C F41.9 Anxiety disorder, unspecified A E@ A SERTRALINE d00880A C F31.9 Bipolar disorder, unspecified A E@ A TICAGRELOR d07721A C D75.9P Z95 Prevent blood clots Presence of cardiac and vascular implants and grafts A EP A . . . E` A ISOTRETINOIN d01245A B L70 Acne A Ep A . . . E A ACYCLOVIR d00001A A0 B00.1 Herpesviral vesicular dermatitis Ap E A DULOXETINE d05355A Dc F32.9 Major depressive disorder, single episode, unspecified Ap E A FENOFIBRATE d04286A Ei 99999 Ap E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus Ap E A METFORMIN; PIOGLITAZONE d05635A Dc E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia Ap E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A0 L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E A ACETAMINOPHEN; OXYCODONE d03431A D& M54 Dorsalgia AP E A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 R60.9 Essential (primary) hypertension Edema, unspecified AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A WARFARIN d00022A C"0 D75.9P Prevent blood clots AP E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E A . . . E A INSULIN DETEMIR d05436A C E10 Type 1 diabetes mellitus A E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A ESOMEPRAZOLE d04749A CDp K21 Gastro-esophageal reflux disease A E A HYDROXYCHLOROQUINE d00817A CDp M06.9 Rheumatoid arthritis, unspecified A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A LIRAGLUTIDE d07466A CDp E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A MELOXICAM d04532A B[ I51.9 Heart disease, unspecified A E A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A E A TRIAMTERENE d00396A CDp I10 Essential (primary) hypertension A E0 A . . . E@ A AMLODIPINE; BENAZEPRIL d03829A CDp I10 Essential (primary) hypertension A0 E@ A METFORMIN d03807A Bz E11 Type 2 diabetes mellitus A0 E@ A NEBIVOLOL d05265A CDp I10 Essential (primary) hypertension A0 EP A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A EP A TERAZOSIN d00386A CDp R35 Polyuria A E` A . . . Ep A ESOMEPRAZOLE d04749A CDp K30 Functional dyspepsia A@ Ep A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A@ Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ Ep A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A@ E A ACETAMINOPHEN; CODEINE d03423A A0 G89 Pain, not elsewhere classified A E A IBUPROFEN d00015A A0 G89 Pain, not elsewhere classified A E A . . . E A . . . E A CARVEDILOL d03847A D I50.9 Heart failure, unspecified A` E A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A` E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A` E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C E78.1 Pure hyperglyceridemia A` E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A` E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B[ D49.9 Neoplasm of unspecified behavior of unspecified site A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A E0 A OMEPRAZOLE d00325A C- K25 R12 Gastric ulcer Heartburn A E@ A AZITHROMYCIN d00091A Ap J20.9 Acute bronchitis, unspecified AP E@ A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis AP E@ A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders AP E@ A MONTELUKAST d04289A Ap J30.9 J45 Allergic rhinitis, unspecified Asthma AP E@ A OSELTAMIVIR d04462A Ap J09.P Prevent flu AP EP A . . . E` A BENAZEPRIL d00730A C- I10 Essential (primary) hypertension A E` A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A C- H60 Otitis externa A E` A CYCLOBENZAPRINE d00963A Ap M79.1 Myalgia A E` A ETODOLAC d00851A A M79.1 Myalgia A E` A HYDROCHLOROTHIAZIDE d00253A C- R60.9 Edema, unspecified A E` A HYDROXYZINE d00907A B G47.0 Insomnia A E` A MELOXICAM d04532A B M79.1 Myalgia A E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E` A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E` A TRAMADOL d03826A C- M79.1 Myalgia A E` A VENLAFAXINE d03181A C- N95 Menopausal and other perimenopausal disorders A Ep A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 Ep A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 Ep A METOPROLOL d00134A C"@ I20.9 Angina pectoris, unspecified A0 E A ALBUTEROL d00749A C J45 Asthma A E A PREDNISONE d00350A A J45 Asthma A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A0 Cr J45 Asthma A@ E A BUDESONIDE d04276A0 Cr J98.9 Respiratory disorder, unspecified A@ E A CLOTRIMAZOLE TOPICAL d04395A0 B= L20.9 Atopic dermatitis, unspecified A@ E A PREDNISONE d00350A0 Cr J45 Asthma A@ E A . . . E A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A0 E A AMLODIPINE; BENAZEPRIL d03829A C- I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 E0 A . . . E@ A . . . EP A . . . E` A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A ARIPIPRAZOLE d04825A C F31.9 Bipolar disorder, unspecified A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A POLYETHYLENE GLYCOL 3350 d05350A C[@ K59.0 Constipation A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E A TOPIRAMATE d04115A Cr G43 Migraine A E A CEFPROZIL d00073A A H66.9 Otitis media, unspecified A E A . . . E A FLUTICASONE; SALMETEROL d04611A C- J45 Asthma A E A LEVALBUTEROL d04427A C- J45 Asthma A E A . . . E A . . . E0 A FLUOXETINE d00236A B= F32.9 Major depressive disorder, single episode, unspecified A0 E0 A LISDEXAMFETAMINE d06663A D* G47.4 Narcolepsy and cataplexy A0 E0 A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A0 E@ A . . . EP A . . . E` A ESCITALOPRAM d04812A B[ F32.9 Major depressive disorder, single episode, unspecified A E` A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A Ep A AMLODIPINE d00689A B I10 Essential (primary) hypertension A` Ep A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension A` Ep A METFORMIN d03807A Bz E11 Type 2 diabetes mellitus A` Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension A` Ep A OMEPRAZOLE d00325A B R12 Heartburn A` Ep A TAMSULOSIN d04121A C N40 Enlarged prostate A` E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A ALENDRONATE d03849A CDp M85.9 Disorders of bone density and structure, unspecified AP E A DABIGATRAN d07137A Bz D75.9P Prevent blood clots AP E A FLECAINIDE d00234A B I49.9 Cardiac arrhythmia, unspecified AP E A METOPROLOL d00134A C I51.9 Heart disease, unspecified AP E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia AP E A . . . E A ALBUTEROL d00749A Cr J45 Asthma A E A . . . E A DOXYCYCLINE d00037A B[ L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A LORATADINE; PSEUDOEPHEDRINE d03818A C- T78.40 Allergy, unspecified A E A . . . E0 A . . . E@ A TAMSULOSIN d04121A C N40 R35 R39.1 Enlarged prostate Polyuria Other difficulties with micturition A EP A . . . E` A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A H66.9 Otitis media, unspecified A E` A FLUTICASONE; SALMETEROL d04611A C J43 J44.9 R06.2 Emphysema Chronic obstructive pulmonary disease, unspecified Wheezing A Ep A . . . E A . . . E A KETOCONAZOLE TOPICAL d03202A C- L30.9 Dermatitis, unspecified A E A . . . E A INSULIN ASPART d04697A C- R73 Elevated blood glucose level A E A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E A . . . E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A . . . E A IBUPROFEN d00015A B M54 Dorsalgia A E0 A . . . E@ A . . . EP A . . . E` A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A Ep A CYANOCOBALAMIN d00413A CP D64.9 Anemia, unspecified A` Ep A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A` Ep A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` Ep A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A` Ep A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus A` Ep A POTASSIUM CHLORIDE d00345A B[ E87.6 Hypokalemia A` E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E A ERYTHROMYCIN d00046A C R11 Nausea and vomiting A E A NORETHINDRONE d00555A B* N92 Excessive, frequent and irregular menstruation A E A . . . E A METHYLPHENIDATE d00900A C- R41 Other symptoms and signs involving cognitive functions and awareness A E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ E28 Ovarian dysfunction A E A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A B K30 Functional dyspepsia A E0 A ETONOGESTREL d04772A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E@ A GLYBURIDE d00248A D E11 Type 2 diabetes mellitus A@ E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E@ A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A@ E@ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ EP A . . . E` A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A Ep A . . . E A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A . . . E A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified A E A VALSARTAN d04113A D I10 Essential (primary) hypertension A E A . . . E A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus AP E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified AP E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension A E A LEVALBUTEROL d04427A C J45 Asthma A E A . . . E0 A LAMOTRIGINE d03809A C"0 F31.9 Bipolar disorder, unspecified A0 E0 A QUETIAPINE d04220A0 C"0 F39 Unspecified mood [affective] disorder A0 E0 A TRAZODONE d00395A C"0 G47.9 Sleep disorder, unspecified A0 E@ A . . . EP A . . . E` A ACETAMINOPHEN; HYDROCODONE d03428A B= T14.9 Unspecified injury A` E` A HYOSCYAMINE; METHENA; MBLUE; PHENYLSAL; SODIUM BIPHOSPHATE d08274A Ap N20.0 Calculus of kidney A` E` A IBUPROFEN d00015A A G89 Pain, not elsewhere classified A` E` A MONTELUKAST d04289A B= R06.2 Wheezing A` E` A PHENDIMETRAZINE d00809A B= E66 Overweight and obesity A` E` A TAMSULOSIN d04121A B N20.0 Calculus of kidney A` Ep A . . . E A . . . E A AMLODIPINE; VALSARTAN d06662A A I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A Cr E87.7 Fluid overload A0 E A POTASSIUM CHLORIDE d00345A C E87.6P Prevent hypokalemia A0 E A . . . E A METFORMIN d03807A Dc R73 Elevated blood glucose level A E A OMEPRAZOLE d00325A Bz R10 Abdominal and pelvic pain A E A . . . E A . . . E A IBUPROFEN d00015A CDp R51 R52 Headache Pain, unspecified A E A OMEPRAZOLE d00325A Cr R10 Abdominal and pelvic pain A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A0 EP A LISDEXAMFETAMINE d06663A Cr F90 Attention-deficit hyperactivity disorders A0 EP A MONTELUKAST d04289A CDp T78.40 Allergy, unspecified A0 E` A . . . Ep A ALLOPURINOL d00023A C- E79.0 M1A Hyperuricemia without signs of inflammatory arthritis and tophaceous disease Chronic gout A Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A ALLOPURINOL d00023A Cr M10.9P Prevent gout AP E A LISINOPRIL d00732A C I21.P Prevent heart attack/myocardial infarction AP E A METFORMIN d03807A B R73 Elevated blood glucose level AP E A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A@ E A GABAPENTIN d03182A CDp M79.7 Fibromyalgia A@ E A MELOXICAM d04532A CDp M13 Other arthritis A@ E A TRAMADOL d03826A C- M79.7 Fibromyalgia A@ E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp R60.9 Edema, unspecified A E A . . . E A . . . E A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A E A CANAGLIFLOZIN d08080A B[ E11 Type 2 diabetes mellitus A` E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A` E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A` E A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A ALBUTEROL d00749A CP R06.2 Wheezing A E A FLUTICASONE d01296A C J45 Asthma A E0 A METFORMIN d03807A0 C R73 Elevated blood glucose level A0 E0 A RAMIPRIL d00728A0 C E11.2P Prevent diabetic kidney disease A0 E0 A SIMVASTATIN d00746A0 D* E78.0 Pure hypercholesterolemia A0 E@ A . . . EP A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A EP A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E` A . . . Ep A . . . E A . . . E A ALBUTEROL d00749A B[ J45 Asthma A E A . . . E A AZITHROMYCIN d00091A C L98.9 Disorder of the skin and subcutaneous tissue, unspecified Ap E A CIPROFLOXACIN d00011A Ap H66.9 Otitis media, unspecified Ap E A HYDROQUINONE TOPICAL d01319A CDp L98.9 Disorder of the skin and subcutaneous tissue, unspecified Ap E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified Ap E A METFORMIN d03807A C- R73 Elevated blood glucose level Ap E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease Ap E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease Ap E A . . . E A . . . E A . . . E A ALENDRONATE d03849A B M81 Osteoporosis without current pathological fracture Ap E A ATENOLOL d00004A C I10 Essential (primary) hypertension Ap E A GABAPENTIN d03182A Cr G25.81 Restless legs syndrome Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A METFORMIN d03807A B E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A TRAZODONE d00395A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia Ap E A . . . E A . . . E A . . . E0 A METHYLPHENIDATE d00900A CP F90 Attention-deficit hyperactivity disorders A E@ A . . . EP A . . . E` A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia A E` A CILOSTAZOL d04382A Cr I70 Atherosclerosis A E` A CLONAZEPAM d00197A Cr G25.81 Restless legs syndrome A E` A GABAPENTIN d03182A C G25.81 Restless legs syndrome A E` A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E` A RANITIDINE d00021A Cr R12 Heartburn A Ep A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A . . . E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A A J45 Asthma A@ E A FLUTICASONE NASAL d04283A C"0 T78.40 Allergy, unspecified A@ E A MONTELUKAST d04289A C"0 J30.9 Allergic rhinitis, unspecified A@ E A PREDNISOLONE d00084A AP J45 Asthma A@ E A . . . E0 A . . . E@ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A@ E@ A MELOXICAM d04532A C- I10 Essential (primary) hypertension A@ E@ A TIZANIDINE d04102A C- I10 Essential (primary) hypertension A@ EP A . . . E` A IBUPROFEN d00015A B= M54 Dorsalgia A Ep A BUDESONIDE; FORMOTEROL d04795A B J45 Asthma A Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A D J45 Asthma AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A DILTIAZEM d00045A D I10 Essential (primary) hypertension AP E A FLUTICASONE; SALMETEROL d04611A D J45 Asthma AP E A VALSARTAN d04113A C I10 Essential (primary) hypertension AP E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B M25.5 Pain in joint A@ E A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A@ E A MORPHINE d00308A B M25.5 Pain in joint A@ E A TRAMADOL d03826A B M25.5 Pain in joint A@ E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E0 A . . . E@ A LEVOTHYROXINE d00278A C[@ 99999 A EP A . . . E` A ATORVASTATIN d04105A C- I63.P Prevent stroke A@ E` A DONEPEZIL d04099A D G30.9 Alzheimer's disease, unspecified A@ E` A LISINOPRIL d00732A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A@ E` A MEMANTINE d04899A C G30.9 G31.8 Alzheimer's disease, unspecified Other specified degenerative diseases of nervous system A@ Ep A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A . . . E A HYDROCHLOROTHIAZIDE d00253A C- I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A METRONIDAZOLE d00108A Ap N76.0 Acute vaginitis A E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A` E A IBUPROFEN d00015A B= M79.1 Myalgia A` E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A` E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A` E A NAPROXEN d00019A B= M79.1 Myalgia A` E A . . . E A CYCLOBENZAPRINE d00963A B M54 Dorsalgia A E A NAPROXEN d00019A B M54 Dorsalgia A E A . . . E A LOSARTAN d03821A B I10 Essential (primary) hypertension A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C- Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A E0 A ALLOPURINOL d00023A CDp M1A Chronic gout A` E0 A FLUOXETINE d00236A B= F32.9 Major depressive disorder, single episode, unspecified A` E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E0 A MELOXICAM d04532A C- M13 Other arthritis A` E0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E0 A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` E@ A . . . EP A CEFUROXIME d00056A B T14.9 Unspecified injury AP EP A DICLOFENAC d00848A B T14.9 Unspecified injury AP EP A DICLOFENAC TOPICAL d04722A B M62.83 Muscle spasm AP EP A METHOCARBAMOL d00965A B M62.83 Muscle spasm AP EP A VILAZODONE d07740A CDp F41.9 Anxiety disorder, unspecified AP E` A . . . Ep A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A@ E A LABETALOL d00016A C- I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ E A ATORVASTATIN d04105A C E78.0 I10 Pure hypercholesterolemia Essential (primary) hypertension A@ E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A@ E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A@ E A . . . E0 A . . . E@ A PREDNISONE d00350A A 55555 A EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Cr L70 Acne A E A RISPERIDONE d03180A Ei F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A0 EP A INSULIN LISPRO d04373A Cr E11 Type 2 diabetes mellitus A0 EP A LISINOPRIL d00732A C[@ I10.P Prevent hypertension A0 E` A . . . Ep A . . . E A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A CDp I10 Essential (primary) hypertension A E A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A E A . . . E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A N39.0 Urinary tract infection, site not specified A E A . . . E A . . . E A . . . E A . . . E A SERTRALINE d00880A B= F41.9 Anxiety disorder, unspecified A E A . . . E A GLIPIZIDE d00246A Cr R73 Elevated blood glucose level A0 E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E0 A ONDANSETRON d00867A A0 R11 Nausea and vomiting A E@ A . . . EP A . . . E` A . . . Ep A . . . E A BENAZEPRIL d00730A Dc I10 Essential (primary) hypertension A E A . . . E A . . . E A ATORVASTATIN d04105A B E78.1 Pure hyperglyceridemia A0 E A CELECOXIB d04380A C- M19.9 M79.1 Osteoarthritis, unspecified site Myalgia A0 E A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A0 E A . . . E A 99999 . . A E A . . . E A . . . E A . . . E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A EP A WARFARIN d00022A D D75.9P Prevent blood clots A E` A . . . Ep A ASPIRIN d00170A B[ I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A Ep A DONEPEZIL d04099A C G30.9 Alzheimer's disease, unspecified A Ep A FLUOXETINE d00236A CDp F41.9 Anxiety disorder, unspecified A Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ep A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A Ep A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A Ep A TAMSULOSIN d04121A C N40 Enlarged prostate A Ep A TRAZODONE d00395A Cr G47.0 Insomnia A E A CHLORPHENIRAMINE; PHENYLEPHRINE d03300A Bb R09.81 Nasal congestion A E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A D M25.5 R51 Pain in joint Headache A E A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A E A CYCLOBENZAPRINE d00963A C[@ M62.83 Muscle spasm A E A DULOXETINE d05355A A` F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A PROMETHAZINE d00787A D R11 Nausea and vomiting A E A THYROID DESICCATED d00655A A@ E03.9 Hypothyroidism, unspecified A E A . . . E A ACETAMINOPHEN; CODEINE d03423A C M79.1 Myalgia A E A CARBIDOPA; LEVODOPA d03473A C G20 Parkinson's disease A E A IBUPROFEN d00015A Cr M79.1 Myalgia A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A METFORMIN d03807A Cr R73 Elevated blood glucose level A E A NITROGLYCERIN d00321A CDp R07.9 Chest pain, unspecified A E A OMEPRAZOLE d00325A C[@ K25 Gastric ulcer A E A TAMSULOSIN d04121A Cr N40 Enlarged prostate A E A TRAMADOL d03826A Cr R10 Abdominal and pelvic pain A E A . . . E A . . . E A ALBUTEROL d00749A C[@ J20.9 J42 J45 Acute bronchitis, unspecified Unspecified chronic bronchitis Asthma A0 E A METRONIDAZOLE d00108A C- J18.9 Pneumonia, unspecified organism A0 E A MONTELUKAST d04289A B= J45 Asthma A0 E A . . . E0 A . . . E@ A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B M25.5 T14.9 Pain in joint Unspecified injury A` E A AZATHIOPRINE d00024A D K51 Ulcerative colitis A` E A BALSALAZIDE d04700A D K51 Ulcerative colitis A` E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` E A PREDNISONE d00350A D K51 Ulcerative colitis A` E A TRAMADOL d03826A B M25.5 Pain in joint A` E A ALPRAZOLAM d00168A C F32.9 Major depressive disorder, single episode, unspecified A E A LACTULOSE d01024A B[ K59.0 Constipation A E A SUMATRIPTAN d03160A C G43 Migraine A E A VENLAFAXINE d03181A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A . . . E A . . . E A . . . E A DILTIAZEM d00045A C I49.9 Cardiac arrhythmia, unspecified A E A . . . E A . . . E0 A 77777 . . A E@ A . . . EP A . . . E` A . . . Ep A MESALAMINE d01031A B K50 Crohn's disease [regional enteritis] A E A . . . E A . . . E A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E A ALENDRONATE d03849A B= M81 Osteoporosis without current pathological fracture AP E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A ATENOLOL d00004A C I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified AP E A INSULIN ISOPHANE; INSULIN REGULAR d04374A Dc E11 Type 2 diabetes mellitus AP E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` E A BENAZEPRIL d00730A CDp I10 Essential (primary) hypertension A` E A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A CDp I10 Essential (primary) hypertension A` E A METFORMIN d03807A CDp R73 Elevated blood glucose level A` E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E A SITAGLIPTIN d05896A C R73 Elevated blood glucose level A` E A ARIPIPRAZOLE d04825A C- F84 Pervasive developmental disorders A E A ARIPIPRAZOLE d04825A C- F84 Pervasive developmental disorders A E A ACETAMINOPHEN; HYDROCODONE d03428A B= M54 Dorsalgia Ap E A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension Ap E A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion Ap E A FUROSEMIDE d00070A C[@ I51.9 Heart disease, unspecified Ap E A GLIPIZIDE d00246A C[@ R73 Elevated blood glucose level Ap E A PANTOPRAZOLE d04514A C[@ R12 Heartburn Ap E A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus Ap E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ALBUTEROL d00749A A J00 Acute nasopharyngitis [common cold] A EP A . . . E` A . . . Ep A . . . E A ALBUTEROL d00749A D J45 Asthma A E A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A C I10 Essential (primary) hypertension A E A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A E A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified A E A CLOBETASOL TOPICAL d01288A D L40 Psoriasis A E A DULOXETINE d05355A CDp F32.9 Major depressive disorder, single episode, unspecified A E A FLUOCINONIDE TOPICAL d01294A C L29.9 Pruritus, unspecified A E A KETOCONAZOLE TOPICAL d03202A C N76.0 Acute vaginitis A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C R10 Abdominal and pelvic pain A E A SUCRALFATE d00377A C[@ R10 Abdominal and pelvic pain A E A TIOTROPIUM d04829A Cr J45 Asthma A E A TRAMADOL d03826A C- M06.9 R51 Rheumatoid arthritis, unspecified Headache A E A TRAZODONE d00395A C[@ G47.0 Insomnia A E A 99999 . . A E A AMOXICILLIN d00088A B H66.9 Otitis media, unspecified A E A . . . E A . . . E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A C[@ I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A NAPROXEN d00019A C- M19.9 Osteoarthritis, unspecified site A` E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A` E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E A . . . E A ALBUTEROL d00749A D: J45 Asthma A E A . . . E A DESIPRAMINE d00145A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E@ A . . . EP A BENZTROPINE d00175A B= R25.1 Tremor, unspecified A@ EP A CLONAZEPAM d00197A B= R45 Symptoms and signs involving emotional state A@ EP A DIPHENHYDRAMINE d00212A B= R25.1 Tremor, unspecified A@ EP A LISINOPRIL d00732A B= 55555 A@ E` A . . . Ep A CILOSTAZOL d04382A D I70 Atherosclerosis A@ Ep A DOXAZOSIN d00726A D R35 Polyuria A@ Ep A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ Ep A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A BUDESONIDE; FORMOTEROL d04795A C"0 J42 Unspecified chronic bronchitis A0 E A CEFDINIR d04256A A J40 Bronchitis, not specified as acute or chronic A0 E A RANITIDINE d00021A A K31.9 Disease of stomach and duodenum, unspecified A0 E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A ANTIHISTAMINES - UNSPECIFIED c00123A C[@ T78.40 Allergy, unspecified A E A ASPIRIN d00170A C[@ I21.P Prevent heart attack/myocardial infarction A E A CITALOPRAM d04332A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A FENOFIBRATE d04286A C[@ E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C[@ I10 Essential (primary) hypertension A E A LORAZEPAM d00149A C[@ G47.9 Sleep disorder, unspecified A E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A E A TRAMADOL d03826A C[@ M54 Dorsalgia A E A . . . E A . . . E A LISINOPRIL d00732A A I10 Essential (primary) hypertension A E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified Ap E A EXENATIDE d05529A Cr E11 Type 2 diabetes mellitus Ap E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension Ap E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus Ap E A PREGABALIN d05508A C M79.2 Neuralgia and neuritis, unspecified Ap E0 A ALLOPURINOL d00023A C M1A Chronic gout Ap E0 A FENOFIBRATE d04286A C[@ E78.0 Pure hypercholesterolemia Ap E0 A ISOSORBIDE MONONITRATE d00269A C I51.9 Heart disease, unspecified Ap E0 A LOSARTAN d03821A CDp I10 Essential (primary) hypertension Ap E0 A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E0 A PANTOPRAZOLE d04514A B K31.9 Disease of stomach and duodenum, unspecified Ap E0 A TAMSULOSIN d04121A C- N40 Enlarged prostate Ap E@ A . . . EP A ROPINIROLE d04215A A F41.9 G25.81 Anxiety disorder, unspecified Restless legs syndrome A E` A . . . Ep A . . . E A CLOPIDOGREL d04258A B= I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E A DONEPEZIL d04099A B= 99999 A E A HYDRALAZINE d00132A Ei I10 Essential (primary) hypertension A E A LABETALOL d00016A Ei I10 Essential (primary) hypertension A E A LINACLOTIDE d07902A B= K59.0 Constipation A E A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus A E A NIFEDIPINE d00051A B 99999 A E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A E A MONTELUKAST d04289A A R06.9 Unspecified abnormalities of breathing A E A . . . E A CEPHALEXIN d00096A Ap L98.9 Disorder of the skin and subcutaneous tissue, unspecified A0 E A IBUPROFEN d00015A Ap L98.9 Disorder of the skin and subcutaneous tissue, unspecified A0 E A NORTRIPTYLINE d00144A B[ M79.2 Neuralgia and neuritis, unspecified A0 E A AMOXICILLIN d00088A AP J20.9 Acute bronchitis, unspecified A E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots A@ E A GABAPENTIN d03182A C B02 Zoster [herpes zoster] A@ E A METOPROLOL d00134A D I10 Essential (primary) hypertension A@ E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A0 E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C[@ R73 Elevated blood glucose level A0 E A . . . E A . . . E A . . . E0 A ACYCLOVIR d00001A B Z51.1 Encounter for antineoplastic chemotherapy and immunotherapy AP E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E0 A SIMVASTATIN d00746A D% E78.0 Pure hypercholesterolemia AP E0 A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B Z51.1 Encounter for antineoplastic chemotherapy and immunotherapy AP E@ A . . . EP A RISPERIDONE d03180A C R41 Other symptoms and signs involving cognitive functions and awareness A E` A . . . Ep A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A0 B Z79.3 Long term (current) use of hormonal contraceptives A E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A` R05 Cough A E A OSELTAMIVIR d04462A A` J09 Influenza due to certain identified influenza viruses A E A . . . E A . . . E A AZITHROMYCIN d00091A AP J02.0 Streptococcal pharyngitis A E A . . . E A . . . E A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A E A . . . E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E A RANITIDINE d00021A C K30 Functional dyspepsia A E A . . . E A IBUPROFEN d00015A CDp M25.5 Pain in joint A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A TRAMADOL d03826A C M25.5 Pain in joint A@ E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A N12 Tubulo-interstitial nephritis, not specified as acute or chronic A E A . . . E° A ATORVASTATIN d04105A CDp 99999 A0 E° A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A0 E° A METFORMIN d03807A CDp R73 Elevated blood glucose level A0 E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A@ B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A Ap J98.9 Respiratory disorder, unspecified A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . EÀ A DILTIAZEM d00045A C I10 Essential (primary) hypertension A@ EÀ A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A@ EÀ A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia A@ EÀ A RANITIDINE d00021A D K21 Gastro-esophageal reflux disease A@ EÐ A . . . Eà A . . . Eð A . . . E A . . . E A ALBUTEROL d00749A C- R06.2 Wheezing A E A ALBUTEROL d00749A C- R06.02 Shortness of breath A E A AZELASTINE NASAL d04068A C J30.9 Allergic rhinitis, unspecified A E A DUTASTERIDE d04788A C N40 Enlarged prostate A E A FLUTICASONE d01296A C- J45 Asthma A E A IPRATROPIUM d00265A C R06.2 Wheezing A E A LAMOTRIGINE d03809A B= G40 Epilepsy and recurrent seizures A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A MOMETASONE NASAL d04223A Cr J30.9 Allergic rhinitis, unspecified A E A MONTELUKAST d04289A C[@ R06.2 Wheezing A E A OMEPRAZOLE d00325A B= K21 Gastro-esophageal reflux disease A E A PREDNISONE d00350A B T78.40 Allergy, unspecified A E A TIOTROPIUM d04829A B R06.2 Wheezing A E A TOPIRAMATE d04115A C G40 G43 Epilepsy and recurrent seizures Migraine A E A TRAMADOL d03826A B[ M79.1 Myalgia A E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A D# E07.9 Disorder of thyroid, unspecified A E A METFORMIN d03807A D# E11 Type 2 diabetes mellitus A E A . . . E0 A . . . E@ A LOSARTAN d03821A B= I10 Essential (primary) hypertension A EP A CARVEDILOL d03847A C 99999 A@ EP A EZETIMIBE d04824A C- E78.0 Pure hypercholesterolemia A@ EP A LISINOPRIL d00732A C 99999 A@ EP A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A@ E` A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus AP E` A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus AP E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E` A METFORMIN d03807A D R73 Elevated blood glucose level AP E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP Ep A . . . EĀ A . . . EĐ A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension Ap EĐ A HYDROCHLOROTHIAZIDE d00253A B[ R60.9 Edema, unspecified Ap EĐ A LISINOPRIL d00732A C[@ E11.2P Prevent diabetic kidney disease Ap EĐ A METFORMIN d03807A C[@ R73 Elevated blood glucose level Ap EĐ A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension Ap EĐ A PREGABALIN d05508A Bz E11.4 Type 2 diabetes mellitus with neurological complications Ap EĐ A RANITIDINE d00021A C K30 Functional dyspepsia Ap EĠ A . . . Eİ A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E A DIGOXIN d00210A CDp I49.9 Cardiac arrhythmia, unspecified AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension AP E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C- I10 Essential (primary) hypertension AP E A DARUNAVIR d05825A C B20 Human immunodeficiency virus [HIV] disease A0 E A EMTRICITABINE; TENOFOVIR d05352A C B20 Human immunodeficiency virus [HIV] disease A0 E A RITONAVIR d03984A Dc B20 Human immunodeficiency virus [HIV] disease A0 E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A` E A CLONIDINE d00044A C I10 Essential (primary) hypertension A` E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A` E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A` E A NAPROXEN d00019A B M25.5 Pain in joint A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A E A WARFARIN d00022A C[@ I26 Pulmonary embolism A E A . . . E0 A AMITRIPTYLINE d00146A Cr G47.0 Insomnia A E0 A CYCLOBENZAPRINE d00963A Cr M62.83 M79.1 Muscle spasm Myalgia A E0 A DULOXETINE d05355A C- M79.2 Neuralgia and neuritis, unspecified A E0 A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A E0 A OXYCODONE d00329A CDp M54 Dorsalgia A E0 A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E0 A WARFARIN d00022A D I26 I80.3 Pulmonary embolism Phlebitis and thrombophlebitis of lower extremities, unspecified A E0 A ZOLPIDEM d00910A Cr G47.0 Insomnia A E@ A . . . EP A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 EP A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A CDp I10 Essential (primary) hypertension A0 EP A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 E` A . . . Ep A METHOTREXATE d00060A C- M06.9 Rheumatoid arthritis, unspecified A Eŀ A ALBUTEROL d00749A C J45 Asthma A0 Eŀ A ALBUTEROL d00749A C J45 Asthma A0 Eŀ A FLUTICASONE; SALMETEROL d04611A Ei J45 Asthma A0 EŐ A 99999 . . A EŐ A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A EŠ A . . . EŰ A . . . E A . . . E A DOXAZOSIN d00726A C- I10 Essential (primary) hypertension A E A . . . E A ALBUTEROL d00749A B[ J45 Asthma A@ E A ALBUTEROL d00749A C R06.2 Wheezing A@ E A ALBUTEROL d00749A D J45 Asthma A@ E A FLUTICASONE d01296A C J45 Asthma A@ E A ALFUZOSIN d04797A C[@ N40 Enlarged prostate A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E A . . . E A WARFARIN d00022A C[@ I26 I80.3 Pulmonary embolism Phlebitis and thrombophlebitis of lower extremities, unspecified A E0 A . . . E@ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A EP A ALBUTEROL d00749A C J45 R06.02 Asthma Shortness of breath A0 EP A IBUPROFEN d00015A CP G43 M13 Migraine Other arthritis A0 EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E` A ASPIRIN d00170A C I51.9P Prevent heart disease A E` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E` A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E` A FUROSEMIDE d00070A C- E87.7 Fluid overload A E` A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A E` A LISINOPRIL d00732A C- I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E` A NIFEDIPINE d00051A Bz I10 Essential (primary) hypertension A E` A OMEPRAZOLE d00325A C- K92.9 Disease of digestive system, unspecified A Ep A . . . Eƀ A . . . EƐ A . . . EƠ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A EƠ A OMEPRAZOLE d00325A B K30 Functional dyspepsia A Eư A . . . E A . . . E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Cr Z79.3 Long term (current) use of hormonal contraceptives A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A INDOMETHACIN d00039A C M1A Chronic gout A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A PAROXETINE d03157A C F39 Unspecified mood [affective] disorder A@ E A . . . E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E0 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 E@ A . . . EP A . . . E` A . . . Ep A . . . Eǀ A 77777 . . A Eǀ A RANITIDINE d00021A D* K27 Peptic ulcer, site unspecified A Eǐ A . . . EǠ A . . . Eǰ A . . . E A . . . E A . . . E A . . . E A . . . E A GLIPIZIDE d00246A Dc R73 Elevated blood glucose level A0 E A METFORMIN d03807A Dc R73 Elevated blood glucose level A0 E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A0 E A . . . E A ALBUTEROL d00749A D= J45 Asthma A0 E A CITALOPRAM d04332A C[@ F41.9 Anxiety disorder, unspecified A0 E A FLUTICASONE; SALMETEROL d04611A B J20.9 Acute bronchitis, unspecified A0 E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . EȀ A . . . EȐ A CETIRIZINE d03827A C[@ 99999 A` EȐ A FUROSEMIDE d00070A C J98.9 Respiratory disorder, unspecified A` EȐ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` EȐ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` EȐ A OMEPRAZOLE d00325A C[@ 99999 A` EȐ A RIVAROXABAN d07356A Cr D75.9P Prevent blood clots A` EȠ A CEFDINIR d04256A A J01.9 J40 Acute sinusitis, unspecified Bronchitis, not specified as acute or chronic A EȰ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A ETHINYL ESTRADIOL; ETONOGESTREL d04773A C Z79.3 Long term (current) use of hormonal contraceptives A E A CONJUGATED ESTROGENS TOPICAL d04396A Cr N95 Menopausal and other perimenopausal disorders A E A LOTEPREDNOL OPHTHALMIC d04292A C H57.9 Unspecified disorder of eye and adnexa A E A AMLODIPINE; OLMESARTAN d06905A Cr I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A D# I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A0 E A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation A E A . . . E0 A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A B J00 R05 Acute nasopharyngitis [common cold] Cough A E@ A FLUTICASONE NASAL d04283A B[ R09.81 Nasal congestion A E@ A MONTELUKAST d04289A B R06.2 Wheezing A EP A AMLODIPINE d00689A C I20.9 Angina pectoris, unspecified A EP A ATORVASTATIN d04105A C 99999 A EP A CARVEDILOL d03847A C I10 Essential (primary) hypertension A EP A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A EP A OMEPRAZOLE d00325A C 99999 A EP A SITAGLIPTIN d05896A C E11.P Prevent diabetes A EP A TIMOLOL d00139A C I10 Essential (primary) hypertension A EP A VALSARTAN d04113A C 99999 A E` A . . . Ep A . . . Eɀ A . . . Eɐ A ADALIMUMAB d04835A B L40 M06.9 Psoriasis Rheumatoid arthritis, unspecified A0 Eɐ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A0 Eɐ A TORSEMIDE d03189A Bz I10 R60.9 Essential (primary) hypertension Edema, unspecified A0 Eɠ A . . . Eɰ A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A0 Eɰ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D"8 I10 Essential (primary) hypertension A0 Eɰ A VENLAFAXINE d03181A Cr F43.1 Post-traumatic stress disorder (PTSD) A0 E A . . . E A . . . E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A SPIRONOLACTONE d00373A C"0 L70 Acne A E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . Eʀ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A Eʐ A ONDANSETRON d00867A A R11 Nausea and vomiting A Eʠ A . . . Eʰ A . . . E A FUROSEMIDE d00070A C- R12 Heartburn A0 E A LISINOPRIL d00732A CDp R12 Heartburn A0 E A OMEPRAZOLE d00325A C[@ R12 Heartburn A0 E A TRIAMTERENE d00396A B I10 Essential (primary) hypertension A E A . . . E A ALBUTEROL d00749A0 C R09.3 Abnormal sputum A` E A AMLODIPINE d00689A0 CDp 99999 A` E A FORMOTEROL; MOMETASONE d07660A0 C R06.2 Wheezing A` E A SIMVASTATIN d00746A0 C- E78.0 Pure hypercholesterolemia A` E A TAMSULOSIN d04121A C R35 Polyuria A` E A TRIAMCINOLONE TOPICAL d03206A C L23 Allergic contact dermatitis A` E A . . . E A . . . E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 Ep A MELOXICAM d04532A C- M19.9 Osteoarthritis, unspecified site A0 Ep A TRAMADOL d03826A C M19.9 Osteoarthritis, unspecified site A0 Eˀ A . . . Eː A . . . Eˠ A . . . E˰ A ALBUTEROL d00749A Bz J45 Asthma A E˰ A AZELASTINE NASAL d04068A B[ J30.9 Allergic rhinitis, unspecified A E˰ A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A E˰ A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A E˰ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E˰ A METOPROLOL d00134A A@ I10 Essential (primary) hypertension A E˰ A METOPROLOL d00134A C I10 Essential (primary) hypertension A E˰ A MOMETASONE NASAL d04223A B J30.9 Allergic rhinitis, unspecified A E˰ A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A E A . . . E A TRAMADOL d03826A A R10 Abdominal and pelvic pain A E A . . . E A . . . E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A . . . E A . . . E0 A AMOXICILLIN d00088A Ap J06.9 Acute upper respiratory infection, unspecified A E@ A . . . EP A . . . E` A . . . Ep A RANITIDINE d00021A A@ R05 Cough A È A ACETAMINOPHEN; HYDROCODONE d03428A Cr M25.5 Pain in joint A@ È A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ È A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease A@ È A PAROXETINE d03157A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E̐ A . . . E̠ A . . . Ḛ A . . . E A . . . E A DILTIAZEM d00045A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ E A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A@ E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E A WARFARIN d00022A D I48.9 Unspecified atrial fibrillation and atrial flutter A@ E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A@ E A IBANDRONATE d05357A Bz M81 Osteoporosis without current pathological fracture A@ E A ZOLPIDEM d00910A C G47.0 Insomnia A@ E A ACETAMINOPHEN; OXYCODONE d03431A C- R07.9 Chest pain, unspecified A@ E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A@ E A RANITIDINE d00021A B K92.9 Disease of digestive system, unspecified A@ E A TRAMADOL d03826A B= M54 Dorsalgia A@ E A . . . E A . . . E A . . . E0 A 99999 . . A E0 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E0 A CLINDAMYCIN d00043A B K04.7 Periapical abscess without sinus A E0 A CLOPIDOGREL d04258A B I21.P Prevent heart attack/myocardial infarction A E0 A HYDROXYCHLOROQUINE d00817A Dc L93 Lupus erythematosus A E0 A NIFEDIPINE d00051A Dc I10 Essential (primary) hypertension A E0 A PREDNISONE d00350A Dc L93 Lupus erythematosus A E0 A PROPRANOLOL d00032A B I10 Essential (primary) hypertension A E@ A . . . EP A CLOTRIMAZOLE TOPICAL d04395A Ap B35 Dermatophytosis A E` A . . . Ep A AMLODIPINE; BENAZEPRIL d03829A Dc I10 Essential (primary) hypertension A Ep A TRAMADOL d03826A C- M25.5 M54 M79.1 Pain in joint Dorsalgia Myalgia A È A TAMOXIFEN d00381A CDp C50.P Prevent barest cancer A0 È A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified A0 È A VENLAFAXINE d03181A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E͐ A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A E͠ A . . . EͰ A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A NORTRIPTYLINE d00144A C G99.8 Other specified disorders of nervous system in diseases classified elsewhere A E A INSULIN ASPART d04697A C9 E11 Type 2 diabetes mellitus AP E A INSULIN DETEMIR d05436A B= E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP E A LOVASTATIN d00280A B[ E78.0 Pure hypercholesterolemia AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E0 A AMPHETAMINE d00803A B- F90 Attention-deficit hyperactivity disorders A E@ A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ E@ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E@ A RANITIDINE d00021A C 55555 A@ E@ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ EP A . . . E` A FLUTICASONE d01296A B- J00.P Prevent common cold A E` A POLYMYXIN B; TRIMETHOPRIM OPHTHALMIC d03529A A H10 Conjunctivitis A Ep A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A . . . Eΐ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A Eΐ A ATENOLOL d00004A C I10 Essential (primary) hypertension A Eΐ A CONJUGATED ESTROGENS d00541A D Z79.890 Hormone replacement therapy A Eΐ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A Eΐ A LANSOPRAZOLE d03828A C K30 Functional dyspepsia A Eΐ A OXYBUTYNIN d00328A B N32.81 Overactive bladder A Eΐ A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A Eΐ A RIVAROXABAN d07356A B= D75.9P Prevent blood clots A EΠ A . . . Eΰ A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A Eΰ A MONTELUKAST d04289A CDp J30.9 J45 R05 Allergic rhinitis, unspecified Asthma Cough A E A DIAZEPAM d00148A Cr G40 Epilepsy and recurrent seizures A E A ALLOPURINOL d00023A C[@ M1A Chronic gout A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A DIVALPROEX SODIUM d03833A Dc F31.9 Bipolar disorder, unspecified A E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A E A ALBUTEROL d00749A D J42 Unspecified chronic bronchitis A@ E A FLUTICASONE; SALMETEROL d04611A D J45 Asthma A@ E A HYDROCHLOROTHIAZIDE d00253A DU R60.9 Edema, unspecified A@ E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B Z79.3 Long term (current) use of hormonal contraceptives A E A LORAZEPAM d00149A C F32.9 Major depressive disorder, single episode, unspecified A E A OLANZAPINE d04050A C F29 Unspecified psychosis not due to a substance or known physiological condition A E A . . . E0 A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E@ A ALBUTEROL d00749A C R06.9 Unspecified abnormalities of breathing A E@ A ALBUTEROL d00749A C R06.9 Unspecified abnormalities of breathing A E@ A FLUTICASONE NASAL d04283A B[ H04 Disorders of lacrimal system A E@ A FLUTICASONE; VILANTEROL d08100A C R06.9 Unspecified abnormalities of breathing A E@ A GLIPIZIDE d00246A C E11.P Prevent diabetes A E@ A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E@ A IPRATROPIUM d00265A C R06.9 Unspecified abnormalities of breathing A E@ A ISOSORBIDE d00653A C H40 Glaucoma A E@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A E@ A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction A E@ A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol A EP A . . . E` A . . . Ep A . . . Eπ A ALBUTEROL d00749A D J45 Asthma A0 Eπ A CETIRIZINE d03827A D T78.40 Allergy, unspecified A0 Eπ A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A0 Eϐ A . . . EϠ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified AP EϠ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP EϠ A ESCITALOPRAM d04812A C- F32.9 Major depressive disorder, single episode, unspecified AP EϠ A GEMCITABINE d04010A B E78.0 I51.9 Pure hypercholesterolemia Heart disease, unspecified AP EϠ A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP Eϰ A ATENOLOL d00004A Cr 99999 AP Eϰ A DILTIAZEM d00045A CDp 99999 AP Eϰ A RANITIDINE d00021A CDp 99999 AP Eϰ A TAMSULOSIN d04121A Cr 99999 AP Eϰ A WARFARIN d00022A C- I63 Cerebral infarction AP E A NORETHINDRONE d00555A Bz Z79.3 Long term (current) use of hormonal contraceptives A E A PREDNISONE d00350A Ap J42 Unspecified chronic bronchitis A E A 99999 . . A E A . . . E A . . . E A . . . E A NIFEDIPINE d00051A B= 55555 A E A OMEPRAZOLE d00325A C K30 Functional dyspepsia A E0 A . . . E@ A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A EP A CETIRIZINE d03827A C[@ T78.40 Allergy, unspecified A E` A . . . Ep A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A EЀ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EЀ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 N20.0 Essential (primary) hypertension Calculus of kidney A EА A . . . EР A . . . Eа A ACETAMINOPHEN; HYDROCODONE d03428A C- M13 M54 Other arthritis Dorsalgia Ap Eа A BIMATOPROST OPHTHALMIC d04754A C- H04 Disorders of lacrimal system Ap Eа A LOSARTAN d03821A Ei I10 Essential (primary) hypertension Ap Eа A METFORMIN; SITAGLIPTIN d06720A Ei E11 Type 2 diabetes mellitus Ap Eа A METOPROLOL d00134A Ei I10 Essential (primary) hypertension Ap Eа A SIMVASTATIN d00746A C- I63.P Prevent stroke Ap Eа A TAMSULOSIN d04121A C- N40 Enlarged prostate Ap E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . Eр A . . . Eѐ A . . . EѠ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ EѠ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ EѠ A METOPROLOL d00134A B I49.9 Cardiac arrhythmia, unspecified A@ EѠ A PRIMIDONE d00352A C- R25.1 Tremor, unspecified A@ EѰ A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A EѰ A BUDESONIDE; FORMOTEROL d04795A C J44.9 Chronic obstructive pulmonary disease, unspecified A EѰ A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A EѰ A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A EѰ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EѰ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EѰ A METOPROLOL d00134A C I10 Essential (primary) hypertension A EѰ A SERTRALINE d00880A Bz F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C I10 Essential (primary) hypertension A@ E A PANTOPRAZOLE d04514A B B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A@ E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E A ZOLPIDEM d00910A Cr G47.0 Insomnia A@ E A . . . E A 99999 . . A E A ALPRAZOLAM d00168A0 D3T F41.9 G47.0 Anxiety disorder, unspecified Insomnia A@ E A FLUOXETINE d00236A0 D3T F41.9 F42 Anxiety disorder, unspecified Obsessive-compulsive disorder A@ E A MIRABEGRON d07876A0 C N32.81 N39.4 R35 Overactive bladder Other specified urinary incontinence Polyuria A@ E A OMEPRAZOLE d00325A0 B- K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E0 A . . . E@ A . . . EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E` A . . . Ep A ACETAMINOPHEN; HYDROCODONE d03428A C M54 M79.1 Dorsalgia Myalgia A0 Ep A METOPROLOL d00134A C- I10 Essential (primary) hypertension A0 Ep A WARFARIN d00022A C D75.9P Prevent blood clots A0 EҀ A . . . EҐ A . . . EҠ A . . . EҰ A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A E A ATAZANAVIR d04882A D B20 Human immunodeficiency virus [HIV] disease A E A EMTRICITABINE; TENOFOVIR d05352A C[@ B20 Human immunodeficiency virus [HIV] disease A E A . . . E A . . . E A . . . E A . . . E0 A ESOMEPRAZOLE d04749A C- 55555 A E@ A . . . EP A . . . E` A . . . Ep A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A EӀ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ EӀ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A@ EӀ A METOPROLOL d00134A C- I49.9 Cardiac arrhythmia, unspecified A@ EӀ A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A@ EӐ A . . . EӠ A . . . EӰ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A EӰ A ESOMEPRAZOLE d04749A B R12 Heartburn A EӰ A GLYBURIDE d00248A D ^ E11 Type 2 diabetes mellitus A EӰ A GLYBURIDE; METFORMIN d04703A D R73 Elevated blood glucose level A EӰ A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A EӰ A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A EӰ A LEVOTHYROXINE d00278A D ^ E03.9 Hypothyroidism, unspecified A EӰ A METOPROLOL d00134A D ^ I50.9 Heart failure, unspecified A EӰ A OMEPRAZOLE d00325A B R12 Heartburn A EӰ A RANITIDINE d00021A B K92.9 Disease of digestive system, unspecified A EӰ A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A@ E A PAROXETINE d03157A D F41.9 Anxiety disorder, unspecified A@ E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ E A TAMSULOSIN d04121A C[@ R39.1 Other difficulties with micturition A@ E A . . . E A . . . E A . . . E A METFORMIN d03807A C R73 Elevated blood glucose level A E A . . . E A . . . E0 A . . . E@ A . . . EP A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ EP A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A@ EP A PRAVASTATIN d00348A CO E78.0 Pure hypercholesterolemia A@ EP A WARFARIN d00022A CO I21 I63 Z79.0 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Cerebral infarction Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E` A . . . Ep A . . . EԀ A . . . EԐ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EԠ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E A GLIPIZIDE d00246A B- E11 Type 2 diabetes mellitus Ap E A INSULIN GLARGINE d04538A C R73 Elevated blood glucose level Ap E A LISINOPRIL d00732A C[@ E11.2 Type 2 diabetes mellitus with kidney complications Ap E A NABUMETONE d00310A C[@ E11 Type 2 diabetes mellitus Ap E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C[@ I21.P Prevent heart attack/myocardial infarction Ap E A PRASUGREL d07409A B- D75.9P Prevent blood clots Ap E A DULOXETINE d05355A Dc F32.9 M54 Major depressive disorder, single episode, unspecified Dorsalgia A E A CEFIXIME d00072A AP N39.0 Urinary tract infection, site not specified A E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A D,3 E78.0 Pure hypercholesterolemia A E A DONEPEZIL d04099A C- G31.9 Degenerative disease of nervous system, unspecified A E A ESOMEPRAZOLE d04749A D K21 Gastro-esophageal reflux disease A E A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified A E A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A MEMANTINE d04899A C G31.9 Degenerative disease of nervous system, unspecified A E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A E A PIOGLITAZONE d04442A C- E11 Type 2 diabetes mellitus A E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . EՀ A . . . EՐ A FUROSEMIDE d00070A C K76.9 Liver disease, unspecified A EՐ A SPIRONOLACTONE d00373A C R60.9 Edema, unspecified A Eՠ A . . . Eհ A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CHOLESTYRAMINE d00193A Cr R19.7 Diarrhea, unspecified A E A DIGOXIN d00210A C I49.9 Cardiac arrhythmia, unspecified A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A QUINAPRIL d00365A C I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A E A WARFARIN d00022A D= I48.9 I49.9 Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified A E A . . . E A 99999 . . A@ E A CANAGLIFLOZIN d08080A B E11 Type 2 diabetes mellitus A@ E A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A . . . E A EMPAGLIFLOZIN d08275A C E11 Type 2 diabetes mellitus AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A NAPROXEN d00019A C M25.5 M79.1 Pain in joint Myalgia AP E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E A METHIMAZOLE d00290A B E05 Thyrotoxicosis [hyperthyroidism] A E0 A DORZOLAMIDE OPHTHALMIC d03805A C- H40 Glaucoma A E0 A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A E@ A . . . EP A . . . E` A METFORMIN d03807A Bz R73 Elevated blood glucose level A Ep A . . . Eր A ADAPALENE; BENZOYL PEROXIDE TOPICAL d07382A B L70 Acne A Eր A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E֠ A . . . Eְ A . . . E A . . . E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E A . . . E A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus A0 E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E A SITAGLIPTIN d05896A B[ E11 Type 2 diabetes mellitus A0 E A . . . E A . . . E A CLOPIDOGREL d04258A C[@ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E A DULOXETINE d05355A Cr M54 Dorsalgia A@ E A SIMVASTATIN d00746A C- I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A@ E A TOPIRAMATE d04115A C- M79.2 Neuralgia and neuritis, unspecified A@ E0 A DIVALPROEX SODIUM d03833A B[ F32.9 Major depressive disorder, single episode, unspecified A0 E0 A FLUOXETINE d00236A C"0 F32.9 Major depressive disorder, single episode, unspecified A0 E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E@ A . . . EP A AMOXICILLIN; CLAVULANATE d00089A A J02 Acute pharyngitis A EP A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A R05 Cough A E` A . . . Ep A . . . E׀ A . . . Eא A . . . Eנ A . . . Eװ A . . . E A . . . E A AMLODIPINE d00689A C N28.9 Disorder of kidney and ureter, unspecified A0 E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E A MEMANTINE d04899A C R41 Other symptoms and signs involving cognitive functions and awareness A0 E A ACETAZOLAMIDE d00161A C H40 Glaucoma A E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A0 C I51.9 Heart disease, unspecified AP E A NITROGLYCERIN d00321A0 C- R07.9 Chest pain, unspecified AP E A OMEPRAZOLE d00325A0 C K21 R12 Gastro-esophageal reflux disease Heartburn AP E A ALBUTEROL d00749A0 D"8 R06.9 Unspecified abnormalities of breathing B E A ALBUTEROL d00749A0 D"8 R06.9P Prevent breathing difficulty B E A AZITHROMYCIN d00091A0 . J40 Bronchitis, not specified as acute or chronic B E A BUDESONIDE d04276A0 D"8 J44.9 Chronic obstructive pulmonary disease, unspecified B E A BUSPIRONE d00182A0 B F41.9 Anxiety disorder, unspecified B E A FINASTERIDE d00563A0 C[@ R35 Polyuria B E A LAMOTRIGINE d03809A0 C F43.1 Post-traumatic stress disorder (PTSD) B E A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified B E A LORAZEPAM d00149A0 C F43.1 Post-traumatic stress disorder (PTSD) B E A LOSARTAN d03821A0 C I10 Essential (primary) hypertension B E A NICOTINE d00316A . F17.2 Nicotine dependence B E A OMEPRAZOLE d00325A0 C K31.9 Disease of stomach and duodenum, unspecified B E A SILDENAFIL d04299A0 C 55555 B E A TEMAZEPAM d00384A0 Dc G47.0 Insomnia B E A TIOTROPIUM d04829A0 C J44.9 Chronic obstructive pulmonary disease, unspecified B E A TOLTERODINE d04294A0 C E78.0 Pure hypercholesterolemia B E A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A` E A FENTANYL d00233A B M54 Dorsalgia A` E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A` E A PREGABALIN d05508A C M79.7 Fibromyalgia A` E A VERAPAMIL d00048A D' I10 Essential (primary) hypertension A` E A DESOGESTREL; ETHINYL ESTRADIOL d03782A Bz Z79.3 Long term (current) use of hormonal contraceptives A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . Eؐ A . . . Eؠ A . . . Eذ A . . . E A . . . E A CYCLOBENZAPRINE d00963A Cr M19.9 Osteoarthritis, unspecified site A E A . . . E A . . . E A ALLOPURINOL d00023A C[@ M1A Chronic gout A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A NIACIN d00314A Cr E78.0 Pure hypercholesterolemia A E A PREGABALIN d05508A C[@ M79.2 Neuralgia and neuritis, unspecified A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A` E A METOPROLOL d00134A C E78.1 Pure hyperglyceridemia A` E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A PRIMIDONE d00352A Cr G25.0 Essential tremor A` E A WARFARIN d00022A C I48.9 Unspecified atrial fibrillation and atrial flutter A` E0 A . . . E@ A . . . EP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CDp E34 Other endocrine disorders A E` A . . . Ep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 Ep A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 Ep A HYDROXYCHLOROQUINE d00817A C L93 Lupus erythematosus A0 Eـ A . . . Eِ A AZITHROMYCIN d00091A Ap B99.9 Unspecified infectious disease A E٠ A . . . Eٰ A ACETAMINOPHEN; HYDROCODONE d03428A Cr M79.6 Pain in limb, hand, foot, fingers and toes B Eٰ A ALBUTEROL; IPRATROPIUM d04066A C J44.9 Chronic obstructive pulmonary disease, unspecified B Eٰ A ARIPIPRAZOLE d04825A Cr F32.9 Major depressive disorder, single episode, unspecified B Eٰ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia B Eٰ A BACLOFEN d00967A B M79.1 Myalgia B Eٰ A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified B Eٰ A DULOXETINE d05355A Cr F32.9 Major depressive disorder, single episode, unspecified B Eٰ A FLUTICASONE NASAL d04283A Cr J30.2 Other seasonal allergic rhinitis B Eٰ A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma B Eٰ A GABAPENTIN d03182A Cr M25.5 Pain in joint B Eٰ A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus B Eٰ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension B Eٰ A MELOXICAM d04532A B= M25.5 Pain in joint B Eٰ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus B Eٰ A OMEPRAZOLE d00325A Cr K21 K25 Gastro-esophageal reflux disease Gastric ulcer B Eٰ A OXYBUTYNIN d00328A CDp R32 Unspecified urinary incontinence B Eٰ A SALMETEROL d03759A B J44.9 Chronic obstructive pulmonary disease, unspecified B E A . . . E A CARVEDILOL d03847A CDp I49.9 Cardiac arrhythmia, unspecified A E A CLOPIDOGREL d04258A C- I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A C- 99999 A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A C- E78.0P Prevent high cholesterol A E A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A A Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E0 A . . . E@ A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E@ A ONDANSETRON d00867A B R11 Nausea and vomiting A EP A . . . E` A . . . Ep A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap Ep A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified Ap Ep A MELOXICAM d04532A B[ M79.2 Neuralgia and neuritis, unspecified Ap Ep A OXYBUTYNIN d00328A C R32 Unspecified urinary incontinence Ap Ep A OXYCODONE d00329A Cr M54 Dorsalgia Ap Ep A ROPINIROLE d04215A C G25.81 Restless legs syndrome Ap Ep A ZOLPIDEM d00910A C G47.0 Insomnia Ap Eڀ A TOBRAMYCIN OPHTHALMIC d03222A A@ H10 Conjunctivitis A Eڐ A . . . Eڠ A . . . Eڰ A LEVOTHYROXINE d00278A Ei E07.9 Disorder of thyroid, unspecified A E A . . . E A . . . E A CYCLOBENZAPRINE d00963A B= M79.1 Myalgia A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I50.9 Heart failure, unspecified A E A NAPROXEN d00019A Ap M79.1 Myalgia A E A OMEPRAZOLE d00325A B= K21 Gastro-esophageal reflux disease A E A PROMETHAZINE d00787A C R11 Nausea and vomiting A E A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified A E A VERAPAMIL d00048A Cr I10 Essential (primary) hypertension A E A ZOLPIDEM d00910A C G47.0 Insomnia A E A ASPIRIN d00170A A I63.P Prevent stroke A E A METFORMIN d03807A A E11 Type 2 diabetes mellitus A E A CEPHALEXIN d00096A Ap L20.9 Atopic dermatitis, unspecified A E A TRIAMCINOLONE TOPICAL d03206A Ap L20.9 Atopic dermatitis, unspecified A E A . . . E A ALBUTEROL d00749A C R06.9P Prevent breathing difficulty A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . Eۀ A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A Eې A ERYTHROMYCIN d00046A C- L70 Acne A E۠ A . . . E۰ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A@ E۰ A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified A@ E۰ A TRAZODONE d00395A CDp G47.0 Insomnia A@ E۰ A VENLAFAXINE d03181A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E A . . . E A GEMFIBROZIL d00245A Cr E78.1 Pure hyperglyceridemia A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A DIVALPROEX SODIUM d03833A B G47.0 Insomnia A@ E A GABAPENTIN d03182A Bz M79.2 Neuralgia and neuritis, unspecified A@ E A NALTREXONE d01406A B F39 Unspecified mood [affective] disorder A@ E A PAROXETINE d03157A Bz F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder A@ E A BACLOFEN d00967A Dc M62.83 Muscle spasm A E A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E A HYDRALAZINE d00132A D* I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A E A HYDROCODONE d03075A Cr M25.5 M54 Pain in joint Dorsalgia A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E A ISOSORBIDE MONONITRATE d00269A Bz M54 Dorsalgia A E A METOPROLOL d00134A D* I10 Essential (primary) hypertension A E A NYSTATIN d01233A CDp B37 Candidiasis A E A OMEPRAZOLE d00325A C 99999 A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A TRAMADOL d03826A C M54 Dorsalgia A E A TRIAMCINOLONE TOPICAL d03206A C[@ L29.9 Pruritus, unspecified A E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` EP A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A` EP A DIGOXIN d00210A C 99999 A` EP A FUROSEMIDE d00070A C- I51.9 Heart disease, unspecified A` EP A LISINOPRIL d00732A C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` EP A SPIRONOLACTONE d00373A B I51.9 Heart disease, unspecified A` E` A ALLOPURINOL d00023A C M1A Chronic gout AP E` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E` A CLONIDINE d00044A C- I10 Essential (primary) hypertension AP E` A LOSARTAN d03821A C- I10 Essential (primary) hypertension AP E` A PROPRANOLOL d00032A C- R25.1 Tremor, unspecified AP Ep A FLUTICASONE NASAL d04283A A J00 R09.81 Acute nasopharyngitis [common cold] Nasal congestion A0 Ep A LISINOPRIL d00732A A F32.9 Major depressive disorder, single episode, unspecified A0 Ep A MELOXICAM d04532A D M25.5 Pain in joint A0 E܀ A CLINDAMYCIN d00043A A K04.7 Periapical abscess without sinus A E܀ A ONDANSETRON d00867A A R11 Nausea and vomiting A Eܐ A ESOMEPRAZOLE d04749A B= K21 Gastro-esophageal reflux disease A Eܐ A IBUPROFEN d00015A B N30 Cystitis A Eܠ A ATORVASTATIN d04105A C"@ E78.0 Pure hypercholesterolemia AP Eܠ A FINASTERIDE d00563A Cr N40 Enlarged prostate AP Eܠ A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified AP Eܠ A METOPROLOL d00134A C"@ I21.P Prevent heart attack/myocardial infarction AP Eܠ A TAMSULOSIN d04121A D# N40 Enlarged prostate AP Eܰ A . . . E A . . . E A . . . E A . . . E A CLONIDINE d00044A C I10 Essential (primary) hypertension A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A` E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A` E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A . . . E0 A DESOGESTREL; ETHINYL ESTRADIOL d03782A Dc Z79.3 Long term (current) use of hormonal contraceptives A E@ A . . . EP A ATORVASTATIN d04105A D N28.9 Disorder of kidney and ureter, unspecified AP EP A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus AP EP A LISINOPRIL d00732A D 99999 AP EP A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP EP A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus AP E` A . . . Ep A . . . E݀ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified Ap E݀ A ATENOLOL d00004A CDp R07.9 Chest pain, unspecified Ap E݀ A GLIPIZIDE d00246A C R73 Elevated blood glucose level Ap E݀ A LISINOPRIL d00732A CDp E11.2 Type 2 diabetes mellitus with kidney complications Ap E݀ A METFORMIN d03807A C R73 Elevated blood glucose level Ap E݀ A SIMVASTATIN d00746A C E11 Type 2 diabetes mellitus Ap E݀ A SITAGLIPTIN d05896A CDp E11 Type 2 diabetes mellitus Ap Eݐ A NYSTATIN TOPICAL d04399A A B37 Candidiasis A Eݠ A . . . Eݰ A DABIGATRAN d07137A C[@ I49.9 Cardiac arrhythmia, unspecified AP Eݰ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension AP Eݰ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Eݰ A METOPROLOL d00134A C[@ I49.9 Cardiac arrhythmia, unspecified AP Eݰ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E A . . . E A ANXIOLYTICS, SEDATIVES, AND HYPNOTICS - UNSPECIFIED c00067A C G47.0 Insomnia Ap E A CARISOPRODOL d00960A D M62.83 Muscle spasm Ap E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus Ap E A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A TRAMADOL d03826A D M79.2 Neuralgia and neuritis, unspecified Ap E A TRAZODONE d00395A Dc G47.0 G47.9 Insomnia Sleep disorder, unspecified Ap E A . . . E A . . . E A VERAPAMIL d00048A Cr I49.9 Cardiac arrhythmia, unspecified A E A . . . E A SITAGLIPTIN d05896A B* E11 Type 2 diabetes mellitus A E0 A . . . E@ A CLONAZEPAM d00197A D= F32.9 Major depressive disorder, single episode, unspecified A0 E@ A DIVALPROEX SODIUM d03833A C F32.9 Major depressive disorder, single episode, unspecified A0 E@ A FLUOXETINE d00236A CDp F31.9 F32.9 F41.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 EP A . . . E` A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E` A LOSARTAN d03821A C I10 Essential (primary) hypertension A Ep A . . . Eހ A ALBUTEROL; IPRATROPIUM d04066A B[ R06.9P Prevent breathing difficulty A Eހ A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia A Eހ A FORMOTEROL; MOMETASONE d07660A B= R06.9 Unspecified abnormalities of breathing A Eހ A FUROSEMIDE d00070A C- I51.9 Heart disease, unspecified A Eހ A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus A Eހ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A Eހ A LEVALBUTEROL d04427A B[ R06.9 R07.9 Unspecified abnormalities of breathing Chest pain, unspecified A Eހ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A Eހ A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A Eސ A . . . Eޠ A . . . Eް A . . . E A . . . E A CONJUGATED ESTROGENS d00541A Dc Z79.890 Hormone replacement therapy A@ E A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A@ E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A@ E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E A ACYCLOVIR d00001A C B00.1 Herpesviral vesicular dermatitis A` E A FLUOXETINE d00236A C F39 F43.1 Unspecified mood [affective] disorder Post-traumatic stress disorder (PTSD) A` E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified A` E A RANITIDINE d00021A C K30 Functional dyspepsia A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A@ M79.6 Pain in limb, hand, foot, fingers and toes A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CAPTOPRIL d00006A D* I10 Essential (primary) hypertension A E A CYCLOSPORINE OPHTHALMIC d04836A C[@ H04 Disorders of lacrimal system A E A ESOMEPRAZOLE d04749A Dc K21 Gastro-esophageal reflux disease A E A FELODIPINE d00231A Dc I10 Essential (primary) hypertension A E A MELOXICAM d04532A D M13 Other arthritis A E A POLYETHYLENE GLYCOL 3350 d05350A CDp K59.0 Constipation A E A RIVAROXABAN d07356A C[@ I49.9 Cardiac arrhythmia, unspecified A E A . . . E0 A CELECOXIB d04380A B= M79.1 Myalgia A E0 A CETIRIZINE d03827A BZ R09.81 T78.40 Nasal congestion Allergy, unspecified A E@ A FLUTICASONE NASAL d04283A CDp J30.2 Other seasonal allergic rhinitis A E@ A LEVOTHYROXINE d00278A D E04 Other nontoxic goiter A EP A . . . E` A . . . Ep A . . . E߀ A . . . Eߐ A . . . Eߠ A BUPROPION d00181A Bz F41.9 F90 Anxiety disorder, unspecified Attention-deficit hyperactivity disorders A Eߠ A CITALOPRAM d04332A Bz F32.9 Major depressive disorder, single episode, unspecified A E߰ A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A B[ I10 R60.9 Essential (primary) hypertension Edema, unspecified A@ E A PRAVASTATIN d00348A C- E78.0P I63.P Prevent high cholesterol Prevent stroke A@ E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A@ E A . . . E A GABAPENTIN d03182A C M25.5 Pain in joint A` E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A` E A LEVOFLOXACIN d04109A AP J09 Influenza due to certain identified influenza viruses A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A PRAVASTATIN d00348A C M10.9 Gout, unspecified A` E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A AMLODIPINE d00689A D# I10 Essential (primary) hypertension A0 E A ATENOLOL d00004A D# I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A MESALAMINE d01031A C K51 Ulcerative colitis A E A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A PRAVASTATIN d00348A C E78.0P Prevent high cholesterol A E@ A . . . EP A . . . E` A . . . Ep A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ Ep A GABAPENTIN d03182A Bz M79.2 Neuralgia and neuritis, unspecified A@ Ep A PRAVASTATIN d00348A B[ E78.0 Pure hypercholesterolemia A@ Ep A TRAMADOL d03826A Bz M19.9 Osteoarthritis, unspecified site A@ E A . . . E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A B= F41.9 Anxiety disorder, unspecified A0 E A ESTRADIOL d00537A C[@ Z79.890 Hormone replacement therapy A0 E A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A E A GEMFIBROZIL d00245A C E78.1 Pure hyperglyceridemia A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E A LEVOCETIRIZINE d05851A D J30.1 Allergic rhinitis due to pollen A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A TRAZODONE d00395A Cr F41.9 Anxiety disorder, unspecified A E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ E A TOLTERODINE d04294A C N42.9 Disorder of prostate, unspecified A@ E A . . . E0 A METOPROLOL d00134A C- I49.9 Cardiac arrhythmia, unspecified A E@ A . . . EP A . . . E` A . . . Ep A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified AP Ep A INSULIN DETEMIR d05436A B= E11 Type 2 diabetes mellitus AP Ep A PANTOPRAZOLE d04514A C"0 K22 Other diseases of esophagus AP Ep A PIOGLITAZONE d04442A B= E11 Type 2 diabetes mellitus AP Ep A PREGABALIN d05508A C& E11.4 Type 2 diabetes mellitus with neurological complications AP E A CLINDAMYCIN d00043A A J01.9 Acute sinusitis, unspecified A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A J01.9 Acute sinusitis, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E A DOXYLAMINE; PYRIDOXINE d04654A B R11 Nausea and vomiting A E A . . . E A . . . E A . . . E A . . . E A . . . E A ANASTROZOLE d03873A C[@ Z79 Long term (current) drug therapy AP E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified AP E A TADALAFIL d04896A CDp N52.9 Male erectile dysfunction, unspecified AP E A TESTOSTERONE d00558A C[@ E29.1 Testicular hypofunction AP E A ALLOPURINOL d00023A C M10.9 Gout, unspecified A` E A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A` E A OLMESARTAN d04801A C I10 Essential (primary) hypertension A` E A ALBUTEROL d00749A0 D J45 Asthma A E A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A0 D E78.0 Pure hypercholesterolemia A E A GLIPIZIDE d00246A0 C- E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A0 Bz E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A E A PREDNISONE d00350A0 D* J45 Asthma A E A RANITIDINE d00021A0 Cr K21 Gastro-esophageal reflux disease A E A THEOPHYLLINE d00142A0 Dc J45 Asthma A E A ZAFIRLUKAST d04053A0 Dc J45 Asthma A E0 A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C"0 Z79.3 Long term (current) use of hormonal contraceptives A E@ A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A C I10 Essential (primary) hypertension AP E@ A BUPROPION d00181A C- F41.9 Anxiety disorder, unspecified AP E@ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E@ A NALTREXONE d01406A B< F41.9 Anxiety disorder, unspecified AP E@ A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP EP A . . . E` A 99999 . . A Ep A . . . E A . . . E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A NYSTATIN TOPICAL d04399A A L30.9 Dermatitis, unspecified A E A ALPRAZOLAM d00168A B G47.0 G47.9 Insomnia Sleep disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A MONTELUKAST d04289A Cr J45 Asthma A E A . . . E A 55555 A Cr 55555 A@ E A ESOMEPRAZOLE d04749A B K30 Functional dyspepsia A@ E A METHIMAZOLE d00290A Cr E05 Thyrotoxicosis [hyperthyroidism] A@ E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A Cr L71 Rosacea Ap Ep A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap Ep A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus Ap Ep A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus Ap Ep A METOPROLOL d00134A C E78.0 I51.9 Pure hypercholesterolemia Heart disease, unspecified Ap Ep A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap Ep A TESTOSTERONE d00558A Dc E29.1 Testicular hypofunction Ap E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma A0 E A FORMOTEROL; MOMETASONE d07660A C J45 Asthma A0 E A MONTELUKAST d04289A C[@ J45 Asthma A0 E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C K92.9 Disease of digestive system, unspecified A E A . . . E A DUTASTERIDE d04788A D N40 Enlarged prostate A E A . . . E A . . . E A . . . E0 A IBUPROFEN d00015A A0 R50.9 Fever, unspecified A E0 A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E@ A CABERGOLINE d04112A C- E07.9 Disorder of thyroid, unspecified A EP A . . . E` A ESOMEPRAZOLE d04749A A K30 Functional dyspepsia A E` A FLUTICASONE NASAL d04283A B J30.9 Allergic rhinitis, unspecified A Ep A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A D I51.9 K76.9 N28.9 Heart disease, unspecified Liver disease, unspecified Disorder of kidney and ureter, unspecified A@ E A METOPROLOL d00134A D I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A D K30 Functional dyspepsia A@ E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap E A CYANOCOBALAMIN d00413A C E53.9 Vitamin B deficiency, unspecified Ap E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified Ap E A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap E A OMEPRAZOLE d00325A C K30 Functional dyspepsia Ap E A TRAMADOL d03826A CDp T14.9 Unspecified injury Ap E A ZOLPIDEM d00910A C G47.0 Insomnia Ap E A . . . E A . . . E A ALBUTEROL d00749A C- J44.9 R06.2 Chronic obstructive pulmonary disease, unspecified Wheezing A E A . . . E A . . . E A AMLODIPINE d00689A Dc E78.0 Pure hypercholesterolemia A0 E A FENOFIBRATE d04286A Dc E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A0 E0 A ATORVASTATIN d04105A D* 99999 AP E0 A GLIPIZIDE d00246A D* 99999 AP E0 A METOPROLOL d00134A D* 99999 AP E0 A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A D 99999 AP E0 A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A D* 99999 AP E@ A . . . EP A ALENDRONATE d03849A C[@ M81 Osteoporosis without current pathological fracture A EP A NADOLOL d00018A C I49.9 Cardiac arrhythmia, unspecified A E` A . . . Ep A CIPROFLOXACIN d00011A A N12 Tubulo-interstitial nephritis, not specified as acute or chronic A@ Ep A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A@ Ep A ESOMEPRAZOLE d04749A C- K31.9 Disease of stomach and duodenum, unspecified A@ Ep A TRAMADOL d03826A Bz M54 Dorsalgia A@ E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A` E A ANASTROZOLE d03873A C C50 Malignant neoplasm of breast A` E A ATENOLOL d00004A C I10 Essential (primary) hypertension A` E A CIPROFLOXACIN d00011A B J40 Bronchitis, not specified as acute or chronic A` E A LINACLOTIDE d07902A B K59.0 Constipation A` E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN; CLAVULANATE d00089A AP J01.9 Acute sinusitis, unspecified A E A CIPROFLOXACIN d00011A Ap H10 Conjunctivitis A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A` E A DONEPEZIL d04099A C G30.9 Alzheimer's disease, unspecified A` E A GABAPENTIN d03182A C I99.9 Unspecified disorder of circulatory system A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A MEMANTINE d04899A C G30.9 Alzheimer's disease, unspecified A` E A BECLOMETHASONE d00760A C J45 Asthma A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A GLYBURIDE d00248A B E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A C- E11 Type 2 diabetes mellitus AP E A METFORMIN d03807A B E11 Type 2 diabetes mellitus AP E A REPAGLINIDE d04267A B E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A ENALAPRIL d00013A C I10 Essential (primary) hypertension A0 E A GABAPENTIN d03182A CDp L29.9 Pruritus, unspecified A0 E A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease A0 E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E A AMLODIPINE; BENAZEPRIL d03829A B I10 Essential (primary) hypertension A E A . . . E A . . . E A OXYBUTYNIN d00328A CP N32.81 Overactive bladder A E A . . . E A CARBAMAZEPINE d00058A C G40 Epilepsy and recurrent seizures AP E A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures AP E A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures AP E A TOPIRAMATE d04115A C G40 Epilepsy and recurrent seizures AP E A TRAMADOL d03826A C 55555 AP E A . . . E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A E A SERTRALINE d00880A C F43.1 Post-traumatic stress disorder (PTSD) A E0 A . . . E@ A 99999 . . A EP A . . . E` A . . . Ep A . . . E A CETIRIZINE d03827A B= T78.40 Allergy, unspecified A E A FLUOXETINE d00236A B= F41.9 R32 Anxiety disorder, unspecified Unspecified urinary incontinence A E A . . . E A . . . E A PREDNISOLONE d00084A AP R05 R09.3 Cough Abnormal sputum A E A . . . E A . . . E A DICYCLOMINE d00999A C R10 Abdominal and pelvic pain A0 E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E A . . . E A . . . E A AMLODIPINE d00689A C[@ 99999 A E A ASPIRIN d00170A Cr I51.9P Prevent heart disease A E A ATORVASTATIN d04105A C 99999 A E A COLCHICINE d00150A B M06.9 Rheumatoid arthritis, unspecified A E A FUROSEMIDE d00070A C 99999 A E A IBUPROFEN d00015A B M79.6 Pain in limb, hand, foot, fingers and toes A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A D9 E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A Cr 99999 A E A METOPROLOL d00134A Cr 99999 A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` E A CETIRIZINE d03827A D 99999 A` E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A` E A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A` E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A` E A ACETAMINOPHEN; HYDROCODONE d03428A D M13 M25.5 M54 Other arthritis Pain in joint Dorsalgia Ap E A BENAZEPRIL d00730A C- I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A DIGOXIN d00210A C- I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion Ap E A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified Ap E A METOPROLOL d00134A Cr I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A WARFARIN d00022A CDp D75.9P Prevent blood clots Ap E A . . . E A . . . E A . . . E A . . . E A CYANOCOBALAMIN d00413A CDp E53.9P F43.9 G47.0 Prevent vitamin B deficiency Reaction to severe stress, unspecified Insomnia A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia A E0 A FLUTICASONE NASAL d04283A B= J30.1 J30.2 Allergic rhinitis due to pollen Other seasonal allergic rhinitis A E0 A OLOPATADINE NASAL d07132A B= J30.1 J30.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified A E@ A CANDESARTAN d04322A C I10 Essential (primary) hypertension A E@ A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A CELECOXIB d04380A CDp M19.9 Osteoarthritis, unspecified site A E A ESOMEPRAZOLE d04749A D K21 Gastro-esophageal reflux disease A E A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A E A INSULIN DEGLUDEC d08054A A E11 Type 2 diabetes mellitus A E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A PREDNISOLONE OPHTHALMIC d03221A C Z48.8 Encounter for other specified postprocedural aftercare A E A SITAGLIPTIN d05896A CDp E11 Type 2 diabetes mellitus A E A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A Bz Z79.3 Long term (current) use of hormonal contraceptives A E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E@ A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A Cr R32 Unspecified urinary incontinence A0 E@ A LORAZEPAM d00149A Cr G47.0 Insomnia A0 EP A . . . E` A . . . Ep A . . . E A . . . E A AMOXICILLIN d00088A Ap J01.9 Acute sinusitis, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A A E78.0 Pure hypercholesterolemia A E A ALBUTEROL d00749A D* J45 Asthma A E A BECLOMETHASONE d00760A D J45 R06.2 Asthma Wheezing A E A DIGOXIN d00210A D I48.9 Unspecified atrial fibrillation and atrial flutter A E A FLUTICASONE d01296A D J44.9 Chronic obstructive pulmonary disease, unspecified A E A HYDROXYZINE d00907A D F41.9 Anxiety disorder, unspecified A E A LEVOTHYROXINE d00278A D C80.1 Malignant (primary) neoplasm, unspecified A E A OMEPRAZOLE d00325A D K22 Other diseases of esophagus A E A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E A QUETIAPINE d04220A B F31.9 F41.9 F90 Bipolar disorder, unspecified Anxiety disorder, unspecified Attention-deficit hyperactivity disorders A E A TORSEMIDE d03189A B R60.9 Edema, unspecified A E A . . . E A . . . E A HYDROCODONE d03075A B= G89 K92.9 Pain, not elsewhere classified Disease of digestive system, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A CDp G43 Migraine A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A . . . E0 A DIVALPROEX SODIUM d03833A C G43 Migraine AP E0 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives AP E0 A OXCARBAZEPINE d04513A C F31.9 Bipolar disorder, unspecified AP E0 A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified AP E0 A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified AP E@ A . . . EP A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A A I10 Essential (primary) hypertension A E` A ALBUTEROL d00749A CDp R05 Cough A Ep A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A CANAGLIFLOZIN d08080A B[ E11 Type 2 diabetes mellitus Ap E A CETIRIZINE d03827A C[@ T78.40 Allergy, unspecified Ap E A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A C I10 Essential (primary) hypertension Ap E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A METFORMIN d03807A Bb E11 Type 2 diabetes mellitus Ap E A ATENOLOL; CHLORTHALIDONE d03258A0 C 99999 Ap E A ATORVASTATIN d04105A0 C 99999 Ap E A CLOPIDOGREL d04258A0 C 99999 Ap E A FINASTERIDE d00563A0 C 99999 Ap E A LOSARTAN d03821A0 C 99999 Ap E A OMEPRAZOLE d00325A0 C K30 Functional dyspepsia Ap E A TAMSULOSIN d04121A0 C N40 Enlarged prostate Ap E A . . . E A BECLOMETHASONE d00760A C J45.P Prevent asthma A0 E A LISINOPRIL d00732A Dc E11.2 I50.9 Type 2 diabetes mellitus with kidney complications Heart failure, unspecified A0 E A METFORMIN d03807A Dc R73 Elevated blood glucose level A0 E A DULOXETINE d05355A B M79.2 Neuralgia and neuritis, unspecified A` E A FUROSEMIDE d00070A B N28.9 Disorder of kidney and ureter, unspecified A` E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A` E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A D* E04 Other nontoxic goiter A` E A SOLIFENACIN d05413A B N32.9 Bladder disorder, unspecified A` E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E A PAROXETINE d03157A C F42 Obsessive-compulsive disorder A E A BENZTROPINE d00175A D F20 Schizophrenia A E A FLUPHENAZINE d00237A D F20 Schizophrenia A E A IBANDRONATE d05357A B M81 Osteoporosis without current pathological fracture A E A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A E A ALBUTEROL d00749A A J18.9 Pneumonia, unspecified organism A E A PREDNISONE d00350A A0 J18.9 Pneumonia, unspecified organism A E A . . . E A AMOXICILLIN d00088A B B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia Ap E A METFORMIN d03807A C K31.9 Disease of stomach and duodenum, unspecified Ap E A METHOCARBAMOL d00965A B= R10 Abdominal and pelvic pain Ap E A METRONIDAZOLE d00108A B B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere Ap E A NAPROXEN d00019A B= R10 Abdominal and pelvic pain Ap E0 A . . . E@ A . . . EP A BUDESONIDE d04276A D J45 Asthma A EP A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A EP A GABAPENTIN d03182A C[@ M79.7 Fibromyalgia A EP A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EP A LOSARTAN d03821A C- I10 Essential (primary) hypertension A EP A METHOTREXATE d00060A C- L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified A EP A TIZANIDINE d04102A C M62.83 Muscle spasm A EP A TRAZODONE d00395A C F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A@ E A SITAGLIPTIN d05896A C"0 E11 Type 2 diabetes mellitus A@ E A ESTRADIOL; NORETHINDRONE d04375A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified A E A . . . E A . . . E A CARBIDOPA; LEVODOPA d03473A C G20 Parkinson's disease A E A MIDODRINE d04047A C I99.9 Unspecified disorder of circulatory system A E0 A ICOSAPENT d07891A B[ E78.1 Pure hyperglyceridemia A@ E0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E0 A RIVAROXABAN d07356A Ei I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A@ E0 A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A@ E@ A . . . EP A 99999 . . A E` A . . . Ep A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A@ Ep A LISINOPRIL d00732A CDp N19 Unspecified kidney failure A@ Ep A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ Ep A PRAVASTATIN d00348A CDp I21.P Prevent heart attack/myocardial infarction A@ E A . . . E A . . . E A . . . E A CARVEDILOL d03847A B[ I48.9 Unspecified atrial fibrillation and atrial flutter AP E A FUROSEMIDE d00070A C I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified AP E A LEVOTHYROXINE d00278A C 99999 AP E A LOSARTAN d03821A B I10 I50.9 Essential (primary) hypertension Heart failure, unspecified AP E A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia AP E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE; ATORVASTATIN d05048A C E78.0 Pure hypercholesterolemia A E A . . . E0 A . . . E@ A ATENOLOL d00004A D* I10 Essential (primary) hypertension A0 E@ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp I10 Essential (primary) hypertension A0 E@ A RANITIDINE d00021A C K25 K30 Gastric ulcer Functional dyspepsia A0 EP A FUROSEMIDE d00070A C 99999 AP EP A LOVASTATIN d00280A C 99999 AP EP A METFORMIN d03807A C E78.0 Pure hypercholesterolemia AP EP A NIACIN d00314A C 99999 AP EP A TAMSULOSIN d04121A Bz 55555 AP E` A . . . Ep A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A@ E A METOPROLOL d00134A D I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A@ E A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A@ E A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A CLOPIDOGREL d04258A C D75.9P I49.9 Prevent blood clots Cardiac arrhythmia, unspecified A0 E A METOPROLOL d00134A C I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A0 E A HYDROCODONE d03075A C M54 Dorsalgia A0 E A METOPROLOL d00134A B R00 Abnormalities of heart beat A0 E A ROSUVASTATIN d04851A A E78.0 Pure hypercholesterolemia A0 E A GLYBURIDE d00248A CDp E11 Type 2 diabetes mellitus AP E A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A B E11 Type 2 diabetes mellitus AP E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A E A ACYCLOVIR d00001A CDp B34.9 Viral infection, unspecified A E A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A E A ESOMEPRAZOLE d04749A D K21 K22 Gastro-esophageal reflux disease Other diseases of esophagus A E A FENTANYL d00233A CDp M54 Dorsalgia A E A MEGESTROL d01348A C E66 Overweight and obesity A E A ONDANSETRON d00867A CDp R11 Nausea and vomiting A E A PROCHLORPERAZINE d00355A CDp R11 Nausea and vomiting A E A ALBUTEROL d00749A B= J45 Asthma A E A ALLOPURINOL d00023A Cr M1A Chronic gout A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A BECLOMETHASONE d00760A B= J45 Asthma A E A ESOMEPRAZOLE d04749A Cr K30 Functional dyspepsia A E A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A E A MELOXICAM d04532A B[ M25.5 Pain in joint A E A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A E A OXYBUTYNIN d00328A B= N39.4 Other specified urinary incontinence A E A PREGABALIN d05508A Cr M79.7 Fibromyalgia A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A TRIAMTERENE d00396A B I10 Essential (primary) hypertension A E A VALSARTAN d04113A B[ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A MOMETASONE NASAL d04223A C) H93.9 Unspecified disorder of ear A E A MONTELUKAST d04289A C[@ J45 Asthma A E0 A . . . E@ A DICLOFENAC d00848A Cr M54 Dorsalgia A` E@ A GABAPENTIN d03182A Cr M54 Dorsalgia A` E@ A LAMOTRIGINE d03809A Cr F39 Unspecified mood [affective] disorder A` E@ A PRAZOSIN d00138A Cr F43.1 Post-traumatic stress disorder (PTSD) A` E@ A SILDENAFIL d04299A Cr N52.9 Male erectile dysfunction, unspecified A` E@ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` EP A . . . E` A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E` A FEXOFENADINE d04040A C[@ T78.40 Allergy, unspecified A E` A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E` A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D0z I10 Essential (primary) hypertension A E` A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E` A METOPROLOL d00134A C I10 Essential (primary) hypertension A E` A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A E` A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A Ep A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A E A . . . E A . . . E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A CEPHALEXIN d00096A A L08.9 L70 Local infection of the skin and subcutaneous tissue, unspecified Acne A E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0P Prevent high cholesterol A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A CITALOPRAM d04332A C F43.9 Reaction to severe stress, unspecified AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E78.0 Pure hypercholesterolemia AP E A TAMOXIFEN d00381A Cr C50 Malignant neoplasm of breast AP E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J45 R06.9P Asthma Prevent breathing difficulty A0 E A FLUTICASONE d01296A C J45 R06.2 Asthma Wheezing A0 E A MONTELUKAST d04289A C- J45 R06.9 Asthma Unspecified abnormalities of breathing A0 E A ACYCLOVIR d00001A C[@ B00.1 Herpesviral vesicular dermatitis A0 E A METHIMAZOLE d00290A C[@ E05 Thyrotoxicosis [hyperthyroidism] A0 E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Cr J18.9P Prevent pneumonia A0 E A . . . E0 A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A E0 A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E@ A . . . EP A . . . E` A BENAZEPRIL d00730A C[@ I10 Essential (primary) hypertension A E` A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A Ep A . . . E A . . . E A . . . E A . . . E A ADALIMUMAB d04835A C M06.9 Rheumatoid arthritis, unspecified A E A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A E A . . . E A . . . E A METFORMIN d03807A C- R73 Elevated blood glucose level A E A AMOXICILLIN d00088A B B96.81 H66.9 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere Otitis media, unspecified A E A . . . E A . . . E A ALBUTEROL d00749A C J45 R06.02 R06.2 Asthma Shortness of breath Wheezing A0 E A FLUTICASONE d01296A C J45 Asthma A0 E A MONTELUKAST d04289A C J45 T78.40 Asthma Allergy, unspecified A0 E0 A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A@ E0 A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified A@ E0 A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ E0 A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A@ E@ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E@ A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A EP A . . . E` A . . . Ep A ETHINYL ESTRADIOL; ETONOGESTREL d04773A C- Z79.3 Long term (current) use of hormonal contraceptives A0 Ep A IBUPROFEN d00015A B M54 Dorsalgia A0 Ep A PREGABALIN d05508A B= M54 Dorsalgia A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A0 E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A0 E A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A0 E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A EP A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A EP A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EP A HYDROCHLOROTHIAZIDE d00253A C[@ I10 R60.9 Essential (primary) hypertension Edema, unspecified A EP A INSULIN ISOPHANE; INSULIN REGULAR d04374A C[@ E11 Type 2 diabetes mellitus A EP A LABETALOL d00016A C[@ I10 Essential (primary) hypertension A EP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EP A METFORMIN; SITAGLIPTIN d06720A Bz E11 Type 2 diabetes mellitus A EP A PREGABALIN d05508A B M79.2 Neuralgia and neuritis, unspecified A EP A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E` A . . . Ep A METOPROLOL d00134A CDp R00 Abnormalities of heart beat A E A . . . E A . . . E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A` R05 Cough A E A OSELTAMIVIR d04462A A` J09 Influenza due to certain identified influenza viruses A E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A Ap N92 Excessive, frequent and irregular menstruation A E A FUROSEMIDE d00070A C[@ K76.9 Liver disease, unspecified A@ E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A@ E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E A SPIRONOLACTONE d00373A C[@ K76.9 Liver disease, unspecified A@ E A . . . E A . . . E A . . . E0 A PANTOPRAZOLE d04514A A K21 Gastro-esophageal reflux disease A E@ A . . . EP A . . . E` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A@ E` A INDOMETHACIN d00039A B M1A Chronic gout A@ E` A PROBENECID d00031A B M1A Chronic gout A@ Ep A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C[@ R45 Symptoms and signs involving emotional state A E A . . . E A FLUORIDE TOPICAL d04397A B[ K02 Dental caries A E A . . . E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A E A CEPHALEXIN d00096A A H66.9 Otitis media, unspecified A E A OFLOXACIN OTIC d04265A B* H60 Otitis externa A E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension Ap E A FUROSEMIDE d00070A0 C- R60.9 Edema, unspecified Ap E A LEVOTHYROXINE d00278A0 DJ$ E07.9 Disorder of thyroid, unspecified Ap E A LOSARTAN d03821A0 B I10 Essential (primary) hypertension Ap E A MONTELUKAST d04289A0 C J45 Asthma Ap E A PANTOPRAZOLE d04514A0 C- K21 Gastro-esophageal reflux disease Ap E A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia Ap E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A DOXEPIN d00217A C K30 Functional dyspepsia A E A . . . E A ENALAPRIL d00013A D= I10 Essential (primary) hypertension A@ E A GLIPIZIDE d00246A D= E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A D= E11 Type 2 diabetes mellitus A@ E A ROSUVASTATIN d04851A CP E78.0 Pure hypercholesterolemia A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A CLINDAMYCIN; TRETINOIN TOPICAL d05973A C L70 Acne A E A . . . E A ALBUTEROL d00749A D9 J45 Asthma AP E A BECLOMETHASONE d00760A A J45 Asthma AP E A IBUPROFEN d00015A C M06.9 Rheumatoid arthritis, unspecified AP E A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified AP E A PREDNISONE d00350A C M06.9 Rheumatoid arthritis, unspecified AP E0 A . . . E@ A . . . EP A . . . E` A CARVEDILOL d03847A C- I21.P Prevent heart attack/myocardial infarction A@ E` A FUROSEMIDE d00070A C R60.9 Edema, unspecified A@ E` A LISINOPRIL d00732A C- I21.P Prevent heart attack/myocardial infarction A@ E` A SIMVASTATIN d00746A C- E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A@ Ep A . . . E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Cr I10 Essential (primary) hypertension A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus AP E A INSULIN DETEMIR d05436A C"0 E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C- I10 Essential (primary) hypertension AP E A PAROXETINE d03157A Cr F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension AP E A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia AP E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP E A NAPROXEN d00019A B= M25.5 Pain in joint AP E A PHENTERMINE d00806A B E66 Overweight and obesity AP E A HYDROCODONE d03075A Ap K08.4 Partial loss of teeth A E A . . . E A . . . E A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A E A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A E A . . . E0 A FAMOTIDINE d00141A C- K21 Gastro-esophageal reflux disease A@ E0 A FLUOXETINE d00236A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E0 A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A B M81.P Prevent bone loss/osteoporosis A@ E0 A TOPIRAMATE d04115A Cr G43 Migraine A@ E@ A . . . EP A . . . E` A . . . Ep A . . . E A BIMATOPROST OPHTHALMIC d04754A D H40 Glaucoma A0 E A DORZOLAMIDE OPHTHALMIC d03805A C- H40 Glaucoma A0 E A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A METFORMIN d03807A C R73 Elevated blood glucose level A0 E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E A ROPINIROLE d04215A Cr G25.81 Restless legs syndrome A0 E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A CLONAZEPAM d00197A C F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A E A CYCLOBENZAPRINE d00963A C M54 Dorsalgia A E A DICLOFENAC d00848A C M54 Dorsalgia A E A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E A ESOMEPRAZOLE d04749A C[@ K21 Gastro-esophageal reflux disease A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A MONTELUKAST d04289A C T78.40 Allergy, unspecified A E A PHENTERMINE d00806A C- E66 Overweight and obesity A E A TOPIRAMATE d04115A B E66 Overweight and obesity A E A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A@ E A METOPROLOL d00134A C- I49.9 Cardiac arrhythmia, unspecified A@ E A . . . E0 A . . . E@ A 99999 . . A EP A . . . E` A . . . Ep A IBUPROFEN d00015A B M54 Dorsalgia A E A . . . E A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified A0 E A FEXOFENADINE; PSEUDOEPHEDRINE d04270A C J30.2 Other seasonal allergic rhinitis A0 E A TESTOSTERONE d00558A C- E29.1 Testicular hypofunction A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A EP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ EP A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A B E11 Type 2 diabetes mellitus A@ EP A LINAGLIPTIN d07767A C- E11 Type 2 diabetes mellitus A@ EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A PAROXETINE d03157A A F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A ALBUTEROL d00749A C- R06.02 Shortness of breath A0 E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A0 E A FLUTICASONE; SALMETEROL d04611A C- R06.02 Shortness of breath A0 E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B M54 T14.9 Dorsalgia Unspecified injury A E A ALBUTEROL d00749A C J45 Asthma A E A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A E A DEXLANSOPRAZOLE d07395A CP K27 Peptic ulcer, site unspecified A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A IBUPROFEN d00015A B[ M25.5 M79.1 Pain in joint Myalgia A E A OXYCODONE d00329A C M54 Dorsalgia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A SPIRONOLACTONE d00373A BZ R60.9 Edema, unspecified A E A TIOTROPIUM d04829A B~ J43 J44.9 J45 Emphysema Chronic obstructive pulmonary disease, unspecified Asthma A E0 A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A E@ A . . . EP A . . . E` A CLARITHROMYCIN d00097A Ap H66.9 Otitis media, unspecified A E` A IBUPROFEN d00015A Ap H93.9 Unspecified disorder of ear A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A TAMSULOSIN d04121A B N40 R35 R39.1 Enlarged prostate Polyuria Other difficulties with micturition A E A CLOPIDOGREL d04258A C 99999 A@ E A DILTIAZEM d00045A C 99999 A@ E A ENALAPRIL d00013A C I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A C 99999 A@ E A . . . E A . . . E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E A TIMOLOL OPHTHALMIC d04037A C- H40 Glaucoma A E0 A . . . E@ A AMLODIPINE d00689A C- R39.9 Unspecified symptoms and signs involving the genitourinary system A` E@ A FUROSEMIDE d00070A C- 77777 A` E@ A GLIPIZIDE d00246A C- 77777 A` E@ A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` E@ A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A` E@ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A` EP A . . . E` A . . . Ep A ALPRAZOLAM d00168A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A ALBUTEROL d00749A C J45 Asthma A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E A CLOPIDOGREL d04258A B Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A0 E A METOPROLOL d00134A B I51.9 Heart disease, unspecified A0 E A . . . E A . . . E A . . . E A . . . E A CITALOPRAM d04332A C F39 Unspecified mood [affective] disorder AP E A DULOXETINE d05355A B F32.9 Major depressive disorder, single episode, unspecified AP E A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension AP E A OXCARBAZEPINE d04513A C F29 Unspecified psychosis not due to a substance or known physiological condition AP E A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A E A INSULIN ASPART d04697A B E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus AP E A LINAGLIPTIN; METFORMIN d07825A B E11 Type 2 diabetes mellitus AP E A MECLIZINE d00859A B R42 Dizziness and giddiness AP E A OMEPRAZOLE d00325A Bz T88.7P Prevent drug side effect AP E A ROSUVASTATIN d04851A CP E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A E@ A ALBUTEROL d00749A B J45 Asthma A0 E@ A MONTELUKAST d04289A B J30.9 J45 Allergic rhinitis, unspecified Asthma A0 E@ A PREDNISONE d00350A A J45 Asthma A0 EP A ESTRADIOL d00537A C- Z79.3 Long term (current) use of hormonal contraceptives A E` A . . . Ep A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C[@ F90 Attention-deficit hyperactivity disorders A E A CITALOPRAM d04332A Bz F32.9 Major depressive disorder, single episode, unspecified A E A FAMOTIDINE d00141A C R10 Abdominal and pelvic pain A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E A ATROPINE; DIPHENOXYLATE d03506A C R19.7 Diarrhea, unspecified A` E A CIMETIDINE d00140A D K30 Functional dyspepsia A` E A GLIMEPIRIDE d03864A Bz R73 Elevated blood glucose level A` E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A DGJ E04 Other nontoxic goiter A` E A METFORMIN; SITAGLIPTIN d06720A C R73 Elevated blood glucose level A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A CARBIDOPA; LEVODOPA d03473A C G20 Parkinson's disease A E A CITALOPRAM d04332A C[0 G20 Parkinson's disease A E A DEXLANSOPRAZOLE d07395A C@ K21 Gastro-esophageal reflux disease A E A FLURBIPROFEN d00239A C M19.9 Osteoarthritis, unspecified site A E A MINOCYCLINE d00110A D L70 Acne A E A MIRTAZAPINE d04025A C G47.0 Insomnia A E A MODAFINIL d04378A C F32.9 Major depressive disorder, single episode, unspecified A E A MONTELUKAST d04289A C@ J30.9 Allergic rhinitis, unspecified A E A SELEGILINE d00976A B F32.9 Major depressive disorder, single episode, unspecified A E A SIMVASTATIN d00746A D& E78.0 Pure hypercholesterolemia A E A CELECOXIB d04380A B M19.9 Osteoarthritis, unspecified site AP E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified AP E A MEGESTROL d01348A Bz R63 Symptoms and signs concerning food and fluid intake AP E A METOPROLOL d00134A Bz R07.9 Chest pain, unspecified AP E A RAMIPRIL d00728A Bz I10 Essential (primary) hypertension AP E A . . . E A AZITHROMYCIN d00091A A J01.9 Acute sinusitis, unspecified A` E A CETIRIZINE d03827A A T78.40 Allergy, unspecified A` E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E A NIFEDIPINE d00051A B= I10 Essential (primary) hypertension A` E A PROMETHAZINE d00787A A R05 Cough A` E A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A` E A . . . E0 A . . . E@ A FELODIPINE d00231A Dc I10 Essential (primary) hypertension A@ E@ A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A@ E@ A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A@ E@ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ EP A . . . E` A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus AP E` A OLMESARTAN d04801A C I10 Essential (primary) hypertension AP E` A PANTOPRAZOLE d04514A C[@ K27 Peptic ulcer, site unspecified AP E` A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E` A REPAGLINIDE d04267A C- E11 Type 2 diabetes mellitus AP Ep A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A AMOXICILLIN d00088A Ap Z48.8 Encounter for other specified postprocedural aftercare A0 E A CLONAZEPAM d00197A B[ F41.9 H93.9 Anxiety disorder, unspecified Unspecified disorder of ear A0 E A IBUPROFEN d00015A Ap R52 Pain, unspecified A0 E A . . . E A . . . E A ALBUTEROL d00749A CP J45 Asthma A0 E A FLUTICASONE d01296A CP J45 Asthma A0 E A IBUPROFEN d00015A C M79.1 Myalgia A0 E A LEFLUNOMIDE d04349A Cr M06.9 Rheumatoid arthritis, unspecified A E A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A E A . . . E A BENZONATATE d00796A A R05 Cough A E A FLUTICASONE NASAL d04283A A R09.81 Nasal congestion A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ISONIAZID d00101A B B99.9 Unspecified infectious disease A EP A . . . E` A LOSARTAN d03821A C I10 Essential (primary) hypertension A Ep A . . . E A . . . E A IBUPROFEN d00015A Bz N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A ALBUTEROL d00749A C J45 Asthma A E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E A FUROSEMIDE d00070A C J98.9 Respiratory disorder, unspecified A E A GLIPIZIDE d00246A C R73 Elevated blood glucose level A E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E A SPIRONOLACTONE d00373A C L70 Acne A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A ESOMEPRAZOLE d04749A B 55555 A` E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A` E A LEVOTHYROXINE d00278A CDp E07.9 Disorder of thyroid, unspecified A` E A METFORMIN d03807A C R73 Elevated blood glucose level A` E A RAMIPRIL d00728A C I10 Essential (primary) hypertension A` E A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A E A SERTRALINE d00880A B N95 Menopausal and other perimenopausal disorders A E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus AP E A LANSOPRAZOLE d03828A C- K30 Functional dyspepsia A E A TOPIRAMATE d04115A C[@ G43 Migraine A E A . . . E A . . . E A . . . E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E 0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E 0 A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap E 0 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension Ap E 0 A PANTOPRAZOLE d04514A C K22 Other diseases of esophagus Ap E 0 A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation Ap E 0 A SAXAGLIPTIN d07467A C E11 Type 2 diabetes mellitus Ap E @ A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A E P A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E P A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E P A RANITIDINE d00021A Dc K30 Functional dyspepsia A@ E P A TRAMADOL d03826A Cr M13 M25.5 Other arthritis Pain in joint A@ E ` Ap . . . E p A CARVEDILOL d03847A B I10 Essential (primary) hypertension A@ E p A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E p A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E p A POTASSIUM CHLORIDE d00345A C E87.6P Prevent hypokalemia A@ E A . . . E A SERTRALINE d00880A C- F41.9 N94 Anxiety disorder, unspecified Pain and other conditions associated with female genital organs and menstrual cycle A E A . . . E A . . . E A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A . . . E0 A CYCLOBENZAPRINE d00963A C"0 M62.83 Muscle spasm A@ E0 A DIAZEPAM d00148A C"0 G47.9 M62.83 Sleep disorder, unspecified Muscle spasm A@ E0 A HYDROMORPHONE d00255A B M54 Dorsalgia A@ E0 A MORPHINE d00308A B M54 Dorsalgia A@ E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A E A ALLOPURINOL d00023A C M1A Chronic gout A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A IRBESARTAN d04222A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E A CARVEDILOL d03847A C[@ I21.P Prevent heart attack/myocardial infarction AP E A CLOPIDOGREL d04258A C[@ I21.P Prevent heart attack/myocardial infarction AP E A SIMVASTATIN d00746A Cr 99999 AP E A TAMSULOSIN d04121A C 55555 AP E A AMLODIPINE d00689A D3T I10 Essential (primary) hypertension Ap E A ATENOLOL d00004A D6. I21.P Prevent heart attack/myocardial infarction Ap E A FUROSEMIDE d00070A D I51.9 Heart disease, unspecified Ap E A LOSARTAN d03821A Cr I50.9 Heart failure, unspecified Ap E A NITROFURANTOIN d00112A C- N39.0 Urinary tract infection, site not specified Ap E A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia Ap E A PRAVASTATIN d00348A D* E78.0 Pure hypercholesterolemia Ap E A . . . E A ACYCLOVIR d00001A C[@ A60.9 Anogenital herpesviral infection, unspecified A E A IBUPROFEN d00015A C M54 M79.1 Dorsalgia Myalgia A E A TRIAMCINOLONE TOPICAL d03206A C L40 Psoriasis A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A INSULIN GLARGINE d04538A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A0 E A LIRAGLUTIDE d07466A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A . . . E A LATANOPROST OPHTHALMIC d04017A C"@ H40 Glaucoma A E A . . . E A ATORVASTATIN d04105A0 C- E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A0 C- I10 Essential (primary) hypertension A E A FLUTICASONE NASAL d04283A0 D R09.81 Nasal congestion A E A GABAPENTIN d03182A0 D M79.2 Neuralgia and neuritis, unspecified A E A LISINOPRIL d00732A0 C- I10 Essential (primary) hypertension A E A LUBIPROSTONE d05736A0 C K59.0 Constipation A E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A E A NITROGLYCERIN d00321A0 C R07.9 Chest pain, unspecified A E A OXCARBAZEPINE d04513A0 D G40 Epilepsy and recurrent seizures A E A OXYCODONE d00329A0 C M54 Dorsalgia A E A SUCRALFATE d00377A0 C K21 Gastro-esophageal reflux disease A E A AZITHROMYCIN d00091A Ap J42 Unspecified chronic bronchitis A E A . . . E A . . . E A . . . E0 A . . . E@ A HYDROCHLOROTHIAZIDE d00253A CP I10 Essential (primary) hypertension A@ E@ A LEVOTHYROXINE d00278A CP E03.9 Hypothyroidism, unspecified A@ E@ A LISINOPRIL d00732A CP I10 Essential (primary) hypertension A@ E@ A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A@ EP A . . . E` A . . . Ep A 77777 . . A E A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified A0 E A MINOCYCLINE d00110A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A0 E A NORETHINDRONE d00555A C[@ Z79.3 Long term (current) use of hormonal contraceptives A0 E A . . . E A . . . E A . . . E A CHLORTHALIDONE d00192A D* I10 Essential (primary) hypertension Ap E A FLUOXETINE d00236A CP F32.9 Major depressive disorder, single episode, unspecified Ap E A LOSARTAN d03821A CP I10 Essential (primary) hypertension Ap E A METOCLOPRAMIDE d00298A Bz K30 Functional dyspepsia Ap E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease Ap E A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia Ap E A TRAMADOL d03826A CP M54 Dorsalgia Ap E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E@ A . . . EP A ESTRADIOL TOPICAL d04210A C N95 Menopausal and other perimenopausal disorders A E` A . . . Ep A OXCARBAZEPINE d04513A C- G40 Epilepsy and recurrent seizures A E A LACOSAMIDE d07349A B[ G40 Epilepsy and recurrent seizures A0 E A LEVETIRACETAM d04499A CDp G40 Epilepsy and recurrent seizures A0 E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E A ETONOGESTREL d04772A C"0 Z79.3 Long term (current) use of hormonal contraceptives A E A DULOXETINE d05355A B[ F32.9 Major depressive disorder, single episode, unspecified A E A 77777 . . A E A . . . E A . . . E A LEVOCETIRIZINE d05851A C- T78.40 Allergy, unspecified A E A TRIAMTERENE d00396A C[@ I10 Essential (primary) hypertension A E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E0 A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia AP E0 A GLIPIZIDE; METFORMIN d04823A C E11 Type 2 diabetes mellitus AP E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP E0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E@ A . . . EP A . . . E` A . . . Ep A . . . E A AMILORIDE d00169A C- I10 Essential (primary) hypertension Ap E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension Ap E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified Ap E A LACTULOSE d01024A C- K59.0 Constipation Ap E A METFORMIN d03807A A` E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A C- K31.9 Disease of stomach and duodenum, unspecified Ap E A RIFAXIMIN d05294A C- K76.9 Liver disease, unspecified Ap E A TRAZODONE d00395A B( G47.9 Sleep disorder, unspecified A E A . . . E A . . . E A OXYCODONE d00329A AP G89 Pain, not elsewhere classified A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B[ L70 Acne A E A FINASTERIDE d00563A D"8 N40 Enlarged prostate A E A LORAZEPAM d00149A C[@ F41.9 Anxiety disorder, unspecified A E A . . . E A DEXMETHYLPHENIDATE d04777A C- F90 Attention-deficit hyperactivity disorders A E A . . . E A SOLIFENACIN d05413A C- N32.81 Overactive bladder A E0 A DIVALPROEX SODIUM d03833A Cr G40 Epilepsy and recurrent seizures A@ E0 A GABAPENTIN d03182A C G25.81 Restless legs syndrome A@ E0 A SERTRALINE d00880A C[@ F41.9 Anxiety disorder, unspecified A@ E0 A TRAZODONE d00395A CDp G47.0 Insomnia A@ E@ A . . . EP A CARBIDOPA d00184A C[@ G99.8 Other specified disorders of nervous system in diseases classified elsewhere A0 EP A CARBIDOPA; LEVODOPA d03473A C[@ G99.8 Other specified disorders of nervous system in diseases classified elsewhere A0 EP A CLONAZEPAM d00197A C- G99.8 Other specified disorders of nervous system in diseases classified elsewhere A0 E` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E` A METFORMIN d03807A D= E11 Type 2 diabetes mellitus A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B= M79.1 M79.2 Myalgia Neuralgia and neuritis, unspecified A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B= F32.9 R41 Major depressive disorder, single episode, unspecified Other symptoms and signs involving cognitive functions and awareness A E A . . . E A . . . E A . . . E0 A ALBUTEROL d00749A C J45 Asthma A0 E0 A FLUOCINOLONE TOPICAL d01293A B[ L20.9 Atopic dermatitis, unspecified A0 E0 A FLUTICASONE d01296A C J45 Asthma A0 E@ A . . . EP A FINASTERIDE d00563A C N42.9 Disorder of prostate, unspecified AP EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP EP A LEVOTHYROXINE d00278A C E05 Thyrotoxicosis [hyperthyroidism] AP EP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP EP A TAMSULOSIN d04121A C N42.9 Disorder of prostate, unspecified AP E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A A I10 Essential (primary) hypertension A Ep A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E A RISPERIDONE d03180A C F90 Attention-deficit hyperactivity disorders A E A CETIRIZINE d03827A Ap J30.9 Allergic rhinitis, unspecified A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A ALBUTEROL d00749A C[@ J45 Asthma A E A ALBUTEROL d00749A C J45 Asthma A E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E A IPRATROPIUM d00265A C J45 Asthma A E A LEVOTHYROXINE d00278A C[@ 99999 A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A MOMETASONE NASAL d04223A Cr J30.9 Allergic rhinitis, unspecified A E A MONTELUKAST d04289A Cr 99999 A E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A E A SAXAGLIPTIN d07467A C[@ R73 Elevated blood glucose level A E A THEOPHYLLINE d00142A DGJ J45 Asthma A E A IBUPROFEN d00015A A 55555 A E A ESCITALOPRAM d04812A Cr F41.9 Anxiety disorder, unspecified A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E0 A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A@ E0 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E@ A CLONAZEPAM d00197A B= F41.9 Anxiety disorder, unspecified A@ E@ A DULOXETINE d05355A B F32.9 Major depressive disorder, single episode, unspecified A@ E@ A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A@ E@ A TRAZODONE d00395A Dc G47.0 Insomnia A@ EP A . . . E` A . . . Ep A . . . E A DONEPEZIL d04099A C[@ G47.0 Insomnia A E A RALOXIFENE d04261A C M06.9 Rheumatoid arthritis, unspecified A E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E A TAMSULOSIN d04121A C[@ R32 Unspecified urinary incontinence A@ E A . . . E A . . . E A . . . E A . . . E A APOMORPHINE d04991A C- G20 Parkinson's disease AP E A CARBIDOPA; LEVODOPA d03473A Ap G20 Parkinson's disease AP E A RASAGILINE d05612A C[@ G20 Parkinson's disease AP E A ROPINIROLE d04215A B G20 Parkinson's disease AP E A ROPINIROLE d04215A C[@ G20 Parkinson's disease AP E A BECLOMETHASONE NASAL d04275A C T78.40 Allergy, unspecified A0 E A LANSOPRAZOLE d03828A CDp K21 K59.0 Gastro-esophageal reflux disease Constipation A0 E A MONTELUKAST d04289A C[@ T78.40 Allergy, unspecified A0 E A ACYCLOVIR d00001A C B02 Zoster [herpes zoster] A E A ALBUTEROL d00749A C- R06.02 Shortness of breath A E A ASPIRIN d00170A C[@ I10 Essential (primary) hypertension A E A IBUPROFEN d00015A C M54 Dorsalgia A E A INSULIN ASPART d04697A C[@ E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A B I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A SERTRALINE d00880A C F39 Unspecified mood [affective] disorder A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A TRAZODONE d00395A C G47.0 Insomnia A E A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A` E A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A` E A MECLIZINE d00859A AP R42 Dizziness and giddiness A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A OXYBUTYNIN d00328A Dc N32.81 Overactive bladder A E 0 A ALBUTEROL d00749A C J45 Asthma AP E 0 A BUDESONIDE; FORMOTEROL d04795A B[ J45 Asthma AP E 0 A CETIRIZINE; PSEUDOEPHEDRINE d04764A CP T78.40 Allergy, unspecified AP E 0 A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders AP E 0 A MONTELUKAST d04289A CP J45 Asthma AP E @ A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A0 E @ A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E @ A TEMAZEPAM d00384A CDp G47.0 Insomnia A0 E P A . . . E ` A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C- Z79.3 Long term (current) use of hormonal contraceptives A0 E ` A IBUPROFEN d00015A A0 J02 Acute pharyngitis A0 E ` A PENICILLIN d00116A A J03 Acute tonsillitis A0 E p A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia AP E p A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension AP E p A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E p A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E p A VERAPAMIL d00048A Cr I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A FLUTICASONE NASAL d04283A C- T78.40 Allergy, unspecified A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GABAPENTIN d03182A Cr M54 Dorsalgia A E A HYDROCODONE d03075A C- T14.9 Unspecified injury A E A LISINOPRIL d00732A Cr I21.P Prevent heart attack/myocardial infarction A E A NEBIVOLOL d05265A Cr I49.9 Cardiac arrhythmia, unspecified A E A POTASSIUM CHLORIDE d00345A B[ E87.6 Hypokalemia A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A . . . E A . . . E A . . . E A . . . E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A E A . . . E A . . . E A FLUTICASONE; SALMETEROL d04611A C J40 J45 Bronchitis, not specified as acute or chronic Asthma A E A CANDESARTAN d04322A C I10 Essential (primary) hypertension A0 E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A0 E A TRAMADOL d03826A CDp M25.5 Pain in joint A0 E A ANALGESICS - UNSPECIFIED c00058A Ap M54 Dorsalgia A E 0 A . . . E @ A . . . E P A ALBUTEROL d00749A C J45 Asthma A` E P A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` E P A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Dc F90 Attention-deficit hyperactivity disorders A` E P A DOXYCYCLINE d00037A C- L70 Acne A` E P A NAPROXEN d00019A C- G43 Migraine A` E P A TOPIRAMATE d04115A C[@ G43 Migraine A` E ` A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified AP E ` A CETIRIZINE d03827A C T78.40 Allergy, unspecified AP E ` A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified AP E ` A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C I10 Essential (primary) hypertension AP E ` A LEVOTHYROXINE d00278A Dc E07.9 Disorder of thyroid, unspecified AP E p A . . . E A . . . E A . . . E A 99999 . . AP E A DIPHENHYDRAMINE d00212A Ap J30.9 Allergic rhinitis, unspecified AP E A INSULIN ISOPHANE (NPH) d04370A C"0 E11 Type 2 diabetes mellitus AP E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E A PROMETHAZINE d00787A C R11 Nausea and vomiting AP E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E A GABAPENTIN d03182A CDp M79.2 R60.9 Neuralgia and neuritis, unspecified Edema, unspecified A` E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E A METFORMIN d03807A C R73 Elevated blood glucose level A` E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A` E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma A E ` A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E ` A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E ` A INSULIN LISPRO d04373A Bz E11 Type 2 diabetes mellitus A E ` A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A E ` A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified A E ` A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E ` A LORAZEPAM d00149A D F41.9 Anxiety disorder, unspecified A E ` A MEMANTINE d04899A C- G31.9 Degenerative disease of nervous system, unspecified A E ` A MIRTAZAPINE d04025A D G47.0 Insomnia A E ` A NAPROXEN d00019A CDp M19.9 Osteoarthritis, unspecified site A E ` A TIZANIDINE d04102A C"0 M54 Dorsalgia A E p A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A 77777 . . A E A ATORVASTATIN d04105A C 99999 A E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A CLONIDINE d00044A Ei I10 Essential (primary) hypertension A E A IBUPROFEN d00015A D# M06.9 M19.9 Rheumatoid arthritis, unspecified Osteoarthritis, unspecified site A E A INDAPAMIDE d00260A C I50.9 Heart failure, unspecified A E A INSULIN GLULISINE d05278A Ei E10 Type 1 diabetes mellitus A E A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A E A . . . E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A E A HYDROMORPHONE d00255A Cr M54 Dorsalgia A E A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A OXYCODONE d00329A C M54 Dorsalgia A E A SAXAGLIPTIN d07467A C E11 Type 2 diabetes mellitus A E A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C A49.9P Prevent bacterial infection A E A ATORVASTATIN d04105A D; E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A C H93.9 Unspecified disorder of ear A E A . . . E 0 A LEVETIRACETAM d04499A Ap R25.2 Cramp and spasm AP E 0 A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified AP E 0 A LISINOPRIL d00732A C9 I10 Essential (primary) hypertension AP E 0 A NORETHINDRONE d00555A C9 Z79.3 Long term (current) use of hormonal contraceptives AP E 0 A PANTOPRAZOLE d04514A C9 R12 Heartburn AP E @ A AMLODIPINE; BENAZEPRIL d03829A CP I10 Essential (primary) hypertension A` E @ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E @ A HYDROCHLOROTHIAZIDE d00253A CP I10 Essential (primary) hypertension A` E @ A LEVOTHYROXINE d00278A CP E03.9 Hypothyroidism, unspecified A` E @ A LINAGLIPTIN d07767A C E11 Type 2 diabetes mellitus A` E @ A METFORMIN d03807A C E11.P Prevent diabetes A` E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A AMITRIPTYLINE d00146A D G47.0 Insomnia A E A BACLOFEN d00967A D# M79.1 Myalgia A E A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A E A DOXAZOSIN d00726A C I10 Essential (primary) hypertension A E A FAMOTIDINE d00141A Cr T88.7P Prevent drug side effect A E A HYDROCODONE d03075A Dc M54 Dorsalgia A E A INSULIN ASPART d04697A Cr E10 Type 1 diabetes mellitus A E A INSULIN GLARGINE d04538A Cr E10 Type 1 diabetes mellitus A E A LISINOPRIL d00732A D I21.P Prevent heart attack/myocardial infarction A E A METFORMIN d03807A D E10 Type 1 diabetes mellitus A E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E A LEVOTHYROXINE d00278A CP E06.3 Autoimmune thyroiditis A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M79.2 Neuralgia and neuritis, unspecified A E A BETAMETHASONE TOPICAL d03197A B R21 Rash and other nonspecific skin eruption A E A CLINDAMYCIN d00043A B N76.0 Acute vaginitis A E A DICLOFENAC d00848A Bz M79.2 Neuralgia and neuritis, unspecified A E A ESTRADIOL d00537A CDp Z79.890 Hormone replacement therapy A E A ESTRADIOL TOPICAL d04210A C N95 Menopausal and other perimenopausal disorders A E A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E A LACTULOSE d01024A Cr K59.0 Constipation A E A . . . E 0 A . . . E @ A . . . E P A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E P A PREDNISONE d00350A Bz 55555 A E ` A ALBUTEROL d00749A Cr J45 Asthma A E ` A ALBUTEROL d00749A C J45 Asthma A E ` A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E ` A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A E ` A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A E ` A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E ` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E ` A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E ` A TRAZODONE d00395A Cr F41.9 Anxiety disorder, unspecified A E ` A WARFARIN d00022A C I99.9 Unspecified disorder of circulatory system A E p A . . . E A LEVOTHYROXINE d00278A B[ E03.9 Hypothyroidism, unspecified A E A ACETAMINOPHEN; HYDROCODONE d03428A B[ M54 Dorsalgia A E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E A CYCLOBENZAPRINE d00963A B[ M54 Dorsalgia A E A DEXLANSOPRAZOLE d07395A C- R12 Heartburn A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap N39.0 Urinary tract infection, site not specified A E A TRAMADOL d03826A Ap N30 Cystitis A E A . . . E A . . . E A AMLODIPINE d00689A C9 I10 Essential (primary) hypertension A` E A CARBIDOPA; LEVODOPA d03473A C9 E11 G20 Type 2 diabetes mellitus Parkinson's disease A` E A ENTACAPONE d04460A B= G20 Parkinson's disease A` E A INSULIN ISOPHANE (NPH) d04370A B E11 Type 2 diabetes mellitus A` E A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus A` E A SIMVASTATIN d00746A C9 G20 Parkinson's disease A` E A . . . E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A METHYLPHENIDATE d00900A C"0 F90 Attention-deficit hyperactivity disorders A E A . . . E A MESALAMINE d01031A C[@ K92.9 Disease of digestive system, unspecified A E A TIMOLOL OPHTHALMIC d04037A C- H40 Glaucoma A E0 A . . . E@ A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E@ A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E@ A CLOPIDOGREL d04258A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E@ A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E@ A PANTOPRAZOLE d04514A C K25 K30 Gastric ulcer Functional dyspepsia A E@ A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A E@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E@ A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified A EP A METOPROLOL d00134A D I49.9 Cardiac arrhythmia, unspecified A EP A PRAVASTATIN d00348A A E78.0 Pure hypercholesterolemia A E` A . . . Ep A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A ACYCLOVIR d00001A C A60.9 Anogenital herpesviral infection, unspecified AP E A BECLOMETHASONE d00760A C J45 Asthma AP E A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified AP E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives AP E A TRAZODONE d00395A C G47.0 Insomnia AP E A . . . E A . . . E A . . . E A CIPROFLOXACIN d00011A A A09 Infectious gastroenteritis and colitis, unspecified A@ E A DIVALPROEX SODIUM d03833A CDp G40 Epilepsy and recurrent seizures A@ E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A@ E A METRONIDAZOLE d00108A Ap A09 Infectious gastroenteritis and colitis, unspecified A@ E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A DOCUSATE d01021A C- K59.0 Constipation AP Ep A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified AP Ep A LEVOTHYROXINE d00278A BZ E03.9 Hypothyroidism, unspecified AP Ep A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP Ep A TAMSULOSIN d04121A C N40 R35 Enlarged prostate Polyuria AP E A . . . E A CEPHALEXIN d00096A AP A49.9 Bacterial infection, unspecified A E A HYDROCODONE d03075A AP R52 Pain, unspecified A E A . . . E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP E A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified AP E A OMEPRAZOLE d00325A CDp K31.9 M79.7 Disease of stomach and duodenum, unspecified Fibromyalgia AP E A TRAMADOL d03826A C[@ M25.5 Pain in joint AP E A . . . E A . . . E A HYDROXYCHLOROQUINE d00817A C L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified A@ E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E A METHOTREXATE d00060A B[ L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified A@ E A PREDNISONE d00350A C- L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified A@ E A ALOGLIPTIN; PIOGLITAZONE d07965A C E11 Type 2 diabetes mellitus A E A ASPIRIN d00170A C D75.9P Prevent blood clots A E A CLOPIDOGREL d04258A C[@ I21.P I80.3 Prevent heart attack/myocardial infarction Phlebitis and thrombophlebitis of lower extremities, unspecified A E A ESCITALOPRAM d04812A A F32.9 Major depressive disorder, single episode, unspecified A E A MELOXICAM d04532A CDp 55555 A E A METHOTREXATE d00060A CDp 55555 A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A PREDNISONE d00350A C[@ 55555 A E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A E A TRAMADOL d03826A CDp M79.1 Myalgia A E A ALBUTEROL d00749A C[@ J45 Asthma A E A CIPROFLOXACIN d00011A A0 N30 Cystitis A E A . . . E0 A . . . E@ A GRISEOFULVIN d00100A B= 55555 A EP A BACLOFEN d00967A C[@ M62.83 Muscle spasm A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A` E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E A OMEPRAZOLE d00325A C K27 Peptic ulcer, site unspecified A` E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A` E A TESTOSTERONE d00558A C E29.1 Testicular hypofunction A` E A . . . E A . . . E A NORTRIPTYLINE d00144A B G43.P R51 Prevent migraine Headache A E A . . . E A . . . E0 A GRISEOFULVIN d00100A B* B35 Dermatophytosis A E@ A . . . EP A . . . E` A CETIRIZINE d03827A B T78.40 Allergy, unspecified A Ep Ap . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A CELECOXIB d04380A C M19.9 M85.9 Osteoarthritis, unspecified site Disorders of bone density and structure, unspecified A E A ESTRADIOL d00537A C N95 Menopausal and other perimenopausal disorders A E A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A E A HYDROCHLOROTHIAZIDE d00253A D I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A MEDROXYPROGESTERONE d00284A C N95 Menopausal and other perimenopausal disorders A E A METFORMIN d03807A C R73 Elevated blood glucose level A E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A E A . . . E A . . . E A . . . E0 A BENZOYL PEROXIDE; ERYTHROMYCIN TOPICAL d03857A C L70 Acne A E0 A CLINDAMYCIN TOPICAL d01241A B L70 Acne A E0 A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E0 A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C L70 N92 Z79.3 Acne Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E0 A DULOXETINE d05355A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E0 A FLUORIDE TOPICAL d04397A C K02 Dental caries A E0 A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E0 A PROPRANOLOL d00032A C F41.9 R00 Anxiety disorder, unspecified Abnormalities of heart beat A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M54 Pain in joint Dorsalgia Ap E A ALBUTEROL d00749A B J20.9 Acute bronchitis, unspecified Ap E A FLUOXETINE d00236A Dc F31.9 Bipolar disorder, unspecified Ap E A MORPHINE d00308A C M54 Dorsalgia Ap E A OMEPRAZOLE d00325A C R10 Abdominal and pelvic pain Ap E A RISPERIDONE d03180A CDp F31.9 Bipolar disorder, unspecified Ap E A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified Ap E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B[ I10 Essential (primary) hypertension A E A ALBUTEROL d00749A C J45 Asthma A0 E A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A0 E A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation A0 E A ALBUTEROL; IPRATROPIUM d04066A B[ J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A BUDESONIDE; FORMOTEROL d04795A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A0 E A CARVEDILOL d03847A Bz I51.9 Heart disease, unspecified A0 E A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia A0 E A RAMIPRIL d00728A C I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A FENOFIBRIC ACID d07371A C K21 Gastro-esophageal reflux disease A` E A IBUPROFEN d00015A CDp R51 Headache A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A Cr E78.0 Pure hypercholesterolemia A` E A SOLIFENACIN d05413A B N32.81 Overactive bladder A` E A . . . E0 A ALLOPURINOL d00023A Ap E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A E0 A ALLOPURINOL d00023A Cr M10.9 Gout, unspecified A E0 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E0 A DOXAZOSIN d00726A C R35 Polyuria A E0 A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified A E0 A LEFLUNOMIDE d04349A Cr M06.9 Rheumatoid arthritis, unspecified A E0 A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E0 A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E0 A WARFARIN d00022A C D75.9P I80.3 Prevent blood clots Phlebitis and thrombophlebitis of lower extremities, unspecified A E@ A . . . EP A ACYCLOVIR d00001A D* A60.9 Anogenital herpesviral infection, unspecified A EP A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EP A AZITHROMYCIN d00091A Ap J40 Bronchitis, not specified as acute or chronic A EP A CODEINE; GUAIFENESIN d03393A A R05 R09.3 Cough Abnormal sputum A EP A ESTRADIOL d00537A D# N95 Menopausal and other perimenopausal disorders A EP A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia A EP A FLUTICASONE; VILANTEROL d08100A A@ R06.9 Unspecified abnormalities of breathing A EP A LEVOFLOXACIN d04109A A` J18.9 Pneumonia, unspecified organism A EP A LOSARTAN d03821A CDp 99999 A EP A METOPROLOL d00134A CDp 99999 A EP A RANITIDINE d00021A Cr K30 Functional dyspepsia A EP A TIZANIDINE d04102A B= M79.1 Myalgia A E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A Ep A . . . E A 99999 . . A E A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A NITROFURANTOIN d00112A A` N30 Cystitis A E A . . . E A ALLOPURINOL d00023A C E79.0 M1A Hyperuricemia without signs of inflammatory arthritis and tophaceous disease Chronic gout A@ E A DESONIDE TOPICAL d01290A Cr L29.9 Pruritus, unspecified A@ E A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A@ E A GEMFIBROZIL d00245A Cr E78.1 Pure hyperglyceridemia A@ E A ALBUTEROL d00749A CDp J45 Asthma AP E A NORETHINDRONE d00555A C[@ N94 Pain and other conditions associated with female genital organs and menstrual cycle AP E A PROMETHAZINE d00787A C"0 R11 Nausea and vomiting AP E A RIZATRIPTAN d04328A C"0 G43 Migraine AP E A TOPIRAMATE d04115A C"0 G43 Migraine AP E A . . . E0 A 99999 . . A E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E@ A ATORVASTATIN d04105A B[ I10 Essential (primary) hypertension A E@ A ETHACRYNIC ACID d00649A B N18.9 Chronic kidney disease, unspecified A E@ A ETRAVIRINE d07076A D B20 Human immunodeficiency virus [HIV] disease A E@ A INSULIN ISOPHANE (NPH) d04370A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E@ A LAMIVUDINE d03858A B[ B20 Human immunodeficiency virus [HIV] disease A E@ A LISINOPRIL d00732A C I63.P Prevent stroke A E@ A LOPERAMIDE d01025A C R19.7 Diarrhea, unspecified A E@ A METOPROLOL d00134A C I10 Essential (primary) hypertension A E@ A METOPROLOL d00134A C I10 Essential (primary) hypertension A E@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E@ A PANCRELIPASE d01002A C K92.9 Disease of digestive system, unspecified A E@ A RALTEGRAVIR d07048A D B20 Human immunodeficiency virus [HIV] disease A E@ A TACROLIMUS d03752A C T86.9P Prevent transplanted organ and tissue rejection A E@ A TENOFOVIR d04774A D B20 Human immunodeficiency virus [HIV] disease A EP A CEFPROZIL d00073A0 AP H66.9 J02.0 Otitis media, unspecified Streptococcal pharyngitis A E` A . . . Ep A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 Ep A MELOXICAM d04532A CDp M54 Dorsalgia A0 Ep A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A ATORVASTATIN d04105A D"8 E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A . . . E A . . . E A CARVEDILOL d03847A D I10 Essential (primary) hypertension A@ E A COLESEVELAM d04695A C E78.0 Pure hypercholesterolemia A@ E A ESCITALOPRAM d04812A C- F32.9 Major depressive disorder, single episode, unspecified A@ E A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A D I10 Essential (primary) hypertension A@ E A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E A ROSUVASTATIN d04851A B 55555 A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A0 E0 A LISDEXAMFETAMINE d06663A A F90 Attention-deficit hyperactivity disorders A0 E0 A METHYLPHENIDATE d00900A C"@ F90 Attention-deficit hyperactivity disorders A0 E@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E@ A QUINAPRIL d00365A C I10 Essential (primary) hypertension A0 E@ A TAMSULOSIN d04121A C N40 Enlarged prostate A0 EP A . . . E` A . . . Ep A SUMATRIPTAN d03160A D G43 Migraine A E A ACETAMINOPHEN; CODEINE d03423A CDp M19.9 Osteoarthritis, unspecified site Ap E A AMIODARONE d00002A B I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension Ap E A FUROSEMIDE d00070A B I51.9 Heart disease, unspecified Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified Ap E A RIVAROXABAN d07356A B D75.9P Prevent blood clots Ap E A . . . E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp G47.4 Narcolepsy and cataplexy A E A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E0 A DICYCLOMINE d00999A B* K58 Irritable bowel syndrome AP E0 A ELUXADOLINE d08401A A K58 Irritable bowel syndrome AP E0 A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis AP E0 A LORAZEPAM d00149A CDp F41.9 Anxiety disorder, unspecified AP E0 A LOVASTATIN d00280A A0 E78.0 I63.P Pure hypercholesterolemia Prevent stroke AP E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A CLOPIDOGREL d04258A0 C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A ISOSORBIDE d00653A0 CDp I51.9 Heart disease, unspecified A E A MONTELUKAST d04289A0 C 55555 A E A NITROGLYCERIN d00321A0 Cr I20.9 Angina pectoris, unspecified A E A OLMESARTAN d04801A0 C- E11 Type 2 diabetes mellitus A E A PANTOPRAZOLE d04514A0 C K21 Gastro-esophageal reflux disease A E A ROSUVASTATIN d04851A0 C E78.0 Pure hypercholesterolemia A E A SITAGLIPTIN d05896A0 C E11 Type 2 diabetes mellitus A E A TORSEMIDE d03189A0 C- I51.9 Heart disease, unspecified A E A VILAZODONE d07740A0 B F32.9 Major depressive disorder, single episode, unspecified A E A ZONISAMIDE d04527A0 B# M79.2 Neuralgia and neuritis, unspecified A E A ALBUTEROL d00749A B J45 Asthma A E A . . . E A BENZTROPINE d00175A C F32.9 Major depressive disorder, single episode, unspecified A@ E A CLINDAMYCIN d00043A A Z79 Long term (current) drug therapy A@ E A HALOPERIDOL d00027A C R45 Symptoms and signs involving emotional state A@ E A HYDROCHLOROTHIAZIDE d00253A DR I10 Essential (primary) hypertension A@ E A ASPIRIN d00170A D I21.P Prevent heart attack/myocardial infarction A` E A CODEINE d00012A C- M54 Dorsalgia A` E A FOSINOPRIL d00242A C I10 Essential (primary) hypertension A` E A HYDROCHLOROTHIAZIDE d00253A Cr E87.7 I10 Fluid overload Essential (primary) hypertension A` E A METOPROLOL d00134A CP I10 Essential (primary) hypertension A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A LEVOTHYROXINE d00278A D ^ E03.9 Hypothyroidism, unspecified A0 E A LISINOPRIL d00732A C[@ I10.P Prevent hypertension A0 E A MONTELUKAST d04289A C[@ J30.9 Allergic rhinitis, unspecified A0 E0 A . . . E@ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E@ A IRBESARTAN d04222A Cr I10 Essential (primary) hypertension A@ E@ A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A@ E@ A METOPROLOL d00134A Cr 99999 A@ EP A . . . E` A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension AP E` A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia AP E` A HYDROCHLOROTHIAZIDE d00253A B= I10 Essential (primary) hypertension AP E` A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension AP E` A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B= B99.9 Unspecified infectious disease AP Ep A . . . E A . . . E A . . . E A BENZONATATE d00796A A J00 Acute nasopharyngitis [common cold] A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A NORETHINDRONE d00555A C"0 Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E0 A LISDEXAMFETAMINE d06663A B= F90 Attention-deficit hyperactivity disorders A E@ A ALENDRONATE d03849A C 55555 A E@ A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A EP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CDp Z79.3 Long term (current) use of hormonal contraceptives A E` A METHIMAZOLE d00290A C ` E05 Thyrotoxicosis [hyperthyroidism] A E` A PROPRANOLOL d00032A C ` I49.9 R00 R07.9 Cardiac arrhythmia, unspecified Abnormalities of heart beat Chest pain, unspecified A Ep A . . . E A . . . E A . . . E A IRBESARTAN d04222A C- E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A SAXAGLIPTIN d07467A CDp E11 Type 2 diabetes mellitus A0 E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A D& E03.9 Hypothyroidism, unspecified A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A . . . E A . . . E A AMOXICILLIN; CLAVULANATE d00089A A A49.9P Prevent bacterial infection A E A ALLOPURINOL d00023A D N20.0 Calculus of kidney AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A FENOFIBRIC ACID d07371A C E78.0 Pure hypercholesterolemia AP E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension AP E A METFORMIN d03807A Cr R73 Elevated blood glucose level AP E A . . . E A . . . E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified A E0 A . . . E@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A EP A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A EP A DIGOXIN d00210A C I50.9 Heart failure, unspecified A EP A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A EP A FUROSEMIDE d00070A C J98.9 Respiratory disorder, unspecified A EP A GLYBURIDE; METFORMIN d04703A Dc E11 Type 2 diabetes mellitus A EP A ISOSORBIDE DINITRATE d00268A C I20.9 Angina pectoris, unspecified A EP A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A EP A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A EP A WARFARIN d00022A C 99999 A E` A LEVOTHYROXINE d00278A D* 99999 A E` A PREGABALIN d05508A Cr M79.7 Fibromyalgia A Ep A ALBUTEROL d00749A C J45 Asthma A Ep A FLUTICASONE; SALMETEROL d04611A C- J45 Asthma A E A . . . E A . . . E A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A0 E A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A0 E A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia A0 E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus AP E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A FINASTERIDE d00563A Ei N40 Enlarged prostate Ap E A FOSINOPRIL d00242A Ei I10 Essential (primary) hypertension Ap E A HYDROCHLOROTHIAZIDE d00253A Ei I10 Essential (primary) hypertension Ap E A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E A NIFEDIPINE d00051A Ei I10 Essential (primary) hypertension Ap E A OXYBUTYNIN d00328A Ei N42.9 Disorder of prostate, unspecified Ap E A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia Ap E A . . . E A PHENYTOIN d00143A D& G40 Epilepsy and recurrent seizures A E A DEXMETHYLPHENIDATE d04777A C- F90 Attention-deficit hyperactivity disorders A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A AMOXICILLIN; CLAVULANATE d00089A Ap J02 Acute pharyngitis A Ep A CHLORPHENIRAMINE; HYDROCODONE; PSEUDOEPHEDRINE d03416A Ap J02 Acute pharyngitis A E A ALBUTEROL d00749A C J42 J45 Unspecified chronic bronchitis Asthma A0 E A CLONIDINE d00044A B F90 G47.0 Attention-deficit hyperactivity disorders Insomnia A0 E A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A E A . . . E A . . . E A AMLODIPINE d00689A C[@ 99999 A0 E A METOPROLOL d00134A C[@ 99999 A0 E A OMEPRAZOLE d00325A C[@ 99999 A0 E A . . . E0 A ACETAMINOPHEN; CODEINE d03423A B R10 R51 Abdominal and pelvic pain Headache A0 E0 A DOCUSATE d01021A B[ K59.0 Constipation A0 E0 A IBUPROFEN d00015A B G89 R10 Pain, not elsewhere classified Abdominal and pelvic pain A0 E@ A . . . EP A . . . E` A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A Ep A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ACETAMINOPHEN; CODEINE d03423A A R52 Pain, unspecified A E A RANITIDINE d00021A Ap K30 Functional dyspepsia A E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A AMLODIPINE d00689A C 99999 Ap E 0 A BIMATOPROST OPHTHALMIC d04754A C H40 Glaucoma Ap E 0 A BUMETANIDE d00179A C I50.9 Heart failure, unspecified Ap E 0 A ISOSORBIDE MONONITRATE d00269A C 99999 Ap E 0 A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E 0 A POTASSIUM CHLORIDE d00345A B[ E87.6 Hypokalemia Ap E 0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E @ A . . . E P A ENOXAPARIN d03041A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E P A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A@ E P A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus A@ E P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E ` A LAMOTRIGINE d03809A B G40 Epilepsy and recurrent seizures A E p A . . . E A . . . E A CYCLOBENZAPRINE d00963A C- M79.1 Myalgia A E A IBUPROFEN d00015A C- M54 Dorsalgia A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A@ E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A@ E A GUANFACINE d00717A C[@ F90 Attention-deficit hyperactivity disorders A@ E A TRAZODONE d00395A Cr G47.0 Insomnia A@ E A DICLOFENAC d00848A CDp G43 Migraine A` E A DONEPEZIL d04099A Cr G31.9 Degenerative disease of nervous system, unspecified A` E A IBUPROFEN d00015A Cr G43 Migraine A` E A NAPROXEN d00019A Cr G43 Migraine A` E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` E A ZOLPIDEM d00910A Cr G47.9 Sleep disorder, unspecified A` E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A CETIRIZINE d03827A C[@ T78.40 Allergy, unspecified AP E @ A FORMOTEROL; MOMETASONE d07660A C- J45 Asthma AP E @ A GENTAMICIN d00014A C H66.9 Otitis media, unspecified AP E @ A MOMETASONE NASAL d04223A C[@ J30.9 Allergic rhinitis, unspecified AP E @ A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease AP E P A RANITIDINE d00021A B K30 Functional dyspepsia A E ` A . . . E p A . . . E A . . . E A BUPROPION d00181A C F43.1 Post-traumatic stress disorder (PTSD) A E A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A E A . . . E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A MEDROXYPROGESTERONE d00284A C- Z79.3 Long term (current) use of hormonal contraceptives A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CDp 55555 A E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C[@ I10 Essential (primary) hypertension A E 0 A . . . E @ A ALBUTEROL d00749A D J45 R06.2 Asthma Wheezing A E @ A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E P A ALENDRONATE d03849A CP M85.9 Disorders of bone density and structure, unspecified A E P A DASATINIB d05831A D C96.9 Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified A E P A FUROSEMIDE d00070A D R60.9 Edema, unspecified A E P A HYDROCODONE d03075A D T14.9 Unspecified injury A E P A HYDROXYUREA d01373A Cr Z51.1 Encounter for antineoplastic chemotherapy and immunotherapy A E P A INSULIN ASPART d04697A D:u E10 Type 1 diabetes mellitus A E P A MONTELUKAST d04289A C J98.9 Respiratory disorder, unspecified A E P A POTASSIUM CHLORIDE d00345A D R60.9 Edema, unspecified A E P A QUINAPRIL d00365A D I10 Essential (primary) hypertension A E P A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E ` A . . . E p A . . . E A . . . E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A Dc R60.9 Edema, unspecified A@ E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A BK I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A BK 99999 AP E A CARVEDILOL d03847A BK 99999 AP E A HYDRALAZINE d00132A BK 99999 AP E A ISOSORBIDE DINITRATE d00268A BK E11 Type 2 diabetes mellitus AP E A LEVONORGESTREL d00557A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E A VALACYCLOVIR d03838A A@ B00.1 Herpesviral vesicular dermatitis A E A . . . E 0 A . . . E @ A CARISOPRODOL d00960A CP M62.83 Muscle spasm Ap E @ A LIDOCAINE TOPICAL d00683A B M79.2 Neuralgia and neuritis, unspecified Ap E @ A LORAZEPAM d00149A CP F41.9 Anxiety disorder, unspecified Ap E @ A OXYCODONE d00329A CP M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified Ap E @ A PREGABALIN d05508A CP M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia Ap E @ A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E @ A TEMAZEPAM d00384A C G47.0 Insomnia Ap E P A . . . E ` A . . . E p A . . . E A . . . E A LEVOTHYROXINE d00278A DGJ E03.9 Hypothyroidism, unspecified A0 E A METFORMIN d03807A C- R73 Elevated blood glucose level A0 E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A TOBRAMYCIN OPHTHALMIC d03222A AP H10 Conjunctivitis A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A DIVALPROEX SODIUM d03833A B[ F90 Attention-deficit hyperactivity disorders A E A IBUPROFEN d00015A Ap R51 Headache A E A . . . E A . . . E A 99999 . . A E A OMEPRAZOLE d00325A B= K21 Gastro-esophageal reflux disease A E 0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E @ A . . . E P A RANITIDINE d00021A C K21 R12 Gastro-esophageal reflux disease Heartburn A E ` A . . . E p A . . . E A ALLOPURINOL d00023A CDp E79.0 M1A Hyperuricemia without signs of inflammatory arthritis and tophaceous disease Chronic gout A@ E A DOCUSATE d01021A C K59.0 Constipation A@ E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ E A TAMSULOSIN d04121A C N40 R39.1 Enlarged prostate Other difficulties with micturition A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E! A LINACLOTIDE d07902A B K59.0 Constipation A E! A RABEPRAZOLE d04448A Bz K21 Gastro-esophageal reflux disease A E! A . . . E! A . . . E!0 A . . . E!@ A . . . E!P A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E!P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E!` A . . . E!p A . . . E! A . . . E! A . . . E! A CHLORTHALIDONE d00192A0 C I10 Essential (primary) hypertension A@ E! A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A@ E! A PREDNISONE d00350A0 A L23 Allergic contact dermatitis A@ E! A TRIAMCINOLONE TOPICAL d03206A0 A L23 Allergic contact dermatitis A@ E! A INFLIXIMAB d04342A CP M06.9 Rheumatoid arthritis, unspecified A E! A CARVEDILOL d03847A C- I50.9 Heart failure, unspecified A@ E! A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A@ E! A HYDRALAZINE d00132A C- I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A@ E! A ISOSORBIDE DINITRATE d00268A C- R07.9 Chest pain, unspecified A@ E! A CHLORDIAZEPOXIDE d00189A D* F41.9 Anxiety disorder, unspecified A E! A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm A E! A ESZOPICLONE d05421A C G47.0 Insomnia A E! A HYDROXYCHLOROQUINE d00817A B[ L93 Lupus erythematosus A E! A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A E! A MESALAMINE d01031A B K51 Ulcerative colitis A E! A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A E! A TIMOLOL OPHTHALMIC d04037A C[@ H40 Glaucoma A E! A . . . E! A AMLODIPINE d00689A0 D I10 Essential (primary) hypertension AP E! A CIMETIDINE d00140A0 D K21 Gastro-esophageal reflux disease AP E! A METFORMIN d03807A0 Dc E11 Type 2 diabetes mellitus AP E! A METOPROLOL d00134A0 C I10 Essential (primary) hypertension AP E! A OMEPRAZOLE d00325A0 C- K21 K58 Gastro-esophageal reflux disease Irritable bowel syndrome AP E" A . . . E" A . . . E" A . . . E"0 A . . . E"@ A . . . E"P A . . . E"` A . . . E"p A ATENOLOL; CHLORTHALIDONE d03258A D I10 Essential (primary) hypertension A` E"p A CILOSTAZOL d04382A C[@ I70 Atherosclerosis A` E"p A LOPERAMIDE d01025A D R19.7 Diarrhea, unspecified A` E"p A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia A` E"p A PRAVASTATIN d00348A Bz E78.0 Pure hypercholesterolemia A` E"p A SPIRONOLACTONE d00373A CDp I10 Essential (primary) hypertension A` E" A KETOPROFEN d00028A A G89 Pain, not elsewhere classified A E" A . . . E" A DORZOLAMIDE OPHTHALMIC d03805A Dc H40 Glaucoma A` E" A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion A` E" A IRBESARTAN d04222A D I10 Essential (primary) hypertension A` E" A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E" A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A` E" A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E" A . . . E" A ESCITALOPRAM d04812A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E" A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B[ N92 Excessive, frequent and irregular menstruation A E" A . . . E" A . . . E" A BUSPIRONE d00182A CDp F41.9 Anxiety disorder, unspecified A` E" A DEXLANSOPRAZOLE d07395A C[@ K21 Gastro-esophageal reflux disease A` E" A DICYCLOMINE d00999A C R10 Abdominal and pelvic pain A` E" A FENOFIBRIC ACID d07371A CDp E78.1 Pure hyperglyceridemia A` E" A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A` E" A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified A` E# A . . . E# A AMLODIPINE d00689A B- I21.P Prevent heart attack/myocardial infarction A@ E# A DIPHENHYDRAMINE d00212A C I10 Essential (primary) hypertension A@ E# A OLANZAPINE d04050A C F43.9 Reaction to severe stress, unspecified A@ E# A TOPIRAMATE d04115A C G47.0 Insomnia A@ E# A . . . E#0 A LEVETIRACETAM d04499A B= Z79 Long term (current) drug therapy A` E#0 A METHYLPREDNISOLONE d00293A A M19.9 Osteoarthritis, unspecified site A` E#0 A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A` E#0 A TADALAFIL d04896A B N42.9 Disorder of prostate, unspecified A` E#0 A TAMSULOSIN d04121A CDp N40 Enlarged prostate A` E#0 A TIZANIDINE d04102A A M25.5 T14.9 Pain in joint Unspecified injury A` E#@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E#@ A HYDROXYCHLOROQUINE d00817A C L93 Lupus erythematosus A0 E#@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E#P A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E#P A MELOXICAM d04532A C- M19.9 Osteoarthritis, unspecified site A0 E#P A TIZANIDINE d04102A C- M79.1 Myalgia A0 E#` A 99999 . . AP E#` A AMLODIPINE d00689A C I63.P Prevent stroke AP E#` A DABIGATRAN d07137A Cr I48.9 Unspecified atrial fibrillation and atrial flutter AP E#` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I50.9 Heart failure, unspecified AP E#` A METOPROLOL d00134A C R07.9 Chest pain, unspecified AP E#p A ACETAMINOPHEN; HYDROCODONE d03428A C- R10 Abdominal and pelvic pain A E#p A DOCUSATE d01021A CDp K59.0 Constipation A E#p A NITROFURANTOIN d00112A Ap 55555 A E#p A OMEPRAZOLE d00325A C K92.9 Disease of digestive system, unspecified A E#p A ONDANSETRON d00867A C' R11.P Prevent nausea or vomiting A E#p A OXYBUTYNIN d00328A B[ R35 Polyuria A E#p A TIMOLOL OPHTHALMIC d04037A B* H40 Glaucoma A E#p A TRAVOPROST OPHTHALMIC d04753A CDp H40 Glaucoma A E# A CLONAZEPAM d00197A C G47.9 Sleep disorder, unspecified A0 E# A DIVALPROEX SODIUM d03833A C F31.9 Bipolar disorder, unspecified A0 E# A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E# A . . . E# A . . . E# A . . . E# A IBUPROFEN d00015A C R51 Headache A E# A OXYCODONE d00329A B= G89 Pain, not elsewhere classified A E# A . . . E# A . . . E# A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E$ A . . . E$ A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia A` E$ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` E$ A MELOXICAM d04532A C T14.9 Unspecified injury A` E$ A OMEPRAZOLE d00325A Dc K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A` E$ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` E$ A TRAMADOL d03826A C M54 Dorsalgia A` E$ A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A E$ A BIMATOPROST OPHTHALMIC d04754A D* H40 Glaucoma A E$ A FLUOROMETHOLONE OPHTHALMIC d03227A C H40 Glaucoma A E$ A FUROSEMIDE d00070A CDp 99999 A E$ A METOPROLOL d00134A CDp 99999 A E$ A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A E$ A TIMOLOL OPHTHALMIC d04037A B H40 Glaucoma A E$ A TIMOLOL OPHTHALMIC d04037A Dc H40 Glaucoma A E$0 A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A@ E$0 A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A@ E$0 A IBUPROFEN d00015A CDp M54 Dorsalgia A@ E$0 A METHOCARBAMOL d00965A C[@ M79.1 Myalgia A@ E$@ A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A E$@ A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E$P A . . . E$` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E$` A ISOSORBIDE MONONITRATE d00269A C I20.9 Angina pectoris, unspecified AP E$` A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E$` A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E$` A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia AP E$p A . . . E$ A . . . E$ A . . . E$ A . . . E$ A . . . E$ A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E$ A CLOPIDOGREL d04258A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E$ A FLUTICASONE NASAL d04283A CP J30.9 Allergic rhinitis, unspecified A E$ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E$ A LISINOPRIL d00732A C I21.P Prevent heart attack/myocardial infarction A E$ A METOPROLOL d00134A C I50.9 Heart failure, unspecified A E$ A MONTELUKAST d04289A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E$ A NAPROXEN d00019A C M19.9 Osteoarthritis, unspecified site A E$ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E$ A . . . E$ A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A B Z79.3 Long term (current) use of hormonal contraceptives A E% A AMOXICILLIN d00088A A N30 Cystitis A E% A AMOXICILLIN; CLAVULANATE d00089A A N30 Cystitis A E% A AMOXICILLIN d00088A A J00 Acute nasopharyngitis [common cold] A E% A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E% A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Bz F90 Attention-deficit hyperactivity disorders A E%0 A BACLOFEN d00967A CDp M79.1 Myalgia B E%0 A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified B E%0 A DEXLANSOPRAZOLE d07395A CDp B96.81 K21 R12 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere Gastro-esophageal reflux disease Heartburn B E%0 A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified B E%0 A GABAPENTIN d03182A C- M54 Dorsalgia B E%0 A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus B E%0 A IBUPROFEN d00015A C M54 Dorsalgia B E%0 A LACTULOSE d01024A B K59.0 Constipation B E%0 A LINACLOTIDE d07902A B= K59.0 Constipation B E%0 A LIRAGLUTIDE d07466A C- E11 Type 2 diabetes mellitus B E%0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension B E%0 A LUBIPROSTONE d05736A CDp K59.0 Constipation B E%0 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus B E%0 A NEBIVOLOL d05265A CDp I10 Essential (primary) hypertension B E%0 A OXYMORPHONE d00833A CDp M54 Dorsalgia B E%0 A PRAVASTATIN d00348A C- I21.P Prevent heart attack/myocardial infarction B E%0 A SAXAGLIPTIN d07467A C- E11 Type 2 diabetes mellitus B E%@ A . . . E%P A . . . E%` A ETHINYL ESTRADIOL; NORGESTIMATE d03781A0 C- Z79.3 Long term (current) use of hormonal contraceptives A E%p A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E%p A AZITHROMYCIN d00091A Ap J18.9 Pneumonia, unspecified organism A E%p A BENZONATATE d00796A B= J42 Unspecified chronic bronchitis A E%p A FINASTERIDE d00563A Cr N39.4 Other specified urinary incontinence A E%p A FUROSEMIDE d00070A C"0 R60.9 Edema, unspecified A E%p A MOMETASONE d05262A Cr R07.9 Chest pain, unspecified A E%p A MONTELUKAST d04289A C"0 J44.9 Chronic obstructive pulmonary disease, unspecified A E%p A POTASSIUM CHLORIDE d00345A C[@ 99999 A E%p A ROPINIROLE d04215A CDp 55555 A E%p A TAMSULOSIN d04121A B R35 Polyuria A E%p A WARFARIN d00022A C- I49.9 Cardiac arrhythmia, unspecified A E% A . . . E% A . . . E% A AZITHROMYCIN d00091A Ap J01.9 Acute sinusitis, unspecified A E% A RANITIDINE d00021A B T78.40 Allergy, unspecified A E% A . . . E% A CEFDINIR d04256A A` J02 Acute pharyngitis A@ E% A CYPROHEPTADINE d00790A C R51 Headache A@ E% A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A@ E% A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A@ E% A . . . E% A . . . E% A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E% A COLESTIPOL d00744A CDp E78.0 Pure hypercholesterolemia Ap E% A CONJUGATED ESTROGENS d00541A0 D9 N95 Z79.890 Menopausal and other perimenopausal disorders Hormone replacement therapy Ap E% A ESOMEPRAZOLE d04749A0 Cr K31.9 Disease of stomach and duodenum, unspecified Ap E% A GEMFIBROZIL d00245A C- E78.0 Pure hypercholesterolemia Ap E% A LOSARTAN d03821A Cr I10 Essential (primary) hypertension Ap E% A SUCRALFATE d00377A CDp K31.9 Disease of stomach and duodenum, unspecified Ap E& A CARVEDILOL d03847A B I10 Essential (primary) hypertension A E& A NITROFURANTOIN d00112A A N39.0 Urinary tract infection, site not specified A E& A LIDOCAINE TOPICAL d00683A B= K92.9 Disease of digestive system, unspecified A E& A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E&0 A . . . E&@ A . . . E&P A . . . E&` A PREDNISONE d00350A A 55555 A E&` A TRANEXAMIC ACID d00529A B[ 55555 A E&p A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A E&p A MONTELUKAST d04289A C J45 Asthma A E& A NAPROXEN d00019A B M79.1 Myalgia A E& A . . . E& A . . . E& A . . . E& A CIPROFLOXACIN d00011A B N42.9 Disorder of prostate, unspecified A E& A FINASTERIDE d00563A Ei R35 Polyuria A E& A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E& A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E& A OMEPRAZOLE d00325A C- T88.7P Prevent drug side effect A E& A PHENAZOPYRIDINE d00337A A N32.9 Bladder disorder, unspecified A E& A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E& A TAMSULOSIN d04121A C R32 Unspecified urinary incontinence A E& A TRAMADOL d03826A B< N42.9 Disorder of prostate, unspecified A E& A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E& A LAMOTRIGINE d03809A CDp G40 Epilepsy and recurrent seizures A E& A . . . E& A . . . E' A . . . E' A MONTELUKAST d04289A B T78.40 Allergy, unspecified A E' A . . . E'0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E'0 A FINASTERIDE d00563A C[@ N40 Enlarged prostate A` E'0 A LINAGLIPTIN d07767A C E11 Type 2 diabetes mellitus A` E'0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E'0 A OMEPRAZOLE d00325A C[@ K25 Gastric ulcer A` E'0 A TAMSULOSIN d04121A C[@ N40 R39.1 Enlarged prostate Other difficulties with micturition A` E'@ A . . . E'P A . . . E'` A ETHINYL ESTRADIOL; NORGESTREL d03241A C Z79.3 Long term (current) use of hormonal contraceptives A E'p A . . . E' A . . . E' A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A@ E' A LEVALBUTEROL d04427A Dc J45 Asthma A@ E' A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E' A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A@ E' A CLONAZEPAM d00197A C[@ F41.9 Anxiety disorder, unspecified A E' A ETHINYL ESTRADIOL; NORGESTREL d03241A C Z79.3 Long term (current) use of hormonal contraceptives A E' A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A E' A METHYLPREDNISOLONE d00293A A0 J00 Acute nasopharyngitis [common cold] A E' A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified A E' A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E' A . . . E' A . . . E' A . . . E( A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E( A ESOMEPRAZOLE d04749A Cr K30 Functional dyspepsia A` E( A LEVOTHYROXINE d00278A C 99999 A` E( A LEVOTHYROXINE d00278A C 99999 A` E( A METOPROLOL d00134A C R07.9 Chest pain, unspecified A` E( A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A` E( A . . . E( A . . . E(0 A . . . E(@ A . . . E(P A . . . E(` A AMOXICILLIN d00088A Ap R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems A E(p A . . . E( A . . . E( A 99999 . . A E( A . . . E( A . . . E( A ALPRAZOLAM d00168A B[ F41.9 Anxiety disorder, unspecified A E( A HYDROXYZINE d00907A B[ G47.0 Insomnia A E( A SERTRALINE d00880A C- F41.9 Anxiety disorder, unspecified A E( A . . . E( A . . . E) A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E) A . . . E) A . . . E)0 A . . . E)@ A ALBUTEROL d00749A B J44.9 Chronic obstructive pulmonary disease, unspecified Ap E)@ A ALBUTEROL d00749A0 C- J44.9 Chronic obstructive pulmonary disease, unspecified Ap E)@ A ALPRAZOLAM d00168A D F32.9 Major depressive disorder, single episode, unspecified Ap E)@ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp I10 R60.9 Essential (primary) hypertension Edema, unspecified Ap E)@ A HYDROCODONE d03075A D M79.2 Neuralgia and neuritis, unspecified Ap E)@ A PRAVASTATIN d00348A D* E78.0 Pure hypercholesterolemia Ap E)@ A PREDNISONE d00350A C- J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma Ap E)P A . . . E)` A . . . E)p A . . . E) A . . . E) A . . . E) A METHYLPHENIDATE d00900A A F90 Attention-deficit hyperactivity disorders A E) A CLONIDINE d00044A C- G47.0 Insomnia A E) A DEXMETHYLPHENIDATE d04777A C- F90 Attention-deficit hyperactivity disorders A E) A CETIRIZINE d03827A CDp J30.9 Allergic rhinitis, unspecified A E) A . . . E) A . . . E) A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D= I10 Essential (primary) hypertension AP E) A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level AP E) A INSULIN GLULISINE d05278A C- R73 Elevated blood glucose level AP E) A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia AP E) A METFORMIN d03807A C R73 Elevated blood glucose level AP E* A . . . E* A . . . E* A . . . E*0 A . . . E*@ A . . . E*P A . . . E*` A . . . E*p A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A@ E*p A FLUTICASONE; SALMETEROL d04611A C[@ J45 Asthma A@ E*p A MOMETASONE NASAL d04223A CDp J30.9 Allergic rhinitis, unspecified A@ E*p A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A@ E* A . . . E* A AZITHROMYCIN d00091A AP J03 Acute tonsillitis A E* A ESOMEPRAZOLE d04749A B[ K30 Functional dyspepsia A E* A . . . E* A . . . E* A . . . E* A CARVEDILOL d03847A Bz I10 Essential (primary) hypertension A@ E* A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A@ E* A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A@ E* A VERAPAMIL d00048A C- I10 Essential (primary) hypertension A@ E* A . . . E* A ALBUTEROL d00749A C R06.2 Wheezing A E+ A . . . E+ A . . . E+ A . . . E+0 A . . . E+@ A ACETAMINOPHEN; HYDROCODONE d03428A0 B[ M54 Dorsalgia A E+P A . . . E+` A GUANFACINE d00717A B= F39 Unspecified mood [affective] disorder A0 E+` A METHYLPHENIDATE d00900A A F90 Attention-deficit hyperactivity disorders A0 E+` A QUETIAPINE d04220A Bz G47.9 Sleep disorder, unspecified A0 E+p A . . . E+ A . . . E+ A . . . E+ A . . . E+ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E+ A DICLOFENAC d00848A B M25.5 Pain in joint A@ E+ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E+ A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A@ E+ A GABAPENTIN d03182A B= M79.2 Neuralgia and neuritis, unspecified A@ E+ A LAMOTRIGINE d03809A B F32.9 Major depressive disorder, single episode, unspecified A@ E+ A OMEPRAZOLE d00325A D R12 Heartburn A@ E+ A OXYCODONE d00329A B= G89 Pain, not elsewhere classified A@ E+ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A@ E+ A IBUPROFEN d00015A C M54 T14.9 Dorsalgia Unspecified injury A@ E+ A PAROXETINE d03157A Dc F42 Obsessive-compulsive disorder A@ E+ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E+ A DIGOXIN d00210A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E+ A DONEPEZIL d04099A Cr R41 Other symptoms and signs involving cognitive functions and awareness A E+ A FUROSEMIDE d00070A C[@ I51.9 Heart disease, unspecified A E+ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E+ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E+ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E+ A MEMANTINE d04899A Cr R41 Other symptoms and signs involving cognitive functions and awareness A E+ A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A E+ A POTASSIUM CHLORIDE d00345A C[@ R60.9 Edema, unspecified A E+ A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E+ A WARFARIN d00022A C I48.9 Unspecified atrial fibrillation and atrial flutter A E+ A . . . E, A . . . E, A . . . E, A . . . E,0 A . . . E,@ A ALBUTEROL d00749A Cr J45 Asthma A E,P A NYSTATIN TOPICAL d04399A B H66.9 Otitis media, unspecified A E,` A . . . E,p A . . . E, A . . . E, A AMLODIPINE d00689A D# I10 Essential (primary) hypertension A E, A . . . E, A . . . E, A . . . E, A FLUTICASONE NASAL d04283A C- T78.40 Allergy, unspecified A0 E, A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 E, A VALACYCLOVIR d03838A C B00.9 Herpesviral infection, unspecified A0 E, A . . . E, A ALBUTEROL d00749A C- J43 Emphysema Ap E, A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E, A MEMANTINE d04899A C G31.9 Degenerative disease of nervous system, unspecified Ap E, A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap E, A METOPROLOL d00134A C- I20.9 Angina pectoris, unspecified Ap E, A MIDODRINE d04047A B= I99.9 Unspecified disorder of circulatory system Ap E, A WARFARIN d00022A D"8 D75.9P Prevent blood clots Ap E- A . . . E- A . . . E- A . . . E-0 A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A@ E-0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E-0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E-0 A NIFEDIPINE d00051A C 55555 A@ E-@ A . . . E-P A . . . E-` A . . . E-p A ALBUTEROL d00749A C9 J45 Asthma A0 E-p A FLUTICASONE d01296A C"0 J45 Asthma A0 E-p A PREDNISONE d00350A AP J45 Asthma A0 E- A . . . E- A . . . E- A . . . E- A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E- A TAMSULOSIN d04121A B N40 Enlarged prostate A E- A . . . E- A . . . E- A . . . E- A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E- A LEVOTHYROXINE d00278A DQE E03.9 Hypothyroidism, unspecified A E. A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A E. A CLONIDINE d00044A B I10 Essential (primary) hypertension A E. A FEBUXOSTAT d07397A B E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A E. A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A E. A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E. A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A E. A NEBIVOLOL d05265A CDp I10 Essential (primary) hypertension A E. A VALSARTAN d04113A C I10 Essential (primary) hypertension A E. A 99999 . . A E. A ATORVASTATIN d04105A C 99999 A@ E. A LEVOTHYROXINE d00278A D ^ E07.9 Disorder of thyroid, unspecified A@ E. A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E. A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E.0 A . . . E.@ A CLONAZEPAM d00197A CDp F41.9 Anxiety disorder, unspecified A0 E.@ A DAPSONE TOPICAL d05543A B= L70 Acne A0 E.@ A SERTRALINE d00880A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E.P A . . . E.` A ARIPIPRAZOLE d04825A Cr F32.9 Major depressive disorder, single episode, unspecified A E.` A ASPIRIN d00170A Cr I21.P Prevent heart attack/myocardial infarction A E.` A CLOPIDOGREL d04258A Cr I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E.` A DICLOFENAC d00848A Cr M79.1 Myalgia A E.` A DICLOFENAC d00848A Cr M54 Dorsalgia A E.` A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E.` A METOPROLOL d00134A Cr I50.9 Heart failure, unspecified A E.` A OMEPRAZOLE d00325A Cr K27 Peptic ulcer, site unspecified A E.` A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E.` A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A E.` A TEMAZEPAM d00384A Cr F41.9 Anxiety disorder, unspecified A E.p A . . . E. A . . . E. A . . . E. A . . . E. A CYCLOBENZAPRINE d00963A B[ M62.83 Muscle spasm A E. A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E. A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E. A LEVOTHYROXINE d00278A Ap 99999 A E. A LISINOPRIL d00732A Cr E11.2P Prevent diabetic kidney disease A E. A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E. A NAPROXEN d00019A C- M54 Dorsalgia A E. A TRAMADOL d03826A C[@ M54 Dorsalgia A E. A . . . E. A . . . E. A ALBUTEROL d00749A Cr J45 Asthma A E. A . . . E/ A . . . E/ A . . . E/ A . . . E/0 A HYDROCORTISONE TOPICAL d03205A C[@ L20.9 Atopic dermatitis, unspecified A E/0 A LISDEXAMFETAMINE d06663A A F90 Attention-deficit hyperactivity disorders A E/@ A . . . E/P A . . . E/` A . . . E/p A ESCITALOPRAM d04812A B F41.9 Anxiety disorder, unspecified A@ E/p A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E/p A INSULIN ASPART d04697A D# E11 Type 2 diabetes mellitus A@ E/p A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E/ A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A D% I10 Essential (primary) hypertension A E/ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E/ A . . . E/ A FLUOXETINE d00236A B= F20 Schizophrenia A@ E/ A MIRTAZAPINE d04025A C G47.0 Insomnia A@ E/ A RISPERIDONE d03180A B= F20 Schizophrenia A@ E/ A ZOLPIDEM d00910A C G47.0 Insomnia A@ E/ A . . . E/ A . . . E/ A ALBUTEROL d00749A CDp J43 Emphysema A E/ A BUPROPION d00181A C F31.9 F32.9 F41.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E/ A DIPHENHYDRAMINE d00212A C G47.0 Insomnia A E/ A DIVALPROEX SODIUM d03833A C F39 Unspecified mood [affective] disorder A E/ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E/ A HYDROCODONE d03075A CDp M79.2 Neuralgia and neuritis, unspecified A E/ A IPRATROPIUM d00265A CDp J43 Emphysema A E/ A MORPHINE d00308A CDp M79.2 Neuralgia and neuritis, unspecified A E/ A TIOTROPIUM d04829A CDp J43 Emphysema A E/ A . . . E0 A . . . E0 A . . . E0 A . . . E00 A . . . E0@ A . . . E0P A . . . E0` A . . . E0p A RANITIDINE d00021A D K30 Functional dyspepsia A E0 A . . . E0 A FLUTICASONE NASAL d04283A Bz J30.9 Allergic rhinitis, unspecified A0 E0 A LEVOTHYROXINE d00278A Bz E03.9 Hypothyroidism, unspecified A0 E0 A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A0 E0 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A D G43 Migraine A E0 A ACETIC ACID; HYDROCORTISONE OTIC d03625A B[ H93.9 Unspecified disorder of ear A E0 A ALBUTEROL d00749A B R05 R06.02 Cough Shortness of breath A E0 A CYCLOBENZAPRINE d00963A C G47.0 Insomnia A E0 A GABAPENTIN d03182A C M54 Dorsalgia A E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E0 A METOPROLOL d00134A CP I20.9 Angina pectoris, unspecified A E0 A MIRTAZAPINE d04025A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E0 A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A E0 A NITROGLYCERIN d00321A CP I20.9 Angina pectoris, unspecified A E0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E0 A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E0 A . . . E0 A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A` E0 A FLUTICASONE NASAL d04283A Dc J30.9 Allergic rhinitis, unspecified A` E0 A FUROSEMIDE d00070A B I51.9 Heart disease, unspecified A` E0 A LOSARTAN d03821A C I50.9 Heart failure, unspecified A` E0 A METFORMIN d03807A Dc R73 Elevated blood glucose level A` E0 A TAMSULOSIN d04121A D R39.1 Other difficulties with micturition A` E0 A . . . E0 A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension AP E0 A ASPIRIN; DIPYRIDAMOLE d04497A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets AP E0 A OMEPRAZOLE d00325A D K22 R12 Other diseases of esophagus Heartburn AP E0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E0 A TAMSULOSIN d04121A B R39.1 Other difficulties with micturition AP E0 A . . . E1 A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A CDp E11 Type 2 diabetes mellitus A E1 A . . . E1 A . . . E10 A . . . E1@ A ACETAMINOPHEN; HYDROCODONE d03428A Cr M19.9 Osteoarthritis, unspecified site A0 E1@ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E1@ A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A0 E1P A . . . E1` A . . . E1p A ALBUTEROL d00749A CDp J45 Asthma A@ E1p A BECLOMETHASONE d00760A C- J45 Asthma A@ E1p A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A@ E1p A NAPROXEN d00019A Bz M54 Dorsalgia A@ E1 A . . . E1 A . . . E1 A DIVALPROEX SODIUM d03833A C G40 Epilepsy and recurrent seizures A E1 A SERTRALINE d00880A C& F41.9 Anxiety disorder, unspecified A E1 A ALBUTEROL d00749A C J45 Asthma A E1 A ALBUTEROL d00749A C J45 Asthma A E1 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E1 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E1 A DESLORATADINE d04785A Ei T78.40 Allergy, unspecified A E1 A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E1 A GLIMEPIRIDE d03864A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E1 A INSULIN ASPART d04697A Ei E11 Type 2 diabetes mellitus A E1 A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E1 A IPRATROPIUM d00265A C J45 Asthma A E1 A MONTELUKAST d04289A C J45 Asthma A E1 A MONTELUKAST d04289A D J45 Asthma A E1 A TELMISARTAN d04364A C I10 Essential (primary) hypertension A E1 A . . . E1 A . . . E1 A . . . E2 A . . . E2 A . . . E2 A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A E20 A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified A E20 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E2@ A . . . E2P A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A E2` A ETHINYL ESTRADIOL; ETHYNODIOL d03388A C L70 Acne A E2p A . . . E2 A . . . E2 A . . . E2 A ACETAMINOPHEN; OXYCODONE d03431A C[@ M54 Dorsalgia A E2 A AMLODIPINE d00689A C E78.0 Pure hypercholesterolemia A E2 A ESOMEPRAZOLE d04749A C[@ K21 Gastro-esophageal reflux disease A E2 A FUROSEMIDE d00070A C- I10 R60.9 Essential (primary) hypertension Edema, unspecified A E2 A GABAPENTIN d03182A B E11.4 Type 2 diabetes mellitus with neurological complications A E2 A INSULIN ASPART d04697A C[@ R73 Elevated blood glucose level A E2 A INSULIN DETEMIR d05436A C[@ E11 Type 2 diabetes mellitus A E2 A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E2 A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia A E2 A VALSARTAN d04113A C I10 Essential (primary) hypertension A E2 A ALPRAZOLAM d00168A C G47.9 Sleep disorder, unspecified A@ E2 A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A@ E2 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E2 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E2 A . . . E2 A ACETAMINOPHEN; OXYCODONE d03431A A G43 Migraine A E2 A GLYBURIDE d00248A B R73 Elevated blood glucose level A E2 A ACETAMINOPHEN; CODEINE d03423A Ap T14.9 Unspecified injury A@ E2 A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ E2 A SAXAGLIPTIN d07467A Ap E11 Type 2 diabetes mellitus A@ E2 A TRAMADOL d03826A Ap T14.9 Unspecified injury A@ E3 A . . . E3 A ATORVASTATIN d04105A Cr I51.9P Prevent heart disease A E3 A DEXLANSOPRAZOLE d07395A B K58 Irritable bowel syndrome A E3 A DICLOFENAC d00848A B M13 Other arthritis A E3 A DULOXETINE d05355A C- F32.9 Major depressive disorder, single episode, unspecified A E3 A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E3 A LEVOTHYROXINE d00278A Cr E05 Thyrotoxicosis [hyperthyroidism] A E3 A LINAGLIPTIN d07767A B E11 Type 2 diabetes mellitus A E3 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E3 A METOPROLOL d00134A Cr I99.9 Unspecified disorder of circulatory system A E3 A MIRABEGRON d07876A A R35 Polyuria A E3 A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E3 A SPIRONOLACTONE d00373A C[@ I51.9 Heart disease, unspecified A E3 A TRAZODONE d00395A Cr F32.9 Major depressive disorder, single episode, unspecified A E3 A DIFLUPREDNATE OPHTHALMIC d07298A B H26.9 Unspecified cataract A@ E3 A KETOROLAC OPHTHALMIC d03214A B H26.9 Unspecified cataract A@ E3 A OFLOXACIN OPHTHALMIC d03977A B H26.9 Unspecified cataract A@ E3 A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A@ E30 A ALPRAZOLAM d00168A C- F41.9 R25.1 Anxiety disorder, unspecified Tremor, unspecified A E30 A AMITRIPTYLINE d00146A B M79.2 Neuralgia and neuritis, unspecified A E30 A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E30 A HYDROXYCHLOROQUINE d00817A B L93 Lupus erythematosus A E30 A METOCLOPRAMIDE d00298A C K21 R11 Gastro-esophageal reflux disease Nausea and vomiting A E30 A NEBIVOLOL d05265A B I10 Essential (primary) hypertension A E30 A TOPIRAMATE d04115A C G40 G43 Epilepsy and recurrent seizures Migraine A E30 A TRAMADOL d03826A C G43 M19.9 Migraine Osteoarthritis, unspecified site A E3@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E3P A . . . E3` A IBANDRONATE d05357A C- M81 Osteoporosis without current pathological fracture A E3` A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E3p A . . . E3 A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A E3 A . . . E3 A FLUTICASONE d01296A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified AP E3 A FLUTICASONE; SALMETEROL d04611A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified AP E3 A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus AP E3 A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP E3 A SITAGLIPTIN d05896A CDp E11 Type 2 diabetes mellitus AP E3 A . . . E3 A . . . E3 A . . . E3 A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A@ E3 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E3 A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A@ E3 A TOBRAMYCIN OPHTHALMIC d03222A C H10 Conjunctivitis A@ E3 A ISOTRETINOIN d01245A B[ L70 Acne A E4 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ E4 A DILTIAZEM d00045A C[@ I10 Essential (primary) hypertension A@ E4 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A@ E4 A TAMSULOSIN d04121A C R39.9 Unspecified symptoms and signs involving the genitourinary system A@ E4 A CITALOPRAM d04332A B= F41.9 Anxiety disorder, unspecified A0 E4 A FLUTICASONE d01296A C J45 Asthma A0 E4 A MONTELUKAST d04289A C J45 Asthma A0 E4 A 99999 . . A E40 A . . . E4@ A POLYETHYLENE GLYCOL 3350 d05350A Bz K59.0 Constipation A E4P A ANTIDIABETIC AGENTS - UNSPECIFIED c00099A C E11 Type 2 diabetes mellitus A@ E4P A LISINOPRIL d00732A C- I51.9 Heart disease, unspecified A@ E4P A PIRFENIDONE d08031A A J98.9 Respiratory disorder, unspecified A@ E4P A RIVAROXABAN d07356A B[ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E4` A . . . E4p A ESOMEPRAZOLE d04749A C9 K30 Functional dyspepsia A E4 A . . . E4 A . . . E4 A RANITIDINE d00021A Dc K30 Functional dyspepsia A E4 A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A@ E4 A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E4 A HYDROCODONE d03075A C[@ M25.5 M54 Pain in joint Dorsalgia A@ E4 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E4 A . . . E4 A . . . E4 A . . . E4 A . . . E5 A . . . E5 A ALLOPURINOL d00023A C- M10.9 Gout, unspecified A` E5 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E5 A IBUPROFEN d00015A C M19.9 Osteoarthritis, unspecified site A` E5 A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E5 A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A` E5 A TERAZOSIN d00386A C I10 Essential (primary) hypertension A` E5 A . . . E50 A . . . E5@ A . . . E5P A . . . E5` A ACETAMINOPHEN; BUTALBITAL d03456A A R51 Headache A E5` A CYCLOBENZAPRINE d00963A A M79.1 Myalgia A E5p A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E5p A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E5p A FEBUXOSTAT d07397A C M1A Chronic gout A E5p A FUROSEMIDE d00070A B I10 Essential (primary) hypertension A E5p A METOPROLOL d00134A B I21.P Prevent heart attack/myocardial infarction A E5p A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E5p A RANITIDINE d00021A B K30 Functional dyspepsia A E5p A VALSARTAN d04113A C- I10 Essential (primary) hypertension A E5 A . . . E5 A . . . E5 A 99999 . . A0 E5 A MELOXICAM d04532A B M13 Other arthritis A0 E5 A TRAMADOL d03826A B M13 Other arthritis A0 E5 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E5 A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 E5 A VARENICLINE d05807A Ap F17.2 Nicotine dependence A0 E5 A . . . E5 A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A@ E5 A LOSARTAN d03821A D# I10 Essential (primary) hypertension A@ E5 A METOPROLOL d00134A D# I10 Essential (primary) hypertension A@ E5 A SIMVASTATIN d00746A D# E78.0 Pure hypercholesterolemia A@ E5 A . . . E5 A BRIMONIDINE OPHTHALMIC d04048A0 D* H40 Glaucoma A@ E5 A LATANOPROST OPHTHALMIC d04017A0 C H40 Glaucoma A@ E5 A TIMOLOL OPHTHALMIC d04037A0 D* H40 Glaucoma A@ E5 A ZOLPIDEM d00910A0 D* G47.0 Insomnia A@ E6 A . . . E6 A FORMOTEROL; MOMETASONE d07660A CDp J45 Asthma AP E6 A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site AP E6 A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia AP E6 A RANITIDINE d00021A C K30 Functional dyspepsia AP E6 A TIOTROPIUM d04829A CDp J45 Asthma AP E6 A . . . E60 A ALBUTEROL d00749A C- J45 Asthma A E6@ A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E6P A . . . E6` A AMLODIPINE d00689A C I63.P Prevent stroke Ap E6` A FUROSEMIDE d00070A C- R60.9 Edema, unspecified Ap E6` A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A C I10 Essential (primary) hypertension Ap E6` A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified Ap E6` A METOPROLOL d00134A C- I10 Essential (primary) hypertension Ap E6` A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E6` A SPIRONOLACTONE d00373A C R60.9 Edema, unspecified Ap E6p A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E6 A . . . E6 A . . . E6 A ALBUTEROL d00749A0 C J45 R06.2 Asthma Wheezing A E6 A APIXABAN d07804A0 C D75.9P Prevent blood clots A E6 A MONTELUKAST d04289A0 C"0 J45 Asthma A E6 A OMEPRAZOLE d00325A0 C[@ K21 Gastro-esophageal reflux disease A E6 A ROSUVASTATIN d04851A0 C E78.0 Pure hypercholesterolemia A E6 A SOTALOL d00371A0 C I48.9 Unspecified atrial fibrillation and atrial flutter A E6 A TORSEMIDE d03189A0 C R60.9 Edema, unspecified A E6 A TRAMADOL d03826A0 C- T14.9 Unspecified injury A E6 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E6 A GABAPENTIN d03182A CDp G25.81 Restless legs syndrome Ap E6 A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap E6 A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension Ap E6 A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E6 A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap E6 A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus Ap E6 A 99999 . . A E6 A . . . E6 A . . . E6 A . . . E7 A GLYBURIDE d00248A D R73 Elevated blood glucose level A0 E7 A METFORMIN d03807A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A0 E7 A PRAVASTATIN d00348A C- I70 Atherosclerosis A0 E7 A ANTI-INFECTIVES - UNSPECIFIED c00001A B B99.9 Unspecified infectious disease A E7 A CLINDAMYCIN d00043A Ap A49.9 Bacterial infection, unspecified A E70 A ATORVASTATIN d04105A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E7@ A . . . E7P A . . . E7` A . . . E7p A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E7p A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E7 A . . . E7 A ALBUTEROL d00749A B[ R06.2 Wheezing Ap E7 A AZELASTINE NASAL d04068A B R09.81 Nasal congestion Ap E7 A DONEPEZIL d04099A C F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia Ap E7 A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified Ap E7 A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E7 A QUETIAPINE d04220A C F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified Ap E7 A SERTRALINE d00880A C F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia Ap E7 A FENOFIBRATE d04286A0 C E78.0 Pure hypercholesterolemia AP E7 A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension AP E7 A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus AP E7 A PIOGLITAZONE d04442A0 C E11 Type 2 diabetes mellitus AP E7 A ROSUVASTATIN d04851A0 C E78.0 Pure hypercholesterolemia AP E7 A . . . E7 A AMLODIPINE d00689A D* I10 Essential (primary) hypertension A E7 A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A E7 A . . . E7 A . . . E7 A . . . E8 A IBUPROFEN d00015A C R51 Headache A E8 A . . . E8 A . . . E80 A LEVETIRACETAM d04499A CDp G40 Epilepsy and recurrent seizures A E8@ A . . . E8P A VALSARTAN d04113A B I10 N28.9 Essential (primary) hypertension Disorder of kidney and ureter, unspecified A E8` A . . . E8p A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E8 A . . . E8 A ALBUTEROL d00749A C- J20.9 J42 Acute bronchitis, unspecified Unspecified chronic bronchitis Ap E8 A ALPRAZOLAM d00168A C- F41.0 G47.0 R45 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Insomnia Symptoms and signs involving emotional state Ap E8 A CITALOPRAM d04332A B F41.9 Anxiety disorder, unspecified Ap E8 A IBUPROFEN d00015A A M25.5 Pain in joint Ap E8 A LEVOTHYROXINE d00278A C- E04 Other nontoxic goiter Ap E8 A TOPIRAMATE d04115A C9 F41.9 Anxiety disorder, unspecified Ap E8 A ZIPRASIDONE d04747A B F41.9 G47.0 Anxiety disorder, unspecified Insomnia Ap E8 A TACROLIMUS d03752A D= T86.9P Prevent transplanted organ and tissue rejection A E8 A . . . E8 A FAMOTIDINE d00141A C[@ K30 Functional dyspepsia A E8 A ALBUTEROL d00749A C J45 Asthma A` E8 A ALBUTEROL d00749A CDp J45 Asthma A` E8 A BECLOMETHASONE d00760A C9 J45 Asthma A` E8 A CETIRIZINE d03827A B[ T78.40 Allergy, unspecified A` E8 A FLUTICASONE NASAL d04283A B[ J30.2 J30.9 Other seasonal allergic rhinitis Allergic rhinitis, unspecified A` E8 A MONTELUKAST d04289A B[ J30.9 J45 Allergic rhinitis, unspecified Asthma A` E8 A . . . E8 A . . . E9 A . . . E9 A ESCITALOPRAM d04812A C[@ F41.9 Anxiety disorder, unspecified A E9 A . . . E90 A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease A E9@ A ALPRAZOLAM d00168A CDp G47.0 Insomnia A0 E9@ A OMEPRAZOLE d00325A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A0 E9@ A RANITIDINE d00021A C K30 Functional dyspepsia A0 E9P A . . . E9` A . . . E9p A . . . E9 A . . . E9 A . . . E9 A . . . E9 A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E9 A . . . E9 A . . . E9 A . . . E9 A . . . E: A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A0 E: A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A0 E: A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A0 E: A . . . E: A . . . E:0 A . . . E:@ A . . . E:P A . . . E:` A LISINOPRIL d00732A B E11.2 Type 2 diabetes mellitus with kidney complications A E:` A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E:p A . . . E: A . . . E: A ATORVASTATIN d04105A C- I10 Essential (primary) hypertension AP E: A CLOPIDOGREL d04258A C"0 R63 Symptoms and signs concerning food and fluid intake AP E: A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP E: A INSULIN REGULAR d04369A C- E11 Type 2 diabetes mellitus AP E: A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP E: A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E: A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A0 E: A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A0 E: A . . . E: A ACETAMINOPHEN; HYDROCODONE d03428A Cr M79.7 Fibromyalgia AP E: A AMITRIPTYLINE d00146A B[ F32.9 Major depressive disorder, single episode, unspecified AP E: A ATORVASTATIN d04105A B8 E78.0 Pure hypercholesterolemia AP E: A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E: A TOLTERODINE d04294A C N32.81 Overactive bladder AP E: A 99999 . . A E: A LANSOPRAZOLE d03828A A 99999 A E: A . . . E: A . . . E; A . . . E; A . . . E; A . . . E;0 A ALBUTEROL d00749A C J45 Asthma A E;@ A . . . E;P A . . . E;` A IRBESARTAN d04222A B I10 Essential (primary) hypertension A E;` A RANITIDINE d00021A B K27 Peptic ulcer, site unspecified A E;p A CETIRIZINE d03827A B[ T78.40 Allergy, unspecified A` E;p A CLOPIDOGREL d04258A B I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A` E;p A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E;p A LOVASTATIN d00280A B[ E78.0 Pure hypercholesterolemia A` E;p A SILDENAFIL d04299A C N52.9 Male erectile dysfunction, unspecified A` E;p A TAMSULOSIN d04121A B N40 Enlarged prostate A` E; A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E; A RIZATRIPTAN d04328A C G43 Migraine A E; A ATENOLOL d00004A D# I10 Essential (primary) hypertension A` E; A HYDROCHLOROTHIAZIDE d00253A D# R60.9 Edema, unspecified A` E; A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A` E; A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A` E; A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` E; A SITAGLIPTIN d05896A B[ E11 Type 2 diabetes mellitus A` E; A FLUCONAZOLE d00071A A0 B35 Dermatophytosis A E; A CITALOPRAM d04332A Bz F39 Unspecified mood [affective] disorder A E; A DESOGESTREL; ETHINYL ESTRADIOL d03782A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E; A CEFDINIR d04256A A0 55555 A E; A 77777 . . A E; A . . . E; A . . . E< A . . . E< A . . . E< A . . . E<0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E<0 A CIPROFLOXACIN d00011A D N39.0 Urinary tract infection, site not specified A@ E<0 A GABAPENTIN d03182A C50 M79.2 Neuralgia and neuritis, unspecified A@ E<0 A LINACLOTIDE d07902A Bz K59.0 Constipation A@ E<@ A OMEPRAZOLE; SODIUM BICARBONATE d05770A B K30 Functional dyspepsia A E
A MONTELUKAST d04289A Bz J30.9 Allergic rhinitis, unspecified A E> A . . . E> A . . . E>0 A . . . E>@ A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E>P A . . . E>` A . . . E>p A . . . E> A . . . E> A . . . E> A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E> A ATORVASTATIN d04105A C[@ E78.1 Pure hyperglyceridemia A E> A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A E> A FENOFIBRIC ACID d07371A C[@ E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A E> A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A E> A HYDROCHLOROTHIAZIDE d00253A Bz I10 Essential (primary) hypertension A E> A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E> A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A E> A SITAGLIPTIN d05896A C[@ E11 Type 2 diabetes mellitus A E> A . . . E> A . . . E> A . . . E> A GUANFACINE d00717A B F99 Mental disorder, not otherwise specified A E> A . . . E? A . . . E? A . . . E? A . . . E?0 A 99999 . . A0 E?0 A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A0 E?0 A INSULIN DETEMIR d05436A D E11 Type 2 diabetes mellitus A0 E?@ A . . . E?P A . . . E?` A . . . E?p A ESOMEPRAZOLE d04749A C- K21 Gastro-esophageal reflux disease A` E?p A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia A` E?p A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A` E?p A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E?p A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A` E?p A THYROID DESICCATED d00655A D,3 E03.9 Hypothyroidism, unspecified A` E? A . . . E? A . . . E? A AMITRIPTYLINE d00146A C- G47.0 Insomnia A E? A BACLOFEN d00967A C- M54 Dorsalgia A E? A DULOXETINE d05355A C[@ M79.1 Myalgia A E? A FINASTERIDE d00563A D N40 Enlarged prostate A E? A GABAPENTIN d03182A C M54 Dorsalgia A E? A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E? A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease A E? A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E? A TAMSULOSIN d04121A C N40 Enlarged prostate A E? A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A E? A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E? A . . . E? A . . . E? A . . . E? A . . . E@ A . . . E@ A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CP I10 Essential (primary) hypertension A E@ A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CP Z79.3 Long term (current) use of hormonal contraceptives A E@0 A . . . E@@ A . . . E@P A . . . E@` A . . . E@p A . . . E@ A . . . E@ A . . . E@ A ALBUTEROL d00749A C R05 Cough A` E@ A CEPHALEXIN d00096A A H66.9 Otitis media, unspecified A` E@ A CITALOPRAM d04332A C"0 F41.9 Anxiety disorder, unspecified A` E@ A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension A` E@ A HYDROCORTISONE; NEOMYCIN; POLYMYXIN B OTIC d03543A A H66.9 Otitis media, unspecified A` E@ A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A` E@ A BENZONATATE d00796A B R05 Cough A@ E@ A ISONIAZID d00101A Ap B99.9 Unspecified infectious disease A@ E@ A RIFAPENTINE d04327A Ap B99.9 Unspecified infectious disease A@ E@ A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A@ E@ A VALACYCLOVIR d03838A Ap B00.1 Herpesviral vesicular dermatitis A E@ A . . . E@ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E@ A FUROSEMIDE d00070A D I51.9 R60.9 Heart disease, unspecified Edema, unspecified A E@ A ISOSORBIDE MONONITRATE d00269A CDp I21.P R07.9 Prevent heart attack/myocardial infarction Chest pain, unspecified A E@ A LOSARTAN d03821A CDp I10 I21.P I50.9 Essential (primary) hypertension Prevent heart attack/myocardial infarction Heart failure, unspecified A E@ A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E@ A METOPROLOL d00134A C I50.9 Heart failure, unspecified A E@ A OMEPRAZOLE d00325A CDp B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E@ A SIMVASTATIN d00746A C E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A E@ A WARFARIN d00022A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E@ A . . . EA A . . . EA A ATORVASTATIN d04105A C- 99999 A` EA A AZATHIOPRINE d00024A CO 99999 A` EA A CILOSTAZOL d04382A CO 99999 A` EA A GABAPENTIN d03182A CO 99999 A` EA A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A` EA A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus A` EA A . . . EA0 A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A@ EA0 A ESCITALOPRAM d04812A C F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A@ EA0 A ESTRADIOL; NORETHINDRONE d04375A C- N95 Z79.890 Menopausal and other perimenopausal disorders Hormone replacement therapy A@ EA0 A ZOLPIDEM d00910A C G47.0 Insomnia A@ EA@ A NORETHINDRONE d00555A C Z79.3 Long term (current) use of hormonal contraceptives A EAP A . . . EA` A . . . EAp A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A EAp A MONTELUKAST d04289A C- J30.2 Other seasonal allergic rhinitis A EA A . . . EA A . . . EA A . . . EA A . . . EA A . . . EA A . . . EA A GLIPIZIDE d00246A A E11 Type 2 diabetes mellitus A0 EA A GLYBURIDE d00248A D E11 Type 2 diabetes mellitus A0 EA A LISINOPRIL d00732A D E11.2 Type 2 diabetes mellitus with kidney complications A0 EA A . . . EB A AMLODIPINE d00689A C[@ 99999 A` EB A CILOSTAZOL d04382A C- I70 Atherosclerosis A` EB A LEVOTHYROXINE d00278A Cr C80.1 Malignant (primary) neoplasm, unspecified A` EB A OMEPRAZOLE d00325A C- 99999 A` EB A TAMSULOSIN d04121A C- R39.1 Other difficulties with micturition A` EB A TRAMADOL d03826A C- M25.5 M79.6 Pain in joint Pain in limb, hand, foot, fingers and toes A` EB A . . . EB A . . . EB0 A ATENOLOL d00004A D I21.P Prevent heart attack/myocardial infarction A EB0 A FOSINOPRIL d00242A D I10 Essential (primary) hypertension A EB0 A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A EB0 A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A EB0 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A EB0 A PRAMIPEXOLE d04145A D G25.81 Restless legs syndrome A EB0 A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A EB0 A SITAGLIPTIN d05896A D E11 Type 2 diabetes mellitus A EB@ A TERBINAFINE d04012A Bz B35 Dermatophytosis A EBP A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A EB` A NORETHINDRONE d00555A B Z79.3 Long term (current) use of hormonal contraceptives A EBp A ANTIDIABETIC AGENTS - UNSPECIFIED c00099A Bz R73 Elevated blood glucose level AP EBp A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A D I10 Essential (primary) hypertension AP EBp A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus AP EBp A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP EBp A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP EB A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A@ EB A DIVALPROEX SODIUM d03833A C F31.9 Bipolar disorder, unspecified A@ EB A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified A@ EB A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A@ EB A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A EB A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A EB A . . . EB A . . . EB A CLOPIDOGREL d04258A C I21 I80.3 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Phlebitis and thrombophlebitis of lower extremities, unspecified A EB A GEMFIBROZIL d00245A Cr E78.0 Pure hypercholesterolemia A EB A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A EB A LISINOPRIL d00732A Cr I50.9 Heart failure, unspecified A EB A MELOXICAM d04532A Cr M54 Dorsalgia A EB A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A EB A METOPROLOL d00134A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A EB A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A EB A TERAZOSIN d00386A Cr N40 Enlarged prostate A EB A . . . EB A . . . EB A . . . EC A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension Ap EC A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia Ap EC A DAPAGLIFLOZIN d07928A B E11 Type 2 diabetes mellitus Ap EC A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus Ap EC A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension Ap EC A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap EC A VARDENAFIL d04893A C N52.9 Male erectile dysfunction, unspecified Ap EC A . . . EC A . . . EC0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` EC0 A INSULIN d00262A C E11 Type 2 diabetes mellitus A` EC0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A` EC0 A LOVASTATIN d00280A C E78.0P Prevent high cholesterol A` EC0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EC0 A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` EC@ A . . . ECP A . . . EC` A . . . ECp A . . . EC A . . . EC A . . . EC A . . . EC A . . . EC A . . . EC A FINASTERIDE d00563A CDp N40 Enlarged prostate A0 EC A GABAPENTIN d03182A B[ M54 Dorsalgia A0 EC A TAMSULOSIN d04121A CDp N40 Enlarged prostate A0 EC A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F84 F90 Pervasive developmental disorders Attention-deficit hyperactivity disorders A@ EC A BENZTROPINE d00175A C T88.7P Prevent drug side effect A@ EC A RISPERIDONE d03180A C F84 Pervasive developmental disorders A@ EC A TRAZODONE d00395A C G47.0 Insomnia A@ EC A . . . ED A . . . ED A DIVALPROEX SODIUM d03833A C- F20 F31.9 Schizophrenia Bipolar disorder, unspecified A0 ED A ERYTHROMYCIN d00046A C- 77777 A0 ED A PALIPERIDONE d06297A B F31.9 F91.9 Bipolar disorder, unspecified Conduct disorder, unspecified A0 ED A 99999 . . A ED0 A . . . ED@ A GUAIFENESIN; HYDROCODONE d03396A A R52 Pain, unspecified A ED@ A LISINOPRIL d00732A C 55555 A EDP A . . . ED` A . . . EDp A . . . ED A . . . ED A . . . ED A . . . ED A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A0 ED A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 ED A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 ED A . . . ED A ALBUTEROL d00749A Cr J44.9 R06.02 R06.2 Chronic obstructive pulmonary disease, unspecified Shortness of breath Wheezing A ED A . . . ED A IBUPROFEN d00015A CDp M54 R51 Dorsalgia Headache A EE A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CDp Z79.3 Long term (current) use of hormonal contraceptives A EE A . . . EE A . . . EE0 A . . . EE@ A ASPIRIN d00170A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A EE@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EE@ A CARVEDILOL d03847A C I10 Essential (primary) hypertension A EE@ A FUROSEMIDE d00070A C I51.9 K76.9 N28.9 Heart disease, unspecified Liver disease, unspecified Disorder of kidney and ureter, unspecified A EE@ A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A EE@ A INSULIN REGULAR d04369A C E11 Type 2 diabetes mellitus A EE@ A ISOSORBIDE MONONITRATE d00269A C R07.9 Chest pain, unspecified A EE@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EE@ A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A EE@ A TICAGRELOR d07721A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A EEP A . . . EE` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A EE` A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A EEp A 99999 . . A EEp A DEXAMETHASONE; DICLOFENAC; METHOCARBAMOL h00038A B[ M25.5 Pain in joint A EE A . . . EE A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EE A . . . EE A METRONIDAZOLE d00108A B N76.0 Acute vaginitis A EE A DIVALPROEX SODIUM d03833A C[@ G40 Epilepsy and recurrent seizures A0 EE A LITHIUM d00061A C- F31.9 Bipolar disorder, unspecified A0 EE A OLANZAPINE d04050A Dc F32.9 F99 Major depressive disorder, single episode, unspecified Mental disorder, not otherwise specified A0 EE A . . . EE A . . . EE A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A EF A BUPROPION d00181A B= F32.9 Major depressive disorder, single episode, unspecified A EF A . . . EF A . . . EF0 A CETIRIZINE d03827A Ap T78.40 Allergy, unspecified A EF@ A ALBUTEROL d00749A B J45 Asthma A EFP A . . . EF` A . . . EFp A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap EFp A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma Ap EFp A DORZOLAMIDE OPHTHALMIC d03805A Cr H40 Glaucoma Ap EFp A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma Ap EFp A LOSARTAN d03821A D I10 Essential (primary) hypertension Ap EFp A METOPROLOL d00134A D I10 Essential (primary) hypertension Ap EFp A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia Ap EF A . . . EF A . . . EF A . . . EF A . . . EF A . . . EF A . . . EF A . . . EF A . . . EG A . . . EG A . . . EG A . . . EG0 A . . . EG@ A . . . EGP A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A EGP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EG` A . . . EGp A . . . EG A SERTRALINE d00880A C- F41.9 Anxiety disorder, unspecified A EG A PREDNISOLONE d00084A A J42 Unspecified chronic bronchitis A EG A CALCITONIN d00598A C- M81 Osteoporosis without current pathological fracture A@ EG A DONEPEZIL d04099A CDp R41 Other symptoms and signs involving cognitive functions and awareness A@ EG A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A@ EG A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia A@ EG A . . . EG A . . . EG A . . . EG A . . . EG A . . . EH A . . . EH A AMOXICILLIN d00088A A J02 Acute pharyngitis A EH A . . . EH0 A . . . EH@ A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A EHP A . . . EH` A . . . EHp A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D% Z79.3 Long term (current) use of hormonal contraceptives A EH A . . . EH A . . . EH A . . . EH A ETONOGESTREL d04772A C ` Z79.3 Long term (current) use of hormonal contraceptives A EH A . . . EH A ENTECAVIR d05525A Bz B19 Unspecified viral hepatitis A EH A PANCRELIPASE d01002A Bz K92.9 Disease of digestive system, unspecified A EH A . . . EH A FUROSEMIDE d00070A C R60.9 Edema, unspecified A0 EH A INSULIN d00262A D# E11 Type 2 diabetes mellitus A0 EH A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 EI A AMIODARONE d00002A C[@ I49.9 Cardiac arrhythmia, unspecified A EI A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A EI A GEMFIBROZIL d00245A Cr E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A EI A MEMANTINE d04899A CDp G31.9 Degenerative disease of nervous system, unspecified A EI A METOPROLOL d00134A C[@ I49.9 Cardiac arrhythmia, unspecified A EI A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia A EI A RIVASTIGMINE d04537A CDp G30.9 Alzheimer's disease, unspecified A EI A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified A EI A WARFARIN d00022A C[@ D75.9P Prevent blood clots A EI A . . . EI A . . . EI0 A . . . EI@ A METOPROLOL d00134A Cr I49.9 Cardiac arrhythmia, unspecified A EIP A . . . EI` A . . . EIp A . . . EI A . . . EI A . . . EI A . . . EI A METHOCARBAMOL d00965A B M79.1 Myalgia A@ EI A MONTELUKAST d04289A C- J45 Asthma A@ EI A NORETHINDRONE d00555A C- Z79.3 Long term (current) use of hormonal contraceptives A@ EI A OMEPRAZOLE d00325A C K30 Functional dyspepsia A@ EI A . . . EI A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A EI A INSULIN ISOPHANE; INSULIN REGULAR d04374A C- E11 Type 2 diabetes mellitus A EI A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A EI A BACLOFEN d00967A0 CDp M62.83 M79.1 Muscle spasm Myalgia A EI A INSULIN ASPART d04697A CDp R73 Elevated blood glucose level A EI A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A EI A LOSARTAN d03821A Ei I51.9 Heart disease, unspecified A EI A METFORMIN d03807A B R73 Elevated blood glucose level A EI A METOPROLOL d00134A D I49.9 Cardiac arrhythmia, unspecified A EI A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EI A TRAMADOL d03826A B[ M54 Dorsalgia A EJ A . . . EJ A . . . EJ A . . . EJ0 A . . . EJ@ A . . . EJP A AMLODIPINE d00689A D I10 Essential (primary) hypertension A0 EJP A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A0 EJP A OLMESARTAN d04801A D I10 Essential (primary) hypertension A0 EJ` A . . . EJp A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A` EJp A CILOSTAZOL d04382A C"0 I70 Atherosclerosis A` EJp A DONEPEZIL d04099A C"0 F99 Mental disorder, not otherwise specified A` EJp A METOPROLOL d00134A D I10 Essential (primary) hypertension A` EJp A SERTRALINE d00880A C"0 F32.9 Major depressive disorder, single episode, unspecified A` EJp A TAMSULOSIN d04121A D N40 Enlarged prostate A` EJ A . . . EJ A . . . EJ A . . . EJ A IBUPROFEN d00015A A0 R50.9 Fever, unspecified A EJ A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A EJ A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A EJ A . . . EJ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A EJ A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A EJ A . . . EK A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A EK A . . . EK A . . . EK0 A . . . EK@ A . . . EKP A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A EKP A PAROXETINE d03157A B F41.9 Anxiety disorder, unspecified A EK` A . . . EKp A GASTROINTESTINAL AGENTS - UNSPECIFIED c00087A B= R10 Abdominal and pelvic pain A EK A . . . EK A ALBUTEROL d00749A B J44.9 Chronic obstructive pulmonary disease, unspecified A EK A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EK A BUDESONIDE; FORMOTEROL d04795A C J44.9 Chronic obstructive pulmonary disease, unspecified A EK A DIGOXIN d00210A D I50.9 Heart failure, unspecified A EK A ENALAPRIL d00013A D I10 Essential (primary) hypertension A EK A LABETALOL d00016A C- I10 Essential (primary) hypertension A EK A OXYCODONE d00329A CDp M54 Dorsalgia A EK A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A EK A TIOTROPIUM d04829A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A EK A TORSEMIDE d03189A D I10 Essential (primary) hypertension A EK A . . . EK A . . . EK A . . . EK A . . . EK A . . . EK A . . . EL A . . . EL A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 EL A METOPROLOL d00134A Cr 99999 A0 EL A ZOLPIDEM d00910A Dc G47.0 Insomnia A0 EL A OLOPATADINE OPHTHALMIC d04117A C- H10.1 Acute atopic conjunctivitis A EL0 A AMOXICILLIN d00088A Ap H66.9 J02 Otitis media, unspecified Acute pharyngitis A EL@ A . . . ELP A . . . EL` A CHLORZOXAZONE d00962A B M79.1 Myalgia A0 EL` A DULOXETINE d05355A Cr F41.9 Anxiety disorder, unspecified A0 EL` A SPIRONOLACTONE d00373A B L70 Acne A0 ELp A . . . EL A . . . EL A . . . EL A . . . EL A . . . EL A . . . EL A . . . EL A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A R05 Cough A EL A AMLODIPINE d00689A D# I10 Essential (primary) hypertension A EL A FLUTICASONE; SALMETEROL d04611A C- J81 Pulmonary edema A EL A GLIPIZIDE d00246A D# E11.P Prevent diabetes A EL A ISOSORBIDE MONONITRATE d00269A D# I21.P Prevent heart attack/myocardial infarction A EL A METOCLOPRAMIDE d00298A D# K21 Gastro-esophageal reflux disease A EL A METOPROLOL d00134A D# I10 Essential (primary) hypertension A EL A ONDANSETRON d00867A D# K58 Irritable bowel syndrome A EL A TRAMADOL d03826A B M54 T14.9 Dorsalgia Unspecified injury A EM A . . . EM A . . . EM A LEVOTHYROXINE d00278A C 99999 A EM0 A . . . EM@ A . . . EMP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EMP A CARVEDILOL d03847A C Z79 Long term (current) drug therapy A EMP A EVEROLIMUS d05626A C Z79 Long term (current) drug therapy A EMP A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A EMP A ISOSORBIDE MONONITRATE d00269A C I99.9 Unspecified disorder of circulatory system A EMP A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C A49.9 J18.9P Bacterial infection, unspecified Prevent pneumonia A EMP A TACROLIMUS d03752A C Z79 Long term (current) drug therapy A EMP A TRAZODONE d00395A C- G47.0 Insomnia A EM` A . . . EMp A AMOXICILLIN d00088A B L70 Acne A EM A . . . EM A . . . EM A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ EM A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A@ EM A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A B I10 Essential (primary) hypertension A@ EM A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ EM A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ EM A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ EM A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease A@ EM A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia A@ EM A ENALAPRIL d00013A C E11.2P Prevent diabetic kidney disease A0 EM A INSULIN ASPART d04697A B E11 Type 2 diabetes mellitus A0 EM A INSULIN ISOPHANE; INSULIN REGULAR d04374A Dc E11 Type 2 diabetes mellitus A0 EM A . . . EM A . . . EM A HYDROCORTISONE TOPICAL d03205A B[ L30.9 Dermatitis, unspecified A EN A . . . EN A . . . EN A . . . EN0 A . . . EN@ A . . . ENP A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction A` ENP A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified A` ENP A DOXAZOSIN d00726A C[@ N40 Enlarged prostate A` ENP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A` ENP A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A` ENP A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A` EN` A . . . ENp A . . . EN A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A EN A GLIMEPIRIDE d03864A DU E11 Type 2 diabetes mellitus A EN A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus A EN A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A EN A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A EN A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A EN A OMEPRAZOLE d00325A C- K30 Functional dyspepsia A EN A SITAGLIPTIN d05896A C[@ E11 Type 2 diabetes mellitus A EN A . . . EN A . . . EN A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP EN A ATORVASTATIN d04105A B E78.1 Pure hyperglyceridemia AP EN A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension AP EN A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP EN A SERTRALINE d00880A Dc F32.9 Major depressive disorder, single episode, unspecified AP EN A . . . EN A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A0 EN A METOPROLOL d00134A C[@ I21.P Prevent heart attack/myocardial infarction A0 EN A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A0 EN A 99999 . . A EN A MUPIROCIN TOPICAL d01267A B 55555 A EN A . . . EO A . . . EO A ALPRAZOLAM d00168A D G47.0 Insomnia A EO A AZITHROMYCIN d00091A A` K04.7 Periapical abscess without sinus A EO A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A EO A CEPHALEXIN d00096A . 99999 A EO A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A EO A IBUPROFEN d00015A Ei M25.5 M54 M79.6 Pain in joint Dorsalgia Pain in limb, hand, foot, fingers and toes A EO A METOPROLOL d00134A C[@ 99999 A EO A NITROGLYCERIN d00321A D R07.9 Chest pain, unspecified A EO A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A EO A . . . EO0 A ERYTHROMYCIN OPHTHALMIC d03973A Ap H10 Conjunctivitis A EO@ A . . . EOP A . . . EO` A . . . EOp A ACETAMINOPHEN; HYDROCODONE d03428A Dc M25.5 M54 T14.9 Pain in joint Dorsalgia Unspecified injury A` EOp A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A` EOp A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A` EOp A CYCLOBENZAPRINE d00963A Dc M54 M79.1 T14.9 Dorsalgia Myalgia Unspecified injury A` EOp A ESTRADIOL d00537A Cr N95 Menopausal and other perimenopausal disorders A` EOp A MEDROXYPROGESTERONE d00284A Cr N95 Menopausal and other perimenopausal disorders A` EO A . . . EO A . . . EO A . . . EO A TRIAMCINOLONE TOPICAL d03206A C- L20.9 Atopic dermatitis, unspecified A EO A CLONAZEPAM d00197A Bz G47.9 Sleep disorder, unspecified A EO A . . . EO A FLUTICASONE d01296A C- R06.2 Wheezing A EO A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A EO A CLOPIDOGREL d04258A D I21.P Prevent heart attack/myocardial infarction A EO A FINASTERIDE d00563A C[@ N40 Enlarged prostate A EO A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A EO A METFORMIN d03807A D E11 Type 2 diabetes mellitus A EO A METOPROLOL d00134A D I10 I20.9 Essential (primary) hypertension Angina pectoris, unspecified A EO A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus A EO A RAMIPRIL d00728A D I10 I21.P I50.9 Essential (primary) hypertension Prevent heart attack/myocardial infarction Heart failure, unspecified A EO A RIVAROXABAN d07356A B D75.9P Prevent blood clots A EP A . . . EP A ALBUTEROL d00749A A J45 Asthma A EP A FLUTICASONE d01296A A J45 Asthma A EP A CYCLOBENZAPRINE d00963A A M62.83 M79.1 Muscle spasm Myalgia A EP0 A . . . EP@ A . . . EPP A . . . EP` A . . . EPp A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A@ EPp A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ EPp A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A@ EPp A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A@ EP A ATORVASTATIN d04105A0 C- E78.0 Pure hypercholesterolemia A` EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A0 C- I10 Essential (primary) hypertension A` EP A LACOSAMIDE d07349A0 Bz G40 Epilepsy and recurrent seizures A` EP A METFORMIN d03807A0 C- E11 Type 2 diabetes mellitus A` EP A VENLAFAXINE d03181A0 C F32.9 Major depressive disorder, single episode, unspecified A` EP A ZONISAMIDE d04527A0 A@ G40 Epilepsy and recurrent seizures A` EP A . . . EP A . . . EP A . . . EP A . . . EP A . . . EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A EP A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A EP A FLUOCINOLONE TOPICAL d01293A B L98.9 Disorder of the skin and subcutaneous tissue, unspecified A EQ A DICLOFENAC TOPICAL d04722A0 B M19.9 M25.5 Osteoarthritis, unspecified site Pain in joint A` EQ A GABAPENTIN d03182A0 CDp M79.1 Myalgia A` EQ A LOSARTAN d03821A0 C I10 Essential (primary) hypertension A` EQ A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A` EQ A OXYBUTYNIN d00328A0 B R32 Unspecified urinary incontinence A` EQ A ROSUVASTATIN d04851A0 C- E78.0 Pure hypercholesterolemia A` EQ A . . . EQ A ALBUTEROL d00749A C- J45 Asthma A EQ A PREDNISONE d00350A Ap J45 Asthma A EQ0 A 99999 . . A EQ@ A . . . EQP A . . . EQ` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A EQp A . . . EQ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EQ A BENZONATATE d00796A B= J40 Bronchitis, not specified as acute or chronic A EQ A DEXTROMETHORPHAN; PROMETHAZINE d03360A A R05 Cough A EQ A GEMFIBROZIL d00245A B E78.0 Pure hypercholesterolemia A EQ A INSULIN ASPART d04697A B E11 Type 2 diabetes mellitus A EQ A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus A EQ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A EQ A METOPROLOL d00134A B[ R52 Pain, unspecified A EQ A OMEPRAZOLE d00325A C- K25.P Prevent gastric ulcer A EQ A VALSARTAN d04113A C- I21.P Prevent heart attack/myocardial infarction A EQ A FLUTICASONE NASAL d04283A CP J30.2 Other seasonal allergic rhinitis Ap EQ A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus Ap EQ A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma Ap EQ A OMEPRAZOLE d00325A CP K21 Gastro-esophageal reflux disease Ap EQ A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia Ap EQ A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus Ap EQ A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma Ap EQ A AMITRIPTYLINE d00146A B= R51 Headache A EQ A . . . EQ A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A EQ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A EQ A . . . EQ A . . . EQ A . . . ER A . . . ER A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CP I10 Essential (primary) hypertension A ER A TOPIRAMATE d04115A CP G43 Migraine A ER A . . . ER0 A . . . ER@ A . . . ERP A CYCLOBENZAPRINE d00963A C- G47.9 Sleep disorder, unspecified AP ERP A LANSOPRAZOLE d03828A Ei K30 Functional dyspepsia AP ERP A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified AP ERP A TRAMADOL d03826A C M54 Dorsalgia AP ERP A VALSARTAN d04113A C I10 Essential (primary) hypertension AP ER` A . . . ERp A ACETAMINOPHEN; HYDROCODONE d03428A C- G43 M25.5 M54 Migraine Pain in joint Dorsalgia A@ ERp A ALPRAZOLAM d00168A C F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A@ ERp A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ ERp A IBUPROFEN d00015A C- M25.5 M54 T14.9 Pain in joint Dorsalgia Unspecified injury A@ ER A FINASTERIDE d00563A C N40 Enlarged prostate A0 ER A PROPRANOLOL d00032A C G25.0 R25.1 Essential tremor Tremor, unspecified A0 ER A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 ER A IBUPROFEN d00015A C M06.9 M19.9 M54 Rheumatoid arthritis, unspecified Osteoarthritis, unspecified site Dorsalgia A ER A LOSARTAN d03821A C I10 Essential (primary) hypertension A ER A . . . ER A . . . ER A CETIRIZINE d03827A B= L23 Allergic contact dermatitis A ER A IBUPROFEN d00015A A0 J02.0 Streptococcal pharyngitis A ER A . . . ER A . . . ER A . . . ES A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 ES A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 ES A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 ES A . . . ES A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A ES0 A BUPROPION d00181A B F17.2 Nicotine dependence A ES@ A . . . ESP A . . . ES` A . . . ESp A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ ESp A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A@ ESp A METFORMIN d03807A B R73 Elevated blood glucose level A@ ESp A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ ES A . . . ES A AMITRIPTYLINE d00146A A M54 Dorsalgia A0 ES A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A0 ES A MELOXICAM d04532A A M79.1 T14.9 Myalgia Unspecified injury A0 ES A LEVOTHYROXINE d00278A D,3 E03.9 Hypothyroidism, unspecified A ES A VALACYCLOVIR d03838A B B02 Zoster [herpes zoster] A ES A . . . ES A . . . ES A AMLODIPINE d00689A B I10 Essential (primary) hypertension A ES A METFORMIN d03807A C E11 Type 2 diabetes mellitus A ES A . . . ET A RANITIDINE d00021A B K30 Functional dyspepsia A ET A ALBUTEROL d00749A C J45 Asthma A0 ET A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 ET A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 ET A . . . ET0 A . . . ET@ A . . . ETP A AZILSARTAN d07754A B I10 Essential (primary) hypertension A0 ETP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 ETP A METOPROLOL d00134A C"@ 99999 A0 ET` A ALBUTEROL d00749A CDp J45 R06.2 Asthma Wheezing A ET` A FLUTICASONE d01296A CDp J45 R06.2 Asthma Wheezing A ETp A . . . ET A . . . ET A . . . ET A . . . ET A CLARITHROMYCIN d00097A A A49.9 Bacterial infection, unspecified A ET A ENALAPRIL d00013A C- I10 Essential (primary) hypertension A ET A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A ET A . . . ET A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 ET A INSULIN ISOPHANE; INSULIN REGULAR d04374A D E11 Type 2 diabetes mellitus A0 ET A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 EU A . . . EU A . . . EU A . . . EU0 A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified A EU@ A CELECOXIB d04380A C R52 Pain, unspecified A` EU@ A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A` EU@ A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness A` EU@ A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified A` EU@ A OMEPRAZOLE d00325A C K30 Functional dyspepsia A` EU@ A PREDNISONE d00350A C 55555 A` EUP A . . . EU` A . . . EUp A . . . EU A . . . EU A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ EU A CLOPIDOGREL d04258A C[@ D75.9P I21.P Z79.0 Prevent blood clots Prevent heart attack/myocardial infarction Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ EU A DILTIAZEM d00045A C- I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A@ EU A TAMSULOSIN d04121A C R35 Polyuria A@ EU A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A EU A CITALOPRAM d04332A . F32.9 Major depressive disorder, single episode, unspecified A EU A . . . EU A . . . EU A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A Ei G43 Migraine A EU A ARIPIPRAZOLE d04825A Ei F32.9 Major depressive disorder, single episode, unspecified A EU A CLONAZEPAM d00197A CDp F41.9 Anxiety disorder, unspecified A EU A DEXTROAMPHETAMINE d00804A Ei F43.1 Post-traumatic stress disorder (PTSD) A EU A ETHINYL ESTRADIOL; ETONOGESTREL d04773A C[@ G43 Migraine A EU A NORTRIPTYLINE d00144A Ei F32.9 Major depressive disorder, single episode, unspecified A EU A RIZATRIPTAN d04328A C[@ G43 Migraine A EU A TIZANIDINE d04102A C- G47.9 Sleep disorder, unspecified A EU A . . . EU A . . . EV A . . . EV A ESOMEPRAZOLE d04749A Cr K30 Functional dyspepsia A0 EV A HYDROCHLOROTHIAZIDE d00253A B= R60.9 Edema, unspecified A0 EV A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 EV A CYCLOBENZAPRINE d00963A Ap 99999 AP EV A IRON SUCROSE d04725A B F43.9 G47.0 Reaction to severe stress, unspecified Insomnia AP EV A NAPROXEN d00019A B= M54 Dorsalgia AP EV A RANITIDINE d00021A Ap K25.P Prevent gastric ulcer AP EV A TRAMADOL d03826A Ap M54 Dorsalgia AP EV0 A . . . EV@ A . . . EVP A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified AP EVP A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified AP EVP A IPRATROPIUM d00265A C J44.9 Chronic obstructive pulmonary disease, unspecified AP EVP A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP EVP A PREDNISONE d00350A C J44.9 Chronic obstructive pulmonary disease, unspecified AP EV` A . . . EVp A AMLODIPINE; ATORVASTATIN d05048A C E78.0 Pure hypercholesterolemia AP EVp A EXENATIDE d05529A CDp E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP EVp A LISINOPRIL d00732A C E11.2 Type 2 diabetes mellitus with kidney complications AP EVp A MESALAMINE d01031A C"@ K51 K92.9 Ulcerative colitis Disease of digestive system, unspecified AP EVp A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP EV A . . . EV A . . . EV A . . . EV A ALBUTEROL d00749A B R05 R06.02 Cough Shortness of breath A EV A . . . EV A . . . EV A . . . EV A AZITHROMYCIN d00091A B 99999 AP EV A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified AP EV A GALANTAMINE d04750A B= R41 Other symptoms and signs involving cognitive functions and awareness AP EV A PANTOPRAZOLE d04514A B= K92.9 Disease of digestive system, unspecified AP EV A TIOTROPIUM d04829A C J40 Bronchitis, not specified as acute or chronic AP EW A . . . EW A . . . EW A ALBUTEROL d00749A Cr J45 Asthma A@ EW A ALBUTEROL d00749A C J45 Asthma A@ EW A FLUTICASONE d01296A C[@ J45 Asthma A@ EW A MONTELUKAST d04289A C- R06.2 Wheezing A@ EW0 A LISINOPRIL d00732A A I10 Essential (primary) hypertension A0 EW0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 EW0 A SIMVASTATIN d00746A A E78.0 Pure hypercholesterolemia A0 EW@ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension AP EW@ A MEMANTINE d04899A B G31.9 Degenerative disease of nervous system, unspecified AP EW@ A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia AP EW@ A TRAMADOL d03826A Cr M25.5 M54 R51 Pain in joint Dorsalgia Headache AP EW@ A ZOLPIDEM d00910A B= G47.0 Insomnia AP EWP A . . . EW` A . . . EWp A . . . EW A AMLODIPINE; VALSARTAN d06662A C I10 Essential (primary) hypertension A EW A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A EW A ALENDRONATE d03849A Cr M85.9 Disorders of bone density and structure, unspecified A EW A . . . EW A . . . EW A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension Ap EW A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia Ap EW A INSULIN ASPART d04697A Dc E11 Type 2 diabetes mellitus Ap EW A INSULIN ISOPHANE (NPH) d04370A Dc E11 Type 2 diabetes mellitus Ap EW A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease Ap EW A TRAMADOL d03826A Dc M19.9 Osteoarthritis, unspecified site Ap EW A VALSARTAN d04113A Dc I10 Essential (primary) hypertension Ap EW A . . . EW A . . . EW A BUPROPION d00181A Bz F32.9 Major depressive disorder, single episode, unspecified A EW A DESOGESTREL; ETHINYL ESTRADIOL d03782A C Z79.3 Long term (current) use of hormonal contraceptives A EX A . . . EX A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A EX A . . . EX0 A . . . EX@ A . . . EXP A . . . EX` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 EX` A ATENOLOL d00004A D& I10 Essential (primary) hypertension A0 EX` A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A0 EXp A CYCLOBENZAPRINE d00963A C[@ M62.83 Muscle spasm A@ EXp A HYDROXYZINE d00907A C[@ F41.9 Anxiety disorder, unspecified A@ EXp A NAPROXEN d00019A C[@ M79.1 Myalgia A@ EXp A ZOLPIDEM d00910A C G47.0 Insomnia A@ EX A 99999 . . A EX A . . . EX A . . . EX A . . . EX A . . . EX A AMLODIPINE; BENAZEPRIL d03829A Cr I51.9P Prevent heart disease A EX A DEXAMETHASONE; NEOMYCIN; POLYMYXIN B OPHTHALMIC d03537A C- H57.9 Unspecified disorder of eye and adnexa A EX A FLUOROMETHOLONE OPHTHALMIC d03227A Cr H57.9 Unspecified disorder of eye and adnexa A EX A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A EX A LATANOPROST OPHTHALMIC d04017A C H57.9 Unspecified disorder of eye and adnexa A EX A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A EX A OFLOXACIN OPHTHALMIC d03977A C- H57.9 Unspecified disorder of eye and adnexa A EX A ROSUVASTATIN d04851A Ei E78.0 Pure hypercholesterolemia A EX A TIMOLOL OPHTHALMIC d04037A C H57.9 Unspecified disorder of eye and adnexa A EX A . . . EX A . . . EY A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia Ap EY A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction Ap EY A EZETIMIBE d04824A C- E78.0 Pure hypercholesterolemia Ap EY A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified Ap EY A MESALAMINE d01031A C K50 Crohn's disease [regional enteritis] Ap EY A METOPROLOL d00134A C- I49.9 Cardiac arrhythmia, unspecified Ap EY A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified Ap EY A . . . EY A FAMOTIDINE d00141A C K30 Functional dyspepsia A0 EY A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 EY A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 EY0 A . . . EY@ A . . . EYP A ALBUTEROL d00749A A@ J40 Bronchitis, not specified as acute or chronic A0 EYP A CEFDINIR d04256A Ap H66.9 Otitis media, unspecified A0 EYP A PREDNISOLONE d00084A AP J40 Bronchitis, not specified as acute or chronic A0 EY` A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A0 EY` A IBANDRONATE d05357A C M81 Osteoporosis without current pathological fracture A0 EY` A IRBESARTAN d04222A Ei I10 Essential (primary) hypertension A0 EYp A . . . EY A ALBUTEROL d00749A C- R06.2 Wheezing Ap EY A AMLODIPINE d00689A C- I10 Essential (primary) hypertension Ap EY A CLORAZEPATE d00198A A0 F41.9 Anxiety disorder, unspecified Ap EY A HOMATROPINE; HYDROCODONE d03340A C R05 Cough Ap EY A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified Ap EY A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease Ap EY A ZOLPIDEM d00910A C- G47.9 Sleep disorder, unspecified Ap EY A . . . EY A . . . EY A . . . EY A . . . EY A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A EY A ACETAMINOPHEN; HYDROCODONE d03428A Cr M19.9 Osteoarthritis, unspecified site A EY A ALBUTEROL d00749A B J20.9 Acute bronchitis, unspecified A EY A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A EY A CEPHALEXIN d00096A A J01.9 Acute sinusitis, unspecified A EY A ESOMEPRAZOLE d04749A Cr K92.9 Disease of digestive system, unspecified A EY A FLUTICASONE NASAL d04283A B J30.9 Allergic rhinitis, unspecified A EY A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Cr I10 Essential (primary) hypertension A EY A INSULIN ISOPHANE (NPH) d04370A C E11 Type 2 diabetes mellitus A EY A PANCRELIPASE d01002A Cr K92.9 Disease of digestive system, unspecified A EY A PREGABALIN d05508A Cr M62.83 Muscle spasm A EY A ATORVASTATIN d04105A C9 E78.0 Pure hypercholesterolemia A EY A DILTIAZEM d00045A B I51.9 Heart disease, unspecified A EY A FUROSEMIDE d00070A Bz R60.9 Edema, unspecified A EY A LOSARTAN d03821A D* I10 Essential (primary) hypertension A EY A METFORMIN d03807A C- R73 Elevated blood glucose level A EY A METOPROLOL d00134A C- I51.9 R25.1 Heart disease, unspecified Tremor, unspecified A EY A RALOXIFENE d04261A Dc M81 Osteoporosis without current pathological fracture A EY A RIVAROXABAN d07356A B Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A EZ A . . . EZ A ALBUTEROL d00749A CDp J45 Asthma A EZ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A EZ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A EZ A FLUTICASONE NASAL d04283A Bz J30.2 Other seasonal allergic rhinitis A EZ A GUANFACINE d00717A C- F90 Attention-deficit hyperactivity disorders A EZ A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A EZ A RISPERIDONE d03180A C- F90 Attention-deficit hyperactivity disorders A EZ A TRAZODONE d00395A C- G47.0 Insomnia A EZ A . . . EZ0 A CYPROTERONE; ETHINYL ESTRADIOL h00037A C N92 Excessive, frequent and irregular menstruation A EZ@ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A0 EZ@ A CETIRIZINE d03827A B T78.40 Allergy, unspecified A0 EZ@ A NAPROXEN d00019A B M13 Other arthritis A0 EZP A . . . EZ` A ATENOLOL d00004A C 99999 A@ EZ` A ENALAPRIL d00013A D I51.9 Heart disease, unspecified A@ EZ` A FENOFIBRATE d04286A Cr I20.9 Angina pectoris, unspecified A@ EZ` A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ EZp A . . . EZ A . . . EZ A . . . EZ A . . . EZ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A EZ A CEPHALEXIN d00096A C- N30 Cystitis A EZ A FINASTERIDE d00563A CDp R39.9 Unspecified symptoms and signs involving the genitourinary system A EZ A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A EZ A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A EZ A MECLIZINE d00859A C R42 Dizziness and giddiness A EZ A METOPROLOL d00134A C[@ 99999 A EZ A NITROGLYCERIN d00321A D"8 R07.9 Chest pain, unspecified A EZ A OMEPRAZOLE d00325A C[@ R12 Heartburn A EZ A OXYCODONE d00329A C M54 Dorsalgia A EZ A PREDNISONE d00350A A@ J81 R06.9 Pulmonary edema Unspecified abnormalities of breathing A EZ A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A EZ A WARFARIN d00022A C- D75.9P Prevent blood clots A EZ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C"0 I10 Essential (primary) hypertension A EZ A . . . EZ A . . . EZ A . . . E[ A DIAZEPAM d00148A CDp F32.9 Major depressive disorder, single episode, unspecified A E[ A FLUTICASONE NASAL d04283A CDp R09.81 Nasal congestion A E[ A FORMOTEROL; MOMETASONE d07660A Ap J45 Asthma A E[ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E[ A LISINOPRIL d00732A Ap I10 Essential (primary) hypertension A E[ A METFORMIN d03807A B E11.P Prevent diabetes A E[ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E[ A MONTELUKAST d04289A C[@ J45 Asthma A E[ A OMEPRAZOLE d00325A B= K27 Peptic ulcer, site unspecified A E[ A WARFARIN d00022A C D75.9P Prevent blood clots A E[ A CITALOPRAM d04332A C[@ F32.9 Major depressive disorder, single episode, unspecified A E[ A IMMUNOLOGIC AGENTS - UNSPECIFIED c00254A D G99.8 Other specified disorders of nervous system in diseases classified elsewhere A E[ A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A@ E[ A HYDROXYCHLOROQUINE d00817A D L93 Lupus erythematosus A@ E[ A MONTELUKAST d04289A CDp J30.2 Other seasonal allergic rhinitis A@ E[ A RANITIDINE d00021A C K21 T78.40 Gastro-esophageal reflux disease Allergy, unspecified A@ E[0 A . . . E[@ A ARIPIPRAZOLE d04825A C F39 Unspecified mood [affective] disorder A@ E[@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E[@ A PAROXETINE d03157A D F31.9 F41.9 Bipolar disorder, unspecified Anxiety disorder, unspecified A@ E[@ A TOPIRAMATE d04115A C R25.1 Tremor, unspecified A@ E[P A . . . E[` A ALBUTEROL d00749A C J45 Asthma A E[` A FLUTICASONE d01296A C J45 Asthma A E[p A . . . E[ A . . . E[ A . . . E[ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E[ A GLIPIZIDE d00246A Ap E11 Type 2 diabetes mellitus A` E[ A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A` E[ A MEMANTINE d04899A C G31.8 Other specified degenerative diseases of nervous system A` E[ A METFORMIN d03807A Ap E11 Type 2 diabetes mellitus A` E[ A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A` E[ A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension A0 E[ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A0 E[ A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension A0 E[ A . . . E[ A . . . E[ A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A E[ A EXENATIDE d05529A B E11 Type 2 diabetes mellitus A` E[ A FLUOXETINE d00236A C 55555 A` E[ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A` E[ A MONTELUKAST d04289A C- J30.2 Other seasonal allergic rhinitis A` E[ A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease A` E[ A ROPINIROLE d04215A C G25.81 Restless legs syndrome A` E\ A DABIGATRAN d07137A Cr I26 Pulmonary embolism A E\ A DICLOFENAC d00848A Cr M79.1 Myalgia A E\ A ESOMEPRAZOLE d04749A Cr K30 Functional dyspepsia A E\ A FENOFIBRIC ACID d07371A Cr E78.0 Pure hypercholesterolemia A E\ A LIDOCAINE TOPICAL d00683A Cr M79.2 Neuralgia and neuritis, unspecified A E\ A LIRAGLUTIDE d07466A Cr E11 Type 2 diabetes mellitus A E\ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E\ A MOMETASONE NASAL d04223A Cr J30.9 Allergic rhinitis, unspecified A E\ A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus A E\ A TEMAZEPAM d00384A Cr G47.0 Insomnia A E\ A VERAPAMIL d00048A Cr I49.9 Cardiac arrhythmia, unspecified A E\ A CITALOPRAM d04332A C F32.9 F41.9 F43.1 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A@ E\ A CYCLOBENZAPRINE d00963A C M54 M79.1 Dorsalgia Myalgia A@ E\ A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A@ E\ A HYDROCODONE d03075A C- M25.5 M54 Pain in joint Dorsalgia A@ E\ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E\ A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A@ E\ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A@ E\ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E\0 A . . . E\@ A . . . E\P A ACETAMINOPHEN; HYDROCODONE d03428A Cr M25.5 M54 M79.6 Pain in joint Dorsalgia Pain in limb, hand, foot, fingers and toes AP E\P A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension AP E\P A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E\P A PREDNISONE d00350A A R42 Dizziness and giddiness AP E\P A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia AP E\` A ALBUTEROL d00749A C"0 R06.2 Wheezing A E\p A . . . E\ A . . . E\ A . . . E\ A DILTIAZEM d00045A B= I10 Essential (primary) hypertension A E\ A . . . E\ A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A E\ A ETHINYL ESTRADIOL; ETHYNODIOL d03388A C Z79.3 Long term (current) use of hormonal contraceptives A0 E\ A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A0 E\ A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified A0 E\ A . . . E\ A LISINOPRIL d00732A AP I10 Essential (primary) hypertension A E\ A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E] A CEPHALEXIN d00096A B= B99.9 Unspecified infectious disease A E] A . . . E] A . . . E]0 A DOCUSATE d01021A B* K59.0 Constipation A@ E]0 A IBUPROFEN d00015A B* G89 Pain, not elsewhere classified A@ E]0 A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ E]0 A METOPROLOL d00134A B I10 Essential (primary) hypertension A@ E]@ A . . . E]P A . . . E]` A . . . E]p A AZITHROMYCIN d00091A A J02 R05 Acute pharyngitis Cough A E]p A IBUPROFEN d00015A A@ R50.9 Fever, unspecified A E] A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E] A . . . E] A . . . E] A . . . E] A . . . E] A . . . E] A . . . E] A . . . E^ A . . . E^ A . . . E^ A ATORVASTATIN d04105A C- I21.P Prevent heart attack/myocardial infarction AP E^ A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia AP E^ A INSULIN ISOPHANE (NPH) d04370A Dc R73 Elevated blood glucose level AP E^ A INSULIN REGULAR d04369A C- R73 Elevated blood glucose level AP E^ A METFORMIN d03807A D* E11 Type 2 diabetes mellitus AP E^0 A . . . E^@ A . . . E^P A . . . E^` A . . . E^p A . . . E^ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E^ A . . . E^ A . . . E^ A . . . E^ A . . . E^ A . . . E^ A AMOXICILLIN d00088A B K04.7P Prevent tooth infection A E^ A TRAMADOL d03826A B M79.1 Myalgia A E^ A . . . E_ A LEVOTHYROXINE d00278A Cr 99999 AP E_ A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E_ A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E_ A SIMVASTATIN d00746A C I21.P Prevent heart attack/myocardial infarction AP E_ A WARFARIN d00022A C Z95 Presence of cardiac and vascular implants and grafts AP E_ A . . . E_ A ALLOPURINOL d00023A B[ M10.9 Gout, unspecified Ap E_ A ATORVASTATIN d04105A CP I63.P Prevent stroke Ap E_ A CLOPIDOGREL d04258A CP 55555 Ap E_ A FUROSEMIDE d00070A B[ R60.9 Edema, unspecified Ap E_ A LOSARTAN d03821A D I10 Essential (primary) hypertension Ap E_ A METFORMIN d03807A B[ R73 Elevated blood glucose level Ap E_ A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E_0 A . . . E_@ A . . . E_P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E_` A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 E_` A ESOMEPRAZOLE d04749A C- K21 Gastro-esophageal reflux disease A0 E_` A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CDp I10 Essential (primary) hypertension A0 E_p A . . . E_ A IBUPROFEN d00015A Ap T14.9 Unspecified injury A E_ A ALLOPURINOL d00023A C M1A Chronic gout Ap E_ A ASPIRIN d00170A C[@ D75.9P Prevent blood clots Ap E_ A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E_ A NAPROXEN d00019A C M54 Dorsalgia Ap E_ A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease Ap E_ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E_ A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E_ A ESCITALOPRAM d04812A A F41.9 Anxiety disorder, unspecified A E_ A . . . E_ A . . . E_ A . . . E_ A METHIMAZOLE d00290A D E05 Thyrotoxicosis [hyperthyroidism] A0 E_ A OLMESARTAN d04801A CP I10 Essential (primary) hypertension A0 E_ A VERAPAMIL d00048A Dc I10 Essential (primary) hypertension A0 E_ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E` A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ E` A CARVEDILOL d03847A CDp I48.9 Unspecified atrial fibrillation and atrial flutter A@ E` A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E` A . . . E` A ALBUTEROL d00749A C- J45 Asthma AP E` A CEFDINIR d04256A A J09 Influenza due to certain identified influenza viruses AP E` A FLUTICASONE; SALMETEROL d04611A C J45 Asthma AP E` A MONTELUKAST d04289A C- J45 Asthma AP E` A PREDNISOLONE d00084A AP J42 Unspecified chronic bronchitis AP E`0 A . . . E`@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E`@ A ZOLPIDEM d00910A B G47.0 Insomnia A E`P A TAMOXIFEN d00381A B C50.P Prevent barest cancer A E`` A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E`` A CLONIDINE d00044A B[ I10 Essential (primary) hypertension A E`` A CLOPIDOGREL d04258A C[@ D75.9P Prevent blood clots A E`` A LABETALOL d00016A C[@ I10 Essential (primary) hypertension A E`` A MYCOPHENOLATE MOFETIL d03839A C[@ T86.9P Prevent transplanted organ and tissue rejection A E`` A NIFEDIPINE d00051A C[@ I10 I20.9 Essential (primary) hypertension Angina pectoris, unspecified A E`` A OXYCODONE d00329A C[@ M25.5 Pain in joint A E`` A PREDNISONE d00350A C[@ T86.9P Prevent transplanted organ and tissue rejection A E`` A TACROLIMUS d03752A C[@ T86.9P Prevent transplanted organ and tissue rejection A E`` A TAMSULOSIN d04121A B[ N40 Enlarged prostate A E`p A . . . E` A ALBUTEROL d00749A D J45 Asthma A E` A CEFDINIR d04256A A N39.0 Urinary tract infection, site not specified A0 E` A CEFDINIR d04256A A N39.0 Urinary tract infection, site not specified A0 E` A CEFIXIME d00072A A@ N39.0 Urinary tract infection, site not specified A0 E` A . . . E` A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E` A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E` A . . . E` A . . . E` A . . . E` A 99999 . . A Ea A . . . Ea A ATENOLOL d00004A0 C 99999 A Ea A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A Ea A FENOFIBRATE d04286A0 C E78.0 Pure hypercholesterolemia A Ea A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A Ea A LEVOTHYROXINE d00278A0 C E07.9 Disorder of thyroid, unspecified A Ea A LOSARTAN d03821A0 C I10 Essential (primary) hypertension A Ea A NAPROXEN d00019A0 C T14.9 Unspecified injury A Ea A NORTRIPTYLINE d00144A0 C F32.9 Major depressive disorder, single episode, unspecified A Ea A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A0 C E78.0 Pure hypercholesterolemia A Ea A RISEDRONATE d04300A0 C M81.P Prevent bone loss/osteoporosis A Ea A SITAGLIPTIN d05896A0 C E11 Type 2 diabetes mellitus A Ea A . . . Ea0 A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A Ea@ A SERTRALINE d00880A C9 F42 Obsessive-compulsive disorder A EaP A . . . Ea` A CARISOPRODOL d00960A D M54 Dorsalgia A Eap A . . . Ea A . . . Ea A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A Ea A LEVOTHYROXINE d00278A CP E07.9 Disorder of thyroid, unspecified A Ea A . . . Ea A . . . Ea A . . . Ea A . . . Ea A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A@ Ea A FINASTERIDE d00563A C N40 Enlarged prostate A@ Ea A OMEPRAZOLE d00325A C- K27 Peptic ulcer, site unspecified A@ Ea A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A@ Eb A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ Eb A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ Eb A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ Eb A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A@ Eb A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A Eb A DOXAZOSIN d00726A C- I10 N40 Essential (primary) hypertension Enlarged prostate A Eb A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A Eb A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Eb A LIOTHYRONINE d00658A C E03.9 Hypothyroidism, unspecified A Eb A LOSARTAN d03821A C- I10 Essential (primary) hypertension A Eb A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Eb A MONTELUKAST d04289A C- L50 Urticaria A Eb A NAPROXEN d00019A B[ M13 Other arthritis A Eb A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A Eb A . . . Eb0 A . . . Eb@ A . . . EbP A DICLOFENAC d00848A CDp M06.9 Rheumatoid arthritis, unspecified A0 EbP A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A0 EbP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 Eb` A . . . Ebp A . . . Eb A . . . Eb A . . . Eb A . . . Eb A . . . Eb A ALBUTEROL d00749A B* J45 Asthma A Eb A . . . Eb A AMPHETAMINE d00803A C F90 Attention-deficit hyperactivity disorders A Eb A IBUPROFEN d00015A C- G43 Migraine A Eb A . . . Ec A ALBUTEROL; IPRATROPIUM d04066A Ei J45 Asthma A Ec A ASPIRIN; DIPYRIDAMOLE d04497A Ei Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A Ec A CARVEDILOL d03847A Ei 99999 A Ec A CLINDAMYCIN d00043A Ei A49.9 Bacterial infection, unspecified A Ec A FAMOTIDINE d00141A Ei 99999 A Ec A FLUOXETINE d00236A Ei 99999 A Ec A FLUTICASONE; SALMETEROL d04611A Ei J42 Unspecified chronic bronchitis A Ec A GABAPENTIN d03182A Ei M79.2 Neuralgia and neuritis, unspecified A Ec A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified A Ec A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension A Ec A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A Ec A ALFUZOSIN d04797A D R35 Polyuria AP Ec A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP Ec A METOPROLOL d00134A D I10 Essential (primary) hypertension AP Ec A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified AP Ec A ZOLPIDEM d00910A D G47.0 Insomnia AP Ec A . . . Ec0 A . . . Ec@ A . . . EcP A . . . Ec` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C 99999 A Ec` A METOPROLOL d00134A C I10 Essential (primary) hypertension A Ecp A . . . Ec A TESTOSTERONE d00558A C E29.1 Testicular hypofunction A Ec A . . . Ec A . . . Ec A . . . Ec A . . . Ec A MOMETASONE d05262A Cr J45 Asthma A0 Ec A MONTELUKAST d04289A C J45 Asthma A0 Ec A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 Ec A AMLODIPINE d00689A B I10 Essential (primary) hypertension A@ Ec A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Bz I10 Essential (primary) hypertension A@ Ec A INSULIN DETEMIR d05436A C R73 Elevated blood glucose level A@ Ec A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ Ec A . . . Ed A . . . Ed A ALLOPURINOL d00023A D M1A Chronic gout AP Ed A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Ed A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension AP Ed A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP Ed A OMEPRAZOLE d00325A D"8 K21 Gastro-esophageal reflux disease AP Ed A . . . Ed0 A ALLOPURINOL d00023A CDp E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A` Ed0 A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension A` Ed0 A CLOPIDOGREL d04258A CDp I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A` Ed0 A ENALAPRIL d00013A CDp I10 Essential (primary) hypertension A` Ed0 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` Ed0 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A` Ed@ A FOSINOPRIL d00242A D I10 Essential (primary) hypertension A Ed@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EdP A AMLODIPINE d00689A B I10 Essential (primary) hypertension A@ EdP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ EdP A METOPROLOL d00134A B I10 Essential (primary) hypertension A@ EdP A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus A@ Ed` A AMLODIPINE; BENAZEPRIL d03829A Dc I10 Essential (primary) hypertension A Ed` A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A Edp A . . . Ed A . . . Ed A ALPRAZOLAM d00168A C F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A Ed A CITALOPRAM d04332A A F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Ed A . . . Ed A AMLODIPINE d00689A B< I10 Essential (primary) hypertension A Ed A . . . Ed A ACEBUTOLOL d00128A D I49.9 Cardiac arrhythmia, unspecified A0 Ed A ETHINYL ESTRADIOL; NORGESTIMATE d03781A D N94 Pain and other conditions associated with female genital organs and menstrual cycle A0 Ed A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 Ed A THYROID DESICCATED d00655A C[@ E03.9 Hypothyroidism, unspecified A Ed A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma AP Ed A BRINZOLAMIDE OPHTHALMIC d04301A C H40 Glaucoma AP Ed A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma AP Ed A LOSARTAN d03821A Cr I10 Essential (primary) hypertension AP Ed A PILOCARPINE OPHTHALMIC d01191A C H57.9 Unspecified disorder of eye and adnexa AP Ee A . . . Ee A . . . Ee A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP Ee A LISINOPRIL d00732A C- E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension AP Ee A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP Ee A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia AP Ee A SAXAGLIPTIN d07467A C- E11 Type 2 diabetes mellitus AP Ee0 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C"0 G43 T14.9 Migraine Unspecified injury A@ Ee0 A PROMETHAZINE d00787A C"0 R11 Nausea and vomiting A@ Ee0 A SUMATRIPTAN d03160A B G43 Migraine A@ Ee0 A TOPIRAMATE d04115A B[ G43 Migraine A@ Ee@ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EeP A ACETAMINOPHEN; HYDROCODONE d03428A C- K08.8 Other specified disorders of teeth and supporting structures A` EeP A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` EeP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` EeP A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A` EeP A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` EeP A TAMSULOSIN d04121A B N40 Enlarged prostate A` Ee` A . . . Eep A . . . Ee A . . . Ee A ATENOLOL d00004A Dc I10 Essential (primary) hypertension AP Ee A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Ee A LOSARTAN d03821A CDp I10 Essential (primary) hypertension AP Ee A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia AP Ee A WARFARIN d00022A D I48.9 Unspecified atrial fibrillation and atrial flutter AP Ee A . . . Ee A LISINOPRIL d00732A CDp 99999 A0 Ee A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 Ee A SIMVASTATIN d00746A CDp 99999 A0 Ee A ATORVASTATIN d04105A Ei 99999 A Ee A CLOPIDOGREL d04258A Ei 99999 A Ee A DICLOFENAC d00848A Ei 99999 A Ee A DONEPEZIL d04099A Ei 99999 A Ee A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A Ee A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A Ee A MECLIZINE d00859A Ei 99999 A Ee A METOPROLOL d00134A Ei 99999 A Ee A SERTRALINE d00880A Ei 99999 A Ee A . . . Ee A . . . Ee A . . . Ef A APIXABAN d07804A C"0 D75.9P Prevent blood clots AP Ef A DIGOXIN d00210A C"0 I51.9 Heart disease, unspecified AP Ef A DILTIAZEM d00045A C"0 I51.9 Heart disease, unspecified AP Ef A METOPROLOL d00134A C"0 I51.9 Heart disease, unspecified AP Ef A SERTRALINE d00880A D1 F32.9 Major depressive disorder, single episode, unspecified AP Ef A . . . Ef A . . . Ef0 A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A Ef0 A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A Ef@ A DABIGATRAN d07137A Ei 99999 AP Ef@ A DIGOXIN d00210A Ei 99999 AP Ef@ A HYDRALAZINE d00132A Ei 99999 AP Ef@ A LOSARTAN d03821A Ei 99999 AP Ef@ A POTASSIUM CHLORIDE d00345A Ei 99999 AP EfP A . . . Ef` A . . . Efp A . . . Ef A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A ONDANSETRON d00867A B1 R11 Nausea and vomiting A Ef A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension AP Ef A LOSARTAN d03821A C I10 Essential (primary) hypertension AP Ef A METFORMIN d03807A Cr E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP Ef A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia AP Ef A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia AP Ef A . . . Eg A FEBUXOSTAT d07397A CDp M1A Chronic gout A@ Eg A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A@ Eg A METOPROLOL d00134A D I48.9 Unspecified atrial fibrillation and atrial flutter A@ Eg A WARFARIN d00022A D I48.9 Unspecified atrial fibrillation and atrial flutter A@ Eg A MONTELUKAST d04289A C- J40 T78.40 Bronchitis, not specified as acute or chronic Allergy, unspecified A Eg A . . . Eg0 A . . . Eg@ A . . . EgP A . . . Eg` A . . . Egp A . . . Eg A . . . Eg A . . . Eg A OXCARBAZEPINE d04513A C G40 Epilepsy and recurrent seizures A Eg A LISINOPRIL d00732A Cr E11.2 Type 2 diabetes mellitus with kidney complications A0 Eg A MELOXICAM d04532A C- M13 Other arthritis A0 Eg A METFORMIN d03807A C R73 Elevated blood glucose level A0 Eg A . . . Eg A . . . Eg A . . . Eg A . . . Eh A CLOPIDOGREL d04258A B D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction AP Eh A LISINOPRIL d00732A B I10 Essential (primary) hypertension AP Eh A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP Eh A METOPROLOL d00134A B I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction AP Eh A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia AP Eh A . . . Eh A CYCLOBENZAPRINE d00963A B M79.1 Myalgia A0 Eh A IBUPROFEN d00015A C M25.5 R51 Pain in joint Headache A0 Eh A OMEPRAZOLE d00325A C- K27 Peptic ulcer, site unspecified A0 Eh0 A . . . Eh@ A . . . EhP A BENZTROPINE d00175A C- G25.0 Essential tremor A EhP A HALOPERIDOL d00027A C- F20 Schizophrenia A Eh` A . . . Ehp A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap Ehp A CILOSTAZOL d04382A C I70 Atherosclerosis Ap Ehp A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap Ehp A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C I10 Essential (primary) hypertension Ap Ehp A RANITIDINE d00021A C K30 Functional dyspepsia Ap Ehp A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap Ehp A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus Ap Eh A . . . Eh A URINARY ANTI-INFECTIVES - UNSPECIFIED c00017A A0 N39.0 Urinary tract infection, site not specified A Eh A . . . Eh A LEVOTHYROXINE d00278A CDp E07.9 Disorder of thyroid, unspecified A Eh A . . . Eh A . . . Eh A . . . Eh A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- N92 Excessive, frequent and irregular menstruation A Ei A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Ei A ENALAPRIL d00013A CP I10 Essential (primary) hypertension AP Ei A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP Ei A PANTOPRAZOLE d04514A C K25 Gastric ulcer AP Ei A RANITIDINE d00021A C- B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere AP Ei A ACETAMINOPHEN; HYDROCODONE d03428A B[ M54 Dorsalgia A Ei A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A Ei A RANITIDINE d00021A B K30 Functional dyspepsia A Ei0 A . . . Ei@ A . . . EiP A . . . Ei` A . . . Eip A CLOPIDOGREL d04258A C 99999 A Eip A ESOMEPRAZOLE d04749A C- K21 Gastro-esophageal reflux disease A Eip A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A Eip A LOPERAMIDE d01025A B R19.7 Diarrhea, unspecified A Eip A METOPROLOL d00134A C I10 Essential (primary) hypertension A Eip A METOPROLOL d00134A C I10 Essential (primary) hypertension A Eip A POTASSIUM CHLORIDE d00345A B R25.2 Cramp and spasm A Eip A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A Ei A . . . Ei A . . . Ei A ALBUTEROL d00749A C J45 Asthma A0 Ei A FLUTICASONE d01296A CDp J45 Asthma A0 Ei A MONTELUKAST d04289A CDp T78.40 Allergy, unspecified A0 Ei A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CP F90 Attention-deficit hyperactivity disorders A` Ei A BUSPIRONE d00182A Bz F41.9 Anxiety disorder, unspecified A` Ei A CLONIDINE d00044A C"0 G47.0 Insomnia A` Ei A DIAZEPAM d00148A B F41.9 Anxiety disorder, unspecified A` Ei A LAMOTRIGINE d03809A CO F32.9 Major depressive disorder, single episode, unspecified A` Ei A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A` Ei A ATENOLOL d00004A C I10 Essential (primary) hypertension AP Ei A DILTIAZEM d00045A C I10 Essential (primary) hypertension AP Ei A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension AP Ei A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP Ei A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia AP Ei A . . . Ei A EMOLLIENTS TOPICAL d03770A C N95 Menopausal and other perimenopausal disorders AP Ei A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension AP Ei A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified AP Ei A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP Ei A THYROID DESICCATED d00655A D% E06.3 Autoimmune thyroiditis AP Ei A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C$ I10 Essential (primary) hypertension A Ej A . . . Ej A . . . Ej A . . . Ej0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 Ej0 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 Ej0 A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A D I10 Essential (primary) hypertension A0 Ej@ A . . . EjP A . . . Ej` A . . . Ejp A ALLOPURINOL d00023A D E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A` Ejp A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` Ejp A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D' R60.9 Edema, unspecified A` Ejp A LOSARTAN d03821A C I10 Essential (primary) hypertension A` Ejp A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Ejp A WARFARIN d00022A D/ D75.9P Prevent blood clots A` Ej A . . . Ej A CARVEDILOL d03847A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A0 Ej A LEVOTHYROXINE d00278A D3T E03.9 Hypothyroidism, unspecified A0 Ej A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 Ej A . . . Ej A . . . Ej A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A Ej A . . . Ej A . . . Ej A . . . Ek A AMOXICILLIN d00088A A J02 Acute pharyngitis A Ek A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Ek A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia AP Ek A LISINOPRIL d00732A C I51.9 Heart disease, unspecified AP Ek A METOPROLOL d00134A C Z79 Long term (current) drug therapy AP Ek A TADALAFIL d04896A C N32.9 Bladder disorder, unspecified AP Ek A HYOSCYAMINE d00985A B K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A0 Ek A ONDANSETRON d00867A C R11 Nausea and vomiting A0 Ek A RANITIDINE d00021A C- R12 Heartburn A0 Ek0 A . . . Ek@ A . . . EkP A GLIPIZIDE d00246A A E11 Type 2 diabetes mellitus A EkP A NAPROXEN d00019A A M54 Dorsalgia A Ek` A . . . Ekp A . . . Ek A . . . Ek A . . . Ek A . . . Ek A INSULIN LISPRO d04373A Dc E11 Type 2 diabetes mellitus A Ek A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Ek A . . . Ek A FLECAINIDE d00234A C"@ I48.9 Unspecified atrial fibrillation and atrial flutter A Ek A METOPROLOL d00134A Dc I49.9 Cardiac arrhythmia, unspecified A Ek A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A Ek A . . . El A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C- N94 Pain and other conditions associated with female genital organs and menstrual cycle A El A AMITRIPTYLINE d00146A C G47.0 M79.2 Insomnia Neuralgia and neuritis, unspecified AP El A ASPIRIN d00170A C[@ 99999 AP El A BACLOFEN d00967A Cr M62.83 Muscle spasm AP El A BUMETANIDE d00179A CDp R60.9 Edema, unspecified AP El A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia AP El A . . . El0 A ALBUTEROL d00749A C J45 Asthma A El0 A WARFARIN d00022A C D75.9P I63 Prevent blood clots Cerebral infarction A El@ A DESOGESTREL; ETHINYL ESTRADIOL d03782A B Z79.3 Long term (current) use of hormonal contraceptives A ElP A . . . El` A . . . Elp A . . . El A . . . El A . . . El A ALBUTEROL d00749A Dc J45 Asthma A El A FORMOTEROL; MOMETASONE d07660A C[@ J45 Asthma A El A . . . El A . . . El A ACETAMINOPHEN; CODEINE d03423A B= M19.9 T14.9 Osteoarthritis, unspecified site Unspecified injury A El A BACLOFEN d00967A CDp M62.83 Muscle spasm A El A BUSPIRONE d00182A D"8 F32.9 Major depressive disorder, single episode, unspecified A El A CLONAZEPAM d00197A D"8 F41.9 Anxiety disorder, unspecified A El A ENALAPRIL d00013A D I10 Essential (primary) hypertension A El A FLUOXETINE d00236A D"8 F32.9 R45 Major depressive disorder, single episode, unspecified Symptoms and signs involving emotional state A El A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A El A ZOLPIDEM d00910A C G47.0 Insomnia A El A . . . El A CYPROHEPTADINE d00790A B[ R63 Symptoms and signs concerning food and fluid intake A Em A . . . Em A . . . Em A . . . Em0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A Em@ A . . . EmP A . . . Em` A . . . Emp A . . . Em A . . . Em A LATANOPROST OPHTHALMIC d04017A C[@ H40 Glaucoma A Em A TIMOLOL OPHTHALMIC d04037A C- H40 Glaucoma A Em A . . . Em A . . . Em A ATORVASTATIN d04105A Cr E78.1 Pure hyperglyceridemia AP Em A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified AP Em A IRBESARTAN d04222A Cr I50.9 Heart failure, unspecified AP Em A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP Em A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia AP Em A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A Em A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified A Em A . . . Em A . . . En A . . . En A . . . En A CIPROFLOXACIN OPHTHALMIC d03211A Ap H10 Conjunctivitis A En A PREDNISOLONE OPHTHALMIC d03221A Ap H57.9 Unspecified disorder of eye and adnexa A En0 A . . . En@ A . . . EnP A NYSTATIN d01233A Bz 55555 A En` A FLUORIDE TOPICAL d04397A B K02 Dental caries A Enp A . . . En A . . . En A . . . En A . . . En A PENICILLIN d00116A Ap J02 Acute pharyngitis A En A BUPROPION d00181A0 C F41.9 Anxiety disorder, unspecified Ap En A DEXLANSOPRAZOLE d07395A0 Cr K21 Gastro-esophageal reflux disease Ap En A ESCITALOPRAM d04812A0 C F41.9 Anxiety disorder, unspecified Ap En A ESTRADIOL; NORETHINDRONE d04375A0 C Z79.890 Hormone replacement therapy Ap En A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A0 C[@ I10 Essential (primary) hypertension Ap En A MONTELUKAST d04289A0 CDp J30.9 Allergic rhinitis, unspecified Ap En A TIMOLOL OPHTHALMIC d04037A0 Cr H40 Glaucoma Ap En A . . . En A ALBUTEROL d00749A C J45 Asthma A En A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A En A DOCUSATE d01021A B[ K59.0 Constipation A En A ELBASVIR; GRAZOPREVIR d08418A B= B19 Unspecified viral hepatitis A En A FINASTERIDE d00563A B= N40 Enlarged prostate A En A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A En A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A En A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A En A TAMSULOSIN d04121A Cr N32.9 Bladder disorder, unspecified A En A . . . Eo A MONTELUKAST d04289A Ap J30.9 Allergic rhinitis, unspecified A Eo A . . . Eo A HYDROXYZINE d00907A Cr F41.9 Anxiety disorder, unspecified A Eo A TRAZODONE d00395A Cr F41.9 Anxiety disorder, unspecified A Eo0 A . . . Eo@ A . . . EoP A . . . Eo` A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A Eo` A TRAZODONE d00395A B G47.0 Insomnia A Eop A ALBUTEROL d00749A C J45 Asthma A0 Eop A ALBUTEROL d00749A C J45 Asthma A0 Eop A FLUTICASONE d01296A B J45 Asthma A0 Eo A ACYCLOVIR d00001A C3P B00.9 B02 Herpesviral infection, unspecified Zoster [herpes zoster] Ap Eo A BISACODYL d01015A B K59.0 Constipation Ap Eo A CLONIDINE d00044A B= G47.9 Sleep disorder, unspecified Ap Eo A DIAZEPAM d00148A B[ G40 Epilepsy and recurrent seizures Ap Eo A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease Ap Eo A OXCARBAZEPINE d04513A C50 G40 Epilepsy and recurrent seizures Ap Eo A POLYETHYLENE GLYCOL 3350 d05350A C' K59.0 Constipation Ap Eo A . . . Eo A . . . Eo A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia A Eo A METFORMIN d03807A D E11 Type 2 diabetes mellitus A Eo A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A0 R05 Cough A@ Eo A CODEINE; GUAIFENESIN d03393A B R05 Cough A@ Eo A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A@ Eo A LORATADINE; PSEUDOEPHEDRINE d03818A C T78.40 Allergy, unspecified A@ Eo A ISOTRETINOIN d01245A B L70 Acne A Eo A . . . Eo A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A Eo A PHENTERMINE d00806A A E66 Overweight and obesity A Ep A . . . Ep A . . . Ep A HYDROXYCHLOROQUINE d00817A C M13 Other arthritis A0 Ep A MELOXICAM d04532A B M13 Other arthritis A0 Ep A PANTOPRAZOLE d04514A Bz K21 Gastro-esophageal reflux disease A0 Ep0 A BRIMONIDINE OPHTHALMIC d04048A Dc H40 Glaucoma AP Ep0 A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia AP Ep0 A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified AP Ep0 A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease AP Ep0 A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP Ep@ A . . . EpP A . . . Ep` A . . . Epp A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A Epp A AMOXICILLIN; CLAVULANATE d00089A A K04.7 Periapical abscess without sinus A Ep A AMLODIPINE d00689A B I10 Essential (primary) hypertension AP Ep A AMOXICILLIN; CLAVULANATE d00089A A A49.9P Prevent bacterial infection AP Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Ep A CARVEDILOL d03847A B I10 Essential (primary) hypertension AP Ep A TRAMADOL d03826A B R10 Abdominal and pelvic pain AP Ep A . . . Ep A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Bz F90 Attention-deficit hyperactivity disorders A Ep A ALLOPURINOL d00023A C M1A Chronic gout A` Ep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` Ep A ATENOLOL d00004A C I10 Essential (primary) hypertension A` Ep A COLCHICINE d00150A C M1A Chronic gout A` Ep A FOSINOPRIL d00242A C I10 Essential (primary) hypertension A` Ep A OMEPRAZOLE d00325A C 55555 A` Ep A . . . Ep A . . . Ep A ALBUTEROL d00749A C J45 Asthma A Ep A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A Ep A . . . Eq A . . . Eq A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A Eq A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A Eq0 A . . . Eq@ A FLUOXETINE d00236A Cr F32.9 Major depressive disorder, single episode, unspecified A EqP A . . . Eq` A . . . Eqp A . . . Eq A . . . Eq A . . . Eq A . . . Eq A . . . Eq A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A Eq A . . . Eq A . . . Eq A . . . Er A . . . Er A . . . Er A . . . Er0 A . . . Er@ A . . . ErP A . . . Er` A AZITHROMYCIN d00091A A J01.9 Acute sinusitis, unspecified A0 Er` A LORATADINE; PSEUDOEPHEDRINE d03818A A J01.9 Acute sinusitis, unspecified A0 Er` A PREDNISONE d00350A A J01.9 Acute sinusitis, unspecified A0 Erp A . . . Er A DOXYCYCLINE d00037A A0 J01.9 Acute sinusitis, unspecified A Er A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A Er A . . . Er A ACETAMINOPHEN; HYDROCODONE d03428A0 A M54 Dorsalgia A Er A AMOXICILLIN; CLAVULANATE d00089A0 AP A49.9P R52 Prevent bacterial infection Pain, unspecified A Er A . . . Er A AMLODIPINE d00689A Ei I21.P Prevent heart attack/myocardial infarction A` Er A GALANTAMINE d04750A Ei G47.9 Sleep disorder, unspecified A` Er A ISOSORBIDE MONONITRATE d00269A Ei R07.9 Chest pain, unspecified A` Er A MELOXICAM d04532A Ei M25.5 Pain in joint A` Er A OMEPRAZOLE d00325A Ei K30 Functional dyspepsia A` Er A PANTOPRAZOLE d04514A Ei K30 Functional dyspepsia A` Er A CYCLOBENZAPRINE d00963A CDp M62.83 Muscle spasm A` Er A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` Er A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A` Er A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` Er A LISINOPRIL d00732A Cr E11.2P Prevent diabetic kidney disease A` Er A TERAZOSIN d00386A C I10 Essential (primary) hypertension A` Er A . . . Es A . . . Es A . . . Es A AMLODIPINE d00689A D' I10 I21.P I63.P Essential (primary) hypertension Prevent heart attack/myocardial infarction Prevent stroke Ap Es A CARVEDILOL d03847A D' I10 I50.9 Essential (primary) hypertension Heart failure, unspecified Ap Es A CLOPIDOGREL d04258A D' I63 Cerebral infarction Ap Es A FUROSEMIDE d00070A D' N18.9 N28.9 Chronic kidney disease, unspecified Disorder of kidney and ureter, unspecified Ap Es A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap Es A LEVOTHYROXINE d00278A D 99999 Ap Es A LISINOPRIL d00732A D' E11.2 I10 I50.9 Type 2 diabetes mellitus with kidney complications Essential (primary) hypertension Heart failure, unspecified Ap Es0 A . . . Es@ A . . . EsP A DESOGESTREL; ETHINYL ESTRADIOL d03782A C Z79.3 Long term (current) use of hormonal contraceptives A Es` A . . . Esp A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A` Esp A LACTULOSE d01024A B K58 Irritable bowel syndrome A` Esp A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A` Esp A LOSARTAN d03821A B[ I10 Essential (primary) hypertension A` Esp A MICONAZOLE TOPICAL d03195A B[ B37 Candidiasis A` Esp A OXYBUTYNIN d00328A B N32.9 Bladder disorder, unspecified A` Es A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension AP Es A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 R60.9 Essential (primary) hypertension Edema, unspecified AP Es A NITROGLYCERIN d00321A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction AP Es A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia AP Es A RANITIDINE d00021A C- K30 Functional dyspepsia AP Es A . . . Es A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A Es A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A Es A . . . Es A . . . Es A . . . Es A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders Ap Es A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified Ap Es A MELOXICAM d04532A B[ M54 Dorsalgia Ap Es A MOMETASONE NASAL d04223A B= R09.81 Nasal congestion Ap Es A NAPROXEN d00019A Bz M25.5 Pain in joint Ap Es A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease Ap Es A TRAMADOL d03826A B M54 Dorsalgia Ap Es A FENOFIBRATE d04286A B R60.9 Edema, unspecified A Et A ALBUTEROL d00749A B J45 Asthma A Et A . . . Et A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A@ Et A LOSARTAN d03821A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ Et A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ Et A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ Et0 A . . . Et@ A ENALAPRIL d00013A C I10 Essential (primary) hypertension A@ Et@ A LINAGLIPTIN d07767A C E11 Type 2 diabetes mellitus A@ Et@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ Et@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ EtP A . . . Et` A BUSPIRONE d00182A Bz F41.9 Anxiety disorder, unspecified Ap Et` A CETIRIZINE d03827A Bz T78.40 Allergy, unspecified Ap Et` A CLONAZEPAM d00197A Bz F41.9 Anxiety disorder, unspecified Ap Et` A DULOXETINE d05355A B[ F32.9 Major depressive disorder, single episode, unspecified Ap Et` A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified Ap Et` A MIRTAZAPINE d04025A B[ G47.0 Insomnia Ap Et` A NAPROXEN d00019A C M79.1 Myalgia Ap Etp A . . . Et A TRAMADOL d03826A B T14.9 Unspecified injury A Et A . . . Et A . . . Et A . . . Et A . . . Et A . . . Et A . . . Et A IBUPROFEN d00015A C- M54 Dorsalgia A Eu A . . . Eu A . . . Eu A . . . Eu0 A . . . Eu@ A . . . EuP A . . . Eu` A . . . Eup A ATENOLOL d00004A0 C I10 Essential (primary) hypertension A Eup A CAPTOPRIL d00006A0 C I10 Essential (primary) hypertension A Eup A CLONIDINE d00044A0 C I10 Essential (primary) hypertension A Eup A FINASTERIDE d00563A0 C N39.4 Other specified urinary incontinence A Eup A GLIPIZIDE d00246A0 C E11 Type 2 diabetes mellitus A Eup A INSULIN ISOPHANE (NPH) d04370A0 C- E11 Type 2 diabetes mellitus A Eup A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A Eup A NIACIN d00314A0 C E78.0 Pure hypercholesterolemia A Eup A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia A Eup A TAMSULOSIN d04121A0 C- R35 Polyuria A Eup A VARDENAFIL d04893A0 C- N52.9 Male erectile dysfunction, unspecified A Eu A LEVOTHYROXINE d00278A D"8 E03.9 Hypothyroidism, unspecified A Eu A IBUPROFEN d00015A C- M79.1 Myalgia A Eu A LEVOTHYROXINE d00278A B# E03.9 Hypothyroidism, unspecified A Eu A . . . Eu A 99999 . . A0 Eu A METHOTREXATE d00060A B= M06.9 Rheumatoid arthritis, unspecified A0 Eu A PREDNISONE d00350A B M06.9 Rheumatoid arthritis, unspecified A0 Eu A . . . Eu A . . . Eu A . . . Eu A ACYCLOVIR d00001A B B00.1 Herpesviral vesicular dermatitis A Ev A . . . Ev A BUPROPION d00181A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` Ev A DIMETHYL FUMARATE d08079A B G99.8 Other specified disorders of nervous system in diseases classified elsewhere A` Ev A DOCUSATE d01021A B K59.0 Constipation A` Ev A METHENAMINE d00106A B N30 Cystitis A` Ev A OXYBUTYNIN d00328A B N39.4 Other specified urinary incontinence A` Ev A SENNA d01013A B K59.0 Constipation A` Ev A . . . Ev0 A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A Ev@ A . . . EvP A . . . Ev` A . . . Evp A . . . Ev A . . . Ev A . . . Ev A . . . Ev A . . . Ev A . . . Ev A . . . Ev A . . . Ev A CEPHALEXIN d00096A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A Ev A IBUPROFEN d00015A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A Ew A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A@ Ew A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A@ Ew A MONTELUKAST d04289A C J45 Asthma A@ Ew A RISPERIDONE d03180A Bz F91.9 Conduct disorder, unspecified A@ Ew A ABIRATERONE d07766A B C61 Malignant neoplasm of prostate A Ew A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ew A DICLOFENAC TOPICAL d04722A C M25.5 Pain in joint A Ew A ESOMEPRAZOLE d04749A B= K21 Gastro-esophageal reflux disease A Ew A HYDROMORPHONE d00255A Bz M79.6 Pain in limb, hand, foot, fingers and toes A Ew A KETOCONAZOLE TOPICAL d03202A C- L30.9 Dermatitis, unspecified A Ew A PREDNISONE d00350A B C61 Malignant neoplasm of prostate A Ew A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A Ew A SIPULEUCEL-T d07638A B= Z51.1 Encounter for antineoplastic chemotherapy and immunotherapy A Ew A TAMSULOSIN d04121A B N40 Enlarged prostate A Ew A VALSARTAN d04113A B I10 Essential (primary) hypertension A Ew A ZOLEDRONIC ACID d04708A C- M81 Osteoporosis without current pathological fracture A Ew A IBUPROFEN d00015A A0 R50.9 Fever, unspecified A Ew0 A TRAMADOL d03826A C M54 Dorsalgia A Ew@ A . . . EwP A . . . Ew` A . . . Ewp A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A Ew A 99999 . . A0 Ew A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 Ew A METFORMIN d03807A C- R73 Elevated blood glucose level A0 Ew A LISINOPRIL d00732A B I10 Essential (primary) hypertension A Ew A METOPROLOL d00134A B= I10 Essential (primary) hypertension A Ew A . . . Ew A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A0 Ew A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A0 Ew A TRAMADOL d03826A B M06.9 Rheumatoid arthritis, unspecified A0 Ew A . . . Ew A . . . Ew A ENALAPRIL d00013A C I10 Essential (primary) hypertension A Ew A RANITIDINE d00021A B= K30 Functional dyspepsia A Ex A . . . Ex A . . . Ex A . . . Ex0 A . . . Ex@ A . . . ExP A . . . Ex` A LAMOTRIGINE d03809A C- F31.9 Bipolar disorder, unspecified AP Ex` A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified AP Ex` A LOSARTAN d03821A C- I10 Essential (primary) hypertension AP Ex` A SUVOREXANT d08281A B= G47.0 Insomnia AP Ex` A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP Exp A . . . Ex A . . . Ex A CLONAZEPAM d00197A Cr G47.0 R45 Insomnia Symptoms and signs involving emotional state A` Ex A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` Ex A MELOXICAM d04532A C- M19.9 M54 Osteoarthritis, unspecified site Dorsalgia A` Ex A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A` Ex A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` Ex A TRAMADOL d03826A C[@ M19.9 M54 Osteoarthritis, unspecified site Dorsalgia A` Ex A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A Ex A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A Ex A CETIRIZINE d03827A B T78.40 Allergy, unspecified A Ex A CITALOPRAM d04332A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Ex A . . . Ex A . . . Ex A MONTELUKAST d04289A C J30.9 J45 Allergic rhinitis, unspecified Asthma A Ex A . . . Ey A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A0 Ey A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A0 Ey A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A0 Ey A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ey A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Ey0 A ITRACONAZOLE d00102A B[ B35 Dermatophytosis A Ey@ A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A0 Ey@ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 Ey@ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 EyP A . . . Ey` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 Ey` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 Ey` A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 Eyp A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A Eyp A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension A Eyp A ATORVASTATIN d04105A Cr E78.0P Prevent high cholesterol A Eyp A BACLOFEN d00967A C T14.9 Unspecified injury A Eyp A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A Eyp A MELOXICAM d04532A B M79.1 Myalgia A Eyp A METHOCARBAMOL d00965A B= M79.1 Myalgia A Eyp A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A Eyp A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A Eyp A RAMIPRIL d00728A C E11.2P Prevent diabetic kidney disease A Ey A . . . Ey A . . . Ey A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 Ey A METFORMIN d03807A C R73 Elevated blood glucose level A0 Ey A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 Ey A LEVOTHYROXINE d00278A C E04 Other nontoxic goiter A Ey A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Ey A ALLOPURINOL d00023A C- I10 Essential (primary) hypertension A` Ey A AMLODIPINE d00689A B I10 Essential (primary) hypertension A` Ey A ASPIRIN d00170A C 55555 A` Ey A IBUPROFEN d00015A CDp M54 Dorsalgia A` Ey A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` Ey A OMEPRAZOLE d00325A Ei I51.9 Heart disease, unspecified A` Ey A . . . Ey A . . . Ey A . . . Ez A . . . Ez A ALBUTEROL d00749A D7 J45 Asthma A Ez A FLUTICASONE d01296A D7 J45 Asthma A Ez A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 Ez A LISINOPRIL d00732A CDp 99999 A0 Ez A METFORMIN d03807A D E11 Type 2 diabetes mellitus A0 Ez0 A . . . Ez@ A . . . EzP A . . . Ez` A ESOMEPRAZOLE d04749A CDp K21 Gastro-esophageal reflux disease A0 Ez` A METFORMIN d03807A C R73 Elevated blood glucose level A0 Ez` A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A0 Ezp A NAPROXEN d00019A A M54 Dorsalgia A Ez A . . . Ez A . . . Ez A . . . Ez A . . . Ez A AMLODIPINE d00689A0 C[@ I10 Essential (primary) hypertension Ap Ez A CLOPIDOGREL d04258A0 C I21 I51.9 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Heart disease, unspecified Ap Ez A FENOFIBRATE d04286A0 C[@ E78.1 Pure hyperglyceridemia Ap Ez A FUROSEMIDE d00070A0 C[@ I51.9 Heart disease, unspecified Ap Ez A LISINOPRIL d00732A0 C[@ I50.9 Heart failure, unspecified Ap Ez A NITROGLYCERIN d00321A0 C R07.9 Chest pain, unspecified Ap Ez A PRAVASTATIN d00348A0 C E78.0 Pure hypercholesterolemia Ap Ez A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CP F90 Attention-deficit hyperactivity disorders A Ez A ATENOLOL d00004A C- I99.9 Unspecified disorder of circulatory system A Ez A . . . Ez A . . . E{ A . . . E{ A . . . E{ A . . . E{0 A . . . E{@ A . . . E{P A ALENDRONATE d03849A C< M81 Osteoporosis without current pathological fracture A E{P A AZITHROMYCIN d00091A A0 J01.9 Acute sinusitis, unspecified A E{P A CELECOXIB d04380A B[ M54 Dorsalgia A E{P A DULOXETINE d05355A C F41.9 M79.7 Anxiety disorder, unspecified Fibromyalgia A E{P A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E{P A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease A E{P A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E{P A METHOCARBAMOL d00965A B M54 Dorsalgia A E{` A AMOXICILLIN d00088A A J20.9 Acute bronchitis, unspecified A E{p A . . . E{ A AMITRIPTYLINE d00146A B= F31.9 Bipolar disorder, unspecified A@ E{ A LEVOTHYROXINE d00278A CDp E06.3 Autoimmune thyroiditis A@ E{ A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia A@ E{ A SOLIFENACIN d05413A C N32.81 N39.4 Overactive bladder Other specified urinary incontinence A@ E{ A ALBUTEROL d00749A0 CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E{ A BECLOMETHASONE d00760A0 CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E{ A MELOXICAM d04532A0 D:u M06.9 Rheumatoid arthritis, unspecified Ap E{ A METAXALONE d00964A0 D:u M06.9 Rheumatoid arthritis, unspecified Ap E{ A MONTELUKAST d04289A0 DO R06.2 Wheezing Ap E{ A SUMATRIPTAN d03160A0 D G43 Migraine Ap E{ A TRAMADOL d03826A0 D:u M06.9 Rheumatoid arthritis, unspecified Ap E{ A FUROSEMIDE d00070A B[ I51.9 J98.9 Heart disease, unspecified Respiratory disorder, unspecified AP E{ A POTASSIUM CHLORIDE d00345A B[ E87.6 Hypokalemia AP E{ A ROPINIROLE d04215A C G25.81 Restless legs syndrome AP E{ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E{ A WARFARIN d00022A CDp I26 Pulmonary embolism AP E{ A AZITHROMYCIN d00091A AP H66.9 J01.9 Otitis media, unspecified Acute sinusitis, unspecified A E{ A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A C H66.9 Otitis media, unspecified A E{ A . . . E{ A . . . E{ A 99999 . . A0 E{ A AMLODIPINE; BENAZEPRIL d03829A B= I10 Essential (primary) hypertension A0 E{ A CLINDAMYCIN d00043A Ap K04.7 Periapical abscess without sinus A0 E{ A . . . E| A . . . E| A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D* I10 Essential (primary) hypertension Ap E| A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified Ap E| A LORAZEPAM d00149A D G47.0 Insomnia Ap E| A METOPROLOL d00134A Dc I10 Essential (primary) hypertension Ap E| A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia Ap E| A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E| A ZOLPIDEM d00910A C G47.0 Insomnia Ap E| A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E| A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A E| A GABAPENTIN d03182A B E11.4 Type 2 diabetes mellitus with neurological complications A E| A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E| A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E| A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E| A LOSARTAN d03821A D I10 Essential (primary) hypertension A E| A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E| A OMEPRAZOLE d00325A C- K30 Functional dyspepsia A E|0 A . . . E|@ A . . . E|P A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E|P A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E|P A CILOSTAZOL d04382A Dc I70 Atherosclerosis A E|P A CLONIDINE d00044A Dc I10 Essential (primary) hypertension A E|P A ESOMEPRAZOLE d04749A Dc K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E|P A FUROSEMIDE d00070A Dc N18.9 Chronic kidney disease, unspecified A E|P A INSULIN ASPART d04697A D)Y E11 Type 2 diabetes mellitus A E|P A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus A E|P A TAMSULOSIN d04121A Dc N40 R35 Enlarged prostate Polyuria A E|P A TRAMADOL d03826A C M79.2 Neuralgia and neuritis, unspecified A E|` A . . . E|p A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A C- I10 Essential (primary) hypertension A@ E|p A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E|p A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ E|p A VENLAFAXINE d03181A Cr F41.9 Anxiety disorder, unspecified A@ E| A . . . E| A BESIFLOXACIN OPHTHALMIC d07448A B Z48.8 Encounter for other specified postprocedural aftercare A` E| A BROMFENAC OPHTHALMIC d05518A B H57.9 Unspecified disorder of eye and adnexa A` E| A CARBIDOPA; LEVODOPA d03473A C G20 Parkinson's disease A` E| A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E| A LISINOPRIL d00732A CDp E11.2P Prevent diabetic kidney disease A` E| A LOTEPREDNOL OPHTHALMIC d04292A A H57.9 Unspecified disorder of eye and adnexa A` E| A . . . E| A HYDROCHLOROTHIAZIDE d00253A Ap R60.9 Edema, unspecified A E| A NAPROXEN d00019A Ap T14.9 Unspecified injury A E| A . . . E| A . . . E| A PREDNISONE d00350A D 55555 A E| A AMLODIPINE; BENAZEPRIL d03829A CDp I10 Essential (primary) hypertension A0 E| A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E| A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E} A TESTOSTERONE d00558A B 55555 A E} A . . . E} A . . . E}0 A . . . E}@ A . . . E}P A . . . E}` A RANITIDINE d00021A Ap K21 Gastro-esophageal reflux disease A E}p A FLUOXETINE d00236A C[@ F41.9 Anxiety disorder, unspecified A E}p A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E} A . . . E} A ALLOPURINOL d00023A C M1A N20.0 Chronic gout Calculus of kidney AP E} A ATENOLOL d00004A C- I10 Essential (primary) hypertension AP E} A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E} A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A C I10 Essential (primary) hypertension AP E} A METFORMIN d03807A Dc R73 Elevated blood glucose level AP E} A . . . E} A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A E} A CYCLOBENZAPRINE d00963A B= M13 Other arthritis A@ E} A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A Dc I10 Essential (primary) hypertension A@ E} A MELOXICAM d04532A B M13 Other arthritis A@ E} A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A@ E} A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap N30 Cystitis A E} A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E} A DICLOFENAC d00848A C M19.9 Osteoarthritis, unspecified site A` E} A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 Essential (primary) hypertension A` E} A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E} A SERTRALINE d00880A D* F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E} A TRAMADOL d03826A Cr M19.9 Osteoarthritis, unspecified site A` E} A . . . E~ A ALBUTEROL d00749A C- J45 Asthma A E~ A ETHINYL ESTRADIOL; ETONOGESTREL d04773A CDp Z79.3 Long term (current) use of hormonal contraceptives A E~ A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension A0 E~ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A0 E~ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E~0 A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E~0 A TRAMADOL d03826A B= M19.9 Osteoarthritis, unspecified site A E~@ A . . . E~P A . . . E~` A . . . E~p A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E~ A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension AP E~ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP E~ A DICLOFENAC TOPICAL d04722A C M54 Dorsalgia AP E~ A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A C I10 Essential (primary) hypertension AP E~ A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C- E78.1 Pure hyperglyceridemia AP E~ A ALBUTEROL d00749A D J45 Asthma A E~ A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap E~ A ATENOLOL d00004A D I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified Ap E~ A GEMFIBROZIL d00245A D 99999 Ap E~ A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E~ A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E~ A MONTELUKAST d04289A D J44.9 Chronic obstructive pulmonary disease, unspecified Ap E~ A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia Ap E~ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E~ A CLONAZEPAM d00197A C[@ F41.9 Anxiety disorder, unspecified A0 E~ A LITHIUM d00061A C[@ F31.9 Bipolar disorder, unspecified A0 E~ A VENLAFAXINE d03181A C[@ F32.9 Major depressive disorder, single episode, unspecified A0 E~ A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap E~ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E~ A CHLORTHALIDONE d00192A D I51.9 Heart disease, unspecified Ap E~ A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus Ap E~ A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E~ A METOPROLOL d00134A D I10 Essential (primary) hypertension Ap E~ A SILDENAFIL d04299A C[@ N52.9 Male erectile dysfunction, unspecified Ap E~ A . . . E~ A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A0 E~ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E~ A OMEPRAZOLE d00325A B= K21 Gastro-esophageal reflux disease A0 E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A E A . . . E A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E A GABAPENTIN d03182A B G50 Disorders of trigeminal nerve A E A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A A49.9P Prevent bacterial infection A E0 A ALBUTEROL d00749A Cr J45 Asthma A@ E0 A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A@ E0 A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion A@ E0 A MONTELUKAST d04289A C[@ R06.9 Unspecified abnormalities of breathing A@ E@ A . . . EP A . . . E` A . . . Ep A PSYCHOTHERAPEUTIC AGENTS - UNSPECIFIED c00242A D F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A CAPSAICIN TOPICAL d01321A0 C M54 Dorsalgia Ap E A ELETRIPTAN d04849A0 C G43 Migraine Ap E A ETODOLAC d00851A0 C M79.1 Myalgia Ap E A FLUOXETINE d00236A0 C F41.9 Anxiety disorder, unspecified Ap E A GABAPENTIN d03182A0 C M79.2 Neuralgia and neuritis, unspecified Ap E A MORPHINE d00308A0 C M54 Dorsalgia Ap E A QUETIAPINE d04220A0 Bz G47.0 Insomnia Ap E A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M54 Pain in joint Dorsalgia A@ E A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E A HALOPERIDOL d00027A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A METHYLDOPA d00133A B I10 Essential (primary) hypertension A E A . . . E A AMOXICILLIN d00088A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A . . . E0 A CHLORPHENIRAMINE; PHENYLEPHRINE d03300A Bb R09.81 Nasal congestion A E@ A . . . EP A . . . E` A . . . Ep A . . . E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A METFORMIN d03807A CDp R73 Elevated blood glucose level A@ E A PRAVASTATIN d00348A C- R73 Elevated blood glucose level A@ E A RANITIDINE d00021A Cr K21 Gastro-esophageal reflux disease A@ E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` E A CLOPIDOGREL d04258A CP I21.P Prevent heart attack/myocardial infarction A` E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` E A METOPROLOL d00134A Dc I21.P Prevent heart attack/myocardial infarction A` E A RANITIDINE d00021A Dc K30 Functional dyspepsia A` E A . . . E A . . . E A . . . E A DULOXETINE d05355A B F41.9 Anxiety disorder, unspecified A0 E A HYDROXYZINE d00907A B G47.0 Insomnia A0 E A PRAZOSIN d00138A B G47.9 Sleep disorder, unspecified A0 E A . . . E A . . . E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified Ap E A LEVETIRACETAM d04499A B G40 Epilepsy and recurrent seizures Ap E A LEVOFLOXACIN d04109A A N30 Cystitis Ap E A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A Ei I10 Essential (primary) hypertension Ap E A PANTOPRAZOLE d04514A C K31.9 Disease of stomach and duodenum, unspecified Ap E A SEVELAMER d04363A Cr 99999 Ap E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ERYTHROMYCIN OPHTHALMIC d03973A Ap H10 Conjunctivitis A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A GABAPENTIN d03182A B R07.9 Chest pain, unspecified A E A . . . E A METHYLPHENIDATE d00900A A F90 Attention-deficit hyperactivity disorders A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E A ESCITALOPRAM d04812A Bz F32.9 Major depressive disorder, single episode, unspecified A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ E A . . . E A SUMATRIPTAN d03160A A G43 Migraine A E A . . . E A CARBIDOPA; LEVODOPA d03473A C G20 Parkinson's disease A` E A CLOPIDOGREL d04258A CDp D75.9P Prevent blood clots A` E A FENOFIBRATE d04286A C9 99999 A` E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A` E A ROPINIROLE d04215A C G20 Parkinson's disease A` E A TERAZOSIN d00386A C I10 R35 Essential (primary) hypertension Polyuria A` E A . . . E A METHOCARBAMOL d00965A A M25.5 M62.83 Pain in joint Muscle spasm A E0 A IBUPROFEN d00015A C- G43 Migraine A E@ A . . . EP A . . . E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Ep A . . . E A . . . E A . . . E A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A E A . . . E A ALENDRONATE d03849A C[@ M81 Osteoporosis without current pathological fracture A E A . . . E A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A B[ Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E0 A . . . E@ A . . . EP A ALBUTEROL d00749A C"0 J45 Asthma A EP A BECLOMETHASONE d00760A C"0 J45 Asthma A E` A . . . Ep A . . . E A . . . E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C- I10 Essential (primary) hypertension A E A CAPTOPRIL d00006A C I10 Essential (primary) hypertension A0 E A INSULIN ISOPHANE (NPH) d04370A Cr E11 Type 2 diabetes mellitus A0 E A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A0 E A DOXAZOSIN d00726A B N40 Enlarged prostate A0 E A METHOTREXATE d00060A B L94.0 Localized scleroderma [morphea] A0 E A PREDNISONE d00350A C L94.0 Localized scleroderma [morphea] A0 E A . . . E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E A METHYLDOPA d00133A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Cr Z79.3 Long term (current) use of hormonal contraceptives A E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` EP A HYDROCORTISONE; NEOMYCIN; POLYMYXIN B OPHTHALMIC d04095A Ap H10 Conjunctivitis A` EP A LOSARTAN d03821A B I10 Essential (primary) hypertension A` EP A MECLIZINE d00859A B R42 Dizziness and giddiness A` EP A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` EP A TOBRAMYCIN d00069A B B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A` E` A . . . Ep A . . . E A . . . E A . . . E A PANTOPRAZOLE d04514A CDp K30 Functional dyspepsia A E A HYDRALAZINE; ISOSORBIDE DINITRATE d05540A CDp I10 Essential (primary) hypertension Ap E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension Ap E A POTASSIUM CHLORIDE d00345A CDp I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A CDp I10 Essential (primary) hypertension Ap E A SPIRONOLACTONE d00373A CDp I10 Essential (primary) hypertension Ap E A TORSEMIDE d03189A CDp I10 Essential (primary) hypertension Ap E A ATENOLOL; CHLORTHALIDONE d03258A C I10 Essential (primary) hypertension AP E A EZETIMIBE d04824A C- E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia AP E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Ei M13 Other arthritis Ap E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension Ap E A ATENOLOL d00004A Ei I10 Essential (primary) hypertension Ap E A CLONAZEPAM d00197A Ei F41.9 Anxiety disorder, unspecified Ap E A GABAPENTIN d03182A C[@ G50 Disorders of trigeminal nerve Ap E A LOVASTATIN d00280A Ei E78.0 Pure hypercholesterolemia Ap E A PANTOPRAZOLE d04514A Ei R12 Heartburn Ap E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A0 E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Cr Z79.3 Long term (current) use of hormonal contraceptives A0 E A FLUTICASONE NASAL d04283A C- J30.2 Other seasonal allergic rhinitis A0 E A ACETAMINOPHEN; OXYCODONE d03431A C- M19.9 M25.5 M54 Osteoarthritis, unspecified site Pain in joint Dorsalgia A E A ALLOPURINOL d00023A D N20.0 Calculus of kidney A E A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E A AMOXICILLIN d00088A Cr N12 N39.0 Tubulo-interstitial nephritis, not specified as acute or chronic Urinary tract infection, site not specified A E A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A B 55555 A E A ROPINIROLE d04215A C G25.81 Restless legs syndrome A E A TAMSULOSIN d04121A C R32 Unspecified urinary incontinence A E A TRAMADOL d03826A C R52 Pain, unspecified A E A ZOLPIDEM d00910A B= G47.0 Insomnia A E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia Ap E A DEXAMETHASONE d00206A A@ M85.9 Disorders of bone density and structure, unspecified Ap E A DICLOFENAC d00848A A@ M85.9 Disorders of bone density and structure, unspecified Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A LISINOPRIL d00732A AP I10 Essential (primary) hypertension Ap E A TIMOLOL OPHTHALMIC d04037A C[@ H40 Glaucoma Ap E A TRAVOPROST OPHTHALMIC d04753A C H40 Glaucoma Ap E0 A ACETAMINOPHEN; HYDROCODONE d03428A C M54 M79.1 Dorsalgia Myalgia A@ E0 A ALPRAZOLAM d00168A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E0 A ARIPIPRAZOLE d04825A D F31.9 F32.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A@ E0 A SERTRALINE d00880A D F32.9 F39 F41.9 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Anxiety disorder, unspecified A@ E@ A . . . EP A . . . E` A . . . Ep A ALBUTEROL d00749A AP J45 Asthma A` Ep A AZITHROMYCIN d00091A AP J45 Asthma A` Ep A FLUTICASONE; SALMETEROL d04611A C- J45 Asthma A` Ep A MONTELUKAST d04289A C- J45 Asthma A` Ep A PREDNISONE d00350A AP J45 Asthma A` Ep A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A` E A . . . E A . . . E A . . . E A CIPROFLOXACIN d00011A B1 N40 Enlarged prostate A E A HYDROCHLOROTHIAZIDE d00253A D I10 R60.9 Essential (primary) hypertension Edema, unspecified A@ E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ E A NAPROXEN d00019A C- M25.5 Pain in joint A@ E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C- I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension Ap E A BEPOTASTINE OPHTHALMIC d07482A D H10 Conjunctivitis Ap E A BIMATOPROST OPHTHALMIC d04754A D H40 Glaucoma Ap E A BRIMONIDINE OPHTHALMIC d04048A D H40 Glaucoma Ap E A BROMFENAC OPHTHALMIC d05518A D H57.9 Unspecified disorder of eye and adnexa Ap E A DEXLANSOPRAZOLE d07395A C- K21 Gastro-esophageal reflux disease Ap E A LOSARTAN d03821A CDp E11.2 Type 2 diabetes mellitus with kidney complications Ap E A PREDNISONE d00350A A0 R05 Cough A E0 A ACETAMINOPHEN; HYDROCODONE d03428A C M13 Other arthritis AP E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E0 A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia AP E0 A MELOXICAM d04532A C M25.5 Pain in joint AP E0 A TAMSULOSIN d04121A Cr R60.9 Edema, unspecified AP E@ A CYCLOBENZAPRINE d00963A D= M62.83 Muscle spasm A@ E@ A LEVOTHYROXINE d00278A D= E03.9 Hypothyroidism, unspecified A@ E@ A TOPIRAMATE d04115A Dc G43 Migraine A@ E@ A TRAMADOL d03826A C M79.7 Fibromyalgia A@ EP A . . . E` A ALLOPURINOL d00023A Dc M1A Chronic gout A0 E` A PANTOPRAZOLE d04514A B[ K25 Gastric ulcer A0 E` A TRAMADOL d03826A Ap M25.5 Pain in joint A0 Ep A . . . E A . . . E A ALBUTEROL d00749A C- J45 Asthma A E A . . . E A . . . E A . . . E A DEXLANSOPRAZOLE d07395A A 55555 A0 E A DILTIAZEM d00045A A I10 I21 Essential (primary) hypertension ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A0 E A SUCRALFATE d00377A Cr K30 Functional dyspepsia A0 E A . . . E A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified A E A LOTEPREDNOL OPHTHALMIC d04292A D H10.1 Acute atopic conjunctivitis A E A ALBUTEROL d00749A C- J45.P R06.9P Prevent asthma Prevent breathing difficulty A` E A CEFDINIR d04256A A A49.9P Prevent bacterial infection A` E A FLUTICASONE; SALMETEROL d04611A C[@ J45 Asthma A` E A MOMETASONE NASAL d04223A C R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems A` E A MONTELUKAST d04289A C J45 Asthma A` E A PREDNISOLONE d00084A AP J01.9 Acute sinusitis, unspecified A` E A . . . E A . . . E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E@ A ATENOLOL d00004A C I10 Essential (primary) hypertension A E@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A AMLODIPINE d00689A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A ASPIRIN d00170A C T88.7P Prevent drug side effect A E A BUPROPION d00181A Dc F17.2 Nicotine dependence A E A CLOPIDOGREL d04258A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A FLUTICASONE NASAL d04283A Dc R09.81 Nasal congestion A E A ISOSORBIDE DINITRATE d00268A Dc R07.9 Chest pain, unspecified A E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E A MOXIFLOXACIN OPHTHALMIC d04860A A H26.9 Unspecified cataract A E A NEPAFENAC OPHTHALMIC d05633A A H57.9 Unspecified disorder of eye and adnexa A E A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A E A PREDNISOLONE OPHTHALMIC d03221A A H57.9 Unspecified disorder of eye and adnexa A E A TAMSULOSIN d04121A C R39.9 Unspecified symptoms and signs involving the genitourinary system A E A VARENICLINE d05807A C F17.2 Nicotine dependence A E A ARIPIPRAZOLE d04825A B F32.9 Major depressive disorder, single episode, unspecified A E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A E A . . . E A ASPIRIN d00170A CDp I21.P Z79.0 Prevent heart attack/myocardial infarction Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A@ E A INSULIN ISOPHANE; INSULIN REGULAR d04374A Cr E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E A METFORMIN d03807A Cr 55555 A E A . . . E A LACOSAMIDE d07349A C G40 Epilepsy and recurrent seizures A@ E A LAMOTRIGINE d03809A C G40 Epilepsy and recurrent seizures A@ E A RUFINAMIDE d07069A C G40 Epilepsy and recurrent seizures A@ E A TOPIRAMATE d04115A C G40 Epilepsy and recurrent seizures A@ E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A MOMETASONE NASAL d04223A C[@ J34.9 Unspecified disorder of nose and nasal sinuses A E A . . . E A ACETAMINOPHEN; CODEINE d03423A A K08.8 Other specified disorders of teeth and supporting structures A@ E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A@ E A CYCLOBENZAPRINE d00963A B M54 Dorsalgia A@ E A GABAPENTIN d03182A A M54 Dorsalgia A@ E A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C- J45 Asthma A E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E0 A . . . E@ A . . . EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 EP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E` A . . . Ep A . . . E A AMLODIPINE d00689A C R60.9 Edema, unspecified AP E A CEPHALEXIN d00096A A L08.9 R21 Local infection of the skin and subcutaneous tissue, unspecified Rash and other nonspecific skin eruption AP E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A A I10 Essential (primary) hypertension AP E A TRIAMCINOLONE TOPICAL d03206A A R21 Rash and other nonspecific skin eruption AP E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A FROVATRIPTAN d04776A C G43 Migraine A E A ACYCLOVIR d00001A B B00.1 Herpesviral vesicular dermatitis A@ E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A@ E A ALUMINUM CHLORIDE HEXAHYDRATE TOPICAL d01322A A 55555 A@ E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A@ E A . . . E A ALBUTEROL d00749A C J45 Asthma A E0 A ATENOLOL d00004A D1 I10 Essential (primary) hypertension A` E0 A CARBIDOPA; LEVODOPA d03473A C[@ G20 Parkinson's disease A` E0 A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A D H40 Glaucoma A` E0 A HYDROCHLOROTHIAZIDE d00253A D1 I10 Essential (primary) hypertension A` E0 A LISINOPRIL d00732A D1 I10 Essential (primary) hypertension A` E0 A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A` E@ A HYDROXYZINE d00907A A L29.9 Pruritus, unspecified A0 E@ A MUPIROCIN TOPICAL d01267A A 55555 A0 E@ A PREDNISONE d00350A A L29.9 Pruritus, unspecified A0 EP A AMOXICILLIN d00088A Ap H66.9 J02.0 Otitis media, unspecified Streptococcal pharyngitis A E` A . . . Ep A . . . E A . . . E A . . . E A ALBUTEROL d00749A B J45 Asthma A@ E A CETIRIZINE d03827A B T78.40 Allergy, unspecified A@ E A HYDROXYZINE d00907A B L20.9 Atopic dermatitis, unspecified A@ E A MOMETASONE TOPICAL d01300A C- L20.9 Atopic dermatitis, unspecified A@ E A . . . E A . . . E A CITALOPRAM d04332A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A TRAZODONE d00395A B= G47.0 G47.9 Insomnia Sleep disorder, unspecified A E A . . . E A ALENDRONATE d03849A Dc M81 Osteoporosis without current pathological fracture AP E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A D9 E04 Other nontoxic goiter AP E A OLMESARTAN d04801A C I10 Essential (primary) hypertension AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A . . . E A LISINOPRIL d00732A A I10 Essential (primary) hypertension A0 E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E A SIMVASTATIN d00746A A E78.0 Pure hypercholesterolemia A0 E A GABAPENTIN d03182A C- F41.9 Anxiety disorder, unspecified A E0 A . . . E@ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EP A . . . E` A . . . Ep A . . . E A CETIRIZINE d03827A C- J45 Asthma A E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E A INSULIN REGULAR d04369A Ap E11 Type 2 diabetes mellitus A@ E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E A SPIRONOLACTONE d00373A C- I10 Essential (primary) hypertension A@ E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ E A MOMETASONE NASAL d04223A C T78.40 Allergy, unspecified A@ E A PRAMIPEXOLE d04145A Cr G25.81 Restless legs syndrome A@ E A . . . E A OLMESARTAN d04801A C[@ I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A . . . E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A0 E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C N92 Excessive, frequent and irregular menstruation A0 E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C 55555 A E0 A . . . E@ A GLYBURIDE d00248A D E11 Type 2 diabetes mellitus A0 E@ A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A0 E@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A0 EP A 77777 . . A E` A NORETHINDRONE d00555A C Z79.3 Long term (current) use of hormonal contraceptives A Ep A CONJUGATED ESTROGENS d00541A D# N95 Z79.890 Menopausal and other perimenopausal disorders Hormone replacement therapy A@ Ep A LEVOTHYROXINE d00278A D6. E06.3 Autoimmune thyroiditis A@ Ep A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A@ Ep A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A ALBUTEROL d00749A D J45 Asthma A0 E A AMOXICILLIN; CLAVULANATE d00089A A J06.9 Acute upper respiratory infection, unspecified A0 E A PAROXETINE d03157A Bz F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A CYCLOBENZAPRINE d00963A A@ M62.83 Muscle spasm A@ E A IBUPROFEN d00015A A@ M54 Dorsalgia A@ E A METHYLPREDNISOLONE d00293A A J42 Unspecified chronic bronchitis A@ E A NITROFURANTOIN d00112A A N39.0 Urinary tract infection, site not specified A@ E A . . . E A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A BUPRENORPHINE; NALOXONE d04819A C[@ R52 Pain, unspecified A E A . . . E A TERBINAFINE d04012A B[ B35 Dermatophytosis A E A ACYCLOVIR d00001A B B00.1 Herpesviral vesicular dermatitis A E A CLINDAMYCIN d00043A A` J02.0 Streptococcal pharyngitis A E A ALLOPURINOL d00023A C M1A Chronic gout Ap E A CHLORTHALIDONE d00192A Cr I10 Essential (primary) hypertension Ap E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus Ap E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A PRAVASTATIN d00348A C E78.0 I21.P I63.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction Prevent stroke Ap E A WARFARIN d00022A C D75.9P I21 Prevent blood clots ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Ap E0 A . . . E@ A ALBUTEROL d00749A CDp J45 Asthma A E@ A FLUTICASONE NASAL d04283A CDp T78.40 Allergy, unspecified A EP A . . . E` A . . . Ep A HYOSCYAMINE d00985A Bz R10 Abdominal and pelvic pain A E A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E A ESTERIFIED ESTROGENS; METHYLTESTOSTERONE d03245A C N95 Z79.890 Menopausal and other perimenopausal disorders Hormone replacement therapy A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A@ E A . . . E A . . . E A AZITHROMYCIN d00091A A H66.9 Otitis media, unspecified A E A IBUPROFEN d00015A A H93.9 Unspecified disorder of ear A E A ACETAMINOPHEN; OXYCODONE d03431A C M54 Dorsalgia A@ E A CARISOPRODOL d00960A C M54 Dorsalgia A@ E A NAPROXEN d00019A C M54 Dorsalgia A@ E A TRAMADOL d03826A CDp M54 Dorsalgia A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP E A PIOGLITAZONE d04442A C E78.0 Pure hypercholesterolemia AP E0 A . . . E@ A . . . EP A ALBUTEROL d00749A D ^ J45 Asthma A EP A AMLODIPINE d00689A D ^ I10 Essential (primary) hypertension A EP A ATORVASTATIN d04105A D ^ E78.0 Pure hypercholesterolemia A EP A FLUTICASONE NASAL d04283A D ^ J30.9 Allergic rhinitis, unspecified A EP A INSULIN ISOPHANE (NPH) d04370A D ^ E11 Type 2 diabetes mellitus A EP A LEVOTHYROXINE d00278A D ^ E03.9 Hypothyroidism, unspecified A EP A LISINOPRIL d00732A D ^ I10 Essential (primary) hypertension A EP A METOPROLOL d00134A D ^ I10 Essential (primary) hypertension A EP A OMEPRAZOLE d00325A D ^ K92.9 Disease of digestive system, unspecified A EP A WARFARIN d00022A D ^ I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A EP A ZOLPIDEM d00910A D ^ G47.0 Insomnia A E` A . . . Ep A . . . E A . . . E A AMLODIPINE; TELMISARTAN d07498A C9 I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A B R00 Abnormalities of heart beat A E A QUETIAPINE d04220A Cr G47.9 Sleep disorder, unspecified A E A ROPINIROLE d04215A A G25.81 Restless legs syndrome A E A ACETAMINOPHEN; CODEINE d03423A CDp M25.5 M54 Pain in joint Dorsalgia AP E A ATENOLOL; CHLORTHALIDONE d03258A C[@ I10 Essential (primary) hypertension AP E A FAMOTIDINE d00141A C[@ R12 Heartburn AP E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension AP E A VALSARTAN d04113A C I10 Essential (primary) hypertension AP E A . . . E A . . . E A CLONIDINE d00044A Cr F90 G47.0 Attention-deficit hyperactivity disorders Insomnia A E A . . . E A FENOFIBRATE d04286A Bz E78.0 Pure hypercholesterolemia A E A . . . E A LAMOTRIGINE d03809A CDp G40 Epilepsy and recurrent seizures A0 E A LORAZEPAM d00149A C- G40 Epilepsy and recurrent seizures A0 E A VALPROIC ACID d00083A B G40 Epilepsy and recurrent seizures A0 E0 A ANASTROZOLE d03873A B C50 Malignant neoplasm of breast A E@ A . . . EP A TRIAMCINOLONE TOPICAL d03206A B= L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E` A . . . Ep A ALBUTEROL d00749A C- R05 R06.9 Cough Unspecified abnormalities of breathing A0 Ep A BECLOMETHASONE d00760A C- R05 R06.9 Cough Unspecified abnormalities of breathing A0 Ep A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A ALBUTEROL d00749A C"0 J45 Asthma A E A ACYCLOVIR d00001A Dc B00.9 Herpesviral infection, unspecified A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A LISINOPRIL d00732A C I50.9 Heart failure, unspecified A` E A METAPROTERENOL d00750A Dc I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A` E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A CIPROFLOXACIN d00011A AP B99.9 Unspecified infectious disease A0 E A MUPIROCIN TOPICAL d01267A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A0 E A NAFTIFINE TOPICAL d01277A B= B35 Dermatophytosis A0 E A 99999 . . A E A ACETAMINOPHEN; HYDROCODONE d03428A B M25.5 M54 Pain in joint Dorsalgia AP E A ATENOLOL d00004A C I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METHIMAZOLE d00290A B[ E05 Thyrotoxicosis [hyperthyroidism] AP E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A BENAZEPRIL d00730A CDp 99999 A@ E A HYDROCHLOROTHIAZIDE d00253A CDp 99999 A@ E A METFORMIN d03807A Cr R73 Elevated blood glucose level A@ E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E A . . . E A ALLOPURINOL d00023A C"0 M10.9 Gout, unspecified A E A AMIODARONE d00002A C- I49.9 Cardiac arrhythmia, unspecified A E A APIXABAN d07804A C- D75.9P Prevent blood clots A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A FUROSEMIDE d00070A C- I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc I50.9 Heart failure, unspecified A E A HYDROCODONE d03075A C[@ M25.5 M54 Pain in joint Dorsalgia A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A POTASSIUM CHLORIDE d00345A C- K31.9 Disease of stomach and duodenum, unspecified A E A . . . E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A E A ACETAMINOPHEN; HYDROCODONE d03428A B[ G89 Pain, not elsewhere classified A E A AMOXICILLIN d00088A B K04.7 Periapical abscess without sinus A E A . . . E A . . . E A ESOMEPRAZOLE d04749A CDp K30 Functional dyspepsia A@ E A FENOFIBRATE d04286A Dc E78.0 Pure hypercholesterolemia A@ E A FOSINOPRIL d00242A Dc I21.P Prevent heart attack/myocardial infarction A@ E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A@ E A . . . E A ALBUTEROL d00749A A J20.9 Acute bronchitis, unspecified A E0 A ALLOPURINOL d00023A C E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease AP E0 A CARVEDILOL d03847A D I10 Essential (primary) hypertension AP E0 A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus AP E0 A LOSARTAN d03821A B E11.2 Type 2 diabetes mellitus with kidney complications AP E0 A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia AP E@ A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension A E@ A SIMVASTATIN d00746A C"0 E78.0 Pure hypercholesterolemia A EP A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP EP A BUDESONIDE; FORMOTEROL d04795A B J45 Asthma AP EP A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus AP EP A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP EP A MONTELUKAST d04289A C J45 Asthma AP E` A AZATHIOPRINE d00024A C M35 Other systemic involvement of connective tissue A E` A HYDROXYCHLOROQUINE d00817A CDp M35 Other systemic involvement of connective tissue A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A 99999 . . A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E` A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E` A GLIPIZIDE d00246A Cr 99999 AP E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP E` A METFORMIN d03807A Cr R73 Elevated blood glucose level AP Ep A . . . E A . . . E A . . . E A . . . E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A D R52 Pain, unspecified Ap E A ALPRAZOLAM d00168A Cr G47.0 Insomnia Ap E A FINASTERIDE d00563A B= R39.1 Other difficulties with micturition Ap E A GABAPENTIN d03182A CP M79.2 Neuralgia and neuritis, unspecified Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A C R35 Polyuria Ap E A TEMAZEPAM d00384A Cr G47.0 Insomnia Ap E A . . . E A MIDODRINE d04047A C"0 I49.9 Cardiac arrhythmia, unspecified A E A 77777 . . A E A ARIPIPRAZOLE d04825A C- F90 Attention-deficit hyperactivity disorders A0 E A DEXMETHYLPHENIDATE d04777A C- F90 Attention-deficit hyperactivity disorders A0 E A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified A0 E0 A . . . E@ A . . . EP A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture Ap EP A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap EP A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap EP A LEVOTHYROXINE d00278A C C80.1 Malignant (primary) neoplasm, unspecified Ap EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap EP A LOVASTATIN d00280A C I10 Essential (primary) hypertension Ap EP A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E` A . . . Ep A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A C"0 M79.2 Neuralgia and neuritis, unspecified A` E A ESCITALOPRAM d04812A B[ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A` E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A` E A LORAZEPAM d00149A D F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A` E A ONDANSETRON d00867A C"0 R11.P Prevent nausea or vomiting A` E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A FEBUXOSTAT d07397A CDp M1A Chronic gout Ap E A FLUTICASONE d01296A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified Ap E A METFORMIN d03807A B E11 Type 2 diabetes mellitus Ap E A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A TORSEMIDE d03189A B[ R60.9 Edema, unspecified Ap E A . . . E A ALBUTEROL d00749A Cr J45 Asthma A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A AZITHROMYCIN d00091A A J01.9 Acute sinusitis, unspecified A E A CODEINE; GUAIFENESIN d03393A A R05 Cough A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A PANTOPRAZOLE d04514A C- K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A PREGABALIN d05508A C M79.7 Fibromyalgia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP E A BENAZEPRIL d00730A C[@ I10 Essential (primary) hypertension AP E A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A C I10 Essential (primary) hypertension AP E A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia AP E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E A LISINOPRIL d00732A Cr I63.P Prevent stroke A0 E A WARFARIN d00022A C I26 I80.3 Pulmonary embolism Phlebitis and thrombophlebitis of lower extremities, unspecified A0 E A . . . E A . . . E A . . . E A . . . E0 A ALBUTEROL d00749A Cr J45 Asthma Ap E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E0 A ATENOLOL; CHLORTHALIDONE d03258A C R60.9 Edema, unspecified Ap E0 A BUDESONIDE; FORMOTEROL d04795A C- J45 Asthma Ap E0 A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified Ap E0 A MONTELUKAST d04289A D R06.2 Wheezing Ap E0 A POTASSIUM CHLORIDE d00345A Ap E87.6 Hypokalemia Ap E@ A ATORVASTATIN d04105A C E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia AP E@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E@ A INSULIN LISPRO d04373A Cr E11 Type 2 diabetes mellitus AP E@ A NADOLOL d00018A C I10 Essential (primary) hypertension AP E@ A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension AP EP A CLONIDINE d00044A C G47.0 Insomnia A EP A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E` A . . . Ep A . . . E A . . . E A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A0 E A DIAZEPAM d00148A C- G47.0 Insomnia A0 E A OMEPRAZOLE d00325A C- F41.9 Anxiety disorder, unspecified A0 E A . . . E A . . . E A DOXYCYCLINE d00037A B L70 Acne A E A . . . E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A CARVEDILOL d03847A C- I21.P Prevent heart attack/myocardial infarction A0 E A LISINOPRIL d00732A C- I21.P Prevent heart attack/myocardial infarction A0 E A . . . E0 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A Dc R51 Headache A E0 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A D# M25.5 Pain in joint A E0 A CLONAZEPAM d00197A B= G47.9 Sleep disorder, unspecified A E0 A CLONIDINE d00044A D I10 Essential (primary) hypertension A E0 A DESLORATADINE d04785A D T78.40 Allergy, unspecified A E0 A DEXLANSOPRAZOLE d07395A D K30 Functional dyspepsia A E0 A DONEPEZIL d04099A CDp G31.9 Degenerative disease of nervous system, unspecified A E0 A GABAPENTIN d03182A D M79.6 Pain in limb, hand, foot, fingers and toes A E0 A LISINOPRIL d00732A D1 I10 Essential (primary) hypertension A E0 A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E0 A TEMAZEPAM d00384A D G47.9 Sleep disorder, unspecified A E@ A . . . EP A . . . E` A . . . Ep A . . . E A ISONIAZID d00101A B B99.9 Unspecified infectious disease A E A . . . E A CELECOXIB d04380A B M19.9 Osteoarthritis, unspecified site A` E A DULOXETINE d05355A C R45 Symptoms and signs involving emotional state A` E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A` E A PREGABALIN d05508A C M81 Osteoporosis without current pathological fracture A` E A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A` E A TRAMADOL d03826A C B02 Zoster [herpes zoster] A` E A . . . E A . . . E A . . . E A . . . E A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma A E A FLUOXETINE d00236A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A@ E A PREGABALIN d05508A C[@ M79.2 Neuralgia and neuritis, unspecified A@ E A RANITIDINE d00021A A K30 Functional dyspepsia A@ E0 A THYROID DESICCATED d00655A C[@ E03.9 Hypothyroidism, unspecified A E@ A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EP A . . . E` A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Ep A ATORVASTATIN d04105A C 99999 A@ Ep A CARVEDILOL d03847A C 99999 A@ Ep A CYCLOBENZAPRINE d00963A C 99999 A@ Ep A LISINOPRIL d00732A C 99999 A@ E A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A Cr Z79.3 Long term (current) use of hormonal contraceptives A E A MONTELUKAST d04289A CDp J30.9 J45 Allergic rhinitis, unspecified Asthma A E A . . . E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A CLOBETASOL TOPICAL d01288A D L40 Psoriasis A@ E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A@ E A FLUTICASONE TOPICAL d04284A C[@ L40 Psoriasis A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A D# E78.0 Pure hypercholesterolemia A0 E A OMEPRAZOLE d00325A D# K21 Gastro-esophageal reflux disease A0 E A . . . E A AMIODARONE d00002A Cr 99999 A E A AMLODIPINE; ATORVASTATIN d05048A Cr 99999 A E A CLOPIDOGREL d04258A Cr 99999 A E A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A E A FENOFIBRATE d04286A Cr 99999 A E A FUROSEMIDE d00070A Cr 99999 A E A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus A E A ISOSORBIDE MONONITRATE d00269A Cr 99999 A E A LEVOTHYROXINE d00278A Cr 99999 A E A SERTRALINE d00880A Cr 99999 A E A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus A E0 A . . . E@ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E@ A DICLOFENAC d00848A B[ M25.5 Pain in joint A0 E@ A DOXAZOSIN d00726A C- N42.9 Disorder of prostate, unspecified A0 EP A . . . E` A . . . Ep A DICLOXACILLIN d00153A A0 A49.9 Bacterial infection, unspecified A E A . . . E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A LIOTHYRONINE d00658A C E03.9 Hypothyroidism, unspecified A@ E A AMOXICILLIN d00088A B J01.9 Acute sinusitis, unspecified A@ E A BUPRENORPHINE; NALOXONE d04819A C M54 Dorsalgia A@ E A CLONAZEPAM d00197A C- F41.9 Anxiety disorder, unspecified A@ E A ESZOPICLONE d05421A B G47.0 Insomnia A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C"0 99999 Ap E A FINASTERIDE d00563A C"0 N40 Enlarged prostate Ap E A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension Ap E A LISINOPRIL d00732A C"0 99999 Ap E A MELOXICAM d04532A C"0 99999 Ap E A METOPROLOL d00134A C"0 99999 Ap E A TAMSULOSIN d04121A C"0 N40 R35 R39.1 Enlarged prostate Polyuria Other difficulties with micturition Ap E A PREDNISONE d00350A B H66.9 Otitis media, unspecified A E0 A . . . E@ A AZELASTINE OPHTHALMIC d04541A C[@ H10.1 Acute atopic conjunctivitis A0 E@ A DESONIDE TOPICAL d01290A C- L20.9 Atopic dermatitis, unspecified A0 E@ A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A0 EP A . . . E` A ACETAMINOPHEN; HYDROCODONE d03428A Ap K08.4 Partial loss of teeth A Ep A . . . E A . . . E A . . . E A . . . E A 99999 . . A E A . . . E A BUPROPION d00181A C F90 Attention-deficit hyperactivity disorders A E A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A E A ETANERCEPT d04365A C 55555 A E A GABAPENTIN d03182A C E11.4 M54 Type 2 diabetes mellitus with neurological complications Dorsalgia A E A IBUPROFEN d00015A C M19.9 Osteoarthritis, unspecified site A E A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A OXCARBAZEPINE d04513A C F31.9 Bipolar disorder, unspecified A E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A E A QUETIAPINE d04220A C G47.0 Insomnia A E A RISPERIDONE d03180A C F29 Unspecified psychosis not due to a substance or known physiological condition A E A TOPIRAMATE d04115A C F31.9 Bipolar disorder, unspecified A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A Cr R51 Headache A E A . . . E A . . . E A . . . E A . . . E0 A ASPIRIN d00170A B Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E0 A IBUPROFEN d00015A Cr M25.5 Pain in joint A@ E0 A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E0 A TAMSULOSIN d04121A B N40 Enlarged prostate A@ E@ A . . . EP A NYSTATIN TOPICAL d04399A Ap L30.9 Dermatitis, unspecified A E` A MOMETASONE TOPICAL d01300A C[@ L20.9 Atopic dermatitis, unspecified A Ep A . . . E A . . . E A . . . E A . . . E A OMEPRAZOLE d00325A D* K21 Gastro-esophageal reflux disease A E A ALLOPURINOL d00023A D# M1A Chronic gout A@ E A CALCIUM ACETATE d03689A C"0 N19 Unspecified kidney failure A@ E A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A . . . E A METOPROLOL d00134A B- R07.9 Chest pain, unspecified A E A NITROGLYCERIN d00321A B- R07.9 Chest pain, unspecified A E A 99999 . . A E A ALBUTEROL d00749A C J45 Asthma A E0 A ASPIRIN d00170A B= I21.P Prevent heart attack/myocardial infarction AP E0 A ATORVASTATIN d04105A B= I49.9 Cardiac arrhythmia, unspecified AP E0 A DICLOFENAC d00848A B= M06.9 Rheumatoid arthritis, unspecified AP E0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E0 A OMEPRAZOLE d00325A B= K31.9 Disease of stomach and duodenum, unspecified AP E@ A . . . EP A CETIRIZINE d03827A C T78.40 Allergy, unspecified A EP A OXYBUTYNIN d00328A C N32.81 Overactive bladder A E` A LOSARTAN d03821A B= I10 Essential (primary) hypertension A E` A OXYCODONE d00329A B# G89 M25.5 Pain, not elsewhere classified Pain in joint A Ep A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease Ap E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C"0 I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A C"0 E04 Other nontoxic goiter Ap E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified Ap E A MELOXICAM d04532A C M54 Dorsalgia Ap E A ZOLPIDEM d00910A B G47.0 Insomnia Ap E A BUPROPION d00181A A R41 Other symptoms and signs involving cognitive functions and awareness AP E A CITALOPRAM d04332A B= F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A . . . E A ANTI-INFECTIVES - UNSPECIFIED c00001A AP K08.4 Partial loss of teeth A E A DICLOFENAC d00848A AP K08.4 Partial loss of teeth A E A . . . E A . . . E A . . . E A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A` E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A Cr K25.P Prevent gastric ulcer A` E A PREDNISONE d00350A Cr J98.9 Respiratory disorder, unspecified A` E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Cr J18.9 Pneumonia, unspecified organism A` E A . . . E0 A . . . E@ A . . . EP A ATENOLOL d00004A C I50.9 Heart failure, unspecified A` EP A CILOSTAZOL d04382A C I70 Atherosclerosis A` EP A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A` EP A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A` EP A MECLIZINE d00859A C R42 Dizziness and giddiness A` EP A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E` A . . . Ep A . . . E A . . . E A ALBUTEROL d00749A C R06.9 Unspecified abnormalities of breathing A E A AMLODIPINE d00689A B- I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A B- I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E A IPRATROPIUM d00265A B R05 Cough A E A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A E A METOPROLOL d00134A B I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A Cr I10 Essential (primary) hypertension A E A WARFARIN d00022A Ap I10 Essential (primary) hypertension A E A . . . E A . . . E A 99999 . . A E A CEFDINIR d04256A A J40 Bronchitis, not specified as acute or chronic A E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus AP E A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified AP E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E A METFORMIN d03807A B E11 Type 2 diabetes mellitus AP E A PRAVASTATIN d00348A B E78.0P Prevent high cholesterol AP E A ALENDRONATE d03849A A M81 Osteoporosis without current pathological fracture A@ E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified AP E A MELOXICAM d04532A B* M19.9 Osteoarthritis, unspecified site AP E A MONTELUKAST d04289A Cr J45 R06.9 Asthma Unspecified abnormalities of breathing AP E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP E A ZOLPIDEM d00910A C- G47.0 Insomnia AP E A . . . E0 A . . . E@ A INSULIN DETEMIR d05436A Bz R73 Elevated blood glucose level A0 E@ A METFORMIN d03807A Bz E11 Type 2 diabetes mellitus A0 E@ A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A0 EP A . . . E` A . . . Ep A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A Ep A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A E A . . . E A CYCLOBENZAPRINE d00963A C9 M25.5 M54 T14.9 Pain in joint Dorsalgia Unspecified injury A E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B N92 Excessive, frequent and irregular menstruation A E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A` E A FUROSEMIDE d00070A B= R60.9 Edema, unspecified A` E A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus A` E A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus A` E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A` E A . . . E A HORMONES/HORMONE MODIFIERS - UNSPECIFIED c00097A C- E34 Other endocrine disorders A0 E A METHYLPHENIDATE d00900A B G47.4 Narcolepsy and cataplexy A0 E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A0 E A IBUPROFEN d00015A A K08.8 R50.9 Other specified disorders of teeth and supporting structures Fever, unspecified A E A . . . E A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A E A . . . E0 A HYDROXYZINE d00907A C"0 F41.9 Anxiety disorder, unspecified A@ E0 A METHYLPHENIDATE d00900A C"0 F90 Attention-deficit hyperactivity disorders A@ E0 A QUETIAPINE d04220A C[@ F39 Unspecified mood [affective] disorder A@ E0 A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E@ A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E@ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A EP A . . . E` A CLONIDINE d00044A CDp G47.9 Sleep disorder, unspecified A0 E` A GUANFACINE d00717A C- F90 Attention-deficit hyperactivity disorders A0 E` A LISDEXAMFETAMINE d06663A CDp F90 Attention-deficit hyperactivity disorders A0 Ep A GLYBURIDE d00248A C[@ E11 Type 2 diabetes mellitus A E A . . . E A CARBIDOPA; ENTACAPONE; LEVODOPA d04877A C G25.0 Essential tremor A@ E A FINASTERIDE d00563A C[@ N42.9 Disorder of prostate, unspecified A@ E A OXYBUTYNIN d00328A C[@ N42.9 Disorder of prostate, unspecified A@ E A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A@ E A ALBUTEROL d00749A B= R05 Cough A E A . . . E A . . . E A . . . E A GABAPENTIN d03182A CDp E11.4 Type 2 diabetes mellitus with neurological complications A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A . . . E A . . . E A ANTIDEPRESSANTS - UNSPECIFIED c00249A B= F32.9 Major depressive disorder, single episode, unspecified A E A ETONOGESTREL d04772A C7 Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E0 A . . . E@ A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A@ E@ A CLONIDINE d00044A C- G47.0 Insomnia A@ E@ A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A@ E@ A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A@ EP A ACETAMINOPHEN; CODEINE d03423A C[@ M54 Dorsalgia Ap EP A GABAPENTIN d03182A C[@ M54 Dorsalgia Ap EP A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension Ap EP A MORPHINE d00308A B M54 Dorsalgia Ap EP A ONDANSETRON d00867A C[@ R11 Nausea and vomiting Ap EP A OXYCODONE d00329A C[@ M54 Dorsalgia Ap EP A RANITIDINE d00021A C[@ K21 Gastro-esophageal reflux disease Ap E` A RANITIDINE d00021A D K30 Functional dyspepsia A Ep A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A E0 A HYDROCORTISONE; NEOMYCIN; POLYMYXIN B OTIC d03543A Ap H66.9 Otitis media, unspecified A E0 A NAPROXEN d00019A A T14.9 Unspecified injury A E@ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A EP A . . . E` A . . . Ep A . . . E A ALBUTEROL d00749A C J45 Asthma A E A BECLOMETHASONE d00760A C J45 Asthma A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92 N94 Excessive, frequent and irregular menstruation Pain and other conditions associated with female genital organs and menstrual cycle A E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A . . . E A . . . E A DILTIAZEM d00045A C I48.9 Unspecified atrial fibrillation and atrial flutter A` E A FUROSEMIDE d00070A Dc I51.9 Heart disease, unspecified A` E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A` E A TAMSULOSIN d04121A CDp N40 Enlarged prostate A` E A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A` E A WARFARIN d00022A Dc Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A . . . E A . . . E A CEPHALEXIN d00096A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E A INSULIN DETEMIR d05436A C[@ E11 Type 2 diabetes mellitus Ap E A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A QUINAPRIL d00365A C I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A FLUOXETINE d00236A Cr F41.9 Anxiety disorder, unspecified A E0 A . . . E@ A . . . EP A ACETAZOLAMIDE d00161A C- 55555 A E` A . . . Ep A ETHINYL ESTRADIOL; ETONOGESTREL d04773A B[ Z79.3 Long term (current) use of hormonal contraceptives A Ep A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E A ALLOPURINOL d00023A C M1A Chronic gout A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A CETIRIZINE d03827A Cr J30.9 Allergic rhinitis, unspecified A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A CYCLOSPORINE d00079A C T86.9P Prevent transplanted organ and tissue rejection A E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A C N28.9 Disorder of kidney and ureter, unspecified A E A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A E A GLIPIZIDE d00246A C E11.P Prevent diabetes A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A MYCOPHENOLATE MOFETIL d03839A C T86.9P Prevent transplanted organ and tissue rejection A E A NEBIVOLOL d05265A C I10 Essential (primary) hypertension A E A PREDNISONE d00350A C T86.9P Prevent transplanted organ and tissue rejection A E A SILODOSIN d07354A C[@ R35 Polyuria A E A ZOLPIDEM d00910A Cr G47.0 Insomnia A E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A0 E A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia A0 E A TRAMADOL d03826A C[@ M19.9 Osteoarthritis, unspecified site A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C"0 I10 Essential (primary) hypertension A E A THYROID DESICCATED d00655A Cr E03.9 Hypothyroidism, unspecified A E A CELECOXIB d04380A Bz M54 M79.1 Dorsalgia Myalgia A0 E A OXYCODONE d00329A B G89 M79.6 Pain, not elsewhere classified Pain in limb, hand, foot, fingers and toes A0 E A SERTRALINE d00880A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A PANTOPRAZOLE d04514A Ap B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E A SUCRALFATE d00377A Ap K27 Peptic ulcer, site unspecified A E A . . . E A . . . E A ALPRAZOLAM d00168A C R45 Symptoms and signs involving emotional state Ap E A BACLOFEN d00967A C- M62.83 Muscle spasm Ap E A BUSPIRONE d00182A CDp F32.9 Major depressive disorder, single episode, unspecified Ap E A DIVALPROEX SODIUM d03833A D* G40 Epilepsy and recurrent seizures Ap E A PROPRANOLOL d00032A B R25.1 Tremor, unspecified Ap E A QUETIAPINE d04220A C- F20 Schizophrenia Ap E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified Ap E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A` E A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A` E A GABAPENTIN d03182A B[ G47.0 Insomnia A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A TRAZODONE d00395A D G47.9 Sleep disorder, unspecified A` E A ZOLPIDEM d00910A Dc G47.0 Insomnia A` E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A CELECOXIB d04380A C- M06.9 Rheumatoid arthritis, unspecified A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A0 E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C 99999 A E A . . . E A DEXAMETHASONE; TOBRAMYCIN OPHTHALMIC d03536A A Z48.8 Encounter for other specified postprocedural aftercare A E A . . . E A . . . E A CEPHALEXIN d00096A A0 J02 Acute pharyngitis A E A . . . E0 A . . . E@ A CODEINE d00012A A R10 Abdominal and pelvic pain A EP A . . . E` A . . . Ep A . . . E A CARBIDOPA; LEVODOPA d03473A C G20 Parkinson's disease A0 E A DONEPEZIL d04099A C[@ R41 Other symptoms and signs involving cognitive functions and awareness A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A NYSTATIN d01233A B B37 Candidiasis A E A . . . E A HYDROCHLOROTHIAZIDE d00253A Ei I10 Essential (primary) hypertension A E A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension A E0 A . . . E@ A . . . EP A . . . E` A BUPROPION d00181A Dc F41.9 Anxiety disorder, unspecified A@ E` A BUSPIRONE d00182A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E` A FLUOXETINE d00236A Dc F41.9 Anxiety disorder, unspecified A@ E` A TRAZODONE d00395A B G47.9 Sleep disorder, unspecified A@ Ep A PROGESTERONE d00550A Bz N95 Menopausal and other perimenopausal disorders A E A ACETAMINOPHEN; CODEINE d03423A D"8 M54 Dorsalgia AP E A IBUPROFEN d00015A B M54 Dorsalgia AP E A RANITIDINE d00021A D"8 K27 Peptic ulcer, site unspecified AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A TAMSULOSIN d04121A C- R39.1 Other difficulties with micturition AP E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 E A FUROSEMIDE d00070A C- R39.9 Unspecified symptoms and signs involving the genitourinary system A0 E A OMEPRAZOLE d00325A D K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A0 E A . . . E A . . . E A . . . E A . . . E A LOSARTAN d03821A C- I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia Ap E A BACLOFEN d00967A B K57 M54 Diverticular disease of intestine Dorsalgia Ap E A COLCHICINE; PROBENECID d03652A C M10.9 Gout, unspecified Ap E A DICLOFENAC d00848A Bz M25.5 Pain in joint Ap E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension Ap E A HYDROCODONE d03075A C K57 Diverticular disease of intestine Ap E A PROPRANOLOL d00032A D I10 Essential (primary) hypertension Ap E A TENOFOVIR d04774A C9 B19 Unspecified viral hepatitis A E A . . . E0 A . . . E@ A . . . EP A AMITRIPTYLINE d00146A C G43.P Prevent migraine A0 EP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A0 EP A NITROFURANTOIN d00112A B N39.0P Prevent urinary tract infection A0 E` A ALLOPURINOL d00023A A E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A E` A ASPIRIN d00170A Bz Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E` A HYDROCHLOROTHIAZIDE d00253A C- R60.9 Edema, unspecified A E` A MELOXICAM d04532A B M25.9 Joint disorder, unspecified A E` A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E` A PHENAZOPYRIDINE d00337A AP N30 Cystitis A E` A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A Ep A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A E A NAPROXEN d00019A B M79.1 Myalgia A E A LEVOTHYROXINE d00278A D= E03.9 Hypothyroidism, unspecified A E A ALBUTEROL d00749A C R05 R06.2 Cough Wheezing A E A ETANERCEPT d04365A C L40 Psoriasis A E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A E A CLINDAMYCIN d00043A Ap K04.7 Periapical abscess without sinus A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp I10 Essential (primary) hypertension A0 E A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A0 E A . . . E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A ALBUTEROL d00749A Dc J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A EP A AMLODIPINE d00689A D I20.9 Angina pectoris, unspecified A EP A BETAMETHASONE TOPICAL d03197A C- L40 Psoriasis A EP A CILOSTAZOL d04382A D I70 Atherosclerosis A EP A ISOSORBIDE MONONITRATE d00269A D I20.9 Angina pectoris, unspecified A EP A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A EP A LISINOPRIL d00732A D I10 Essential (primary) hypertension A EP A METOPROLOL d00134A D I10 Essential (primary) hypertension A EP A NITROGLYCERIN d00321A D R07.9 Chest pain, unspecified A EP A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A EP A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A EP A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A EP A TIZANIDINE d04102A B M62.83 Muscle spasm A EP A VENLAFAXINE d03181A C- F32.9 Major depressive disorder, single episode, unspecified A E` A . . . Ep A . . . E A ALLOPURINOL d00023A D* M1A Chronic gout A E A AMOXICILLIN d00088A C- J01.9 Acute sinusitis, unspecified A E A AMOXICILLIN; CLAVULANATE d00089A C- J40 Bronchitis, not specified as acute or chronic A E A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A E A BUDESONIDE d04276A B J42 Unspecified chronic bronchitis A E A CARBAMAZEPINE d00058A Cr M79.2 Neuralgia and neuritis, unspecified A E A CARBAMAZEPINE d00058A D G40 Epilepsy and recurrent seizures A E A CARVEDILOL d03847A D I50.9 Heart failure, unspecified A E A CLOPIDOGREL d04258A D I49.9 Cardiac arrhythmia, unspecified A E A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A E A LEVALBUTEROL d04427A C[@ J42 Unspecified chronic bronchitis A E A LOSARTAN d03821A B[ I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A 99999 . . A E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A MONTELUKAST d04289A C J45 Asthma A E A . . . E A CYCLOBENZAPRINE d00963A CDp M62.83 M79.1 Muscle spasm Myalgia A` E A HYDROCODONE d03075A CDp M79.1 Myalgia A` E A HYDROXYCHLOROQUINE d00817A Cr L93 Lupus erythematosus A` E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A` E A PREDNISONE d00350A Cr L93 Lupus erythematosus A` E0 A . . . E@ A . . . EP A ATENOLOL d00004A C I10 Essential (primary) hypertension A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B= I10 Essential (primary) hypertension A E A . . . E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A@ E A FLUOXETINE d00236A C F32.9 M79.2 Major depressive disorder, single episode, unspecified Neuralgia and neuritis, unspecified A@ E A GABAPENTIN d03182A C F41.9 Anxiety disorder, unspecified A@ E A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified A@ E A . . . E A . . . E A FENOFIBRATE d04286A Dc E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A Dc E04 Other nontoxic goiter A0 E A VALSARTAN d04113A Dc I10 Essential (primary) hypertension A0 E A . . . E0 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E@ A . . . EP A 99999 . . A E` A . . . Ep A . . . E A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A SUCRALFATE d00377A C- K30 Functional dyspepsia A E A . . . E A . . . E A CLINDAMYCIN d00043A B* K04.7 Periapical abscess without sinus A0 E A FAMOTIDINE d00141A BF R10 Abdominal and pelvic pain A0 E A PANTOPRAZOLE d04514A B= K25 Gastric ulcer A0 E A 99999 . . A E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A D I10 Essential (primary) hypertension A0 E A PAROXETINE d03157A D R10 Abdominal and pelvic pain A0 E A TEMAZEPAM d00384A D G47.9 Sleep disorder, unspecified A0 E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E A . . . E A . . . E A BENZONATATE d00796A A J40 Bronchitis, not specified as acute or chronic A E A ALBUTEROL d00749A B J20.9 Acute bronchitis, unspecified A0 E A AMOXICILLIN d00088A Ap J98.9 Respiratory disorder, unspecified A0 E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A Ap R05 Cough A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A E A BENAZEPRIL d00730A Dc I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E0 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ E0 A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified A@ E0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E0 A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A@ E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified A E A QUETIAPINE d04220A B F41.9 Anxiety disorder, unspecified A E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E A FLUOXETINE d00236A Cr F41.9 Anxiety disorder, unspecified AP E A HYDROCHLOROTHIAZIDE d00253A B R60.9 Edema, unspecified AP E A RANITIDINE d00021A C K30 Functional dyspepsia AP E A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A BECLOMETHASONE NASAL d04275A B J40 T78.40 Bronchitis, not specified as acute or chronic Allergy, unspecified A0 E A FLUTICASONE; SALMETEROL d04611A C"0 J40 T78.40 Bronchitis, not specified as acute or chronic Allergy, unspecified A0 E A MONTELUKAST d04289A C- J40 T78.40 Bronchitis, not specified as acute or chronic Allergy, unspecified A0 E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension A E A BENAZEPRIL d00730A0 C I10 Essential (primary) hypertension A E A CLONIDINE d00044A0 C I10 Essential (primary) hypertension A E A GABAPENTIN d03182A0 C G40 Epilepsy and recurrent seizures A E A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A E A LEVETIRACETAM d04499A0 Cr G40 Epilepsy and recurrent seizures A E A NAPROXEN d00019A0 C M79.2 Neuralgia and neuritis, unspecified A E A OMEPRAZOLE d00325A0 C K21 Gastro-esophageal reflux disease A E A PHENYTOIN d00143A0 C 99999 A E A . . . E A CIPROFLOXACIN d00011A B J20.9 Acute bronchitis, unspecified AP E A FENOFIBRIC ACID d07371A CDp E78.0 Pure hypercholesterolemia AP E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified AP E A METFORMIN d03807A Cr R73 Elevated blood glucose level AP E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A METOPROLOL d00134A B I10 Essential (primary) hypertension A E A . . . E A IBUPROFEN d00015A AP M25.5 Pain in joint A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A@ E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A@ E A ACYCLOVIR d00001A B B34.9P Z51.1 Prevent viral infection Encounter for antineoplastic chemotherapy and immunotherapy A E A TRAMADOL d03826A B M79.1 Myalgia A E0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E0 A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E0 A METFORMIN; SITAGLIPTIN d06720A C E11.P Prevent diabetes A@ E0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E@ A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A BUDESONIDE; FORMOTEROL d04795A C J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E@ A OMEPRAZOLE d00325A C 99999 A E@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E@ A TERAZOSIN d00386A C N40 Enlarged prostate A E@ A TIOTROPIUM d04829A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A UREA TOPICAL d00651A C L98.9 Disorder of the skin and subcutaneous tissue, unspecified A EP A . . . E` A . . . Ep A ACYCLOVIR d00001A C 99999 Ap Ep A ATENOLOL d00004A C 99999 Ap Ep A CARBAMAZEPINE d00058A C 99999 Ap Ep A FELODIPINE d00231A C 99999 Ap Ep A LOSARTAN d03821A C 99999 Ap Ep A SIMVASTATIN d00746A C 99999 Ap Ep A TIMOLOL OPHTHALMIC d04037A CDp H26.9 Unspecified cataract Ap E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E0 A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E@ A DUTASTERIDE d04788A C"0 N40 Enlarged prostate A` E@ A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension A` E@ A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A` E@ A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease A` E@ A PRAVASTATIN d00348A C"0 E78.0 Pure hypercholesterolemia A` E@ A TAMSULOSIN d04121A C"0 N40 Enlarged prostate A` EP A ALBUTEROL d00749A D* J45 Asthma AP EP A CEPHALEXIN d00096A AP N30 Cystitis AP EP A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified AP EP A OLOPATADINE OPHTHALMIC d04117A C H10.1 Acute atopic conjunctivitis AP EP A PREDNISOLONE OPHTHALMIC d03221A D# 55555 AP E` A . . . Ep A ESTRADIOL d00537A D# Z79.890 Hormone replacement therapy A0 Ep A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A0 Ep A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A0 E A DOXYLAMINE; PYRIDOXINE d04654A B= R11 Nausea and vomiting A E A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia A E A ANTINEOPLASTICS - UNSPECIFIED c00020A B D49.9 Neoplasm of unspecified behavior of unspecified site A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B A49.9P Prevent bacterial infection A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A EZETIMIBE; SIMVASTATIN d05348A C[@ E78.0 Pure hypercholesterolemia A E A CLONAZEPAM d00197A C"0 F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A GABAPENTIN d03182A C- M25.5 Pain in joint A E A ENTECAVIR d05525A C B19 Unspecified viral hepatitis A E A . . . E A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified A0 E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A0 E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B I10 Essential (primary) hypertension A0 E A . . . E A . . . E A CYCLOSPORINE OPHTHALMIC d04836A A H04 Disorders of lacrimal system A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E0 A 99999 . . A E@ A . . . EP A . . . E` A ATENOLOL d00004A CP I10 Essential (primary) hypertension A@ E` A HYDROCHLOROTHIAZIDE d00253A CP I10 Essential (primary) hypertension A@ E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E` A SIMVASTATIN d00746A CP E78.0P Prevent high cholesterol A@ Ep A MESALAMINE d01031A C K51 Ulcerative colitis A E A BISOPROLOL d00709A CP I21.P I49.9 Prevent heart attack/myocardial infarction Cardiac arrhythmia, unspecified Ap E A ENALAPRIL d00013A CP I10 Essential (primary) hypertension Ap E A ESZOPICLONE d05421A CP G47.0 Insomnia Ap E A EZETIMIBE d04824A CP E78.0 Pure hypercholesterolemia Ap E A PREGABALIN d05508A Cr M13 Other arthritis Ap E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia Ap E A TRAMADOL d03826A C[@ M13 M79.2 Other arthritis Neuralgia and neuritis, unspecified Ap E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A THYROID DESICCATED d00655A D E03.9 Hypothyroidism, unspecified A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A CYCLOBENZAPRINE d00963A Cr M62.83 Muscle spasm A@ E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E A OXYCODONE d00329A C- M54 Dorsalgia A@ E A PREGABALIN d05508A Dc M79.2 Neuralgia and neuritis, unspecified A@ E A CETIRIZINE d03827A B H10.1 R06.2 R09.81 Acute atopic conjunctivitis Wheezing Nasal congestion A E A . . . E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A0 E A CITALOPRAM d04332A D F32.9 Major depressive disorder, single episode, unspecified A0 E A RAMIPRIL d00728A CDp I10 Essential (primary) hypertension A0 E A . . . E A . . . E A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Bz F31.9 Bipolar disorder, unspecified A E A QUETIAPINE d04220A C F90 Attention-deficit hyperactivity disorders A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A METOPROLOL d00134A C I10 Z95 Essential (primary) hypertension Presence of cardiac and vascular implants and grafts A0 E A TICAGRELOR d07721A C D75.9P Prevent blood clots A0 E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ALPRAZOLAM d00168A B= F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Ep A ESCITALOPRAM d04812A B= F41.9 Anxiety disorder, unspecified A E A . . . E A ALPRAZOLAM d00168A C[@ 55555 A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A LISINOPRIL d00732A D1 I10 Essential (primary) hypertension A0 E A MESALAMINE d01031A CDp K58 Irritable bowel syndrome A E A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C[@ T14.9 Unspecified injury A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A AZELASTINE NASAL d04068A D J30.9 Allergic rhinitis, unspecified A E A BUPROPION d00181A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A CARVEDILOL d03847A Cr I49.9 Cardiac arrhythmia, unspecified A E A CLOPIDOGREL d04258A C- I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E A LIRAGLUTIDE d07466A C- E11 Type 2 diabetes mellitus A E A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A E A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A E A TAMSULOSIN d04121A D N40 Enlarged prostate A E A TORSEMIDE d03189A Cr R60.9 Edema, unspecified A E A WARFARIN d00022A C[@ D75.9P Prevent blood clots A E A ZOLPIDEM d00910A Cr G47.9 Sleep disorder, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D# I10 Essential (primary) hypertension A0 E A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A0 E A ZOLPIDEM d00910A D G47.9 Sleep disorder, unspecified A0 E A CETIRIZINE d03827A A 99999 A E A DEXMETHYLPHENIDATE d04777A A F90 Attention-deficit hyperactivity disorders A E0 A . . . E@ A 77777 . . A EP A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Bz N92 Excessive, frequent and irregular menstruation A E` A . . . Ep A ESOMEPRAZOLE; NAPROXEN d07631A C- T14.9 Unspecified injury A E A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A E A FLUTICASONE NASAL d04283A B J34.9 Unspecified disorder of nose and nasal sinuses A E A CITALOPRAM d04332A C F43.9 Reaction to severe stress, unspecified A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A FLUTICASONE d01296A C J45 Asthma A E A CLOPIDOGREL d04258A B[ D75.9P Prevent blood clots A@ E A LORAZEPAM d00149A C- F41.9 G47.0 Anxiety disorder, unspecified Insomnia A@ E A METOPROLOL d00134A C- I50.9 Heart failure, unspecified A@ E A SOTALOL d00371A C- I50.9 Heart failure, unspecified A@ E A . . . E A AMOXICILLIN d00088A AP B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A0 E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A Ap R05 Cough A0 E A BROMPHENIRAMINE; DIPHENHYDRAMINE d07063A AP J00 Acute nasopharyngitis [common cold] A0 E A . . . E A AZILSARTAN d07754A C- I10 Essential (primary) hypertension Ap E A CEPHALEXIN d00096A C[@ A49.9P Prevent bacterial infection Ap E A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap E A IBUPROFEN d00015A C M19.9 Osteoarthritis, unspecified site Ap E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E A TESTOSTERONE d00558A C"0 E29.1 Testicular hypofunction Ap E0 A METHYLPHENIDATE d00900A B[ F90 Attention-deficit hyperactivity disorders A E@ A . . . EP A CANAGLIFLOZIN d08080A Cr E11 Type 2 diabetes mellitus Ap EP A GLIMEPIRIDE d03864A Cr R73 Elevated blood glucose level Ap EP A HYDROXYZINE d00907A Cr F41.9 Anxiety disorder, unspecified Ap EP A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus Ap EP A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus Ap EP A LEVOTHYROXINE d00278A Cr C80.1 Malignant (primary) neoplasm, unspecified Ap EP A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E` A . . . Ep A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Ep A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A@ E A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A@ E A AMOXICILLIN d00088A A` J03 Acute tonsillitis A@ E A METHYLPREDNISOLONE d00293A A` J03 Acute tonsillitis A@ E A OXYCODONE d00329A A` J03 Acute tonsillitis A@ E A TRAMADOL d03826A C M54 M79.1 Dorsalgia Myalgia A@ E A . . . E A . . . E A CARVEDILOL d03847A C I10 Essential (primary) hypertension Ap E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease Ap E A FUROSEMIDE d00070A C- I50.9 Heart failure, unspecified Ap E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A SPIRONOLACTONE d00373A C- R60.9 Edema, unspecified Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A D I10 Essential (primary) hypertension A E A GLIPIZIDE d00246A C R73 Elevated blood glucose level A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A D R73 Elevated blood glucose level A E A METHADONE d00050A D M54 Dorsalgia A E A METOCLOPRAMIDE d00298A D K31.9 Disease of stomach and duodenum, unspecified A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A PIOGLITAZONE d04442A C R73 Elevated blood glucose level A E A PREGABALIN d05508A CDp M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia A E A TESTOSTERONE d00558A C[@ E29.1 Testicular hypofunction A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A` E A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A` E A ISOSORBIDE MONONITRATE d00269A C- I20.9 Angina pectoris, unspecified A` E A LOSARTAN d03821A C- I51.9 Heart disease, unspecified A` E A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A` E A . . . E A . . . E A FINASTERIDE d00563A CDp N40 Enlarged prostate A0 E A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A0 E A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E A . . . E0 A ARIPIPRAZOLE d04825A B F32.9 Major depressive disorder, single episode, unspecified AP E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E0 A DULOXETINE d05355A D/ F32.9 Major depressive disorder, single episode, unspecified AP E0 A LAMOTRIGINE d03809A B F31.9 Bipolar disorder, unspecified AP E0 A LITHIUM d00061A C[@ F31.9 Bipolar disorder, unspecified AP E@ A . . . EP A . . . E` A PHENTERMINE d00806A B= E66 Overweight and obesity A E` A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A Ep A . . . E A ANASTROZOLE d03873A CDp C50.P Prevent barest cancer A@ E A ATORVASTATIN d04105A D E78.0P Prevent high cholesterol A@ E A HYDROCHLOROTHIAZIDE d00253A C N20.0 Calculus of kidney A@ E A SOTALOL d00371A B I49.9 Cardiac arrhythmia, unspecified A@ E A ACETAMINOPHEN; HYDROCODONE d03428A Ei M54 Dorsalgia B E A ALBUTEROL d00749A Ei R06.2 Wheezing B E A ALLOPURINOL d00023A Ei M1A Chronic gout B E A APIXABAN d07804A Ei I48.9 Unspecified atrial fibrillation and atrial flutter B E A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia B E A DILTIAZEM d00045A Ei I10 Essential (primary) hypertension B E A FLUTICASONE d01296A Ei R06.2 Wheezing B E A FLUTICASONE; SALMETEROL d04611A Ei R06.2 Wheezing B E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Ei I10 Essential (primary) hypertension B E A INSULIN GLARGINE d04538A Ei E11 Type 2 diabetes mellitus B E A INSULIN LISPRO d04373A Ei E11 Type 2 diabetes mellitus B E A IPRATROPIUM d00265A Ei R06.2 Wheezing B E A LEVETIRACETAM d04499A Ei M79.2 Neuralgia and neuritis, unspecified B E A LEVOTHYROXINE d00278A Ei 99999 B E A METOPROLOL d00134A Ei I10 Essential (primary) hypertension B E A MONTELUKAST d04289A Ei J30.9 Allergic rhinitis, unspecified B E A TRAZODONE d00395A Ei G47.0 Insomnia B E A . . . E A CARVEDILOL d03847A C I10 Essential (primary) hypertension Ap E A FLUTICASONE; VILANTEROL d08100A C J81 Pulmonary edema Ap E A FUROSEMIDE d00070A C J98.9 Respiratory disorder, unspecified Ap E A OMEPRAZOLE d00325A Cr R12 Heartburn Ap E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap E A PROCHLORPERAZINE d00355A B= R11 Nausea and vomiting Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A . . . E A AMIODARONE d00002A B= I48.9 Unspecified atrial fibrillation and atrial flutter A E A FLUTICASONE; SALMETEROL d04611A Dc J45 Asthma A E A FUROSEMIDE d00070A B[ R60.9 Edema, unspecified A E A LOSARTAN d03821A C I50.9 Heart failure, unspecified A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E A RIVAROXABAN d07356A Cr D75.9P Prevent blood clots A E A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol A E A TESTOSTERONE d00558A Dc Z79.890 Hormone replacement therapy A E A UMECLIDINIUM; VILANTEROL d08188A Dc J44.9 Chronic obstructive pulmonary disease, unspecified A E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C I99.9 Unspecified disorder of circulatory system B E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified B E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified B E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified B E A CYCLOBENZAPRINE d00963A C M79.7 Fibromyalgia B E A DICYCLOMINE d00999A CP K58 Irritable bowel syndrome B E A FENOFIBRATE d04286A CDp E78.1 Pure hyperglyceridemia B E A FUROSEMIDE d00070A CP R60.9 Edema, unspecified B E A ISOSORBIDE DINITRATE d00268A C I99.9 Unspecified disorder of circulatory system B E A METFORMIN d03807A C E11 Type 2 diabetes mellitus B E A METOPROLOL d00134A C I10 Essential (primary) hypertension B E A MODAFINIL d04378A CP G47.4 Narcolepsy and cataplexy B E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease B E A POTASSIUM CHLORIDE d00345A C R60.9 Edema, unspecified B E A PREGABALIN d05508A C M19.9 Osteoarthritis, unspecified site B E A ROPINIROLE d04215A Cr G25.81 Restless legs syndrome B E A ROPINIROLE d04215A CP G25.81 Restless legs syndrome B E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified B E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A CP A49.9 Bacterial infection, unspecified B E A TRAMADOL d03826A C M19.9 Osteoarthritis, unspecified site B E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E@ A . . . EP A AMLODIPINE; OLMESARTAN d06905A CDp I10 Essential (primary) hypertension AP EP A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP EP A FUROSEMIDE d00070A CDp 99999 AP EP A METOPROLOL d00134A C- 99999 AP EP A PANTOPRAZOLE d04514A C- K92.9 Disease of digestive system, unspecified AP E` A . . . Ep A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A Ep A SERTRALINE d00880A C F41.9 N95 Anxiety disorder, unspecified Menopausal and other perimenopausal disorders A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A0 E A SERTRALINE d00880A Dc F32.9 Major depressive disorder, single episode, unspecified A0 E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A0 E A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A` E A DIAZEPAM d00148A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E A DILTIAZEM d00045A C[@ I10 Essential (primary) hypertension A` E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A` E A HYDROCODONE d03075A C M54 Dorsalgia A` E A RANITIDINE d00021A C[@ K21 Gastro-esophageal reflux disease A` E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ALLOPURINOL d00023A0 . E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease A E@ A AMLODIPINE; VALSARTAN d06662A0 . I10 Essential (primary) hypertension A E@ A BUMETANIDE d00179A0 . N28.9 Disorder of kidney and ureter, unspecified A E@ A CLOPIDOGREL d04258A0 . I63.P Prevent stroke A E@ A DOXAZOSIN d00726A0 . I10 Essential (primary) hypertension A E@ A INSULIN d00262A0 . E11 Type 2 diabetes mellitus A E@ A INSULIN DETEMIR d05436A0 . E11 Type 2 diabetes mellitus A E@ A LEVOTHYROXINE d00278A0 . E03.9 Hypothyroidism, unspecified A E@ A SIMVASTATIN d00746A0 . E78.0 Pure hypercholesterolemia A EP A . . . E` A PANTOPRAZOLE d04514A B K30 Functional dyspepsia A E` A SUCRALFATE d00377A B K30 Functional dyspepsia A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A WARFARIN d00022A CDp D75.9P I49.9 Z95 Prevent blood clots Cardiac arrhythmia, unspecified Presence of cardiac and vascular implants and grafts A0 E A . . . E A DOXEPIN d00217A Cr L29.9 Pruritus, unspecified A0 E A MONTELUKAST d04289A B R06.9 Unspecified abnormalities of breathing A0 E A VALACYCLOVIR d03838A D B00.1 Herpesviral vesicular dermatitis A0 E0 A AZELAIC ACID TOPICAL d03848A0 CDp L71 Rosacea Ap E0 A CYCLOSPORINE OPHTHALMIC d04836A0 CDp H04 Disorders of lacrimal system Ap E0 A FENOFIBRATE d04286A0 C E78.0P Prevent high cholesterol Ap E0 A FLUTICASONE NASAL d04283A Dc J30.2 Other seasonal allergic rhinitis Ap E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E0 A METOPROLOL d00134A0 C I49.9 Cardiac arrhythmia, unspecified Ap E0 A MONTELUKAST d04289A0 CDp J30.9 Allergic rhinitis, unspecified Ap E@ A . . . EP A ALBUTEROL d00749A C- B99.9 R05 Unspecified infectious disease Cough A EP A AZITHROMYCIN d00091A AP H66.9 Otitis media, unspecified A E` A . . . Ep A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A CITALOPRAM d04332A B[ F32.9 Major depressive disorder, single episode, unspecified A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E A LEVOTHYROXINE d00278A D= E07.9 Disorder of thyroid, unspecified Ap E A LISINOPRIL d00732A C I51.9 Heart disease, unspecified Ap E A METOPROLOL d00134A D I10 Essential (primary) hypertension Ap E A PHENOBARBITAL d00340A DU G40 Epilepsy and recurrent seizures Ap E A PHENYTOIN d00143A DU G40 Epilepsy and recurrent seizures Ap E A PHENYTOIN d00143A DU G40 Epilepsy and recurrent seizures Ap E A ABACAVIR; LAMIVUDINE d05354A B B20 Human immunodeficiency virus [HIV] disease A0 E A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A C I10 Essential (primary) hypertension A0 E A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B R10 Abdominal and pelvic pain A` E A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified A` E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` E A METOPROLOL d00134A B I10 Essential (primary) hypertension A` E A TRAMADOL d03826A B R10 Abdominal and pelvic pain A` E A ZOLPIDEM d00910A B G47.0 Insomnia A` E A FLUTICASONE d01296A C J45 Asthma A E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A E A ATENOLOL d00004A D"8 I10 Essential (primary) hypertension A E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E A DULOXETINE d05355A C F32.9 F41.9 M79.2 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Neuralgia and neuritis, unspecified A E A EMTRICITABINE; TENOFOVIR d05352A D"8 B20 Human immunodeficiency virus [HIV] disease A E A GABAPENTIN d03182A D"8 M79.2 Neuralgia and neuritis, unspecified A E A HYDROCHLOROTHIAZIDE; SPIRONOLACTONE d03247A Cr I10 Essential (primary) hypertension A E A LISINOPRIL d00732A D"8 I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A D"8 K21 K25.P Gastro-esophageal reflux disease Prevent gastric ulcer A E A RALTEGRAVIR d07048A C B20 Human immunodeficiency virus [HIV] disease A E A RANITIDINE d00021A Cr K25.P Prevent gastric ulcer A E A ALBUTEROL d00749A0 C"0 R06.9 Unspecified abnormalities of breathing A E A ATORVASTATIN d04105A0 C 55555 A E A CILOSTAZOL d04382A0 C E78.0 Pure hypercholesterolemia A E A EXENATIDE d05529A0 C"0 55555 A E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A0 C 99999 A E A ROFLUMILAST d07684A0 C"0 55555 A E A SILDENAFIL d04299A0 D R06.9 Unspecified abnormalities of breathing A E A TIOTROPIUM d04829A D J44.9 R06.9 Chronic obstructive pulmonary disease, unspecified Unspecified abnormalities of breathing A E A VALSARTAN d04113A0 C"0 55555 A E A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease A E A . . . E A BUSPIRONE d00182A B[ F41.9 Anxiety disorder, unspecified A@ E A ESTRADIOL d00537A CDp N95 Menopausal and other perimenopausal disorders A@ E A LAMOTRIGINE d03809A Cr F31.9 Bipolar disorder, unspecified A@ E A PROGESTERONE d00550A CDp N95 Menopausal and other perimenopausal disorders A@ E A . . . E A BREXPIPRAZOLE d08373A B F32.9 Major depressive disorder, single episode, unspecified AP E A ESZOPICLONE d05421A C- G47.0 Insomnia AP E A LISDEXAMFETAMINE d06663A B 55555 AP E A TRAZODONE d00395A C- G47.9 Sleep disorder, unspecified AP E A VORTIOXETINE d08125A C F32.9 Major depressive disorder, single episode, unspecified AP E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A INSULIN GLARGINE d04538A CDp R73 Elevated blood glucose level A` E A LOSARTAN d03821A C N28.9 Disorder of kidney and ureter, unspecified A` E A METFORMIN d03807A C R73 Elevated blood glucose level A` E A RANITIDINE d00021A C K30 Functional dyspepsia A` E A SERTRALINE d00880A C"0 R45 Symptoms and signs involving emotional state A` E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A . . . E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A Cr F39 N95 Unspecified mood [affective] disorder Menopausal and other perimenopausal disorders A0 E A ESTRADIOL d00537A C N95 Menopausal and other perimenopausal disorders A0 E A PROGESTERONE d00550A C N95 Menopausal and other perimenopausal disorders A0 E A 77777 . . A E A BACLOFEN d00967A C"0 M62.83 Muscle spasm A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 E A LANSOPRAZOLE d03828A C K31.9 Disease of stomach and duodenum, unspecified A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A AMIODARONE d00002A B= I49.9 Cardiac arrhythmia, unspecified A E0 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E0 A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A E0 A DOXAZOSIN d00726A Cr N40 Enlarged prostate A E0 A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E0 A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A E0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E0 A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A E0 A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A E0 A WARFARIN d00022A C I63 Cerebral infarction A E@ A . . . EP A 55555 A B= R52 Pain, unspecified A0 EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EP A MELOXICAM d04532A C- M13 Other arthritis A0 E` A . . . Ep A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A C M79.6 Pain in limb, hand, foot, fingers and toes AP E A ALPRAZOLAM d00168A C- G47.0 Insomnia AP E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified AP E A HYDROXYZINE d00907A Cr T78.40 Allergy, unspecified AP E A TRAZODONE d00395A Bz G47.0 Insomnia AP E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B= Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A ONDANSETRON d00867A A R11 Nausea and vomiting A E A DESOGESTREL; ETHINYL ESTRADIOL d03782A Dc L70 Acne A E A . . . E A ALBUTEROL d00749A C R06.9P Prevent breathing difficulty A E A VALSARTAN d04113A C I10 Essential (primary) hypertension A E0 A . . . E@ A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture A E@ A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A EP A CEFDINIR d04256A A J02.0 Streptococcal pharyngitis A EP A HYDROCORTISONE; NEOMYCIN; POLYMYXIN B OTIC d03543A0 AP H66.9 Otitis media, unspecified A E` A 99999 . . A Ep A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A0 E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A0 E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 E A AZATHIOPRINE d00024A Cr 55555 A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A BENZOYL PEROXIDE; CLINDAMYCIN TOPICAL d04742A B L70 Acne A0 E A SPIRONOLACTONE d00373A A L70 Acne A0 E A TAZAROTENE TOPICAL d04138A B L70 Acne A0 E A . . . E A IBUPROFEN d00015A A K08.8 Other specified disorders of teeth and supporting structures A E A . . . E0 A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia A E0 A LOSARTAN d03821A C N28.9 Disorder of kidney and ureter, unspecified A E@ A . . . EP A . . . E` A CLONIDINE d00044A Ei M79.2 Neuralgia and neuritis, unspecified A E` A FLUTICASONE; SALMETEROL d04611A C R06.9 Unspecified abnormalities of breathing A E` A FUROSEMIDE d00070A C N28.9 Disorder of kidney and ureter, unspecified A E` A GABAPENTIN d03182A Ei G25.81 Restless legs syndrome A E` A LIRAGLUTIDE d07466A C[@ E11 Type 2 diabetes mellitus A E` A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A E` A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E` A MONTELUKAST d04289A Ei J45 Asthma A E` A NADOLOL d00018A Ei I10 Essential (primary) hypertension A E` A POTASSIUM CHLORIDE d00345A C 99999 A E` A RISPERIDONE d03180A C F32.9 Major depressive disorder, single episode, unspecified A E` A TRAMADOL d03826A C M79.7 Fibromyalgia A E` A TRAVOPROST OPHTHALMIC d04753A C[@ H40 Glaucoma A Ep A . . . E A . . . E A AMLODIPINE d00689A A I10 Essential (primary) hypertension A@ E A DRONEDARONE d07458A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A@ E A IRBESARTAN d04222A B I10 Essential (primary) hypertension A@ E A THYROID DESICCATED d00655A Cr E03.9 Hypothyroidism, unspecified A@ E A ATORVASTATIN d04105A B 99999 A@ E A INSULIN GLARGINE d04538A C- I51.9 Heart disease, unspecified A@ E A LISINOPRIL d00732A B 99999 A@ E A METFORMIN d03807A B[ 99999 A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 Essential (primary) hypertension A E A METFORMIN d03807A D I10 Essential (primary) hypertension A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A GENTAMICIN OPHTHALMIC d03974A Ap H10 Conjunctivitis A E A AMPHETAMINE d00803A C[@ F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A E A ATROPINE; DIPHENOXYLATE d03506A D R19.7 Diarrhea, unspecified A E A BRIMONIDINE OPHTHALMIC d04048A D ^ H40 Glaucoma A E A BRINZOLAMIDE OPHTHALMIC d04301A D ^ H40 Glaucoma A E A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A E A INDOMETHACIN d00039A D M13 Other arthritis A E A KETOROLAC OPHTHALMIC d03214A Cr H40 Glaucoma A E A LISINOPRIL d00732A D"8 I10 Essential (primary) hypertension A E A . . . E A ALBUTEROL d00749A C J45 R05 R06.02 Asthma Cough Shortness of breath A E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E0 A . . . E@ A . . . EP A ATENOLOL d00004A Cr I10 Essential (primary) hypertension AP EP A DIVALPROEX SODIUM d03833A D* F39 Unspecified mood [affective] disorder AP EP A FLUPHENAZINE d00237A CDp F31.9 Bipolar disorder, unspecified AP EP A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP EP A QUETIAPINE d04220A B G47.0 Insomnia AP E` A . . . Ep A INSULIN ASPART d04697A C"0 R73 Elevated blood glucose level A@ Ep A INSULIN GLARGINE d04538A C"0 R73 Elevated blood glucose level A@ Ep A METFORMIN d03807A D/ R73 Elevated blood glucose level A@ Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B= N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A RANITIDINE d00021A CDp K30 Functional dyspepsia A E A ATOMOXETINE d04827A CDp F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A 55555 A E A PREDNISONE d00350A A M85.9 Disorders of bone density and structure, unspecified A E A DOXYLAMINE; PYRIDOXINE d04654A B= R11 Nausea and vomiting A E0 A . . . E@ A . . . EP A BIMATOPROST TOPICAL OPHTHALMIC d07374A Ap H57.9 Unspecified disorder of eye and adnexa A0 EP A DEXAMETHASONE; NEOMYCIN; POLYMYXIN B OPHTHALMIC d03537A Bz H57.9 Unspecified disorder of eye and adnexa A0 EP A PREDNISOLONE OPHTHALMIC d03221A Bz H57.9 Unspecified disorder of eye and adnexa A0 E` A . . . Ep A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B M54 Dorsalgia A0 E A CYCLOBENZAPRINE d00963A B M54 Dorsalgia A0 E A PREDNISONE d00350A B M54 Dorsalgia A0 E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E@ A . . . EP A . . . E` A . . . Ep A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B M54 Dorsalgia A` E A CITALOPRAM d04332A C[@ F41.9 Anxiety disorder, unspecified A` E A GABAPENTIN d03182A C G43 Migraine A` E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` E A MORPHINE d00308A B M54 Dorsalgia A` E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A` E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A0 E A CLOBETASOL TOPICAL d01288A C[@ L50 Urticaria A0 E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A0 E A . . . E A CELECOXIB d04380A Cr M79.7 Fibromyalgia A E A CITALOPRAM d04332A B= F32.9 Major depressive disorder, single episode, unspecified A E A CLONAZEPAM d00197A C- F41.9 Anxiety disorder, unspecified A E A DULOXETINE d05355A Cr F41.9 Anxiety disorder, unspecified A E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E A GABAPENTIN d03182A C- G25.81 Restless legs syndrome A E A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A E A QUINAPRIL d00365A C[@ I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A ALFUZOSIN d04797A C[@ N40 Enlarged prostate AP E@ A ALLOPURINOL d00023A C[@ N42.9 Disorder of prostate, unspecified AP E@ A LOSARTAN d03821A Dc 99999 AP E@ A METOPROLOL d00134A Dc E78.0 I10 Pure hypercholesterolemia Essential (primary) hypertension AP E@ A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia AP EP A . . . E` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A@ E` A DROSPIRENONE; ETHINYL ESTRADIOL d04760A Cr L70 Acne A@ E` A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A@ E` A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A@ Ep A . . . E A . . . E A . . . E A . . . E° A 99999 . . A E A . . . E A AMOXICILLIN d00088A A` J02 Acute pharyngitis A E A IBUPROFEN d00015A A R50.9 Fever, unspecified A E A . . . E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A ATENOLOL; CHLORTHALIDONE d03258A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A ATENOLOL d00004A0 C[@ I10 Essential (primary) hypertension Ap E` A GLIPIZIDE d00246A0 C[@ E11 Type 2 diabetes mellitus Ap E` A LEVOTHYROXINE d00278A0 D; E03.9 E04 Hypothyroidism, unspecified Other nontoxic goiter Ap E` A LOSARTAN d03821A0 CDp E11.2 Type 2 diabetes mellitus with kidney complications Ap E` A MEDROXYPROGESTERONE d00284A0 C- Z79.890 Hormone replacement therapy Ap E` A METFORMIN d03807A0 Cr E11 Type 2 diabetes mellitus Ap E` A RANITIDINE d00021A0 Cr K21 Gastro-esophageal reflux disease Ap Ep A DIVALPROEX SODIUM d03833A C G40 Epilepsy and recurrent seizures A EÀ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A EÐ A . . . Eà A . . . Eð A . . . E A MOXIFLOXACIN OPHTHALMIC d04860A Ap H10.P Prevent eye infection A E A TRIAMCINOLONE TOPICAL d03206A Dc L20.9 Atopic dermatitis, unspecified A E A AMLODIPINE d00689A C ` I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A ALLOPURINOL d00023A C[@ M1A Chronic gout AP E0 A DIGOXIN d00210A CDp I10 Essential (primary) hypertension AP E0 A FUROSEMIDE d00070A C[@ I51.9 J98.9 R60.9 Heart disease, unspecified Respiratory disorder, unspecified Edema, unspecified AP E0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP E0 A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia AP E@ A ACYCLOVIR d00001A Cr 55555 A EP A ALBUTEROL d00749A A R06.2 R06.9P Wheezing Prevent breathing difficulty A EP A PREDNISONE d00350A AP J42 T78.40 Unspecified chronic bronchitis Allergy, unspecified A E` A . . . Ep A . . . EĀ A . . . EĐ A . . . EĠ A AMITRIPTYLINE d00146A C[@ G47.0 Insomnia A EĠ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EĠ A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A EĠ A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A EĠ A FUROSEMIDE d00070A C I50.9 R60.9 Heart failure, unspecified Edema, unspecified A EĠ A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A EĠ A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus A EĠ A INSULIN LISPRO d04373A Cr E11 Type 2 diabetes mellitus A EĠ A LOSARTAN d03821A C I10 Essential (primary) hypertension A EĠ A OMEPRAZOLE d00325A C K30 Functional dyspepsia A Eİ A . . . E A ATORVASTATIN d04105A B E78.0 I49.9 Pure hypercholesterolemia Cardiac arrhythmia, unspecified A E A METOPROLOL d00134A A I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A E A BUPROPION d00181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A0 E A RABEPRAZOLE d04448A CDp K21 Gastro-esophageal reflux disease A0 E A ESOMEPRAZOLE d04749A B= K21 Gastro-esophageal reflux disease A E A IBUPROFEN d00015A D M54 Dorsalgia A E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A GLIPIZIDE d00246A C- R73 Elevated blood glucose level A@ E A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ E A . . . E0 A . . . E@ A ACETAMINOPHEN; HYDROCODONE d03428A D M79.6 Pain in limb, hand, foot, fingers and toes A E@ A ALBUTEROL d00749A C- J45 Asthma A E@ A ALBUTEROL; IPRATROPIUM d04066A D R06.9P Prevent breathing difficulty A E@ A FLUTICASONE NASAL d04283A B J30.9 Allergic rhinitis, unspecified A E@ A FLUTICASONE; VILANTEROL d08100A A J42 R06.2 Unspecified chronic bronchitis Wheezing A E@ A LORAZEPAM d00149A D F43.9 Reaction to severe stress, unspecified A E@ A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E@ A OLMESARTAN d04801A Cr I10 Essential (primary) hypertension A E@ A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E@ A QUINIDINE d00020A B M62.83 Muscle spasm A E@ A SALMETEROL d03759A D J42 Unspecified chronic bronchitis A EP A . . . E` A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A` E` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A` E` A MONTELUKAST d04289A C- J30.1 J30.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified A` E` A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A` E` A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A` E` A TERAZOSIN d00386A Cr I10 Essential (primary) hypertension A` Ep A . . . Eŀ A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A EŐ A DUTASTERIDE d04788A CDp L98.9 Disorder of the skin and subcutaneous tissue, unspecified A EŐ A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A EŠ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B= L70 N92 Z79.3 Acne Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A EŰ A . . . E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A 99999 . . A@ E A ACETAMINOPHEN; HYDROCODONE d03428A B G89 Pain, not elsewhere classified A@ E A DOCUSATE d01021A B[ K59.0 Constipation A@ E A RANITIDINE d00021A C K25 Gastric ulcer A@ E A . . . E A . . . E A AMOXICILLIN d00088A A` H66.9 Otitis media, unspecified A E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E A . . . E0 A ATORVASTATIN d04105A C"@ E78.0 Pure hypercholesterolemia A` E0 A DULAGLUTIDE d08290A A E11 Type 2 diabetes mellitus A` E0 A EMPAGLIFLOZIN; LINAGLIPTIN d08344A C- E11 Type 2 diabetes mellitus A` E0 A METFORMIN; SITAGLIPTIN d06720A CDp E11 Type 2 diabetes mellitus A` E0 A METOPROLOL d00134A C"@ I51.9 Heart disease, unspecified A` E0 A SPIRONOLACTONE d00373A B I51.9 Heart disease, unspecified A` E@ A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia A E@ A SERTRALINE d00880A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EP A GLIMEPIRIDE d03864A C[@ R73 Elevated blood glucose level A0 EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A0 EP A INSULIN ISOPHANE; INSULIN REGULAR d04374A B= R73 Elevated blood glucose level A0 E` A ACETAMINOPHEN; TRAMADOL d04766A B M25.5 Pain in joint A` E` A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A Cr I10 Essential (primary) hypertension A` E` A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A` E` A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E` A SIMVASTATIN d00746A B= E78.0 Pure hypercholesterolemia A` Ep A . . . Eƀ A . . . EƐ A . . . EƠ A AMLODIPINE d00689A0 C 99999 A EƠ A CARVEDILOL d03847A0 C I50.9 Heart failure, unspecified A EƠ A ESCITALOPRAM d04812A0 C 99999 A EƠ A FUROSEMIDE d00070A0 C 99999 A EƠ A HYDROCHLOROTHIAZIDE d00253A0 C 99999 A EƠ A HYDROXYZINE d00907A0 C 99999 A EƠ A INSULIN ISOPHANE (NPH) d04370A0 C 99999 A EƠ A LISINOPRIL d00732A0 C 99999 A EƠ A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A EƠ A NITROGLYCERIN d00321A0 C 99999 A EƠ A PANTOPRAZOLE d04514A0 C 99999 A EƠ A PRAVASTATIN d00348A0 C 99999 A Eư A . . . E A CEPHALEXIN d00096A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C- 99999 A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A C- I51.9 Heart disease, unspecified A E A CLOPIDOGREL d04258A C- 99999 A E A HYDRALAZINE d00132A C 99999 A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E A ISOSORBIDE d00653A C 99999 A E A PANTOPRAZOLE d04514A C 99999 A E A . . . E A . . . E0 A . . . E@ A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A EP A . . . E` A OLOPATADINE OPHTHALMIC d04117A B H10 Conjunctivitis A Ep A INSULIN ASPART d04697A D@) R73 Elevated blood glucose level A@ Ep A INSULIN GLARGINE d04538A D@) R73 Elevated blood glucose level A@ Ep A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ Ep A WARFARIN d00022A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ Eǀ A 99999 . . AP Eǀ A COLCHICINE d00150A C[@ M1A Chronic gout AP Eǀ A FUROSEMIDE d00070A C[@ I10 Essential (primary) hypertension AP Eǀ A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified AP Eǀ A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension AP Eǐ A . . . EǠ A . . . Eǰ A . . . E A AMITRIPTYLINE d00146A D* F41.9 Anxiety disorder, unspecified A E A BIMATOPROST OPHTHALMIC d04754A B= H40 Glaucoma A E A CLOTRIMAZOLE TOPICAL d04395A B B37 Candidiasis A E A DONEPEZIL d04099A B= G31.9 Degenerative disease of nervous system, unspecified A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A METOPROLOL d00134A D I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A Bz K21 Gastro-esophageal reflux disease A E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A E A . . . E A CARBIDOPA; LEVODOPA d03473A D G20 Parkinson's disease AP E A GABAPENTIN d03182A C G50 M79.2 Disorders of trigeminal nerve Neuralgia and neuritis, unspecified AP E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified AP E A METOPROLOL d00134A Cr I21.P I49.9 Prevent heart attack/myocardial infarction Cardiac arrhythmia, unspecified AP E A WARFARIN d00022A C D75.9P I26 Prevent blood clots Pulmonary embolism AP E A ACETAMINOPHEN; TRAMADOL d04766A CDp M54 Dorsalgia A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A D I10 Essential (primary) hypertension A E A EPLERENONE d04815A D I10 Essential (primary) hypertension A E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E A FUROSEMIDE d00070A D I51.9 Heart disease, unspecified A E A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A D E11 Type 2 diabetes mellitus A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C[@ E78.0 Pure hypercholesterolemia A E A QUINIDINE d00020A D Z95 Presence of cardiac and vascular implants and grafts A E A TIMOLOL OPHTHALMIC d04037A D H40 Glaucoma A E A WARFARIN d00022A Dc Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A ACEBUTOLOL d00128A C I10 Essential (primary) hypertension A E` A CIPROFLOXACIN d00011A A N39.0 Urinary tract infection, site not specified A E` A CITALOPRAM d04332A C"0 F39 Unspecified mood [affective] disorder A E` A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A E` A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness A E` A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A E` A OMEPRAZOLE d00325A C K92.9 Disease of digestive system, unspecified A E` A QUETIAPINE d04220A B F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder A Ep A . . . EȀ A FLUOXETINE d00236A B F41.9 Anxiety disorder, unspecified A EȐ A . . . EȠ A . . . EȰ A . . . E A . . . E A . . . E A . . . E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A RABEPRAZOLE d04448A C K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E0 A TRETINOIN TOPICAL d01244A B[ L70 Acne A E@ A DESONIDE TOPICAL d01290A AP L20.9 Atopic dermatitis, unspecified A E@ A MUPIROCIN TOPICAL d01267A AP L08.9 Local infection of the skin and subcutaneous tissue, unspecified A EP A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E` A . . . Ep A . . . Eɀ A . . . Eɐ A 99999 . . A` Eɐ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` Eɐ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` Eɐ A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A` Eɐ A CLOPIDOGREL d04258A D I49.9 Cardiac arrhythmia, unspecified A` Eɐ A GABAPENTIN d03182A Dc M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A` Eɠ A . . . Eɰ A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A B I10 Essential (primary) hypertension A0 E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A CELECOXIB d04380A C M19.9 Osteoarthritis, unspecified site A EP A . . . E` A . . . Ep A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B# I10 Essential (primary) hypertension A Eʀ A . . . Eʐ A ENALAPRIL d00013A C I10 Essential (primary) hypertension Ap Eʐ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap Eʐ A INSULIN GLARGINE d04538A C K76.9 Liver disease, unspecified Ap Eʐ A NADOLOL d00018A C- I10 Essential (primary) hypertension Ap Eʐ A PROPRANOLOL d00032A B[ I10 Essential (primary) hypertension Ap Eʐ A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease Ap Eʐ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap Eʠ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A Eʰ A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A0 Eʰ A CLONAZEPAM d00197A C F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A0 Eʰ A ROSUVASTATIN d04851A C"0 E78.0 Pure hypercholesterolemia A0 E A . . . E A 99999 . . A E A . . . E A . . . E A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A E A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A E A IRBESARTAN d04222A Ei I10 Essential (primary) hypertension A E A MONTELUKAST d04289A Dc J45 Asthma A E A PANTOPRAZOLE d04514A C- K30 Functional dyspepsia A E A PREDNISONE d00350A A J45 Asthma A E A VERAPAMIL d00048A C I10 Essential (primary) hypertension A E A WARFARIN d00022A D D75.9P Prevent blood clots A E A ANXIOLYTICS, SEDATIVES, AND HYPNOTICS - UNSPECIFIED c00067A B F41.9 Anxiety disorder, unspecified A E A OSELTAMIVIR d04462A AP J09.P Prevent flu A E0 A . . . E@ A . . . EP A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C[@ G43 Migraine A@ EP A ADAPALENE TOPICAL d04015A C L70 Acne A@ EP A DAPSONE TOPICAL d05543A CDp L70 Acne A@ EP A ETONOGESTREL d04772A0 C- Z79.3 Long term (current) use of hormonal contraceptives A@ E` A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A E` A DILTIAZEM d00045A0 D I10 Essential (primary) hypertension A E` A FINASTERIDE d00563A0 B R39.1 Other difficulties with micturition A E` A LORAZEPAM d00149A0 Dc F41.9 Anxiety disorder, unspecified A E` A OMEPRAZOLE d00325A0 D K30 Functional dyspepsia A E` A SOTALOL d00371A0 C- I49.9 Cardiac arrhythmia, unspecified A E` A TAMSULOSIN d04121A0 Cr R39.1 Other difficulties with micturition A E` A WARFARIN d00022A0 D# D75.9P Prevent blood clots A Ep A FENOFIBRIC ACID d07371A Cr E78.1 Pure hyperglyceridemia A@ Ep A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ Ep A LEVOCETIRIZINE d05851A C[@ T78.40 Allergy, unspecified A@ Ep A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ Eˀ A . . . Eː A . . . Eˠ A . . . E˰ A CLOPIDOGREL d04258A CDp 99999 A` E˰ A ENALAPRIL d00013A CDp I63.P Prevent stroke A` E˰ A METFORMIN d03807A CDp 99999 A` E˰ A NIFEDIPINE d00051A CDp I63 Cerebral infarction A` E˰ A OXYBUTYNIN d00328A CDp R39.1 Other difficulties with micturition A` E˰ A TRAZODONE d00395A C- G47.9 Sleep disorder, unspecified A` E A . . . E A . . . E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A BECLOMETHASONE d00760A CDp J45 Asthma A E0 A . . . E@ A . . . EP A CYCLOBENZAPRINE d00963A C- M62.83 Muscle spasm A E` A . . . Ep A . . . È A . . . E̐ A . . . E̠ A . . . Ḛ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ḛ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A CARBAMAZEPINE d00058A D3T G40 Epilepsy and recurrent seizures A E A . . . E A CARISOPRODOL d00960A B[ M54 Dorsalgia A@ E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B E28 Ovarian dysfunction A@ E A METFORMIN d03807A B* E28 Ovarian dysfunction A@ E A NAPROXEN d00019A B[ M25.9 M79.1 Joint disorder, unspecified Myalgia A@ E A . . . E A . . . E0 A AMLODIPINE d00689A Bz I21.P Prevent heart attack/myocardial infarction A E0 A ATORVASTATIN d04105A C E11 Type 2 diabetes mellitus A E0 A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E0 A GABAPENTIN d03182A B T88.7P Z51.1 Prevent drug side effect Encounter for antineoplastic chemotherapy and immunotherapy A E0 A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A E0 A LEVOFLOXACIN d04109A A@ A49.9P Prevent bacterial infection A E0 A LOSARTAN d03821A B E87.6 Hypokalemia A E0 A OXYCODONE d00329A A R10 Abdominal and pelvic pain A E0 A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified A E0 A TAMSULOSIN d04121A C N40 Enlarged prostate A E0 A TORSEMIDE d03189A C- J81 Pulmonary edema A E0 A WARFARIN d00022A Cr I63 Cerebral infarction A E@ A . . . EP A 77777 . . A E` A . . . Ep A CITALOPRAM d04332A Dc F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Ep A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A È A . . . E͐ A . . . E͠ A . . . EͰ A PENICILLIN V POTASSIUM d07730A A J02.0 Streptococcal pharyngitis A E A IBUPROFEN d00015A A R50.9 Fever, unspecified A E A . . . E A CETIRIZINE d03827A B= K27 Peptic ulcer, site unspecified A E A OMEPRAZOLE d00325A B= K27 Peptic ulcer, site unspecified A E A ACETAMINOPHEN; TRAMADOL d04766A C M79.2 Neuralgia and neuritis, unspecified A@ E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A MELOXICAM d04532A B= M19.9 Osteoarthritis, unspecified site A@ E A . . . E A . . . E A MELOXICAM d04532A Cr M19.9 Osteoarthritis, unspecified site A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A0 E A AZITHROMYCIN d00091A A0 J40 Bronchitis, not specified as acute or chronic A0 E A PREDNISONE d00350A A0 J42 Unspecified chronic bronchitis A0 Eΐ A BACLOFEN d00967A CDp M79.2 Neuralgia and neuritis, unspecified Ap Eΐ A CARBAMAZEPINE d00058A CDp M79.2 Neuralgia and neuritis, unspecified Ap Eΐ A CELECOXIB d04380A B= 55555 Ap Eΐ A DULOXETINE d05355A CDp F41.9 Anxiety disorder, unspecified Ap Eΐ A FLUTICASONE d01296A C J45 Asthma Ap Eΐ A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified Ap Eΐ A OXYBUTYNIN d00328A CDp N32.81 Overactive bladder Ap EΠ A . . . Eΰ A . . . E A . . . E A AMLODIPINE d00689A C 99999 Ap E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified Ap E A GEMFIBROZIL d00245A C[@ 99999 Ap E A INSULIN ASPART d04697A C[@ E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A NAPROXEN d00019A C M54 Dorsalgia Ap E A PANTOPRAZOLE d04514A B 99999 Ap E A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A B= M79.1 Myalgia A E@ A IBUPROFEN d00015A A0 M54 Dorsalgia A EP A . . . E` A ALBUTEROL d00749A D J45 Asthma A Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Eπ A . . . Eϐ A ALENDRONATE d03849A0 Cr M81.P Prevent bone loss/osteoporosis Ap Eϐ A APIXABAN d07804A0 C- D75.9P I63.P Prevent blood clots Prevent stroke Ap Eϐ A CITALOPRAM d04332A0 C F41.9 Anxiety disorder, unspecified Ap Eϐ A LEVETIRACETAM d04499A0 D G40 Epilepsy and recurrent seizures Ap Eϐ A METOPROLOL d00134A0 D= I10 Essential (primary) hypertension Ap Eϐ A PANTOPRAZOLE d04514A0 Cr E87.6 Hypokalemia Ap Eϐ A SIMVASTATIN d00746A0 D= E78.0 Pure hypercholesterolemia Ap EϠ A . . . Eϰ A CABERGOLINE d04112A C D49.9 Neoplasm of unspecified behavior of unspecified site A0 Eϰ A ESOMEPRAZOLE d04749A B K21 Gastro-esophageal reflux disease A0 Eϰ A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A0 E A DESLORATADINE d04785A C- T78.40 Allergy, unspecified A E A DULOXETINE d05355A C[@ F41.9 Anxiety disorder, unspecified A E A EZETIMIBE d04824A A E78.0 Pure hypercholesterolemia A E A GABAPENTIN d03182A C[@ E11.4 Type 2 diabetes mellitus with neurological complications A E A HYDROCHLOROTHIAZIDE; QUINAPRIL d04509A Cr I10 Essential (primary) hypertension A E A METAXALONE d00964A C} M62.83 Muscle spasm A E A METFORMIN; SITAGLIPTIN d06720A B E11 Type 2 diabetes mellitus A E A TEMAZEPAM d00384A C- G47.9 Sleep disorder, unspecified A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A METFORMIN; PIOGLITAZONE d05635A C- E11 Type 2 diabetes mellitus A` E A METHIMAZOLE d00290A C- E05 Thyrotoxicosis [hyperthyroidism] A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A . . . E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ E A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia A@ E A MEMANTINE d04899A C- G31.8 Other specified degenerative diseases of nervous system A@ E A METFORMIN d03807A Cr R73 Elevated blood glucose level A@ E A ALLOPURINOL d00023A B M10.9P Prevent gout A E A AMIODARONE d00002A Ei I48.9 Unspecified atrial fibrillation and atrial flutter A E A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A Ei H40 Glaucoma A E A DOXAZOSIN d00726A C- I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A Ei R60.9 Edema, unspecified A E A LEVOTHYROXINE d00278A Ei 99999 A E A TRAVOPROST OPHTHALMIC d04753A Ei H40 Glaucoma A E A VALSARTAN d04113A C- I10 Essential (primary) hypertension A E A WARFARIN d00022A C- I48.9 Unspecified atrial fibrillation and atrial flutter A E0 A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A` E0 A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A` E0 A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A` E0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E0 A SOTALOL d00371A C I50.9 Heart failure, unspecified A` E0 A TAMSULOSIN d04121A D N40 Enlarged prostate A` E@ A TOBRAMYCIN OPHTHALMIC d03222A A H10 Conjunctivitis A EP A . . . E` A . . . Ep A . . . EЀ A . . . EА A . . . EР A CEPHALEXIN d00096A AP J02 Acute pharyngitis A Eа A . . . E A . . . E A . . . E A ALBUTEROL d00749A D J45 Asthma A@ E A IBUPROFEN d00015A C M54 Dorsalgia A@ E A SERTRALINE d00880A C[@ F32.9 Major depressive disorder, single episode, unspecified A@ E A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E A ANTI-INFECTIVES - UNSPECIFIED c00001A A N12 Tubulo-interstitial nephritis, not specified as acute or chronic A@ E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A@ E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ E A SIMVASTATIN d00746A C E78.0 I63.P Pure hypercholesterolemia Prevent stroke A@ E A AMLODIPINE; PERINDOPRIL d07533A B I10 Essential (primary) hypertension A E A NIFEDIPINE d00051A A I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A . . . EP A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A Cr I10 Essential (primary) hypertension A EP A TAMOXIFEN d00381A C"@ C50.P Prevent barest cancer A E` A . . . Ep A . . . Eр A POLYETHYLENE GLYCOL 3350 d05350A CDp K59.0 Constipation A Eѐ A . . . EѠ A . . . EѰ A . . . E A . . . E A 99999 . . A E A . . . E A . . . E A . . . E A . . . E A BUDESONIDE; FORMOTEROL d04795A B J45 Asthma A0 E A CETIRIZINE d03827A B T78.40 Allergy, unspecified A0 E A MONTELUKAST d04289A B T78.40 Allergy, unspecified A0 E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . EҀ A MUPIROCIN TOPICAL d01267A A 55555 A EҐ A . . . EҠ A . . . EҰ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A EҰ A ZOLPIDEM d00910A CDp G47.0 Insomnia A E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Cr I10 Essential (primary) hypertension A E A CARISOPRODOL d00960A C"0 M54 T14.9 Dorsalgia Unspecified injury A@ E A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A@ E A IBUPROFEN d00015A C"0 M54 Dorsalgia A@ E A ZOLPIDEM d00910A C"0 G47.0 Insomnia A@ E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A` E A METOPROLOL d00134A D* I10 Essential (primary) hypertension A` E A SIMVASTATIN d00746A D* 99999 A` E A SOLIFENACIN d05413A B= N39.4 Other specified urinary incontinence A` E A TRAZODONE d00395A D G47.9 Sleep disorder, unspecified A` E A VENLAFAXINE d03181A D F32.9 Major depressive disorder, single episode, unspecified A` E0 A . . . E@ A . . . EP A DIAZEPAM d00148A A M62.83 Muscle spasm A EP A NAPROXEN d00019A A M54 M79.1 Dorsalgia Myalgia A E` A . . . Ep A BUPROPION d00181A C N95 Menopausal and other perimenopausal disorders A@ Ep A LEVOTHYROXINE d00278A D@) E03.9 Hypothyroidism, unspecified A@ Ep A LOSARTAN d03821A B= I10 Essential (primary) hypertension A@ Ep A ZOLPIDEM d00910A Dc G47.9 Sleep disorder, unspecified A@ EӀ A METRONIDAZOLE d00108A A` N76.0 Acute vaginitis A EӐ A . . . EӠ A . . . EӰ A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- R41 Other symptoms and signs involving cognitive functions and awareness A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A GEMFIBROZIL d00245A B E78.0 Pure hypercholesterolemia A E A ALBUTEROL d00749A C J42 R06.9P Unspecified chronic bronchitis Prevent breathing difficulty A` E A ALBUTEROL; IPRATROPIUM d04066A C J42 J44.9 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified A` E A BIMATOPROST OPHTHALMIC d04754A C"0 H40 Glaucoma A` E A ESZOPICLONE d05421A D G47.0 Insomnia A` E A FLUTICASONE d01296A D J01.9 J42 J44.9 Acute sinusitis, unspecified Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified A` E A PREGABALIN d05508A C M79.7 Fibromyalgia A` E A . . . E A . . . E A . . . E0 A . . . E@ A ESTRADIOL d00537A C- Z79.890 Hormone replacement therapy A0 E@ A PROGESTERONE d00550A C- Z79.890 Hormone replacement therapy A0 E@ A TESTOSTERONE d00558A C E29.1 Testicular hypofunction A0 EP A 55555 A B= N92 Excessive, frequent and irregular menstruation A E` A . . . Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EԀ A . . . EԐ A . . . EԠ A CYANOCOBALAMIN d00413A B E53.9P Prevent vitamin B deficiency A E A . . . E A . . . E A . . . E A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A . . . E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ E A CANAGLIFLOZIN; METFORMIN d08280A Bz R73 Elevated blood glucose level A@ E A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A@ E A . . . E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A AMOXICILLIN d00088A A J02 Acute pharyngitis A Ep A ONDANSETRON d00867A A R11 Nausea and vomiting A EՀ A . . . EՐ A ACETAMINOPHEN; OXYCODONE d03431A Dc M54 Dorsalgia A EՐ A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A EՐ A BUPROPION d00181A Dc F17.2 F90 Nicotine dependence Attention-deficit hyperactivity disorders A EՐ A CYCLOBENZAPRINE d00963A Dc G47.0 Insomnia A EՐ A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified A EՐ A MELOXICAM d04532A Dc M54 M79.7 Dorsalgia Fibromyalgia A EՐ A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A EՐ A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A EՐ A TRAZODONE d00395A Dc G47.0 Insomnia A Eՠ A . . . Eհ A . . . E A PROGESTERONE d00550A C- E34 G47.0 Other endocrine disorders Insomnia A E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A@ E A HYDROCHLOROTHIAZIDE d00253A C I50.9 Heart failure, unspecified A@ E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A . . . E A NAPROXEN d00019A B= R52 Pain, unspecified A E A ATORVASTATIN d04105A C[@ I21.P Prevent heart attack/myocardial infarction A@ E A FUROSEMIDE d00070A C[@ I51.9 Heart disease, unspecified A@ E A METOPROLOL d00134A C[@ I51.9 Heart disease, unspecified A@ E A OMEPRAZOLE d00325A C[@ I51.9 Heart disease, unspecified A@ E A . . . E A ALBUTEROL d00749A Cr J42 Unspecified chronic bronchitis A E A BACLOFEN d00967A C- M62.83 Muscle spasm A E A CHLORHEXIDINE TOPICAL d01231A Cr A49.9P Prevent bacterial infection A E A CITALOPRAM d04332A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A CLONAZEPAM d00197A C F41.9 M62.83 Anxiety disorder, unspecified Muscle spasm A E A DIAZEPAM d00148A D M62.83 Muscle spasm A E A HYDROMORPHONE d00255A B= M25.5 Pain in joint A E A LIDOCAINE TOPICAL d00683A C- M79.2 Neuralgia and neuritis, unspecified A E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A E A NAPROXEN d00019A Cr M25.5 M54 Pain in joint Dorsalgia A E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A E A PSEUDOEPHEDRINE d00769A C R09.81 Nasal congestion A E A TERIPARATIDE d04828A Ap 55555 A E A TRAZODONE d00395A Dc G47.9 Sleep disorder, unspecified A E0 A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A B= I10 Essential (primary) hypertension A@ E0 A LOSARTAN d03821A B= I10 Essential (primary) hypertension A@ E0 A METHYLPHENIDATE d00900A D G47.4 Narcolepsy and cataplexy A@ E0 A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A@ E@ A . . . EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A E` A . . . Ep A . . . Eր A . . . E A . . . E֠ A . . . Eְ A . . . E A . . . E A ATENOLOL d00004A0 C I10 Essential (primary) hypertension Ap E A CYANOCOBALAMIN d00413A0 C D64.9 Anemia, unspecified Ap E A FUROSEMIDE d00070A0 C R60.9 Edema, unspecified Ap E A GABAPENTIN d03182A0 C- M19.9 Osteoarthritis, unspecified site Ap E A LOSARTAN d03821A0 C I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A0 C- E78.0 Pure hypercholesterolemia Ap E A TRAMADOL d03826A0 B[ M54 Dorsalgia Ap E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A . . . E A . . . E A METHYLPHENIDATE d00900A B= 99999 A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E0 A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A0 E0 A MELOXICAM d04532A C M25.5 Pain in joint A0 E0 A RAMIPRIL d00728A CDp I10 Essential (primary) hypertension A0 E@ A . . . EP A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E` A ESOMEPRAZOLE d04749A D K27 Peptic ulcer, site unspecified Ap E` A FEBUXOSTAT d07397A C[@ M1A Chronic gout Ap E` A FUROSEMIDE d00070A C[@ I10 Essential (primary) hypertension Ap E` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension Ap E` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E` A METFORMIN d03807A D= E28 Ovarian dysfunction Ap E` A ROSUVASTATIN d04851A D E78.1 Pure hyperglyceridemia Ap Ep A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders A E׀ A ACETAMINOPHEN; HYDROCODONE d03428A B M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A E׀ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E׀ A CARISOPRODOL d00960A B M62.83 Muscle spasm A E׀ A CLOPIDOGREL d04258A B[ D75.9P Prevent blood clots A E׀ A ISOSORBIDE MONONITRATE d00269A B[ I20.9 Angina pectoris, unspecified A E׀ A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A E׀ A NITROGLYCERIN d00321A B[ R07.9 Chest pain, unspecified A E׀ A TAMSULOSIN d04121A B N40 Enlarged prostate A E׀ A TERAZOSIN d00386A B I10 N40 R35 Essential (primary) hypertension Enlarged prostate Polyuria A E׀ A TRAMADOL d03826A B M54 R51 Dorsalgia Headache A Eא A . . . Eנ A . . . Eװ A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A@ Eװ A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ Eװ A LORAZEPAM d00149A C- F41.9 G47.0 Anxiety disorder, unspecified Insomnia A@ Eװ A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A@ E A . . . E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` E A SITAGLIPTIN d05896A CDp E11 Type 2 diabetes mellitus A` E A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm Ap E A MELOXICAM d04532A B M25.5 M54 Pain in joint Dorsalgia Ap E A METFORMIN d03807A C- R73 Elevated blood glucose level Ap E A MIRTAZAPINE d04025A C[@ F32.9 Major depressive disorder, single episode, unspecified Ap E A RISPERIDONE d03180A C[@ F39 Unspecified mood [affective] disorder Ap E A TAMOXIFEN d00381A CDp C50.P Prevent barest cancer Ap E A VENLAFAXINE d03181A CDp N95 Menopausal and other perimenopausal disorders Ap E A MINOCYCLINE d00110A B= L70 Acne A E A . . . E0 A DASATINIB d05831A CW` C96.9 Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified A E@ A ALBUTEROL d00749A Dc J43 Emphysema A E@ A AMLODIPINE d00689A Dc 99999 A E@ A ATORVASTATIN d04105A Dc 99999 A E@ A CELECOXIB d04380A Cr M79.1 Myalgia A E@ A FLUTICASONE; SALMETEROL d04611A Dc J43 Emphysema A E@ A LISINOPRIL d00732A Dc 99999 A E@ A METOPROLOL d00134A D 99999 A E@ A PENTOXIFYLLINE d00336A B I70 Atherosclerosis A E@ A TIOTROPIUM d04829A0 Dc J43 Emphysema A EP A EMPAGLIFLOZIN d08275A C E11 Type 2 diabetes mellitus Ap EP A GLYBURIDE; METFORMIN d04703A C E11 Type 2 diabetes mellitus Ap EP A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified Ap EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap EP A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap EP A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus Ap EP A RAMIPRIL d00728A C E78.0 Pure hypercholesterolemia Ap E` A . . . Ep A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B= K08.8 Other specified disorders of teeth and supporting structures Ap E A GLIMEPIRIDE d03864A C R73 Elevated blood glucose level Ap E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 R60.9 Essential (primary) hypertension Edema, unspecified Ap E A IBUPROFEN d00015A B= K08.8 Other specified disorders of teeth and supporting structures Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C E11 Type 2 diabetes mellitus Ap E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap Eؐ A . . . Eؠ A EMPAGLIFLOZIN; METFORMIN d08384A Bz E11 Type 2 diabetes mellitus A0 Eؠ A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A0 Eؠ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 Eذ A AMOXICILLIN d00088A A0 J02 Acute pharyngitis A E A AMOXICILLIN d00088A AP J02.0 Streptococcal pharyngitis A E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A NAPROXEN d00019A CDp G43 Migraine A E A SUMATRIPTAN d03160A CDp G43 Migraine A E A . . . E A . . . E A AMOXICILLIN d00088A A J06.9 Acute upper respiratory infection, unspecified A0 E A IBUPROFEN d00015A A R50.9 Fever, unspecified A0 E A OFLOXACIN OPHTHALMIC d03977A A H10 Conjunctivitis A0 E A BUPROPION d00181A A F17.2 Nicotine dependence A E A . . . E0 A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis AP E0 A INSULIN ASPART d04697A B E11 Type 2 diabetes mellitus AP E0 A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus AP E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E0 A VALSARTAN d04113A C I10 Essential (primary) hypertension AP E@ A . . . EP A . . . E` A ALBUTEROL d00749A C J45 Asthma A Ep A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma A` Ep A DORZOLAMIDE OPHTHALMIC d03805A C H40 Glaucoma A` Ep A GLIPIZIDE d00246A Cr R73 Elevated blood glucose level A` Ep A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A` Ep A LISINOPRIL d00732A Cr 99999 A` Ep A METFORMIN d03807A Cr R73 Elevated blood glucose level A` Eـ A . . . Eِ A . . . E٠ A . . . Eٰ A . . . E A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified A E A CONJUGATED ESTROGENS; MEDROXYPROGESTERONE d03819A C[@ N95 Menopausal and other perimenopausal disorders A E A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A E A IBUPROFEN d00015A C- T14.9 Unspecified injury A E A LAMOTRIGINE d03809A B= R41 Other symptoms and signs involving cognitive functions and awareness A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A TRAZODONE d00395A C[@ G47.0 Insomnia A E A VARENICLINE d05807A C[@ F17.2 Nicotine dependence A E A . . . E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A0 E A TERAZOSIN d00386A CDp R39.1 Other difficulties with micturition A0 E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A NYSTATIN; TRIAMCINOLONE TOPICAL d03562A A B35 Dermatophytosis A E` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C"0 Z79.3 Long term (current) use of hormonal contraceptives A Ep A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 Ep A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 Ep A SIMVASTATIN d00746A C- E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A0 Eڀ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 Eڀ A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension A0 Eڀ A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 Eڐ A ATORVASTATIN d04105A D* E78.0 Pure hypercholesterolemia A0 Eڐ A HYDROCHLOROTHIAZIDE d00253A D1 I10 Essential (primary) hypertension A0 Eڐ A LOSARTAN d03821A D1 I10 Essential (primary) hypertension A0 Eڠ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A Eڰ A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified AP Eڰ A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension AP Eڰ A LEVOFLOXACIN d04109A A@ J40 Bronchitis, not specified as acute or chronic AP Eڰ A METOPROLOL d00134A B= I51.9 Heart disease, unspecified AP Eڰ A PREDNISONE d00350A A@ J40 Bronchitis, not specified as acute or chronic AP E A DROSPIRENONE; ESTRADIOL d05530A B Z79.3 Long term (current) use of hormonal contraceptives A E A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A CYCLOBENZAPRINE d00963A C- M62.83 Muscle spasm A@ E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A@ E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A . . . E A . . . E A ALENDRONATE d03849A C 55555 A` E A ALLOPURINOL d00023A C- M1A Chronic gout A` E A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A` E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C[@ R60.9 Edema, unspecified A` E A HYDROXYUREA d01373A C[@ D49.9 Neoplasm of unspecified behavior of unspecified site A` E A ROSUVASTATIN d04851A C I21.P Prevent heart attack/myocardial infarction A` E A . . . E0 A . . . E@ A . . . EP A AMIODARONE d00002A B[ I49.9 Cardiac arrhythmia, unspecified A EP A APIXABAN d07804A B[ D75.9P Prevent blood clots A EP A ATORVASTATIN d04105A Bz E78.1 Pure hyperglyceridemia A EP A CLONAZEPAM d00197A B[ F41.9 Anxiety disorder, unspecified A EP A FENOFIBRATE d04286A C- E78.1 Pure hyperglyceridemia A EP A GABAPENTIN d03182A B[ G25.81 Restless legs syndrome A EP A INSULIN DETEMIR d05436A D E11 Type 2 diabetes mellitus A EP A METOPROLOL d00134A B[ I10 Essential (primary) hypertension A E` A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A` E` A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma A` E` A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified A` E` A OLOPATADINE OPHTHALMIC d04117A B H10.1 Acute atopic conjunctivitis A` E` A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A` E` A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A` Ep A . . . Eۀ A . . . Eې A . . . E۠ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E۠ A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E۠ A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E۠ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E۠ A LISINOPRIL d00732A C E11.2 Type 2 diabetes mellitus with kidney complications A E۠ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E۠ A METOPROLOL d00134A C- I48.9 Unspecified atrial fibrillation and atrial flutter A E۠ A WARFARIN d00022A C- D75.9P Prevent blood clots A E۰ A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A AMITRIPTYLINE d00146A C F32.9 Major depressive disorder, single episode, unspecified A E A PHENYTOIN d00143A Dc G40 Epilepsy and recurrent seizures A E A . . . E A ALENDRONATE d03849A B1 M81 Osteoporosis without current pathological fracture A E A DABIGATRAN d07137A C D75.9P Prevent blood clots A E A DRONEDARONE d07458A Bz I48.9 Unspecified atrial fibrillation and atrial flutter A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A Dc E11.2P Prevent diabetic kidney disease A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E0 A . . . E@ A GABAPENTIN d03182A Ei M79.2 Neuralgia and neuritis, unspecified A E@ A HYDROCODONE d03075A C- M19.9 M79.1 M79.2 Osteoarthritis, unspecified site Myalgia Neuralgia and neuritis, unspecified A E@ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E@ A NYSTATIN TOPICAL d04399A B B37 Candidiasis A E@ A OMEPRAZOLE d00325A C- 99999 A E@ A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E@ A PRAVASTATIN d00348A C- 99999 A E@ A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EP A BROMPHENIRAMINE; DEXTROMETHORPHAN; PHENYLEPHRINE d04905A A0 R05 Cough A E` A . . . Ep A . . . E܀ A . . . Eܐ A FENOFIBRATE d04286A B E78.1 Pure hyperglyceridemia A Eܐ A GLIPIZIDE d00246A C R73 Elevated blood glucose level A Eܐ A INDAPAMIDE d00260A D N18.9 Chronic kidney disease, unspecified A Eܐ A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A Eܐ A NEBIVOLOL d05265A C I50.9 Heart failure, unspecified A Eܐ A NIACIN d00314A B E78.0 Pure hypercholesterolemia A Eܐ A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A Eܐ A WARFARIN d00022A CDp I26 Pulmonary embolism A Eܠ A . . . Eܰ A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A NAPROXEN d00019A B M13 M19.9 M25.5 Other arthritis Osteoarthritis, unspecified site Pain in joint A E A ISOSORBIDE MONONITRATE d00269A D R07.9 Chest pain, unspecified A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A D I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A . . . E A . . . E0 A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E@ A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus AP E@ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E@ A METFORMIN; SITAGLIPTIN d06720A Cr R73 Elevated blood glucose level AP E@ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E@ A TAMSULOSIN d04121A C- 99999 AP EP A ALBUTEROL d00749A D J45 Asthma A EP A ESTRADIOL d00537A C Z79.3 Long term (current) use of hormonal contraceptives A E` A LEVOTHYROXINE d00278A B 99999 A Ep A . . . E݀ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E݀ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E݀ A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E݀ A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A@ Eݐ A . . . Eݠ A . . . Eݰ A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Ap N92 Excessive, frequent and irregular menstruation A E A OMEPRAZOLE d00325A B K21 R12 Gastro-esophageal reflux disease Heartburn A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A DILTIAZEM d00045A Ei I20.9 Angina pectoris, unspecified A E@ A DONEPEZIL d04099A CDp R41 Other symptoms and signs involving cognitive functions and awareness A E@ A ESOMEPRAZOLE d04749A CDp K21 Gastro-esophageal reflux disease A E@ A FLUOXETINE d00236A Cr F32.9 Major depressive disorder, single episode, unspecified A E@ A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E@ A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E@ A IBUPROFEN d00015A CDp G43 M54 Migraine Dorsalgia A E@ A INSULIN d00262A C E11 Type 2 diabetes mellitus A E@ A LEVOTHYROXINE d00278A B[ E03.9 Hypothyroidism, unspecified A E@ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E@ A METOLAZONE d00299A Ei I10 Essential (primary) hypertension A E@ A POTASSIUM CHLORIDE d00345A Cr R60.9 Edema, unspecified A E@ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E@ A THEOPHYLLINE d00142A Cr J45 Asthma A EP A ALBUTEROL d00749A C"0 J45 Asthma A` EP A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A` EP A FLUTICASONE NASAL d04283A Cr J30.2 J34.9 J45 Other seasonal allergic rhinitis Unspecified disorder of nose and nasal sinuses Asthma A` EP A FORMOTEROL; MOMETASONE d07660A C J45 Asthma A` EP A LANSOPRAZOLE d03828A C- K21 Gastro-esophageal reflux disease A` EP A MONTELUKAST d04289A Cr R06.2 Wheezing A` E` A . . . Ep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Eހ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 Eހ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 Eހ A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A0 Eސ A ALBUTEROL d00749A C J45 Asthma A0 Eސ A ALBUTEROL d00749A C J45 Asthma A0 Eސ A FLUTICASONE d01296A C J45 Asthma A0 Eޠ A AMOXICILLIN d00088A A J02 Acute pharyngitis A Eް A . . . E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A C- M1A Chronic gout AP E A AMLODIPINE d00689A D I10 I63.P Essential (primary) hypertension Prevent stroke AP E A CLOPIDOGREL d04258A D I63 Cerebral infarction AP E A LISINOPRIL d00732A D E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension AP E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A C[@ Z79.3 Long term (current) use of hormonal contraceptives A0 E A METHOTREXATE d00060A B T88.7P Prevent drug side effect A0 E A SPIRONOLACTONE d00373A C E28 Ovarian dysfunction A0 E0 A CETIRIZINE d03827A B= T78.40 Allergy, unspecified A E@ A . . . EP A ASPIRIN d00170A C D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction A` EP A GLIPIZIDE d00246A Dc E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A` EP A INSULIN GLARGINE d04538A B= E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` EP A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia A` EP A METFORMIN d03807A Dc R73 Elevated blood glucose level A` E` A . . . Ep A IBUPROFEN d00015A A@ R10 Abdominal and pelvic pain A E߀ A . . . Eߐ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ Eߐ A LISINOPRIL d00732A C N28.9P Prevent kidney disease A@ Eߐ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ Eߐ A SITAGLIPTIN d05896A A E11 Type 2 diabetes mellitus A@ Eߠ A AMOXICILLIN; CLAVULANATE d00089A B* B99.9 J02 J06.9 Unspecified infectious disease Acute pharyngitis Acute upper respiratory infection, unspecified A E߰ A . . . E A . . . E A . . . E A . . . E A ANASTROZOLE d03873A Ei C50 Malignant neoplasm of breast Ap E A CITALOPRAM d04332A Ei F32.9 Major depressive disorder, single episode, unspecified Ap E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B= R60.9 Edema, unspecified Ap E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E A LORAZEPAM d00149A Ei 55555 Ap E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A CDp I21.P Prevent heart attack/myocardial infarction Ap E A SUMATRIPTAN d03160A C G43 Migraine A E A AMITRIPTYLINE d00146A0 C[@ R45 Symptoms and signs involving emotional state A@ E A METOPROLOL d00134A0 C I49.9 Cardiac arrhythmia, unspecified A@ E A OMEPRAZOLE d00325A0 B K31.9 Disease of stomach and duodenum, unspecified A@ E A SUCRALFATE d00377A0 B= K31.9 Disease of stomach and duodenum, unspecified A@ E A . . . E0 A ALBUTEROL d00749A B R06.2 Wheezing A E@ A GABAPENTIN d03182A A M79.2 Neuralgia and neuritis, unspecified A E@ A MELOXICAM d04532A A M79.6 Pain in limb, hand, foot, fingers and toes A EP A . . . E` A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A